{"data": [{"Element": "<div class=\"WordSection1\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b>\u00a0</b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b>\u00a0</b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b>ANNEX\nI</b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film-coated\ntablets </span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Each film-coated tablet contains\n100\u00a0mg lamivudine </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">For the full list of excipients see section\n6.1. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\n<span style=\"text-transform:uppercase\">form</span></span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Film-coated tablet </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Orange</span><span lang=\"EN-GB\">, capsule\nshaped, biconvex film-coated tablet \u2013 engraved with \u201cL 100\u201d\non one side and plain on the other.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical\nparticulars</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva is indicated for the\ntreatment of chronic hepatitis B in adults with: </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">compensated liver disease with evidence of\nactive viral replication, persistently elevated serum alanine aminotransferase\n(ALT) levels and histological evidence of active liver inflammation and / or\nfibrosis. </span><span lang=\"EN-GB\" style=\"color:black\">Initiation of lamivudine\ntreatment should only be considered when the use of an alternative antiviral\nagent with a higher genetic barrier is not available or appropriate (see\nsection 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.2<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">Posology and method of administration</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Therapy with Lamivudine Teva should be\ninitiated by a physician experienced in the management of chronic hepatitis B. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Posology</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Adults</span></i><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The recommended dosage of Lamivudine Teva\nis 100\u00a0mg once daily.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Duration of treatment </span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">The optimal duration of\ntreatment is unknown.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">In patients with HBeAg positive chronic\nhepatitis B (CHB) without cirrhosis, treatment should be administered for at\nleast 6-12 months after HBeAg seroconversion (HBeAg and HBV DNA loss with HBeAb\ndetection) is confirmed, to limit the risk of virological relapse, or until\nHBsAg seroconversion </span><span lang=\"EN-GB\">or there is loss of efficacy\n(see\u00a0section\u00a04.4). Serum ALT and HBV\u00a0DNA levels should be\nfollowed regularly after treatment discontinuation to detect any late\nvirological relapse</span><span lang=\"EN-GB\" style=\"color:black\">.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">In patients with HBeAg negative CHB (pre-core\nmutant) </span><span lang=\"EN-GB\" style=\"color:black\">without cirrhosis, </span><span lang=\"EN-GB\">treatment should be administered at least until\nHBs\u00a0seroconversion or there is evidence of loss of efficacy. </span><span lang=\"EN-GB\" style=\"color:black\">With prolonged treatment, regular reassessment\nis recommended to confirm that continuation of the selected therapy remains\nappropriate for the patient</span><span lang=\"EN-GB\" style=\"color:black\">.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">In patients with cirrhosis and in liver\ntransplant recipients, treatment cessation is not recommended (see section\n5.1). </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">If lamivudine is discontinued, patients\nshould be periodically monitored for evidence of recurrent hepatitis (see\nsection 4.4). </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><i><span lang=\"EN-GB\" style=\"color:black\">Clinical resistance </span></i></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\" style=\"color:black\">In patients with either HBeAg positive or HBeAg negative\nCHB, the development of YMDD (tyrosine-methionine-aspartate-aspartate) mutant\nHBV may result in a diminished therapeutic response to lamivudine, indicated by\na rise in HBV DNA and ALT from previous on-treatment levels. In order to reduce\nthe risk of resistance in patients receiving lamivudine monotherapy, a switch\nto or addition of an alternative agent without cross-resistance to lamivudine\nbased on therapeutic guidelines should be considered if serum HBV DNA remains detectable\nat or beyond 24 weeks of treatment (see section 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">For the treatment of\npatients who are co-infected with HIV and are currently receiving or plan to\nreceive treatment with lamivudine or the combination lamivudine-zidovudine, the\ndose of lamivudine prescribed for HIV infection (usually 150\u00a0mg/twice\ndaily in combination with other antiretrovirals) should be maintained.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Special populations</span></u></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Renal impairment </span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine serum concentrations (AUC) are\nincreased in patients with moderate to severe renal impairment due to decreased\nrenal clearance. The dosage should therefore be reduced for patients with a\ncreatinine clearance of &lt; 50\u00a0ml/minute. Lamivudine Teva is not suitable\nfor patients who require doses below 100\u00a0mg.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Data available in patients undergoing\nintermittent haemodialysis (for less than or equal to 4\u00a0hrs dialysis 2\u20113\ntimes weekly), indicate that following the initial dosage reduction of\nlamivudine to correct for the patient\u2019s creatinine clearance, no further\ndosage adjustments are required while undergoing dialysis. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Data obtained in patients with hepatic\nimpairment, including those with end-stage liver disease awaiting transplant,\nshow that lamivudine pharmacokinetics are not significantly affected by hepatic\ndysfunction. Based on these data, no dose adjustment is necessary in patients\nwith hepatic impairment unless accompanied by renal impairment. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Elderly</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In elderly patients, normal ageing with\naccompanying renal decline has no clinically significant effect on lamivudine\nexposure, except in patients with creatinine clearance of &lt; 50 ml/min.</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">The safety and efficacy of Lamivudine Teva in infants,\nchildren and adolescents aged below 18 years have not been established.\nCurrently available data are described in sections 4.4 and 5.1 but no\nrecommendation on a posology can be made.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Oral use. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva can be\ntaken with or without food.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b>4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or\nto any of the excipients </span><span lang=\"EN-GB\" style=\"color:black\">listed in\nsection 6.1</span><span lang=\"EN-GB\">. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></b></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Lactic acidosis and severe hepatomegaly\nwith steatosis</span></u></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Occurrences of lactic acidosis (in the\nabsence of hypoxaemia), sometimes fatal, usually associated with severe\nhepatomegaly and hepatic steatosis, have been reported with the use of\nnucleoside analogues. As <span style=\"color:black\">lamivudine </span>is a\nnucleoside analogue, this risk cannot be excluded. Treatment with nucleoside\nanalogues should be discontinued when rapidly elevating aminotransferase\nlevels, progressive hepatomegaly or metabolic/lactic acidosis of unknown\naetiology occur. Benign digestive symptoms, such as nausea, vomiting and\nabdominal pain, might be indicative of lactic acidosis development. Severe\ncases, sometimes with fatal outcome, were associated with pancreatitis, liver\nfailure/hepatic steatosis, renal failure and higher levels of serum lactate.\nCaution should be exercised when prescribing nucleoside analogues to any patient\n(particularly obese women) with hepatomegaly, hepatitis or other known risk\nfactors for liver disease and hepatic steatosis (including certain medicinal\nproducts and alcohol). Patients co-infected with hepatitis C and treated with\nalpha interferon and ribivirin may constitute a special risk. These patients\nshould be followed closely.</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\nhepatitis</span></u></p>\n<p class=\"MsoNormal\"><b><i><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></b></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Exacerbations on\ntreatment</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Spontaneous\nexacerbations in chronic hepatitis B are relatively common and are\ncharacterised by transient increases in serum ALT. After initiating antiviral\ntherapy, serum ALT may increase in some patients as serum HBV DNA levels\ndecline. In patients with compensated liver disease, these increases in serum\nALT were generally not accompanied by an increase in serum bilirubin\nconcentrations or signs of hepatic decompensation.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">HBV viral\nsubpopulations with reduced susceptibility to lamivudine (YMDD mutant HBV) have\nbeen identified with extended therapy. In some patients the development of YMDD\nmutant HBV can lead to exacerbation of hepatitis, primarily detected by serum ALT\nelevations and re-emergence of HBV DNA (see section 4.2). In patients who have\nYMDD mutant HBV, a switch to or addition of an alternative agent without cross\nresistance to lamivudine based on therapeutic guidelines should be considered\n(see section 5.1).</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Exacerbations after\ntreatment discontinuation</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Acute exacerbation of\nhepatitis has been observed in patients who have discontinued hepatitis B\ntherapy and is usually </span><span lang=\"EN-GB\" style=\"color:black\">detected by\nserum ALT</span><span lang=\"EN-GB\" style=\"color:black\"> elevations and </span><span lang=\"EN-GB\" style=\"color:black\">re-emergence of HBV DNA</span><span lang=\"EN-GB\" style=\"color:black\">. In the controlled Phase III trials</span><span lang=\"EN-GB\"> <span style=\"color:black\">with no-active-treatment follow-up, the\nincidence of post-treatment ALT elevations (more than 3 times baseline) was\nhigher in lamivudine-treated patients (21%) compared with those receiving\nplacebo (8%). However, the proportion of patients who had post-treatment\nelevations associated with bilirubin elevations was low and similar in both\ntreatment arms (see Table 3 in section 5.1). For lamivudine-treated patients,\nthe majority of post-treatment ALT elevations occurred between 8 and 12 weeks\npost-treatment. Most events have been self-limiting, however some fatalities\nhave been observed. If Lamivudine Teva is discontinued, patients should be\nperiodically monitored both clinically and by assessment of serum liver\nfunction tests (ALT and bilirubin levels), for at least four months, and then\nas clinically indicated. </span></span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:yellow\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Transplantation\nrecipients are at greater risk from active viral replication. Due to the\nmarginal liver function in these patients, hepatitis reactivation at\ndiscontinuation of lamivudine or loss of efficacy during treatment may induce\nsevere and even fatal decompensation. These patients should be monitored for\nclinical, virological and serological parameters associated with hepatitis B,\nliver and renal function, and antiviral response during treatment (at least\nevery month), and, if treatment is discontinued for any reason, for at least 6\nmonths after treatment. Laboratory parameters to be monitored should include\n(as a minimum) serum ALT, bilirubin, albumin, blood urea nitrogen, creatinine,\nand virological status: HBV antigen/antibody, and serum HBV DNA concentrations when possible. Patients experiencing signs of hepatic insufficiency during or\npost-treatment should be monitored more frequently as appropriate.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">For patients who\ndevelop evidence of recurrent hepatitis post-treatment, there are insufficient\ndata on the benefits of re-initiation of lamivudine treatment.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Mitochondrial dysfunction</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Nucleoside and nucleotide analogues have\nbeen demonstrated <i>in vitro</i> and <i>in vivo</i> to cause a variable degree\nof mitochondrial damage. There have been reports of mitochondrial dysfunction\nin infants exposed in utero and/or post-natally to nucleoside analogues. </span><span lang=\"EN-GB\">The main adverse events reported are haematological disorders\n(anaemia, neutropenia), metabolic disorders (hyperlactatemia, hyperlipasemia). </span><span lang=\"EN-GB\">Some late-onset neurological disorders have been reported\n(hypertonia, convulsion, abnormal behaviour).</span><span lang=\"EN-GB\"> The neurological\ndisorders might be transient or permanent.</span><span lang=\"EN-GB\"> Any child\nexposed <i>in utero</i> to nucleoside and nucleotide analogues, should have\nclinical and laboratory follow-up and should be fully investigated for possible\nmitochondrial dysfunction in cases which have relevant signs or symptoms.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Paediatric patients</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine has been administered to\nchildren (2 years and above) and adolescents with compensated chronic hepatitis\nB. However, due to limitations of the data, the administration of lamivudine to\nthis patient population is not currently recommended (see section 5.1). </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Delta hepatitis or\nhepatitis C</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The efficacy of lamivudine in patients\nco-infected with Delta hepatitis or hepatitis C has not been established and\ncaution is advised. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Immunosuppressive\ntreatments</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Data are limited on the use of lamivudine\nin HBeAg negative (pre-core mutant) patients and in those receiving concurrent\nimmunosuppressive regimes, including cancer chemotherapy. </span><span lang=\"EN-GB\" style=\"color:black\">Lamivudine should be used with caution in these\npatients.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Monitoring</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">During treatment with Lamivudine Teva\npatients should be monitored regularly. Serum ALT </span><span lang=\"EN-GB\" style=\"color:black\">and HBV DNA</span><span lang=\"EN-GB\"> levels should be\nmonitored at 3 month intervals and </span><span lang=\"EN-GB\" style=\"color:black\">in\nHBeAg positive patients</span><span lang=\"EN-GB\"> HBeAg should be assessed every\n6 months. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">HIV co-infection</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">For the treatment of patients who are\nco-infected with HIV and are currently receiving or plan to receive treatment\nwith lamivudine or the combination lamivudine-zidovudine, the dose of\nlamivudine prescribed for HIV infection (usually 150\u00a0mg/twice daily in\ncombination with other antiretrovirals) should be maintained. For HIV\nco-infected patients not requiring anti-retroviral therapy, there is a risk of\nHIV mutation when using lamivudine alone for treating chronic hepatitis B.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Transmission of hepatitis B </span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">There is no information available on\nmaternal-foetal transmission of hepatitis B virus in pregnant women receiving\ntreatment with lamivudine. The standard recommended procedures for hepatitis B\nvirus immunisation in infants should be followed. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Patients should be advised that therapy\nwith lamivudine has not been proven to reduce the risk of transmission of\nhepatitis B virus to others and therefore, appropriate precautions should still\nbe taken. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Interactions with other medicinal\nproducts</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva should not be taken with\nany other medicinal products containing lamivudine or medicinal products\ncontaining emtricitabine (see section 4.5).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The combination\nof lamivudine with cladribine is not recommended (see section 4.5).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span style=\"color:#222222;\nbackground:white\">Excipient(s)</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i>Sodium</i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">This medicinal product contains\nless than 1 mmol sodium (23 mg) per film-coated tablet, that is to say\nessentially \u201csodium-free\u201d.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other\nmedicinal products and other forms of interaction</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Interaction studies have only been\nperformed in adults. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The likelihood of metabolic interactions is\nlow due to limited metabolism and plasma protein binding and almost complete\nrenal elimination of unchanged substance. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is predominantly eliminated by\nactive organic cationic secretion. The possibility of interactions with other\nmedicinal products administered concurrently should be considered, particularly\nwhen their main route of elimination is active renal secretion via the organic\ncationic transport system e.g. trimethoprim. Other medicinal products (e.g. ranitidine,\ncimetidine) are eliminated only in part by this mechanism and were shown not to\ninteract with lamivudine. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Substances shown to be predominately\nexcreted either via the active organic anionic pathway, or by glomerular\nfiltration are unlikely to yield clinically significant interactions with\nlamivudine. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Administration of\ntrimethoprim/sulphamethoxazole 160\u00a0mg/800\u00a0mg increased lamivudine\nexposure by about 40\u00a0%. Lamivudine had no effect on the pharmacokinetics\nof trimethoprim or sulphamethoxazole. However, unless the patient has renal\nimpairment, no dosage adjustment of lamivudine is necessary. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">A modest increase in Cmax (28\u00a0%) was\nobserved for zidovudine when administered with lamivudine, however overall\nexposure (AUC) was not significantly altered. Zidovudine had no effect on the\npharmacokinetics of lamivudine (see section 5.2). </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine has no pharmacokinetic\ninteraction with alpha-interferon when the two medicinal products are\nconcurrently administered. There were no observed clinically significant\nadverse interactions in patients taking lamivudine concurrently with commonly used\nimmunosuppressant medicinal products (e.g. cyclosporin A). However, formal\ninteraction studies have not been performed. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Emtricitabine</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Due to similarities, Lamivudine\nTeva should not be administered concomitantly with other cytidine analogues,\nsuch as emtricitabine. Moreover, Lamivudine Teva should not be taken with any\nother medicinal products containing lamivudine </span><span lang=\"EN-GB\">(</span><span lang=\"EN-GB\" style=\"color:black\">see section 4.4)</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Cladribine </span></i></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">In vitro</span></i><span lang=\"EN-GB\" style=\"color:black\"> lamivudine inhibits the intracellular\nphosphorylation of cladribine leading to a potential risk of cladribine loss of\nefficacy in case of combination in the clinical setting. Some clinical findings\nalso support a possible interaction between lamivudine and cladribine. Therefore,\nthe concomitant use of lamivudine with cladribine is not recommended (see\nsection 4.4).</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Sorbitol</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Co-administration of\nsorbitol solution (3.2 g, 10.2 g, 13.4 g) with a single 300 mg dose (Adult HIV\ndaily dose) of lamivudine oral solution resulted in dose-dependent decreases of\n14%, 32%, and 36% in lamivudine exposure (AUC</span><sub><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00a5</span></sub><span lang=\"EN-GB\" style=\"color:black\">) and 28%, 52%, and 55% in the Cmax of lamivudine in\nadults. When possible, avoid chronic co-administration of Lamivudine Teva with medicinal\nproducts containing sorbitol or other osmotic acting poly-alcohols or\nmonosaccharide alcohols (e.g. xylitol, mannitol, lactitol, maltitol). Consider\nmore frequent monitoring of HBV viral load when chronic co-administration\ncannot be avoided. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">A large amount of data on pregnant women\n(more than 1000 exposed outcomes) indicate no malformative toxicity. Lamivudine\nTeva can be used during pregnancy if clinically needed. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">For patients who are\nbeing treated with lamivudine and subsequently become pregnant consideration\nshould be given to the possibility of a recurrence of hepatitis on\ndiscontinuation of lamivudine.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Breast-feeding</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Based on more than 200\nmother/child pairs treated for HIV, serum concentrations of lamivudine in\nbreastfed infants of mothers treated for HIV are very low ( less than 4% of\nmaternal serum concentrations) and progressively decrease to undetectable\nlevels when breastfed infants reach 24 weeks of age. The total amount of\nlamivudine ingested by a breastfed infant is very low and is therefore likely\nto result in exposures exerting a sub-optimal antiviral effect. Maternal\nhepatitis B is not a contraindication to breast-feeding if the newborn is\nadequately managed for hepatitis B prevention at birth, and there is no evidence\nthat the low concentration of lamivudine in human milk leads to adverse reactions\nin breastfed infants. Therefore breastfeeding may be considered in breast-\nfeeding mothers being treated with lamivudine for HBV taking into account the\nbenefit of breast feeding for the child and the benefit of therapy for the\nwoman. Where there is maternal transmission of HBV, despite adequate\nprophylaxis, consideration should be given to discontinuing breastfeeding to\nreduce the risk of the emergence of lamivudine resistant mutants in the infant.\n</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Reproductive\nstudies in animals have shown no effect on male or female fertility (see\nsection 5.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Mitochondrial\ndysfunction: </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Nucleoside and\nnucleotide analogues have been demonstrated <i>in vitro</i> and <i>in vivo</i>\nto cause a variable degree of mitochondrial damage. There have been reports of\nmitochondrial dysfunction in infants exposed in utero and/or post-natally to\nnucleoside analogues (see section 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Patients should be\ninformed that malaise and fatigue have been reported during treatment with\nlamivudine. The clinical status of the patient and the adverse reaction profile\nof lamivudine should be borne in mind when considering the patient's ability to\ndrive or operate machinery.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">Undesirable effects</span></b></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Summary of the\nsafety profile</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The incidence of adverse reactions and\nlaboratory abnormalities (with the exception of elevations of ALT and CPK, see\nbelow) were similar between placebo and lamivudine treated patients). The most\ncommon adverse reactions reported were malaise and fatigue, respiratory tract\ninfections, throat and tonsil discomfort, headache, abdominal discomfort and\npain, nausea, vomiting and diarrhoea. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><u><span lang=\"EN-GB\">Tabulated\nlist of adverse reactions </span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Adverse reactions are listed below by\nsystem organ class and frequency. Frequency categories are only assigned to\nthose adverse reactions considered to be at least possibly causally related to\nlamivudine. Frequencies are defined as: very common (\u2265 1/10), common\n(\u2265 1/100 to &lt; 1/10), uncommon (\u2265 1/1000 to &lt; 1/100), rare\n(\u2265 1/10,000 to &lt; 1/1000),very rare (&lt; 1/10,000)<span style=\"color:black\"> and n</span></span><span lang=\"EN-GB\">ot known (cannot be\nestimated from the available data)</span><span lang=\"EN-GB\" style=\"color:black\">.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">The frequency\ncategories assigned to the adverse reactions are mainly based on experience\nfrom clinical trials including a total of 1,171 patients with chronic hepatitis\nB receiving lamivudine at 100\u00a0mg.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Thrombocytopenia</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Immune system\n  disorders</span></b><span lang=\"EN-GB\" style=\"color:black\">:</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Angioedema</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Hepatobiliary\n  disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Very common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">ALT</span><span lang=\"EN-GB\" style=\"color:black\"> elevations (see section 4.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\n  hepatitis, primarily detected by serum ALT elevations, have been reported\n  \u2018on-treatment\u2019 and following lamivudine withdrawal. Most events\n  have been self-limited, however fatalities have been observed very rarely\n  (see section 4.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rash, pruritus</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Elevations of CPK</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Muscle disorders,\n  including myalgia and cramps* </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Rhabdomyolysis</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">* In Phase III studies\nfrequency observed in the lamivudine treatment group was not greater than\nobserved in the placebo group</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Paediatric\npopulation </span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Based on limited data\nin children aged 2 to 17 years, there were no new safety issues identified\ncompared to adults.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Other special\npopulations</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In patients with HIV infection, cases of\npancreatitis and peripheral neuropathy (or paresthesia) have been reported. In\npatients with chronic hepatitis B there was no observed difference in incidence\nof these events between placebo and lamivudine treated patients. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Cases of lactic acidosis, sometimes fatal,\nusually associated with severe hepatomegaly and hepatic <br/>\nsteatosis, have been reported with the use of combination nucleoside analogue\ntherapy in patients with <br/>\nHIV. There have been rare reports of lactic acidosis in patients receiving\nlamivudine for hepatitis B. <br/>\n<br/>\n</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><u><span lang=\"EN-GB\">Reporting of\nsuspected adverse reactions</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after\nauthorisation of the medicinal product is important. It allows continued\nmonitoring of the benefit/risk balance of the medicinal product. Healthcare professionals\nare asked to report any suspected adverse reactions via <span style=\"background:\nlightgrey\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a></span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Administration of lamivudine at very high\ndose levels in acute animal studies did not result in any organ toxicity.\nLimited data are available on the consequences of ingestion of acute overdoses\nin humans. No fatalities occurred, and the patients recovered. No specific\nsigns or symptoms have been identified following such overdose. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">If overdose occurs the patient should be\nmonitored and standard supportive treatment applied as required. Since\nlamivudine is dialysable, continuous haemodialysis could be used in the\ntreatment of overdose, although this has not been studied. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Pharmacotherapeutic group - </span><span lang=\"EN-GB\" style=\"color:black\">Antivirals for systemic use, nucleoside and\nnucleotide reverse transcriptase inhibitors,</span><span lang=\"EN-GB\">ATC Code:\nJ05AF05. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is an antiviral agent which is\nactive against hepatitis B virus in all cell lines tested and in experimentally\ninfected animals. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is metabolised by both infected\nand uninfected cells to the triphosphate (TP) derivative which is the active\nform of the parent compound. The intracellular half life of the triphosphate in\nhepatocytes is 17\u201119 hours <i>in vitro</i>. Lamivudine-TP acts as a\nsubstrate for the HBV viral polymerase.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The formation of further viral DNA is\nblocked by incorporation of lamivudine-TP into the chain and subsequent chain\ntermination. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine-TP does not interfere with\nnormal cellular deoxynucleotide metabolism. It is also only a weak inhibitor of\nmammalian DNA polymerases alpha and beta. Furthermore, lamivudine-TP has little\neffect on mammalian cell DNA content. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In assays relating to potential substance\neffects on mitochondrial structure and DNA content and function, lamivudine\nlacked appreciable toxic effects. It has a very low potential to decrease\nmitochondrial DNA content, is not permanently incorporated into mitochondrial\nDNA, and does not act as an inhibitor of mitochondrial DNA polymerase gamma. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Clinical experience </span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">Experience in patients with HBeAg positive CHB and compensated liver\ndisease </span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In controlled studies, 1 year of lamivudine therapy significantly\nsuppressed HBV DNA replication [34\u201157\u00a0% of patients were below the\nassay detection limits (Abbott Genostics solution hybridization assay, LLOD\n&lt; 1.6\u00a0pg/ml)}, normalised ALT level (40\u201172\u00a0% of patients),\ninduced HBeAg seroconversion (HBeAg loss and HBeAb detection with HBV DNA loss\n[by conventional assay], 16\u201118\u00a0% of patients), improved histology\n(38\u201152\u00a0% of patients had a \u2265 2 point decrease in the Knodell\nHistologic Activity Index [HAI]) and reduced progression of fibrosis (in 3\u201117\u00a0%\nof patients) and progression to cirrhosis.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Continued lamivudine treatment for an\nadditional 2 years in patients who had failed to achieve HBeAg seroconversion\nin the initial 1 year controlled studies resulted in further improvement in\nbridging fibrosis. In patients with YMDD mutant HBV, 41/82 (50\u00a0%) patients\nhad improvement in liver inflammation and 40/56 (71\u00a0%) patients without\nYMDD mutant HBV had improvement. Improvement in bridging fibrosis occurred in\n19/30 (63\u00a0%) patients without YMDD mutant and 22/44 (50\u00a0%) patients\nwith the mutant. Five percent (3/56) of patients without the YMDD mutant and\n13\u00a0% (11/82) of patients with YMDD mutant showed worsening in liver\ninflammation compared to pre-treatment. Progression to cirrhosis occurred in\n4/68 (6\u00a0%) patients with the YMDD mutant, whereas no patients without the mutant\nprogressed to cirrhosis. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In an extended treatment study in Asian\npatients (NUCB3018) the HBeAg seroconversion rate and ALT normalisation rate at\nthe end of the 5 year treatment period was 48\u00a0% (28/58) and 47\u00a0%\n(15/32), respectively. HBeAg seroconversion was increased in patients with\nelevated ALT levels; 77\u00a0% (20/26) of patients with pre-treatment ALT &gt;\n2 x ULN seroconverted. At the end of 5 years, all patients had HBV DNA levels\nthat were undetectable or lower than pre-treatment levels. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Further results from the trial by YMDD mutant\nstatus are summarised in Table 1. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Table 1: Efficacy results 5 years by\nYMDD status (Asian Study) NUCB3018 </span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:23.15pt;border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:139.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"186\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">Subjects,\u00a0% (no.)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><i><span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span></i></b></p>\n</td>\n<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">YMDD<sup>1</sup></span></p>\n</td>\n<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Non-YMDD<sup>1</sup></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- All patients </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT \u2264 1 x ULN</span><sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\">2</span></sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT &gt; 2 x ULN</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span></u></b><u><span lang=\"EN-GB\" style=\"color:black\"> </span></u></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline<sup>3</sup></span><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Week 260<sup>4</sup></span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 negative </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &lt; baseline </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span></u></b></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Baseline\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Week 260\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &lt;\n  baseline\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>\n<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">38\u00a0 (15/40)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">9\u00a0\u00a0\u00a0\u00a0 (1/11)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">60\u00a0\u00a0 (9/15)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(2/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  (2/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">92\u00a0\u00a0 (23/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">28\u00a0\u00a0 (11/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">73\u00a0\u00a0 (29/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">46\u00a0\u00a0 (13/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">21\u00a0\u00a0\u00a0 (6/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">32\u00a0\u00a0\u00a0 (9/28)</span></p>\n</td>\n<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">72\u00a0\u00a0\u00a0 (13/18)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">33\u00a0\u00a0\u00a0\u00a0 \u00a0(2/6)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">100\u00a0 (11/11)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">6<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(1/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">100\u00a0\u00a0\u00a0 (4/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">33\u00a0\u00a0\u00a0\u00a0 (6/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">67\u00a0\u00a0\u00a0 (12/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:8.0pt\">1 Patients designated as YMDD mutant were those with\n\u22655\u00a0% YMDD mutant HBV at any annual time-point during the 5-year\nperiod. Patients categorised as non-YMDD mutant were those with &gt; 95\u00a0%\nwild-type HBV at all annual time-points during the 5-year study period </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:8.0pt\">2 Upper limit of normal </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:8.0pt\">3 Abbott Genostics solution hybridisation assay (LLOD\n&lt; 1.6\u00a0pg/ml </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\" style=\"font-size:\n8.0pt\">4 Chiron Quantiplex assay (LLOD 0.7\u00a0Meq/ml) </span></p>\n<p class=\"MsoNormal\"><span lang=\"FR\" style=\"font-size:8.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Comparative data according to YMDD status\nwere also available for histological assessment but only up to three years. In\npatients with YMDD mutant HBV, 18/39 (46\u00a0%) had improvements in\nnecroinflammatory activity and 9/39 (23\u00a0%) had worsening. In patients\nwithout the mutant, 20/27 (74\u00a0%) had improvements in necroinflammatory\nactivity and 2/27 (7\u00a0%) had worsening. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Following HBeAg seroconversion, serologic\nresponse and clinical remission are generally durable after stopping\nlamivudine. However, relapse following seroconversion can occur. In a long-term\nfollow-up study of patients who had previously seroconverted and discontinued\nlamivudine, late virological relapse occurred in 39\u00a0% of the subjects.\nTherefore, following HBeAg seroconversion, patients should be periodically\nmonitored to determine that serologic and clinical responses are being\nmaintained. In patients who do not maintain a sustained serological response,\nconsideration should be given to retreatment with either lamivudine or an\nalternative antiviral agent for resumption of clinical control of HBV. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In patients followed for up to 16 weeks\nafter discontinuation of treatment at one year, post-treatment ALT elevations\nwere observed more frequently in patients who had received lamivudine than in\npatients who had received placebo. A comparison of post-treatment ALT\nelevations between weeks 52 and 68 in patients who discontinued lamivudine at\nweek 52 and patients in the same studies who received placebo throughout the\ntreatment course is shown in Table 2. The proportion of patients who had\npost-treatment ALT elevations in association with an increase in bilirubin\nlevels was low and similar in patients receiving either lamivudine or placebo. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Table 2: Post-treatment ALT Elevations\nin 2 Placebo-Controlled Studies in Adults </span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:469.75pt;border-collapse:collapse\" width=\"626\">\n<tr style=\"height:25.25pt\">\n<td rowspan=\"2\" style=\"width:239.25pt;border:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"bottom\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Abnormal Value </span></p>\n</td>\n<td colspan=\"2\" style=\"width:230.5pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"top\" width=\"307\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with ALT Elevation/ </span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with Observations*</span></p>\n</td>\n</tr>\n<tr style=\"height:12.5pt\">\n<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Lamivudine</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Placebo</span></p>\n</td>\n</tr>\n<tr style=\"height:13.25pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;border-top:none;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">37/137\n  (27\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">22/116 (19\u00a0%) </span></p>\n</td>\n</tr>\n<tr style=\"height:13.25pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 3 x baseline value</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u2020 </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">29/137\n  (21\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">9/116\n  (8\u00a0%)</span></p>\n</td>\n</tr>\n<tr style=\"height:25.9pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value and\n  absolute ALT &gt; 500 IU/l </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">21/137\n  (15\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">8/116\n  (7\u00a0%)</span></p>\n</td>\n</tr>\n<tr style=\"height:27.75pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u22652 x baseline value; and\n  bilirubin &gt;2 x ULN and \u22652 x baseline value </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/137\n  (0.7\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/116\n  (0.9\u00a0%)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">*Each patient may be represented in one or\nmore category.</span></p>\n<p class=\"MsoNormal\"><sup><span lang=\"EN-GB\" style=\"position:relative;top:-5.0pt\">\u2020</span></sup><span lang=\"EN-GB\">Comparable to a Grade 3 toxicity in accordance with modified WHO\ncriteria. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ULN = Upper limit of normal. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Experience in patients with HBeAg\nnegative CHB: </span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Initial data indicate the efficacy of\nlamivudine in patients with HBeAg negative CHB is similar to patients with\nHBeAg positive CHB, with 71\u00a0% of patients having HBV DNA suppressed below\nthe detection limit of the assay, 67\u00a0% ALT normalisation and 38\u00a0%\nwith improvement in HAI after one year of treatment. When lamivudine was\ndiscontinued, the majority of patients (70\u00a0%) had a return of viral\nreplication. Data is available from an extended treatment study in HBeAg\nnegative patients (NUCAB3017) treated with lamivudine. After two years of\ntreatment in this study, ALT normalisation and undetectable HBV DNA occurred in\n30/69 (43\u00a0%) and 32/68 (47\u00a0%) patients respectively and improvement\nin necroinflammatory score in 18/49 (37\u00a0%) patients. In patients without\nYMDD mutant HBV, 14/22 (64\u00a0%) showed improvement in necroinflammatory\nscore and 1/22 (5\u00a0%) patients worsened compared to pre-treatment. In\npatients with the mutant, 4/26 (15\u00a0%) patients showed improvement in\nnecroinflammatory score and 8/26 (31\u00a0%) patients worsened compared to\npre-treatment. No patients in either group progressed to cirrhosis. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Frequency of emergence of YMDD mutant\nHBV and impact on the treatment response:</span></i><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine monotherapy results in the\nselection of YMDD mutant HBV in approximately 24\u00a0% of patients following\none year of therapy, increasing to 69\u00a0% following 5 years of therapy.\nDevelopment of YMDD mutant HBV is associated with reduced treatment response in\nsome patients, as evidenced by increased HBV DNA levels and ALT elevations from\nprevious on-therapy levels, progression of signs and symptoms of hepatitis\ndisease and/or worsening of hepatic necroinflammatory findings. Given the risk\nof YMDD mutant HBV, maintenance of lamivudine monotherapy is not appropriate in\npatients with detectable serum HBV DNA at or beyond 24 weeks of treatment (see\nsection 4.4). </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In a retrospective study to determine the\nfactors associated with HBV DNA breakthrough, 159 Asian HBeAg-positive patients\nwere treated with lamivudine and followed up for a median period of almost 30\nmonths. Those with HBV DNA levels greater than 200 copies/mL at 6 months (24\nweeks) of lamivudine therapy had a 60\u00a0% chance of developing the YMDD\nmutant compared with 8\u00a0% of those with HBV DNA levels less than\n200\u00a0copies/mL at 24 weeks of lamivudine therapy. The risk for developing\nYMDD mutant was 63% versus 13% with a cut off of 1000 copies/ml (NUCB3009 and\nNUCB3018).</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><i><span lang=\"EN-GB\">Experience in\npatients with decompensated liver disease</span></i><span lang=\"EN-GB\">: </span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">Placebo\ncontrolled studies have been regarded as inappropriate in patients with\ndecompensated liver disease, and have not been undertaken. In non\u2011controlled\nstudies, where lamivudine was administered prior to and during transplantation,\neffective HBV DNA suppression and ALT normalisation was demonstrated. When\nlamivudine therapy was continued post transplantation there was reduced graft\nre-infection by HBV, increased HBsAg loss and on one-year survival rate of 76\u2011100\u00a0%.\n</span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">As anticipated\ndue to the concomitant immunosuppression, the rate of emergence of YMDD mutant HBV\nafter 52 weeks treatment was higher (36\u00a0%\u201164\u00a0%) in the liver\ntransplant population than in the immunocompetent CHB patients (14\u00a0%\u201132\u00a0%).</span></p>\n<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Experience in CHB patients with advanced\nfibrosis or cirrhosis</span></i><span lang=\"EN-GB\">: </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In a placebo-controlled study in 651\npatients with clinically compensated chronic hepatitis B and histologically\nconfirmed fibrosis or cirrhosis, lamivudine treatment (median duration 32\nmonths) significantly reduced the rate of overall disease progression (34/436,\n7.8\u00a0% for lamivudine versus 38/215, 17.7\u00a0% for placebo, p=0.001),\ndemonstrated by a significant reduction in the proportion of patients having\nincreased Child-Pugh scores (15/436, 3.4\u00a0% versus 19/215, 8.8\u00a0%,\np=0.023) or developing hepatocellular carcinoma (17/436, 3.9\u00a0% versus\n16/215, 7.4\u00a0%, p=0.047). The rate of overall disease progression in the\nlamivudine group was higher for subjects with detectable YMDD mutant HBV DNA\n(23/209, 11\u00a0%) compared to those without detectable YMDD mutant HBV\n(11/221, 5\u00a0%). However, disease progression in YMDD subjects in the\nlamivudine group was lower than the disease progression in the placebo group\n(23/209, 11\u00a0% versus 38/214, 18\u00a0% respectively). Confirmed HBeAg\nseroconversion occurred in 47\u00a0% (118/252) of subjects treated with\nlamivudine and 93\u00a0% (320/345) of subjects receiving lamivudine became HBV\nDNA negative (VERSANT [version 1], bDNA assay, LLOD &lt; 0.7\u00a0MEq/ml)\nduring the study. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Experience in children and adolescents</span></i><span lang=\"EN-GB\">: </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine has been administered to\nchildren and adolescents with compensated CHB in a placebo controlled study of\n286 patients aged 2 to 17 years. This population primarily consisted of\nchildren with minimal hepatitis B. A dose of 3\u00a0mg/kg once daily (up to a\nmaximum of 100\u00a0mg daily) was used in children aged 2 to 11 years and a\ndose of 100\u00a0mg once daily in adolescents aged 12 years and above. This\ndose needs to be further substantiated. The difference in the HBeAg\nseroconversion rates (HBeAg and HBV DNA loss with HBeAb detection) between\nplacebo and lamivudine was not statistically significant in this population\n(rates after one year were 13\u00a0% (12/95) for placebo versus 22\u00a0% (42/191)\nfor lamivudine; p=0.057). The incidence of YMDD mutant HBV was similar to that\nobserved in adults, ranging from 19\u00a0% at week 52 up to 45\u00a0% in\npatients treated continuously for 24 months.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Absorption</span></u><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is well absorbed from the\ngastrointestinal tract, and the bioavailability of oral lamivudine in adults is\nnormally between 80 and 85\u00a0%. Following oral administration, the mean time\n(t</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span><span lang=\"EN-GB\">)\nto maximal serum concentrations (C</span><span lang=\"EN-GB\" style=\"font-size:\n7.0pt\">max</span><span lang=\"EN-GB\">) is about an hour. At therapeutic dose\nlevels i.e. 100\u00a0mg once daily, C</span><span lang=\"EN-GB\" style=\"font-size:\n7.0pt\">max</span><span lang=\"EN-GB\"> is in the order of 1.1\u20111.5\u00a0\u00b5g/ml\nand trough levels were 0.015\u20110.020\u00a0\u00b5g/ml. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Co-administration of lamivudine with food\nresulted in a delay of t</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span><span lang=\"EN-GB\"> and a lower C</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span><span lang=\"EN-GB\"> (decreased by up to 47\u00a0%). However, the extent (based on the\nAUC) of lamivudine absorbed was not influenced, therefore lamivudine can be\nadministered with or without food. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Distribution</span></u><span lang=\"EN-GB\">\n</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">From intravenous studies the mean volume of\ndistribution is 1.3\u00a0l/kg. Lamivudine exhibits linear pharmacokinetics over\nthe therapeutic dose range and displays low plasma protein binding to albumin. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Limited data shows lamivudine penetrates\nthe central nervous system and reaches the cerebro-spinal fluid (CSF). The mean\nlamivudine CSF/serum concentration ratio 2\u20114 hours after oral\nadministration was approximately 0.12. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Biotransformation</span></u><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is predominately cleared by\nrenal excretion of unchanged substance. The likelihood of metabolic substance\ninteractions with lamivudine is low due to the small (5\u201110\u00a0%) extent\nof hepatic metabolism and the low plasma protein binding. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Elimination</span></u><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The mean systemic clearance of lamivudine\nis approximately 0.3\u00a0l/h/kg. The observed half-life of elimination is 5 to\n7 hours. The majority of lamivudine is excreted unchanged in the urine via\nglomerular filtration and active secretion (organic cationic transport system).\nRenal clearance accounts for about 70\u00a0% of lamivudine elimination. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Special populations</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Studies in patients with renal impairment\nshow lamivudine elimination is affected by renal dysfunction. Dose reduction in\npatients with a creatinine clearance of &lt; 50\u00a0ml/min is necessary (see\nsection 4.2). </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The pharmacokinetics of lamivudine are\nunaffected by hepatic impairment. Limited data in patients undergoing liver\ntransplantation show that impairment of hepatic function does not impact\nsignificantly on the pharmacokinetics of lamivudine unless accompanied by renal\ndysfunction. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">In elderly patients the pharmacokinetic\nprofile of lamivudine suggests that normal ageing with accompanying renal\ndecline has no clinically significant effect on lamivudine exposure, except in\npatients with creatinine clearance of &lt; 50\u00a0ml/min (see section 4.2). </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Administration of lamivudine in animal\ntoxicity studies at high doses was not associated with any major organ\ntoxicity. At the highest dosage levels, minor effects on indicators of liver\nand kidney function were seen together with occasional reduction in liver\nweights. Reduction of erythrocytes and neutrophil counts were identified as the\neffects most likely to be of clinical relevance. These events were seen\ninfrequently in clinical studies. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine was not mutagenic in bacterial\ntests but, like many nucleoside analogues showed activity in an <i>in vitro</i>\ncytogenetic assay and the mouse lymphoma assay. Lamivudine was not genotoxic <i>in\nvivo </i>at doses that gave plasma concentrations around 60\u201170 times\nhigher than the anticipated clinical plasma levels. As the <i>in vitro</i>\nmutagenic activity of lamivudine could not be confirmed by <i>in vivo</i>\ntests, it is concluded that lamivudine should not represent a genotoxic hazard\nto patients undergoing treatment. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Reproductive studies in animals have not\nshown evidence of teratogenicity and showed no effect on male or female\nfertility. Lamivudine induces early embryolethality when administered to\npregnant rabbits at exposure levels comparable to those achieved in man, but\nnot in the rat even at very high systemic exposures. </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The results of long term carcinogenicity\nstudies with lamivudine in rats and mice did not shown any carcinogenic\npotential. </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><u><span lang=\"EN-GB\">Tablet core</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Microcrystalline cellulose</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Sodium starch glycolate (Type A)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Magnesium stearate</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Tablet film coat</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"NL\">Hypromellose 3cP</span></p>\n<p class=\"MsoNormal\"><span lang=\"NL\">Hypromellose 6cP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NL\">Titanium dioxide </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Macrogol 400</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Polysorbate 80</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Iron oxide\nyellow </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Iron oxide red </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not applicable</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">2 years</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct does not require any special storage conditions.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">Nature and contents of container</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Blisters:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">White opaque\nPVC/PVdC \u2013 Aluminium blisters </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack sizes of\n28, 30, 84 or 100 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Containers:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">White opaque\nHDPE tablet containers with white opaque polyethylene child resistent screw cap\nwith induction seal </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack size of 60\nfilm-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">White opaque\nHDPE tablet containers with white opaque polypropylene child resistent,\ntamper-evident screw cap with induction seal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack size of 60 film-coated\ntablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not all pack\nsizes may be marketed.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Any unused </span><span lang=\"EN-GB\" style=\"color:black\">medicinal </span><span lang=\"EN-GB\">product or waste material\nshould be disposed of in accordance with local requirements. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Swensweg 5</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">2031GA Haarlem</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Netherlands</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"DE\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/001\u2013\n28 Tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/002\n\u2013 30 Tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/003\n\u2013 84 Tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/004\n\u2013 100 Tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/09/566/005\n\u2013 60 Tablets (bottle)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/09/566/006 \u2013\n60 Tablets </span>(bottle with tamper evident cap)</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF\nFIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of first\nauthorisation: 23 October 2009</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of latest\nrenewal: 09 September 2014 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicinal product is available on the website of the\nEuropean Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a><span style=\"color:black\"> </span></span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">ANNEX\nII</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S)\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS </span></b><b><span style=\"layout-grid-mode:line\">OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span style=\"layout-grid-mode:line\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span style=\"layout-grid-mode:line\">C. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS</span></b><b><span style='font-family:\"TimesNewRoman,Bold\",serif;\nlayout-grid-mode:line'> </span></b><b><span lang=\"EN-GB\">AND REQUIREMENTS OF </span></b><b><span style=\"layout-grid-mode:line\">THE MARKETING AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"TitleB\"><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S)\nRESPONSIBLE FOR BATCH RELEASE</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:70.8pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Name and address of the manufacturer\nresponsible for batch release</span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Teva Pharmaceutical Works Private Limited\nCompany</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Pallagi \u00fat 13</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Debrecen</span><span lang=\"EN-GB\"> H-4042</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hungary</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"DE\">Pharmachemie B.V.</span></p>\n<p class=\"MsoNormal\">Swensweg 5</p>\n<p class=\"MsoNormal\">2031 GA Haarlem</p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The Netherlands</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Teva Operations\nPoland Sp.z o. o.</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Mogilska 80\nStr.</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">31-546\nKrak\u00f3w</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">Poland</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The printed package leaflet of the\nmedicinal product must state the name and address of the manufacturer\nresponsible for the release of the concerned batch.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleB\"><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Medicinal product subject to restricted\nmedical prescription </span><span lang=\"EN-GB\">(See Annex I: Summary of Product\nCharacteristics, section 4.2).</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleB\"><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF </span><span style=\"layout-grid-mode:line\">THE\nMARKETING AUTHORISATION</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic Safety Report</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt\"><span lang=\"EN-GB\" style=\"color:black\">The requirements for submission of periodic safety update\nreports for this medicinal products are set out in the list of Union reference\ndates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC\nand any subsequent updates published on the European medicines web-portal.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Tms Rmn\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Tms Rmn\",serif'>\u00a0</span></p>\n<p class=\"TitleB\"><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:.5in;text-indent:-.5in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk Management Plan (RMP)</span></b></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not applicable.</span></p>\n<p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">A. LABELLING</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">carton</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Each film\u2011coated tablet contains 100\u00a0mg\nof lamivudine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Blisters:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">28 film-coated\ntablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">30 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">84 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">100 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Read the package leaflet before use</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Oral use </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span><span lang=\"EN-GB\">SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the sight\nand reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Swensweg 5</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">2031GA Haarlem</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Netherlands</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/001<span style=\"background:lightgrey\">\u2013 28 Tablets</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nlightgrey\">EU/1/09/566/002 \u2013 30 Tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nlightgrey\">EU/1/09/566/003 \u2013 84 Tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">EU/1/09/566/004 \u2013 100 Tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">2D\nbarcode carrying the unique identifier included.</span><span lang=\"EN-GB\" style=\"color:green\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"display:none\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">PC:</span></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">SN:</span></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">NN:</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr style=\"height:39.25pt\">\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:39.25pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON\n  BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Immediate packaging (blister foil)</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MEDICINAL PRODUCT</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">TEVA B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\n  DATE</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\n  NUMBER</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">Tablet container</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Each film\u2011coated tablet contains 100\u00a0mg\nof lamivudine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Tablet container:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">60 film-coated\ntablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Read the package leaflet before use </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Oral use </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span lang=\"EN-GB\">SIGHT AND </span></b><b><span lang=\"EN-GB\">REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the sight\nand reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Swensweg 5</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">2031GA Haarlem</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Netherlands</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/09/566/005</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">EU/1/09/566/006 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate\npackaging (bottle label):</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">2D\nbarcode carrying the unique identifier included.</span><span lang=\"EN-GB\" style=\"color:green\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate\npackaging (bottle label):</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">&lt;2D\nbarcode carrying the unique identifier included.&gt;</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"display:none\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">PC:</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">SN:</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">NN:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate packaging (bottle label):</span></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no outer packaging is used</span></b></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">&lt;PC:</span></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">SN:</span></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">NN:&gt;</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span></p>\n<b><u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></u></b>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Package leaflet: Information for the patient</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film-coated tablets</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">lamivudine</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you start taking this medicine </span><span lang=\"EN-GB\" style=\"color:black\">because it contains important information for\nyou</span><span lang=\"EN-GB\">.</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor or pharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">This medicine has been prescribed for you only.\nDo not pass it on to others. It may harm them, even if their signs of illness\nare the same as yours.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you get any of the side effects </span><span lang=\"EN-GB\" style=\"color:black\">talk to your doctor or pharmacist. This includes\n</span><span lang=\"EN-GB\">any possible side effects not listed in this leaflet.\nSee section 4.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b><span lang=\"EN-GB\">: </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Lamivudine Teva is and\nwhat it is used for</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style=\"color:black\">What you need to know </span><span lang=\"EN-GB\">before you\ntake Lamivudine Teva</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Lamivudine Teva</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\">5.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">How to store Lamivudine Teva</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style=\"color:black\">Contents of the pack and other</span><span lang=\"EN-GB\">\ninformation</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal\"><b><span lang=\"EN-GB\">1.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">What Lamivudine Teva is and what it is\nused for</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The active ingredient in Lamivudine Teva is\nlamivudine.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lamivudine\nTeva is used to treat long term (chronic) hepatitis B infection in adults.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">Lamivudine Teva\n</span><span lang=\"EN-GB\">is an antiviral medicine that suppresses the hepatitis\nB virus and belongs to a group of medicines called <i>nucleoside analogue\nreverse transcriptase inhibitors (NRTIs)</i>.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">Hepatitis B is\na virus that infects the liver </span><span lang=\"EN-GB\">causes long term\n(chronic) infection, and can lead to liver damage. Lamivudine Teva <span style=\"color:black\">can be used in people whose liver is damaged but still\nfunctions </span>normally<span style=\"color:black\"> (<i>compensated liver\ndisease</i>).</span></span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">Treatment with\nLamivudine Teva can reduce the amount of hepatitis B virus in your body. This\nshould lead to a reduction in liver damage and an improvement in your liver\nfunction. </span><span lang=\"EN-GB\" style=\"color:black\">Not everyone responds to\ntreatment with Lamivudine Teva in the same way. Your doctor will monitor the\neffectiveness of your treatment with regular blood tests.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal\"><b><span lang=\"EN-GB\">2.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\" style=\"color:black\">What you need to know\n</span><span lang=\"EN-GB\">before you take Lamivudine Teva</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Do not take\nLamivudine Teva</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you are <b>allergic </b>to lamivudine or any\nof the other ingredients of </span><span lang=\"EN-GB\" style=\"color:black\">this\nmedicine </span><i><span lang=\"EN-GB\">(listed in Section 6).</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Check\nwith your doctor</span></b><span lang=\"EN-GB\"> if you think this applies to you.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Some people taking Lamivudine Teva or other similar medicines are\nmore at risk of serious side effects. You need to be aware of the extra risks:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you have ever had other types of <b>liver\ndisease</b>, such as hepatitis C.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you are seriously <b>overweight</b>\n(especially if you are a woman).</span></p>\n<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">Talk to your doctor if any of these apply to\nyou</span></b><span lang=\"EN-GB\">. You may need extra check-ups, including blood\ntests, while you are taking your medication. <b>See Section 4 </b>for more\ninformation about the risks. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\">Do not stop\ntaking Lamivudine Teva</span></b><span lang=\"EN-GB\"> without your doctor\u2019s\nadvice, as there is a risk of your hepatitis getting worse. When you stop\ntaking Lamivudine Teva your doctor will monitor you for at least four months to\ncheck for any problems. This will mean taking blood samples to check for any raised\nliver enzyme levels, which may indicate liver damage.</span><span lang=\"EN-GB\" style=\"color:black\"> See section 3 for more information about how to take </span><span lang=\"EN-GB\">Lamivudine Teva</span><span lang=\"EN-GB\" style=\"color:black\">.</span></p>\n<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Look out for important symptoms</span></h2>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Some people taking medicines for hepatitis\nB infection develop other conditions, which can be serious. You need to know\nabout important signs and symptoms to look out for while you are taking\nLamivudine Teva.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><span lang=\"EN-GB\">Read\nthe information \u2018Other possible side effects of therapy for Hepatitis\nB\u2019 in Section\u00a04 of this leaflet.</span></p>\n<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Protect other people</span></h2>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hepatitis B infection is spread by sexual\ncontact with someone who has the infection, or by transfer of infected blood\n(for example, by sharing injection needles). Lamivudine Teva will not stop you\npassing hepatitis B infection on to other people. To protect other people from\nbecoming infected with hepatitis B:</span></p>\n<p class=\"Bullet\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;font-family:Wingdings;color:black\">\u0178<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span></span><b><span lang=\"EN-GB\">Use a condom</span></b><span lang=\"EN-GB\"> when you have oral or\npenetrative sex.</span></p>\n<p class=\"Bullet\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;font-family:Wingdings;color:black\">\u0178<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span></span><b><span lang=\"EN-GB\">Do not risk blood transfer</span></b><span lang=\"EN-GB\"> \u2014 for\nexample, do not share needles.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Other medicines and Lamivudine Teva</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;page-break-after:avoid\"><span lang=\"EN-GB\">Tell your doctor or pharmacist if you are taking, </span><span lang=\"EN-GB\">have recently taken or might take</span><span lang=\"EN-GB\"> any other\nmedicines, including herbal medicines or other medicines you bought without a\nprescription. </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt;line-height:normal\"><span lang=\"EN-GB\">Remember to tell your doctor or pharmacist if you begin taking a new\nmedicine while you are taking Lamivudine Teva.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">These medicines should not be used with </span><span lang=\"EN-GB\">Lamivudine Teva</span><span lang=\"EN-GB\" style=\"color:black\">:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">medicines (usually liquids)\ncontaining sorbitol and other sugar alcohols (such as xylitol, mannitol,\nlactitol or maltitol), if taken regularly</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">other medicines containing lamivudine,\nused to treat HIV infection </span><span lang=\"EN-GB\">(sometimes called the AIDS\nvirus)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">emtricitabine (used to treat\nHIV or hepatitis B infection)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">cladribine, used to treat <b>hairy\ncell leukaemia</b></span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Tell\nyour doctor</span></b><span lang=\"EN-GB\"> if you are being treated with any of\nthese.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Pregnancy </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are\npregnant, </span><span lang=\"EN-GB\" style=\"color:black\">think you may be </span><span lang=\"EN-GB\">pregnant,<span style=\"color:black\"> </span>or are planning to have a\nbaby:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Talk\nto your doctor </span></b><span lang=\"EN-GB\">about the risks and benefits of\ntaking Lamivudine Teva during your pregnancy.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not stop\ntreatment with Lamivudine Teva without your doctor\u2019s advice.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">Breast-feeding</span></b><span lang=\"EN-GB\" style=\"color:\nblack\"> </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Lamivudine Teva</span><span lang=\"EN-GB\" style=\"color:black\"> can pass\ninto breast-milk. If you are breast-feeding, </span><span lang=\"EN-GB\">or\nthinking about breast-feeding:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">Talk to your doctor </span></b><span lang=\"EN-GB\">before you take Lamivudine Teva.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva </span><span lang=\"EN-GB\">may make you feel\ntired, which could <span style=\"color:black\">affect your ability to drive or\nuse machines</span>. </span></p>\n<p class=\"Action\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><span lang=\"EN-GB\">Don\u2019t drive or use machines unless you are\nsure you\u2019re not affected.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lamivudine\nTeva</span></b><b> contains sodium</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">This medicine contains less than\n1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially\n\u201csodium-free\u201d.</p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal\"><b><span lang=\"EN-GB\">3.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">How to take Lamivudine Teva </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Always take this medicine exactly as your doctor has told you to</span></b><span lang=\"EN-GB\">. Check with your doctor or pharmacist if you are not sure. </span></p>\n<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Stay in regular contact with your doctor</span></h2>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva helps to control your\nhepatitis B infection. You need to keep taking it every day to control your\ninfection and stop your illness getting worse.</span></p>\n<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">Keep in touch with your doctor, and do not\nstop taking Lamivudine Teva</span></b><span lang=\"EN-GB\"> without your\ndoctor\u2019s advice.</span></p>\n<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>How much to take</span></h2>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">The usual dose\nof Lamivudine Teva is one tablet (100\u00a0mg lamivudine) once a day. </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Your doctor may prescribe a lower dose if you have problems with your\nkidneys. An <span style=\"color:black\">oral solution</span> of Lamivudine is\navailable for people who need a lower than usual dose, or who can\u2019t take\ntablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor </span></b><span lang=\"EN-GB\" style=\"color:black\">if this applies to you.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are\nalready taking another medicine that contains lamivudine for HIV infection,\nyour doctor will continue to treat you with the higher dose, (usually\n150\u00a0mg twice a day), because the dose of lamivudine in Lamivudine Teva\n(100\u00a0mg) is not enough to treat HIV infection. If you are planning to\nchange your HIV treatment, discuss this change with your doctor first.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Swallow the tablet whole, with some water. Lamivudine\nTeva can be taken with or without food.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">If you take more Lamivudine Teva than you should</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Accidentally\ntaking too much Lamivudine Teva is unlikely to cause any serious problems.</span><span lang=\"EN-GB\"> If you accidentally take too much, tell your doctor or pharmacist,\nor contact your nearest hospital emergency department for further advice.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">If you forget to take Lamivudine Teva</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">If you forget to take a dose, take it as soon as you remember. Then\ncontinue </span><span lang=\"EN-GB\">your treatment as before.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not take a double dose to make up for a missed dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Do not stop taking Lamivudine Teva</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">You must not\nstop taking Lamivudine Teva without consulting your doctor. </span><span lang=\"EN-GB\">There is a risk of your hepatitis getting worse (see section 2).<span style=\"color:black\"> When you stop taking Lamivudine Teva your doctor will\nmonitor you for at least four months to check for any problems. This will mean\ntaking blood samples to check for any raised liver enzyme levels, which may\nindicate liver damage.</span></span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Like all medicines, this\nmedicine can cause side effects, but not everyone gets them. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">As well as\nthe side effects listed below for Lamivudine Teva</span></b><span lang=\"EN-GB\">,\nother conditions can develop during therapy for\u00a0hepatitis B. </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><span lang=\"EN-GB\">It\nis important to read the information under \u2018Other possible side effects\nof therapy for\u00a0hepatitis B\u2019.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Side effects that were\ncommonly reported in Lamivudine clinical trials were tiredness, respiratory\ntract infections, throat discomfort, headache, stomach discomfort and pain,\nnausea, vomiting and diarrhoea, <a name=\"OLE_LINK2\">increases in liver enzymes\nand enzymes produced in the muscles <i>(see below)</i></a>. </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Allergic reaction </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">These are rare (may\naffect up to 1 in 1,000 people). Signs include:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">swelling of eyelids, face or\nlips</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">difficulty swallowing or\nbreathing</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Contact\na doctor immediately</span></b><span lang=\"EN-GB\"> if you get these symptoms. <b>Stop\ntaking Lamivudine Teva</b>.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Side effects thought to be caused by Lamivudine Teva</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">A very common side effect </span></b><span lang=\"EN-GB\">(these may affect <b>more than 1 in 10</b> people) which may show up\nin blood tests is:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">an increase in the level of some liver enzymes <i>(transaminases)</i>,\nwhich may be a sign of inflammation or damage in the liver.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">A common side effect (</span></b><span lang=\"EN-GB\">these may affect<b> up to 1 in 10 </b>people) is:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">cramps and muscle pains </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">skin rash or\n\u2018hives\u2019 anywhere on the body.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">A common side\neffect</span></b><span lang=\"EN-GB\"> which may show up in blood tests is:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">an increase in the level of an enzyme produced\nin the muscles <i>(creatine phosphokinase)</i> which may be a sign that body\ntissue is damaged.</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Other side effects</span></b><span lang=\"EN-GB\" style=\"color:black\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Other side effects<b> </b>have\noccurred in a very small number of people but their exact frequency is unknown</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">breakdown of muscle tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">a worsening of liver disease after Lamivudine\nTeva is stopped or during treatment if the hepatitis B virus becomes resistant\nto Lamivudine Teva. This can be fatal in some people.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">lactic acidosis <i>(see the next section,\n\u2018Other possible side effects of therapy for Hepatitis B\u2019)</i>.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:.5in;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">A side effect which may show up in blood\ntests is:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">a decrease in the number of cells involved in\nblood clotting <i>(thrombocytopenia)</i>.</span></p>\n<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>If you get any side effects</span></h2>\n<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Talk\nto your doctor or pharmacist. </span></b><span lang=\"EN-GB\">This includes any\npossible side effects not listed in this leaflet. </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">Other possible side effects of therapy for Hepatitis B</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva and related medicines (NRTIs) may cause\nother conditions to develop during hepatitis B treatment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is a rare but serious side effect</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Some people taking Lamivudine Teva, or other medicines like\nit (NRTIs), develop a condition called lactic acidosis, together with an\nenlarged liver. </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is caused by a build-up of lactic acid in\nthe body. It is rare; if it happens, it usually develops after a few months of\ntreatment. It can be life-threatening, causing failure of internal organs.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is more likely to develop in people who\nhave liver disease, or in obese (very overweight) people, especially women.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<h3><span style=\"font-size:11.0pt\">Signs of lactic acidosis include:</span></h3>\n<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">deep, rapid, difficult breathing</span></b></p>\n<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">drowsiness</span></b></p>\n<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">numbness</span></b><span lang=\"EN-GB\"> or <b>weakness</b>\nin the limbs</span></p>\n<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">feeling sick</span></b><span lang=\"EN-GB\">\n(nausea), <b>being sick</b> (vomiting) </span></p>\n<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">stomach pain</span></b><span lang=\"EN-GB\">.</span></p>\n<p class=\"Bullet\" style=\"margin-left:0in;text-indent:0in\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:6.0pt\"><span lang=\"EN-GB\">During your treatment,\nyour doctor will monitor you for signs of lactic acidosis. If you have any of\nthe symptoms listed above, or any other symptoms that worry you:</span></p>\n<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">See your doctor as soon as possible</span></b><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoFooter\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif'>Reporting of side effects</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">If you get any side effects, talk to your doctor or pharmacist.</span><span lang=\"EN-GB\" style=\"color:red\"> </span><span lang=\"EN-GB\">This includes any\npossible side effects not listed in this leaflet. You can also report side\neffects directly via <span style=\"background:lightgrey\">the national reporting\nsystem listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a></span><span lang=\"EN-GB\">. By\nreporting side effects you can help provide more information on the safety of\nthis medicine.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nLamivudine Teva</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not take this medicine after the expiry date shown on the\ncontainer or carton and blister pack after EXP. The expiry date refers to the\nlast day of that month.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">This medicinal product does not require any special storage conditions</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not use Lamivudine Teva if you notice any change in the\nappearance of the tablet.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not throw away any medicines in your wastewater or household\nwaste. Ask your pharmacist how to throw away medicines you no longer use. These\nmeasures will help to protect the environment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style=\"color:black\">Contents of the pack and other</span><span lang=\"EN-GB\">\ninformation</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What Lamivudine Teva contains</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The active substance is lamivudine. Each\nfilm-coated tablet contains 100\u00a0mg of lamivudine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The other ingredients are;<i><span style=\"color:green\"> </span></i></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Tablet core: Microcrystalline cellulose, sodium starch\nglycolate, magnesium stearate. Tablet film coat: Hypromellose, titanium dioxide\n(E171), macrogol, polysorbate 80, iron oxide yellow (E172), iron oxide red\n(E172).</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What Lamivudine Teva looks like and contents of the pack</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Orange</span><span lang=\"EN-GB\">, capsule shaped, biconvex film-coated\ntablet \u2013 engraved with \u201cL100\u201d on one side and plain on the\nother</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Lamivudine Teva is available in aluminium blisters containing 28,\n30, 84 or 100 tablets or HDPE containers containing 60 tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Not all pack sizes may beavailable in your country .</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Teva B.V.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Swensweg 5</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">2031GA Haarlem</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Netherlands</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Teva Pharmaceutical Works Private Limited\nCompany</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Pallagi \u00fat 13</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Debrecen</span><span lang=\"EN-GB\"> H-4042</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hungary</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"NL\">Pharmachemie B.V.</span></p>\n<p class=\"MsoNormal\"><span lang=\"NL\">Swensweg 5</span></p>\n<p class=\"MsoNormal\"><span lang=\"NL\">2031 GA Haarlem</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">The Netherlands</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Teva Operations\nPoland Sp.z o. o.</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Mogilska 80\nStr.</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">31-546\nKrak\u00f3w</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Poland</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">For any information about this medicine, please contact the local\nrepresentative of the Marketing Authorisation Holder</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><i><span lang=\"EN-GB\">\u00a0</span></i></b></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:401.4pt;margin-left:9.0pt;border-collapse:collapse\" width=\"535\">\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Teva Pharma Belgium N.V./S.A./AG </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel/T\u00e9l: +32 38207373</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB Teva Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +370 52660203</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;text-autospace:\n  none\"><span style=\"color:black\">\u0422\u0435\u0432\u0430</span><span style=\"color:black\"> </span><span style=\"color:black\">\u0424\u0430\u0440\u043c\u0430</span>\n<span lang=\"BG\">\u0415\u0410\u0414</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Te</span><span lang=\"RU\">\u043b.: +</span><span lang=\"BG\">359 2</span><span lang=\"EN-GB\">4899585</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\" style=\"background:yellow\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Luxembourg/Luxemburg </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Allemagne/<b> </b>Deutschland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l/Tel: +49 73140202</span><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">\u010cesk\u00e1 republika </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva Pharmaceuticals CR, s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+420 251007111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Magyarorsz\u00e1g </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva </span><span lang=\"EN-GB\">Gy\u00f3gyszergy\u00e1r Zrt.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +36 12886400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b>Danmark </b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Teva\n  Denmark A/S </p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tlf: +45 44985511</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Malta </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Teva Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">L-Irlanda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +353 </span><span lang=\"EN-GB\">19127700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: </span><span lang=\"DE\">+49 73140208</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\" style=\"background:yellow\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"NL\">Nederland </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:-1.15pt;line-height:normal;text-autospace:\n  none\"><span lang=\"NL\">Teva Nederland B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: +31 8000228400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NL\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\" style=\"color:black\"> Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: </span><span lang=\"EN-GB\">+372 6610801</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Norge</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Teva Norway AS</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Tlf: +47\n  66775590</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Specifar\n  A.B.E.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IS\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm Arzneimittel Vertriebs-GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +43 1970070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Teva Pharma,\n  S.L.U.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">T\u00e9l: +34 913873280</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals Polska Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +48223459300</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Sant\u00e9</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l: +33 155917800</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Pharma -\n  Produtos Farmac\u00eauticos Lda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel</span><span lang=\"EN-GB\">: </span><span lang=\"EN-GB\">+351\n  214767550</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Pliva Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +385 13720000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals S.R.L</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +40 212306524</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+353 19127700 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Pliva Ljubljana d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +386 15890390</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Finnland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Simi: +358 201805900</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +421 257267911</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Italia\n  S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+39 028917981</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Suomi/Finland</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Puh/Tel:\n  +358 201805900</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Specifar A.B.E.E.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +46 42121100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\"> fili\u0101le Latvij\u0101</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +371 67323666</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva UK\n  Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+44 1977628500</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">This leaflet was last revised in </span></b><span lang=\"EN-GB\">{MM/YYYY}.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span><u><span lang=\"EN-GB\" style=\"color:blue\"> </span></u></p>\n</div>", "ID": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040", "Styles": "None", "Classes": "['WordSection1']", "Text": "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ", "ParentId": "e0984a2c-c5af-4c38-9a3c-f3790c8c6cab"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "94bd1d52-9f21-4cbe-ba0c-d3e85eac4056", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "ff52538e-effc-4b6d-b713-0aa1e5091dfb", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "fd6738c0-86f4-4ebf-ac1b-6372f9c106b8", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "4c85c9cd-f0ba-4e8a-8109-62821d94eb62", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "eb902d65-02f1-4165-b361-eb95afeb21a7", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "a4dfca44-4aa4-4441-a53b-f4076245a37c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "7a90b538-d0ae-47b4-b071-a47053777cb4", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "b09551d8-0aae-405c-b0bf-10dec5ed1f48", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "a55e1381-9be3-44d0-b459-60432b92be76", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "39187bc5-e9ef-48ac-9edf-a281fdb9d4e1", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "357f6776-8166-4783-b165-db1570a0bfbc", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "e5e9e1dc-2547-47b4-9f7e-f7ee95bdd3ec", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "e515e8ba-14e7-42d3-b027-9781dd15ba52", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "722936f0-8b36-4b12-9fc1-a333a1a3e437", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "6f66ca8f-3161-4c5a-96a9-3b3a2affca8d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "ada90406-3819-4291-a375-f4b7ad5adb38", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "87ff2d8d-58c2-489a-a117-20ee342b5bcc", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "cb6c5faf-fe1b-4df3-b51d-b1b6e8ea4cf6", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "672f1a7e-b588-46d0-b664-0731d4755012", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "7fc52ca1-b63a-4d7d-8a85-d47c46a65628", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "1b86d991-f8f4-4efe-a0aa-4ee6c46ce65c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\">\u00a0</p>", "ID": "8df9c352-fd71-459f-b132-cde5291af74c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b>\u00a0</b></p>", "ID": "a12d8161-6882-4829-a7c9-95c80e1c58c9", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b>\u00a0</b>", "ID": "aa8c70d7-8247-464f-b3a7-013d6f1904ff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a12d8161-6882-4829-a7c9-95c80e1c58c9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b>\u00a0</b></p>", "ID": "5c78ffb4-8a5d-4faa-b585-9c0e5e667b28", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b>\u00a0</b>", "ID": "043ebfdc-2eeb-4f0c-b1de-876869680e96", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5c78ffb4-8a5d-4faa-b585-9c0e5e667b28"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b>ANNEX\nI</b></p>", "ID": "8ba59602-1ebc-4ca0-9fdc-cc97f1e9f7d9", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b>ANNEX\nI</b>", "ID": "2e5bbcbe-0891-4a9b-991e-f4eec8816280", "Styles": "None", "Classes": "None", "Text": "ANNEX I", "ParentId": "8ba59602-1ebc-4ca0-9fdc-cc97f1e9f7d9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "30fe3a5f-08e7-4202-aec8-48ff8011be70", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "36f1c29b-8f37-4cd7-82d8-c77fa21ccd98", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "30fe3a5f-08e7-4202-aec8-48ff8011be70"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></p>", "ID": "03da193d-cb6c-4d3a-9220-7f39dde70b15", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span>", "ID": "38ba085e-2548-4d3c-a146-ecd30d6899dc", "Styles": "None", "Classes": "None", "Text": "SUMMARY OF PRODUCT CHARACTERISTICS", "ParentId": "03da193d-cb6c-4d3a-9220-7f39dde70b15"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7ecd10bc-3c1d-4649-b468-776c09fbfb56", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "25e914a8-518d-49eb-b40d-64453f1b3c8c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7ecd10bc-3c1d-4649-b468-776c09fbfb56"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "2291c2b3-5ddb-496d-afd3-a697a5dbd5c4", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "26b3db26-cd66-42ec-950d-35195fc7d8b1", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "2291c2b3-5ddb-496d-afd3-a697a5dbd5c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "6830021e-9116-484c-8fc3-9d5822b65653", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "2c2e817a-9fe2-4b0b-a95b-ba1673cd68d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6830021e-9116-484c-8fc3-9d5822b65653"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "4bf0a913-adbf-450c-9b1b-f89653864279", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "2c2e817a-9fe2-4b0b-a95b-ba1673cd68d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3d4eb8e2-7547-46b4-b6fe-6cf02f905ba3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "46ee41d9-eb67-4867-b02b-70f364885034", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3d4eb8e2-7547-46b4-b6fe-6cf02f905ba3"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film-coated\ntablets </span></p>", "ID": "ff8926cc-eafa-4930-a798-10b5aad92191", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film-coated\ntablets </span>", "ID": "81438458-6ef2-4f15-8d12-ee42dd487e58", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg film-coated tablets ", "ParentId": "ff8926cc-eafa-4930-a798-10b5aad92191"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0472971b-f34b-4565-a752-f5e7cb29d6ee", "Styles": "text-align:justify;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d30eae4c-2ef6-4187-a5d3-941a647b178e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0472971b-f34b-4565-a752-f5e7cb29d6ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3693408c-7693-4489-b5c9-f9fca2185178", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45bbd36e-451e-4c9b-bc80-55cbf54b440c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3693408c-7693-4489-b5c9-f9fca2185178"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span></b></p>", "ID": "ccce17de-0bf6-40fe-b514-9c62ab81dbb4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span></b>", "ID": "c663d764-6d30-4a86-9f36-65e7c842d63e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ccce17de-0bf6-40fe-b514-9c62ab81dbb4"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span>", "ID": "b770a6a2-4440-495e-9c4c-44bb99bd6c20", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE COMPOSITION", "ParentId": "c663d764-6d30-4a86-9f36-65e7c842d63e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3a9c9cf-073f-4895-99c2-33976390d924", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c15fa14-7aba-4e17-8069-9556c6867de9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3a9c9cf-073f-4895-99c2-33976390d924"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Each film-coated tablet contains\n100\u00a0mg lamivudine </span></p>", "ID": "6808c22d-5942-4494-a85f-0c32f209bb49", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Each film-coated tablet contains\n100\u00a0mg lamivudine </span>", "ID": "cbed9252-c0f9-440a-9600-c198fea9d542", "Styles": "None", "Classes": "None", "Text": "Each film-coated tablet contains 100\u00a0mg lamivudine ", "ParentId": "6808c22d-5942-4494-a85f-0c32f209bb49"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">For the full list of excipients see section\n6.1. </span></p>", "ID": "1d27064f-61ff-465b-97e7-61b1c1654b30", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">For the full list of excipients see section\n6.1. </span>", "ID": "26cea85d-967e-417c-860a-b1cd5624a2fd", "Styles": "None", "Classes": "None", "Text": "For the full list of excipients see section 6.1. ", "ParentId": "1d27064f-61ff-465b-97e7-61b1c1654b30"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "98626236-c8f6-4843-9c43-0ff096d1f1c6", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cd4e13c5-7d5f-4321-b566-cff301c060fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "98626236-c8f6-4843-9c43-0ff096d1f1c6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1676023f-1da5-4c57-86c5-6e2392ac2dc7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d9f14a6-e099-42a9-b39e-10868f463d29", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1676023f-1da5-4c57-86c5-6e2392ac2dc7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\n<span style=\"text-transform:uppercase\">form</span></span></b></p>", "ID": "9921ee67-abdd-456b-bbc5-cb7632a60e76", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\n<span style=\"text-transform:uppercase\">form</span></span></b>", "ID": "b46971c9-e883-4b5b-bd56-984b1ccac58a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9921ee67-abdd-456b-bbc5-cb7632a60e76"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\n<span style=\"text-transform:uppercase\">form</span></span>", "ID": "462bc71d-8010-4141-b3ad-b9f5feaa8a66", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL ", "ParentId": "b46971c9-e883-4b5b-bd56-984b1ccac58a"}, {"Element": "<span style=\"text-transform:uppercase\">form</span>", "ID": "27e46d41-f53f-425f-91ed-b44b263fc96d", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "form", "ParentId": "462bc71d-8010-4141-b3ad-b9f5feaa8a66"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a42169c5-158e-4af5-8610-c351a3e70b9b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b0cc6f70-8e77-49d8-bd0c-f6d9c4608655", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a42169c5-158e-4af5-8610-c351a3e70b9b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Film-coated tablet </span></p>", "ID": "2af334fc-c556-441d-a5c7-6ecadb872fd5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Film-coated tablet </span>", "ID": "f376ef6d-e5a1-486b-8bd3-abe8eac72dc8", "Styles": "None", "Classes": "None", "Text": "Film-coated tablet ", "ParentId": "2af334fc-c556-441d-a5c7-6ecadb872fd5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ca203fda-9755-402b-be87-ad92bbb57bdc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d5d70f91-95b1-41bc-9160-2335c7326612", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ca203fda-9755-402b-be87-ad92bbb57bdc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Orange</span><span lang=\"EN-GB\">, capsule\nshaped, biconvex film-coated tablet \u2013 engraved with \u201cL 100\u201d\non one side and plain on the other.</span></p>", "ID": "c9766e34-2981-4557-baa8-eb647885a3dd", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Orange</span>", "ID": "0794ab69-7042-4a56-8236-b743647cf127", "Styles": "None", "Classes": "None", "Text": "Orange", "ParentId": "c9766e34-2981-4557-baa8-eb647885a3dd"}, {"Element": "<span lang=\"EN-GB\">, capsule\nshaped, biconvex film-coated tablet \u2013 engraved with \u201cL 100\u201d\non one side and plain on the other.</span>", "ID": "e29d6789-77bf-4101-886d-e437abe898ee", "Styles": "None", "Classes": "None", "Text": ", capsule shaped, biconvex film-coated tablet \u2013 engraved with \u201cL 100\u201d on one side and plain on the other.", "ParentId": "c9766e34-2981-4557-baa8-eb647885a3dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "211fb79a-f043-4ad1-b4eb-2e201426c1c5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f0103bf5-a0a3-4584-9e2d-4881d9d6e115", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "211fb79a-f043-4ad1-b4eb-2e201426c1c5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical\nparticulars</span></b></p>", "ID": "c7bcb9dd-7cf7-4ce0-ab7c-665d6104461c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical\nparticulars</span></b>", "ID": "e250572a-206a-4147-9b8a-1bef6e5365a8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c7bcb9dd-7cf7-4ce0-ab7c-665d6104461c"}, {"Element": "<span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical\nparticulars</span>", "ID": "3881326e-1466-49fb-9e74-cdca142012ae", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Clinical particulars", "ParentId": "e250572a-206a-4147-9b8a-1bef6e5365a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "19d1c009-196a-46a4-a9cd-586b9e60e4e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8791de6a-9a7c-4011-996f-abf32caa10ea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "19d1c009-196a-46a4-a9cd-586b9e60e4e2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></b></p>", "ID": "8b01b96b-2071-46b1-8713-fadfbfcdbce6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></b>", "ID": "ecb9aa50-6ce6-4892-9a26-512469fb7388", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8b01b96b-2071-46b1-8713-fadfbfcdbce6"}, {"Element": "<span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span>", "ID": "781f267f-c293-4bbe-8e2e-9cf6a7705956", "Styles": "None", "Classes": "None", "Text": "4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications", "ParentId": "ecb9aa50-6ce6-4892-9a26-512469fb7388"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "522983be-b9ba-4b46-a073-af100ad488bd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df802c75-9b1a-4c96-9aa9-7c07c7392aea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "522983be-b9ba-4b46-a073-af100ad488bd"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva is indicated for the\ntreatment of chronic hepatitis B in adults with: </span></p>", "ID": "943d277d-e8e1-42c8-a0c8-977e6a6ea997", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva is indicated for the\ntreatment of chronic hepatitis B in adults with: </span>", "ID": "d0b3ed66-f4f6-452f-9230-790182862c1c", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva is indicated for the treatment of chronic hepatitis B in adults with: ", "ParentId": "943d277d-e8e1-42c8-a0c8-977e6a6ea997"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e69d8d7a-aa58-4074-abd8-e3b8e8135d5f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5fe467f3-bf80-40aa-8354-4c405fb41eea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e69d8d7a-aa58-4074-abd8-e3b8e8135d5f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">compensated liver disease with evidence of\nactive viral replication, persistently elevated serum alanine aminotransferase\n(ALT) levels and histological evidence of active liver inflammation and / or\nfibrosis. </span><span lang=\"EN-GB\" style=\"color:black\">Initiation of lamivudine\ntreatment should only be considered when the use of an alternative antiviral\nagent with a higher genetic barrier is not available or appropriate (see\nsection 5.1).</span></p>", "ID": "af8b72ff-a8d5-4e95-8b7a-085530bb6ac6", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "bb516d06-6b24-442b-b5e7-15295d729531", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "af8b72ff-a8d5-4e95-8b7a-085530bb6ac6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b170752c-33fb-4bd7-af0e-d69f6792ae7b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "bb516d06-6b24-442b-b5e7-15295d729531"}, {"Element": "<span lang=\"EN-GB\">compensated liver disease with evidence of\nactive viral replication, persistently elevated serum alanine aminotransferase\n(ALT) levels and histological evidence of active liver inflammation and / or\nfibrosis. </span>", "ID": "6a892eff-f195-4f17-baeb-59dc7f9586e9", "Styles": "None", "Classes": "None", "Text": "compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active liver inflammation and / or fibrosis. ", "ParentId": "af8b72ff-a8d5-4e95-8b7a-085530bb6ac6"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Initiation of lamivudine\ntreatment should only be considered when the use of an alternative antiviral\nagent with a higher genetic barrier is not available or appropriate (see\nsection 5.1).</span>", "ID": "2400e412-462b-40f6-8c34-26a78194fe00", "Styles": "color:black", "Classes": "None", "Text": "Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate (see section 5.1).", "ParentId": "af8b72ff-a8d5-4e95-8b7a-085530bb6ac6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "339e6ba4-7213-42d4-88a3-48f880c7ca98", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "98ab876c-fe2e-4ce3-9d2b-28f5256365d3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "339e6ba4-7213-42d4-88a3-48f880c7ca98"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.2<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">Posology and method of administration</span></b></p>", "ID": "4eb21b0b-5428-4eee-8cf4-9a2e54bfb43a", "Styles": "margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.2<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b>", "ID": "788a62ae-24bb-432c-8539-e61508689749", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4eb21b0b-5428-4eee-8cf4-9a2e54bfb43a"}, {"Element": "<span lang=\"EN-GB\">4.2<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "7905de4a-d1df-496a-afe2-1870d5aae6f5", "Styles": "None", "Classes": "None", "Text": "4.2", "ParentId": "788a62ae-24bb-432c-8539-e61508689749"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "1c428254-55f7-40f7-9ec6-9b7d9f202cac", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "7905de4a-d1df-496a-afe2-1870d5aae6f5"}, {"Element": "<b><span lang=\"EN-GB\">Posology and method of administration</span></b>", "ID": "25b5f5f5-67c2-440f-bb22-c22bffc63468", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4eb21b0b-5428-4eee-8cf4-9a2e54bfb43a"}, {"Element": "<span lang=\"EN-GB\">Posology and method of administration</span>", "ID": "b65ea45d-4c62-4dcf-9209-521e763d0058", "Styles": "None", "Classes": "None", "Text": "Posology and method of administration", "ParentId": "25b5f5f5-67c2-440f-bb22-c22bffc63468"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "02dd61d0-ccba-4450-af0e-19127d4d3a32", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e27f5222-9e81-4db8-b9f5-8036cc48d4a7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "02dd61d0-ccba-4450-af0e-19127d4d3a32"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Therapy with Lamivudine Teva should be\ninitiated by a physician experienced in the management of chronic hepatitis B. </span></p>", "ID": "02ac1331-eb89-4329-9231-930dcbe3bea5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Therapy with Lamivudine Teva should be\ninitiated by a physician experienced in the management of chronic hepatitis B. </span>", "ID": "2b77e3cc-d49d-4820-8cad-ef6a852314d7", "Styles": "None", "Classes": "None", "Text": "Therapy with Lamivudine Teva should be initiated by a physician experienced in the management of chronic hepatitis B. ", "ParentId": "02ac1331-eb89-4329-9231-930dcbe3bea5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "ca5c98fc-81e4-48e8-a93b-c6c0a91e9d9e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "1ecdcca2-a794-4ab3-bbcc-9694d509faec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ca5c98fc-81e4-48e8-a93b-c6c0a91e9d9e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1b1c09b1-798e-4829-be4f-245bee9b0ab4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1ecdcca2-a794-4ab3-bbcc-9694d509faec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Posology</span></u></p>", "ID": "45a13149-4bf3-4fd4-884a-991f8eb879bf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Posology</span></u>", "ID": "bb608787-3647-4d81-b3ea-3a055376dfb5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45a13149-4bf3-4fd4-884a-991f8eb879bf"}, {"Element": "<span lang=\"EN-GB\">Posology</span>", "ID": "55799425-54db-4105-a033-cf7aaa05c154", "Styles": "None", "Classes": "None", "Text": "Posology", "ParentId": "bb608787-3647-4d81-b3ea-3a055376dfb5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "713510d2-0e6d-4c05-b4ac-eec8bde13783", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64c80714-ebe5-44d0-b8a9-6b1c708e8618", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "713510d2-0e6d-4c05-b4ac-eec8bde13783"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Adults</span></i><span lang=\"EN-GB\"> </span></p>", "ID": "ff98cdc3-f577-4818-99d1-c8cdb61281c7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Adults</span></i>", "ID": "65f03da7-7b9a-44b4-b802-4dced93e197d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff98cdc3-f577-4818-99d1-c8cdb61281c7"}, {"Element": "<span lang=\"EN-GB\">Adults</span>", "ID": "40c296d0-b047-49e3-83d7-a2af30321504", "Styles": "None", "Classes": "None", "Text": "Adults", "ParentId": "65f03da7-7b9a-44b4-b802-4dced93e197d"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "0dd04344-3aa7-476b-9212-3be3aa1e3124", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "ff98cdc3-f577-4818-99d1-c8cdb61281c7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The recommended dosage of Lamivudine Teva\nis 100\u00a0mg once daily.</span></p>", "ID": "064d9a4c-d99e-4505-a0db-89be80c1b6f4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The recommended dosage of Lamivudine Teva\nis 100\u00a0mg once daily.</span>", "ID": "0a928d4c-8916-418e-b49c-e627078b7e47", "Styles": "None", "Classes": "None", "Text": "The recommended dosage of Lamivudine Teva is 100\u00a0mg once daily.", "ParentId": "064d9a4c-d99e-4505-a0db-89be80c1b6f4"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "089dc52e-c35c-4aea-818d-f64bc9908a79", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "33e76959-c2d6-4d7e-a5ed-9648614ff16c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "089dc52e-c35c-4aea-818d-f64bc9908a79"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Duration of treatment </span></i></p>", "ID": "027770e5-0d3b-4617-9829-e05dda2717cc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Duration of treatment </span></i>", "ID": "70ceb0c9-130d-4bc6-af84-1b560aa58260", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "027770e5-0d3b-4617-9829-e05dda2717cc"}, {"Element": "<span lang=\"EN-GB\">Duration of treatment </span>", "ID": "99495894-d53e-4220-a088-a088c2724e4a", "Styles": "None", "Classes": "None", "Text": "Duration of treatment ", "ParentId": "70ceb0c9-130d-4bc6-af84-1b560aa58260"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">The optimal duration of\ntreatment is unknown.</span></p>", "ID": "79a7ff34-0d21-4eec-a689-f026415a3410", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">The optimal duration of\ntreatment is unknown.</span>", "ID": "9ac159d7-869d-4975-93e2-ba15efeb4555", "Styles": "color:black", "Classes": "None", "Text": "The optimal duration of treatment is unknown.", "ParentId": "79a7ff34-0d21-4eec-a689-f026415a3410"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e803cb9c-2912-45e6-b326-7b4ff9700589", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6af2e182-cb5e-4926-b1b3-0a935190cd15", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e803cb9c-2912-45e6-b326-7b4ff9700589"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">In patients with HBeAg positive chronic\nhepatitis B (CHB) without cirrhosis, treatment should be administered for at\nleast 6-12 months after HBeAg seroconversion (HBeAg and HBV DNA loss with HBeAb\ndetection) is confirmed, to limit the risk of virological relapse, or until\nHBsAg seroconversion </span><span lang=\"EN-GB\">or there is loss of efficacy\n(see\u00a0section\u00a04.4). Serum ALT and HBV\u00a0DNA levels should be\nfollowed regularly after treatment discontinuation to detect any late\nvirological relapse</span><span lang=\"EN-GB\" style=\"color:black\">.</span><span lang=\"EN-GB\"> </span></p>", "ID": "ab698b6c-4b18-40ea-9e1f-2ad71dbbc655", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c731d4bb-f2fe-4083-b0fa-c1283f42a68b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ab698b6c-4b18-40ea-9e1f-2ad71dbbc655"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b30c0667-4eef-4ee1-8763-f32b5d2c2c7e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c731d4bb-f2fe-4083-b0fa-c1283f42a68b"}, {"Element": "<span lang=\"EN-GB\">In patients with HBeAg positive chronic\nhepatitis B (CHB) without cirrhosis, treatment should be administered for at\nleast 6-12 months after HBeAg seroconversion (HBeAg and HBV DNA loss with HBeAb\ndetection) is confirmed, to limit the risk of virological relapse, or until\nHBsAg seroconversion </span>", "ID": "715c1730-3d4d-493a-9f4c-e871b164be5e", "Styles": "None", "Classes": "None", "Text": "In patients with HBeAg positive chronic hepatitis B (CHB) without cirrhosis, treatment should be administered for at least 6-12 months after HBeAg seroconversion (HBeAg and HBV DNA loss with HBeAb detection) is confirmed, to limit the risk of virological relapse, or until HBsAg seroconversion ", "ParentId": "ab698b6c-4b18-40ea-9e1f-2ad71dbbc655"}, {"Element": "<span lang=\"EN-GB\">or there is loss of efficacy\n(see\u00a0section\u00a04.4). Serum ALT and HBV\u00a0DNA levels should be\nfollowed regularly after treatment discontinuation to detect any late\nvirological relapse</span>", "ID": "d7b5edb2-d2e0-4301-8283-3c14233e0007", "Styles": "None", "Classes": "None", "Text": "or there is loss of efficacy (see\u00a0section\u00a04.4). Serum ALT and HBV\u00a0DNA levels should be followed regularly after treatment discontinuation to detect any late virological relapse", "ParentId": "ab698b6c-4b18-40ea-9e1f-2ad71dbbc655"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">.</span>", "ID": "9a93a5ee-89e4-4dc4-933c-45535278c2ba", "Styles": "color:black", "Classes": "None", "Text": ".", "ParentId": "ab698b6c-4b18-40ea-9e1f-2ad71dbbc655"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "cbf80b2a-4f0c-4145-955a-70f828acc8ab", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "ab698b6c-4b18-40ea-9e1f-2ad71dbbc655"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">In patients with HBeAg negative CHB (pre-core\nmutant) </span><span lang=\"EN-GB\" style=\"color:black\">without cirrhosis, </span><span lang=\"EN-GB\">treatment should be administered at least until\nHBs\u00a0seroconversion or there is evidence of loss of efficacy. </span><span lang=\"EN-GB\" style=\"color:black\">With prolonged treatment, regular reassessment\nis recommended to confirm that continuation of the selected therapy remains\nappropriate for the patient</span><span lang=\"EN-GB\" style=\"color:black\">.</span><span lang=\"EN-GB\"> </span></p>", "ID": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b8a42e73-0203-447a-8e37-1acc87db408d", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8a68fed2-bddf-4aa4-92f0-3254e8245932", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b8a42e73-0203-447a-8e37-1acc87db408d"}, {"Element": "<span lang=\"EN-GB\">In patients with HBeAg negative CHB (pre-core\nmutant) </span>", "ID": "c257955a-2cad-46c4-b323-3e016eb5b80b", "Styles": "None", "Classes": "None", "Text": "In patients with HBeAg negative CHB (pre-core mutant) ", "ParentId": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">without cirrhosis, </span>", "ID": "36c0c290-3808-416e-86b8-3b5aa3f0a8ac", "Styles": "color:black", "Classes": "None", "Text": "without cirrhosis, ", "ParentId": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a"}, {"Element": "<span lang=\"EN-GB\">treatment should be administered at least until\nHBs\u00a0seroconversion or there is evidence of loss of efficacy. </span>", "ID": "b9a1b115-16ff-4aad-a64e-077d740ea65f", "Styles": "None", "Classes": "None", "Text": "treatment should be administered at least until HBs\u00a0seroconversion or there is evidence of loss of efficacy. ", "ParentId": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">With prolonged treatment, regular reassessment\nis recommended to confirm that continuation of the selected therapy remains\nappropriate for the patient</span>", "ID": "8431bb62-9e12-4be2-93c8-f08f4af0e8c4", "Styles": "color:black", "Classes": "None", "Text": "With prolonged treatment, regular reassessment is recommended to confirm that continuation of the selected therapy remains appropriate for the patient", "ParentId": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">.</span>", "ID": "425202a7-eb5f-4cc3-be70-729b1f2b134f", "Styles": "color:black", "Classes": "None", "Text": ".", "ParentId": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "d0cc392c-5aa8-4194-93b2-285e7a789fae", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "2be6c548-9149-4ca2-b0cd-b74f0c963a7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">In patients with cirrhosis and in liver\ntransplant recipients, treatment cessation is not recommended (see section\n5.1). </span></p>", "ID": "7329468a-74fd-46f8-85bf-5b76e8a7cef9", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "cb122d34-120e-41fc-b4d7-036bad9bc593", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7329468a-74fd-46f8-85bf-5b76e8a7cef9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "df82bdba-f116-4516-8ef8-ec55118c3649", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "cb122d34-120e-41fc-b4d7-036bad9bc593"}, {"Element": "<span lang=\"EN-GB\">In patients with cirrhosis and in liver\ntransplant recipients, treatment cessation is not recommended (see section\n5.1). </span>", "ID": "3e1db0ad-6da8-433f-a6dc-1ef4d5eb17b3", "Styles": "None", "Classes": "None", "Text": "In patients with cirrhosis and in liver transplant recipients, treatment cessation is not recommended (see section 5.1). ", "ParentId": "7329468a-74fd-46f8-85bf-5b76e8a7cef9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "08c39f04-f400-410f-927e-5504f9494f92", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "51343636-0036-4a70-8219-4c61c2343c55", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "08c39f04-f400-410f-927e-5504f9494f92"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">If lamivudine is discontinued, patients\nshould be periodically monitored for evidence of recurrent hepatitis (see\nsection 4.4). </span></p>", "ID": "4f6cea9c-e1dd-43a7-a035-2afbd187f94a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">If lamivudine is discontinued, patients\nshould be periodically monitored for evidence of recurrent hepatitis (see\nsection 4.4). </span>", "ID": "1acab0c3-963e-4330-a570-fb88cc5f3b07", "Styles": "None", "Classes": "None", "Text": "If lamivudine is discontinued, patients should be periodically monitored for evidence of recurrent hepatitis (see section 4.4). ", "ParentId": "4f6cea9c-e1dd-43a7-a035-2afbd187f94a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4be0386-00ba-4442-9d42-86568d3d86b0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "440ab270-0cb2-4b8f-9063-f355a0604eb6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4be0386-00ba-4442-9d42-86568d3d86b0"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><i><span lang=\"EN-GB\" style=\"color:black\">Clinical resistance </span></i></p>", "ID": "b2a63904-49a9-41dd-b1a5-9b3cde648fec", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">Clinical resistance </span></i>", "ID": "9c272503-23e3-41e9-a094-d50db7faeda3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b2a63904-49a9-41dd-b1a5-9b3cde648fec"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Clinical resistance </span>", "ID": "d44c7b03-534b-42e7-b8a8-a0eb3101cde8", "Styles": "color:black", "Classes": "None", "Text": "Clinical resistance ", "ParentId": "9c272503-23e3-41e9-a094-d50db7faeda3"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\" style=\"color:black\">In patients with either HBeAg positive or HBeAg negative\nCHB, the development of YMDD (tyrosine-methionine-aspartate-aspartate) mutant\nHBV may result in a diminished therapeutic response to lamivudine, indicated by\na rise in HBV DNA and ALT from previous on-treatment levels. In order to reduce\nthe risk of resistance in patients receiving lamivudine monotherapy, a switch\nto or addition of an alternative agent without cross-resistance to lamivudine\nbased on therapeutic guidelines should be considered if serum HBV DNA remains detectable\nat or beyond 24 weeks of treatment (see section 5.1).</span></p>", "ID": "9c7ef66d-6ec9-4559-a15e-298a736c3c4e", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">In patients with either HBeAg positive or HBeAg negative\nCHB, the development of YMDD (tyrosine-methionine-aspartate-aspartate) mutant\nHBV may result in a diminished therapeutic response to lamivudine, indicated by\na rise in HBV DNA and ALT from previous on-treatment levels. In order to reduce\nthe risk of resistance in patients receiving lamivudine monotherapy, a switch\nto or addition of an alternative agent without cross-resistance to lamivudine\nbased on therapeutic guidelines should be considered if serum HBV DNA remains detectable\nat or beyond 24 weeks of treatment (see section 5.1).</span>", "ID": "746f6ceb-b75f-4ed8-b17e-e0069586c4ed", "Styles": "color:black", "Classes": "None", "Text": "In patients with either HBeAg positive or HBeAg negative CHB, the development of YMDD (tyrosine-methionine-aspartate-aspartate) mutant HBV may result in a diminished therapeutic response to lamivudine, indicated by a rise in HBV DNA and ALT from previous on-treatment levels. In order to reduce the risk of resistance in patients receiving lamivudine monotherapy, a switch to or addition of an alternative agent without cross-resistance to lamivudine based on therapeutic guidelines should be considered if serum HBV DNA remains detectable at or beyond 24 weeks of treatment (see section 5.1).", "ParentId": "9c7ef66d-6ec9-4559-a15e-298a736c3c4e"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "9b89e263-22d2-49dd-9063-1e2403f4c51f", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "f6562e76-346b-4a02-a72e-b70a92947531", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "9b89e263-22d2-49dd-9063-1e2403f4c51f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">For the treatment of\npatients who are co-infected with HIV and are currently receiving or plan to\nreceive treatment with lamivudine or the combination lamivudine-zidovudine, the\ndose of lamivudine prescribed for HIV infection (usually 150\u00a0mg/twice\ndaily in combination with other antiretrovirals) should be maintained.</span></p>", "ID": "a94f8b59-764a-4935-b356-ae78e6b29940", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">For the treatment of\npatients who are co-infected with HIV and are currently receiving or plan to\nreceive treatment with lamivudine or the combination lamivudine-zidovudine, the\ndose of lamivudine prescribed for HIV infection (usually 150\u00a0mg/twice\ndaily in combination with other antiretrovirals) should be maintained.</span>", "ID": "37bf565f-17e0-497a-9ada-fef4de99d686", "Styles": "color:black", "Classes": "None", "Text": "For the treatment of patients who are co-infected with HIV and are currently receiving or plan to receive treatment with lamivudine or the combination lamivudine-zidovudine, the dose of lamivudine prescribed for HIV infection (usually 150\u00a0mg/twice daily in combination with other antiretrovirals) should be maintained.", "ParentId": "a94f8b59-764a-4935-b356-ae78e6b29940"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "abdd704d-7ee4-4e61-b059-04abc60a8766", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4a8f7fe9-cb55-44a8-8d91-461fa25ae4ed", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "abdd704d-7ee4-4e61-b059-04abc60a8766"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Special populations</span></u></p>", "ID": "33231075-3a8a-4fd9-9ab1-37a7fe98fd0f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Special populations</span></u>", "ID": "59221c96-2714-4943-9142-78364ffb51dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33231075-3a8a-4fd9-9ab1-37a7fe98fd0f"}, {"Element": "<span lang=\"EN-GB\">Special populations</span>", "ID": "d215e39f-1a96-4451-accd-737ba334beb1", "Styles": "None", "Classes": "None", "Text": "Special populations", "ParentId": "59221c96-2714-4943-9142-78364ffb51dc"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "2764ec00-3bd2-4173-99de-9d1a382b9f53", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "c98805d2-6102-405a-a73c-0538bf3fd817", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2764ec00-3bd2-4173-99de-9d1a382b9f53"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f30c7f48-6ad5-46d7-afbd-74d7153fddfc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c98805d2-6102-405a-a73c-0538bf3fd817"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Renal impairment </span></i></p>", "ID": "6275190d-b1f7-451b-ba61-929be06b9564", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Renal impairment </span></i>", "ID": "895a6afb-4b27-42af-98ec-324e77d0dfd0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6275190d-b1f7-451b-ba61-929be06b9564"}, {"Element": "<span lang=\"EN-GB\">Renal impairment </span>", "ID": "1f6b356a-080d-48ee-8281-29c3ef9bd67c", "Styles": "None", "Classes": "None", "Text": "Renal impairment ", "ParentId": "895a6afb-4b27-42af-98ec-324e77d0dfd0"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine serum concentrations (AUC) are\nincreased in patients with moderate to severe renal impairment due to decreased\nrenal clearance. The dosage should therefore be reduced for patients with a\ncreatinine clearance of &lt; 50\u00a0ml/minute. Lamivudine Teva is not suitable\nfor patients who require doses below 100\u00a0mg.</span></p>", "ID": "ccd7a192-b5f1-49b4-bcb9-e9ea0a4f5834", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine serum concentrations (AUC) are\nincreased in patients with moderate to severe renal impairment due to decreased\nrenal clearance. The dosage should therefore be reduced for patients with a\ncreatinine clearance of &lt; 50\u00a0ml/minute. Lamivudine Teva is not suitable\nfor patients who require doses below 100\u00a0mg.</span>", "ID": "4ef63f89-d54f-4a19-9b6e-697b3a98d941", "Styles": "None", "Classes": "None", "Text": "Lamivudine serum concentrations (AUC) are increased in patients with moderate to severe renal impairment due to decreased renal clearance. The dosage should therefore be reduced for patients with a creatinine clearance of < 50\u00a0ml/minute. Lamivudine Teva is not suitable for patients who require doses below 100\u00a0mg.", "ParentId": "ccd7a192-b5f1-49b4-bcb9-e9ea0a4f5834"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "954f10d4-1683-44b6-807e-b3668fc0ebe0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1046625e-6bea-474b-8e15-d0d255f5012d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "954f10d4-1683-44b6-807e-b3668fc0ebe0"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Data available in patients undergoing\nintermittent haemodialysis (for less than or equal to 4\u00a0hrs dialysis 2\u20113\ntimes weekly), indicate that following the initial dosage reduction of\nlamivudine to correct for the patient\u2019s creatinine clearance, no further\ndosage adjustments are required while undergoing dialysis. </span></p>", "ID": "62024d0b-98e6-4cec-8692-56627346d943", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Data available in patients undergoing\nintermittent haemodialysis (for less than or equal to 4\u00a0hrs dialysis 2\u20113\ntimes weekly), indicate that following the initial dosage reduction of\nlamivudine to correct for the patient\u2019s creatinine clearance, no further\ndosage adjustments are required while undergoing dialysis. </span>", "ID": "d224937e-3258-4ab4-b50e-37a1cd277d5e", "Styles": "None", "Classes": "None", "Text": "Data available in patients undergoing intermittent haemodialysis (for less than or equal to 4\u00a0hrs dialysis 2\u20113 times weekly), indicate that following the initial dosage reduction of lamivudine to correct for the patient\u2019s creatinine clearance, no further dosage adjustments are required while undergoing dialysis. ", "ParentId": "62024d0b-98e6-4cec-8692-56627346d943"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "370a8fd1-f2a6-4a48-b1aa-23024b49d613", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b14c0d12-22d0-4806-9c4b-6aa2c687fba2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "370a8fd1-f2a6-4a48-b1aa-23024b49d613"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>", "ID": "d6a475c4-fe20-4d1f-b322-3b94e511cdb1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Hepatic impairment</span></i>", "ID": "7a7997bc-39d1-4d23-bfbe-adb3c82abbc6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d6a475c4-fe20-4d1f-b322-3b94e511cdb1"}, {"Element": "<span lang=\"EN-GB\">Hepatic impairment</span>", "ID": "a562a686-a917-4c10-8249-048f166d9189", "Styles": "None", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "7a7997bc-39d1-4d23-bfbe-adb3c82abbc6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Data obtained in patients with hepatic\nimpairment, including those with end-stage liver disease awaiting transplant,\nshow that lamivudine pharmacokinetics are not significantly affected by hepatic\ndysfunction. Based on these data, no dose adjustment is necessary in patients\nwith hepatic impairment unless accompanied by renal impairment. </span></p>", "ID": "dd326416-e290-4ce1-994d-08c15547c70d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Data obtained in patients with hepatic\nimpairment, including those with end-stage liver disease awaiting transplant,\nshow that lamivudine pharmacokinetics are not significantly affected by hepatic\ndysfunction. Based on these data, no dose adjustment is necessary in patients\nwith hepatic impairment unless accompanied by renal impairment. </span>", "ID": "2c51868c-ac7b-4a19-bfe0-2a4e41502636", "Styles": "None", "Classes": "None", "Text": "Data obtained in patients with hepatic impairment, including those with end-stage liver disease awaiting transplant, show that lamivudine pharmacokinetics are not significantly affected by hepatic dysfunction. Based on these data, no dose adjustment is necessary in patients with hepatic impairment unless accompanied by renal impairment. ", "ParentId": "dd326416-e290-4ce1-994d-08c15547c70d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4dab85aa-09e1-4d21-91f4-ae7d1d387be2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fa3894a8-471b-4d40-b624-637821e3b0d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4dab85aa-09e1-4d21-91f4-ae7d1d387be2"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Elderly</span></i></p>", "ID": "64218cc2-8d02-44e1-8868-6a39d0b26c1a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Elderly</span></i>", "ID": "ccaa3363-2654-42d2-9605-57e00d25ba06", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "64218cc2-8d02-44e1-8868-6a39d0b26c1a"}, {"Element": "<span lang=\"EN-GB\">Elderly</span>", "ID": "160a6af9-4df1-49ee-a0b5-7c09b748891f", "Styles": "None", "Classes": "None", "Text": "Elderly", "ParentId": "ccaa3363-2654-42d2-9605-57e00d25ba06"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In elderly patients, normal ageing with\naccompanying renal decline has no clinically significant effect on lamivudine\nexposure, except in patients with creatinine clearance of &lt; 50 ml/min.</span></p>", "ID": "d828ff1d-9b10-4211-ad05-7625549a3035", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In elderly patients, normal ageing with\naccompanying renal decline has no clinically significant effect on lamivudine\nexposure, except in patients with creatinine clearance of &lt; 50 ml/min.</span>", "ID": "ef6d82cb-ea63-4153-b1fb-9d30deb6c87d", "Styles": "None", "Classes": "None", "Text": "In elderly patients, normal ageing with accompanying renal decline has no clinically significant effect on lamivudine exposure, except in patients with creatinine clearance of < 50 ml/min.", "ParentId": "d828ff1d-9b10-4211-ad05-7625549a3035"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "49f2c0b6-c153-4404-8370-05477d965a41", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "07f763e9-0bb9-4605-9f30-789b7031bf14", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "49f2c0b6-c153-4404-8370-05477d965a41"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "267ae128-aa33-4f5a-ab49-cc9f26aadbe4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "07f763e9-0bb9-4605-9f30-789b7031bf14"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>", "ID": "78deb827-0beb-41fc-a13e-f1be8f6ddbfc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Paediatric population</span></i>", "ID": "4119e241-5ce6-4db4-aaff-2c8136ee1b8e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "78deb827-0beb-41fc-a13e-f1be8f6ddbfc"}, {"Element": "<span lang=\"EN-GB\">Paediatric population</span>", "ID": "89354126-9876-4816-83e4-3a6a7466a17f", "Styles": "None", "Classes": "None", "Text": "Paediatric population", "ParentId": "4119e241-5ce6-4db4-aaff-2c8136ee1b8e"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">The safety and efficacy of Lamivudine Teva in infants,\nchildren and adolescents aged below 18 years have not been established.\nCurrently available data are described in sections 4.4 and 5.1 but no\nrecommendation on a posology can be made.</span></p>", "ID": "ea424e59-0e97-4d72-8d7e-0b2da9acb3d6", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">The safety and efficacy of Lamivudine Teva in infants,\nchildren and adolescents aged below 18 years have not been established.\nCurrently available data are described in sections 4.4 and 5.1 but no\nrecommendation on a posology can be made.</span>", "ID": "bfbe4d80-67bf-4e1a-afa1-7949da03d6b5", "Styles": "color:black", "Classes": "None", "Text": "The safety and efficacy of Lamivudine Teva in infants, children and adolescents aged below 18 years have not been established. Currently available data are described in sections 4.4 and 5.1 but no recommendation on a posology can be made.", "ParentId": "ea424e59-0e97-4d72-8d7e-0b2da9acb3d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "690498ad-5e6b-49a2-920c-98b15c5026c9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c7b7cbc3-0a8b-4e23-85a8-4c3c1d714c5f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "690498ad-5e6b-49a2-920c-98b15c5026c9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "23f7a8e9-2e6c-4170-86d9-b8026e790bf9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c7b7cbc3-0a8b-4e23-85a8-4c3c1d714c5f"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>", "ID": "3b3d764e-6015-4d04-b4ac-14718cd14204", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Method of administration</span></u>", "ID": "4edbcaa7-dda1-4752-90d6-50af6f3586c7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3b3d764e-6015-4d04-b4ac-14718cd14204"}, {"Element": "<span lang=\"EN-GB\">Method of administration</span>", "ID": "3b52477d-8fef-449c-aa54-910b36bac81b", "Styles": "None", "Classes": "None", "Text": "Method of administration", "ParentId": "4edbcaa7-dda1-4752-90d6-50af6f3586c7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Oral use. </span></p>", "ID": "ff9d1f75-2b88-4aa6-9b7b-1c8194097a7e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Oral use. </span>", "ID": "e640de1a-e7b7-4175-9e24-0ff98d27fff0", "Styles": "color:black", "Classes": "None", "Text": "Oral use. ", "ParentId": "ff9d1f75-2b88-4aa6-9b7b-1c8194097a7e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva can be\ntaken with or without food.</span></p>", "ID": "bcc80f02-af24-4c97-94fc-f7418237e1f2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva can be\ntaken with or without food.</span>", "ID": "89737096-08c8-4410-875c-dd3907456993", "Styles": "color:black", "Classes": "None", "Text": "Lamivudine Teva can be taken with or without food.", "ParentId": "bcc80f02-af24-4c97-94fc-f7418237e1f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5e06c22b-fb7e-4008-a0c1-6568445dbc84", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e8172dd3-7f1b-417f-a7b6-4906b4cc1ff7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5e06c22b-fb7e-4008-a0c1-6568445dbc84"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "912f7a6b-c36b-4678-b39f-3f5e85ad4eb3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e8172dd3-7f1b-417f-a7b6-4906b4cc1ff7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b>4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</b></p>", "ID": "4ea736ba-11ec-4646-95c0-fff44b04eddf", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b>4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</b>", "ID": "7e344d88-1732-4e99-88c1-a3f7532c04c5", "Styles": "None", "Classes": "None", "Text": "4.3\u00a0\u00a0\u00a0\u00a0 Contraindications", "ParentId": "4ea736ba-11ec-4646-95c0-fff44b04eddf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "570c2fdb-0bae-4bfb-ab39-3c9420710bd0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or\nto any of the excipients </span><span lang=\"EN-GB\" style=\"color:black\">listed in\nsection 6.1</span><span lang=\"EN-GB\">. </span></p>", "ID": "eea924f5-aa8a-4b41-90ed-c76bc7dd3b74", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Hypersensitivity to the active substance or\nto any of the excipients </span>", "ID": "fca8bf4c-b5ef-43dc-82e9-fa8fbdddbd55", "Styles": "None", "Classes": "None", "Text": "Hypersensitivity to the active substance or to any of the excipients ", "ParentId": "eea924f5-aa8a-4b41-90ed-c76bc7dd3b74"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">listed in\nsection 6.1</span>", "ID": "6bf0e40f-6b13-4d5a-88c0-c4da67d20e7e", "Styles": "color:black", "Classes": "None", "Text": "listed in section 6.1", "ParentId": "eea924f5-aa8a-4b41-90ed-c76bc7dd3b74"}, {"Element": "<span lang=\"EN-GB\">. </span>", "ID": "78f63121-f8f7-401b-a63a-90eacff807a1", "Styles": "None", "Classes": "None", "Text": ". ", "ParentId": "eea924f5-aa8a-4b41-90ed-c76bc7dd3b74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cbc4ce59-ef1c-4df3-b6ef-2d9b84602326", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dad1df20-a0a3-41dd-9bde-30b56d1f3920", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cbc4ce59-ef1c-4df3-b6ef-2d9b84602326"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></b></p>", "ID": "d2ad7ee4-7057-41a8-9d1e-bca80abf8206", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></b>", "ID": "1165ab27-493d-4265-8f6a-713a7068641d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d2ad7ee4-7057-41a8-9d1e-bca80abf8206"}, {"Element": "<span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span>", "ID": "cef5c55b-a2b5-48f3-991e-70d603254685", "Styles": "None", "Classes": "None", "Text": "4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use", "ParentId": "1165ab27-493d-4265-8f6a-713a7068641d"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "acdd8fc9-9e93-407d-ad43-1fcf3c533ca8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "cb06b0e0-0585-484e-9bf4-4f21187ff556", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "acdd8fc9-9e93-407d-ad43-1fcf3c533ca8"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "ea504c32-4415-493d-baec-f61037f0622d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb06b0e0-0585-484e-9bf4-4f21187ff556"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "6c32bf7c-20ea-4a5b-894e-adee78b816be", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "ea504c32-4415-493d-baec-f61037f0622d"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Lactic acidosis and severe hepatomegaly\nwith steatosis</span></u></p>", "ID": "677c1960-2663-48ed-8d76-d46d07e60858", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Lactic acidosis and severe hepatomegaly\nwith steatosis</span></u>", "ID": "200ff074-5962-471c-a220-436f4ae80565", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "677c1960-2663-48ed-8d76-d46d07e60858"}, {"Element": "<span lang=\"EN-GB\">Lactic acidosis and severe hepatomegaly\nwith steatosis</span>", "ID": "a52e344c-5895-4b22-af7c-a90f825e9267", "Styles": "None", "Classes": "None", "Text": "Lactic acidosis and severe hepatomegaly with steatosis", "ParentId": "200ff074-5962-471c-a220-436f4ae80565"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "11866bfc-6693-4eb9-8dee-617a53c56492", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "7c6705de-50b1-40a9-9581-dc1d7fdff06f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "11866bfc-6693-4eb9-8dee-617a53c56492"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3c6ec80f-5430-4fbf-8299-0157efebf0ec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7c6705de-50b1-40a9-9581-dc1d7fdff06f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Occurrences of lactic acidosis (in the\nabsence of hypoxaemia), sometimes fatal, usually associated with severe\nhepatomegaly and hepatic steatosis, have been reported with the use of\nnucleoside analogues. As <span style=\"color:black\">lamivudine </span>is a\nnucleoside analogue, this risk cannot be excluded. Treatment with nucleoside\nanalogues should be discontinued when rapidly elevating aminotransferase\nlevels, progressive hepatomegaly or metabolic/lactic acidosis of unknown\naetiology occur. Benign digestive symptoms, such as nausea, vomiting and\nabdominal pain, might be indicative of lactic acidosis development. Severe\ncases, sometimes with fatal outcome, were associated with pancreatitis, liver\nfailure/hepatic steatosis, renal failure and higher levels of serum lactate.\nCaution should be exercised when prescribing nucleoside analogues to any patient\n(particularly obese women) with hepatomegaly, hepatitis or other known risk\nfactors for liver disease and hepatic steatosis (including certain medicinal\nproducts and alcohol). Patients co-infected with hepatitis C and treated with\nalpha interferon and ribivirin may constitute a special risk. These patients\nshould be followed closely.</span></p>", "ID": "969e7c6c-2270-46d6-aa94-1fbb84284f71", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Occurrences of lactic acidosis (in the\nabsence of hypoxaemia), sometimes fatal, usually associated with severe\nhepatomegaly and hepatic steatosis, have been reported with the use of\nnucleoside analogues. As <span style=\"color:black\">lamivudine </span>is a\nnucleoside analogue, this risk cannot be excluded. Treatment with nucleoside\nanalogues should be discontinued when rapidly elevating aminotransferase\nlevels, progressive hepatomegaly or metabolic/lactic acidosis of unknown\naetiology occur. Benign digestive symptoms, such as nausea, vomiting and\nabdominal pain, might be indicative of lactic acidosis development. Severe\ncases, sometimes with fatal outcome, were associated with pancreatitis, liver\nfailure/hepatic steatosis, renal failure and higher levels of serum lactate.\nCaution should be exercised when prescribing nucleoside analogues to any patient\n(particularly obese women) with hepatomegaly, hepatitis or other known risk\nfactors for liver disease and hepatic steatosis (including certain medicinal\nproducts and alcohol). Patients co-infected with hepatitis C and treated with\nalpha interferon and ribivirin may constitute a special risk. These patients\nshould be followed closely.</span>", "ID": "4d667bc4-7dfe-4e87-a941-989b4bf1a43f", "Styles": "None", "Classes": "None", "Text": "Occurrences of lactic acidosis (in the absence of hypoxaemia), sometimes fatal, usually associated with severe hepatomegaly and hepatic steatosis, have been reported with the use of nucleoside analogues. As is a nucleoside analogue, this risk cannot be excluded. Treatment with nucleoside analogues should be discontinued when rapidly elevating aminotransferase levels, progressive hepatomegaly or metabolic/lactic acidosis of unknown aetiology occur. Benign digestive symptoms, such as nausea, vomiting and abdominal pain, might be indicative of lactic acidosis development. Severe cases, sometimes with fatal outcome, were associated with pancreatitis, liver failure/hepatic steatosis, renal failure and higher levels of serum lactate. Caution should be exercised when prescribing nucleoside analogues to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease and hepatic steatosis (including certain medicinal products and alcohol). Patients co-infected with hepatitis C and treated with alpha interferon and ribivirin may constitute a special risk. These patients should be followed closely.", "ParentId": "969e7c6c-2270-46d6-aa94-1fbb84284f71"}, {"Element": "<span style=\"color:black\">lamivudine </span>", "ID": "982cf219-7ba7-4109-8393-b459b71bc766", "Styles": "color:black", "Classes": "None", "Text": "lamivudine ", "ParentId": "4d667bc4-7dfe-4e87-a941-989b4bf1a43f"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "57286379-3f59-492d-be33-005a53a9988b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "5c97ad6a-8d8f-4841-b7ca-4b5601817671", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "57286379-3f59-492d-be33-005a53a9988b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "732e461a-7bda-4b19-976f-9cefb89229b4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5c97ad6a-8d8f-4841-b7ca-4b5601817671"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\nhepatitis</span></u></p>", "ID": "1c623132-473c-47be-bbe0-8a0728017f6d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\nhepatitis</span></u>", "ID": "fd162200-fdc7-4ee7-a74d-27ceadc0b709", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1c623132-473c-47be-bbe0-8a0728017f6d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\nhepatitis</span>", "ID": "f3bc4b4c-122f-4e48-88f1-beedb1989f69", "Styles": "color:black", "Classes": "None", "Text": "Exacerbations of hepatitis", "ParentId": "fd162200-fdc7-4ee7-a74d-27ceadc0b709"}, {"Element": "<p class=\"MsoNormal\"><b><i><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></b></p>", "ID": "3dad4d00-06c9-4565-aadc-4c88dc5e3558", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><i><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></b>", "ID": "a636d611-7198-4ad8-ae17-7488f17710df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3dad4d00-06c9-4565-aadc-4c88dc5e3558"}, {"Element": "<i><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "99f3d97f-192b-4360-a4d9-e603e03a8ad6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a636d611-7198-4ad8-ae17-7488f17710df"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "9f6e631b-4eaa-48f4-825c-2658ee252f61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "99f3d97f-192b-4360-a4d9-e603e03a8ad6"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "b0f38bce-5652-4884-9611-9a50eb1a3c74", "Styles": "color:black", "Classes": "None", "Text": "", "ParentId": "9f6e631b-4eaa-48f4-825c-2658ee252f61"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "c953f57a-7006-427a-a565-2f2e245b7a4c", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "b0f38bce-5652-4884-9611-9a50eb1a3c74"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Exacerbations on\ntreatment</span></i></p>", "ID": "bf38c578-f13a-4459-89dd-3b3ee882af5d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">Exacerbations on\ntreatment</span></i>", "ID": "671e0f8d-1f43-4730-90bb-2d081da2595d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bf38c578-f13a-4459-89dd-3b3ee882af5d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Exacerbations on\ntreatment</span>", "ID": "a5a69d5a-ad68-4ccb-be04-f9cdeb691ce9", "Styles": "color:black", "Classes": "None", "Text": "Exacerbations on treatment", "ParentId": "671e0f8d-1f43-4730-90bb-2d081da2595d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Spontaneous\nexacerbations in chronic hepatitis B are relatively common and are\ncharacterised by transient increases in serum ALT. After initiating antiviral\ntherapy, serum ALT may increase in some patients as serum HBV DNA levels\ndecline. In patients with compensated liver disease, these increases in serum\nALT were generally not accompanied by an increase in serum bilirubin\nconcentrations or signs of hepatic decompensation.</span></p>", "ID": "3597d476-0a1c-41bf-862a-1c6edabb373a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Spontaneous\nexacerbations in chronic hepatitis B are relatively common and are\ncharacterised by transient increases in serum ALT. After initiating antiviral\ntherapy, serum ALT may increase in some patients as serum HBV DNA levels\ndecline. In patients with compensated liver disease, these increases in serum\nALT were generally not accompanied by an increase in serum bilirubin\nconcentrations or signs of hepatic decompensation.</span>", "ID": "aca56d5d-14ed-4de7-9222-47ba8fa94a7f", "Styles": "color:black", "Classes": "None", "Text": "Spontaneous exacerbations in chronic hepatitis B are relatively common and are characterised by transient increases in serum ALT. After initiating antiviral therapy, serum ALT may increase in some patients as serum HBV DNA levels decline. In patients with compensated liver disease, these increases in serum ALT were generally not accompanied by an increase in serum bilirubin concentrations or signs of hepatic decompensation.", "ParentId": "3597d476-0a1c-41bf-862a-1c6edabb373a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "a91eab47-7474-4cd7-9183-26e402c54f96", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "0ea72e07-9a97-4ff8-94eb-bced764f8067", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "a91eab47-7474-4cd7-9183-26e402c54f96"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">HBV viral\nsubpopulations with reduced susceptibility to lamivudine (YMDD mutant HBV) have\nbeen identified with extended therapy. In some patients the development of YMDD\nmutant HBV can lead to exacerbation of hepatitis, primarily detected by serum ALT\nelevations and re-emergence of HBV DNA (see section 4.2). In patients who have\nYMDD mutant HBV, a switch to or addition of an alternative agent without cross\nresistance to lamivudine based on therapeutic guidelines should be considered\n(see section 5.1).</span></p>", "ID": "2085a14e-e018-40e7-a705-c360994f988d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">HBV viral\nsubpopulations with reduced susceptibility to lamivudine (YMDD mutant HBV) have\nbeen identified with extended therapy. In some patients the development of YMDD\nmutant HBV can lead to exacerbation of hepatitis, primarily detected by serum ALT\nelevations and re-emergence of HBV DNA (see section 4.2). In patients who have\nYMDD mutant HBV, a switch to or addition of an alternative agent without cross\nresistance to lamivudine based on therapeutic guidelines should be considered\n(see section 5.1).</span>", "ID": "7fd8d35a-3b2a-482a-8d48-9e9201a74dda", "Styles": "color:black", "Classes": "None", "Text": "HBV viral subpopulations with reduced susceptibility to lamivudine (YMDD mutant HBV) have been identified with extended therapy. In some patients the development of YMDD mutant HBV can lead to exacerbation of hepatitis, primarily detected by serum ALT elevations and re-emergence of HBV DNA (see section 4.2). In patients who have YMDD mutant HBV, a switch to or addition of an alternative agent without cross resistance to lamivudine based on therapeutic guidelines should be considered (see section 5.1).", "ParentId": "2085a14e-e018-40e7-a705-c360994f988d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "62f64dba-ab79-498b-999c-127a1f52d6b4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "f894d32a-90a3-483a-a424-8b6968870743", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "62f64dba-ab79-498b-999c-127a1f52d6b4"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Exacerbations after\ntreatment discontinuation</span></i></p>", "ID": "ecbc0d3c-c75f-423b-bd3a-77407159fc6a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">Exacerbations after\ntreatment discontinuation</span></i>", "ID": "c14ef829-aac7-495d-9e23-69057b912a55", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ecbc0d3c-c75f-423b-bd3a-77407159fc6a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Exacerbations after\ntreatment discontinuation</span>", "ID": "d4b9a0fd-e4d0-4360-b9bc-4d5438f42f5a", "Styles": "color:black", "Classes": "None", "Text": "Exacerbations after treatment discontinuation", "ParentId": "c14ef829-aac7-495d-9e23-69057b912a55"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Acute exacerbation of\nhepatitis has been observed in patients who have discontinued hepatitis B\ntherapy and is usually </span><span lang=\"EN-GB\" style=\"color:black\">detected by\nserum ALT</span><span lang=\"EN-GB\" style=\"color:black\"> elevations and </span><span lang=\"EN-GB\" style=\"color:black\">re-emergence of HBV DNA</span><span lang=\"EN-GB\" style=\"color:black\">. In the controlled Phase III trials</span><span lang=\"EN-GB\"> <span style=\"color:black\">with no-active-treatment follow-up, the\nincidence of post-treatment ALT elevations (more than 3 times baseline) was\nhigher in lamivudine-treated patients (21%) compared with those receiving\nplacebo (8%). However, the proportion of patients who had post-treatment\nelevations associated with bilirubin elevations was low and similar in both\ntreatment arms (see Table 3 in section 5.1). For lamivudine-treated patients,\nthe majority of post-treatment ALT elevations occurred between 8 and 12 weeks\npost-treatment. Most events have been self-limiting, however some fatalities\nhave been observed. If Lamivudine Teva is discontinued, patients should be\nperiodically monitored both clinically and by assessment of serum liver\nfunction tests (ALT and bilirubin levels), for at least four months, and then\nas clinically indicated. </span></span></p>", "ID": "eec3bdf3-2f67-42dc-9205-b67c3ffb5bdd", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Acute exacerbation of\nhepatitis has been observed in patients who have discontinued hepatitis B\ntherapy and is usually </span>", "ID": "1927c18b-5ac3-473c-ac5c-7e18626f9f7d", "Styles": "color:black", "Classes": "None", "Text": "Acute exacerbation of hepatitis has been observed in patients who have discontinued hepatitis B therapy and is usually ", "ParentId": "eec3bdf3-2f67-42dc-9205-b67c3ffb5bdd"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">detected by\nserum ALT</span>", "ID": "53ffed4f-291b-4e48-99e4-9a5f8d661ff5", "Styles": "color:black", "Classes": "None", "Text": "detected by serum ALT", "ParentId": "eec3bdf3-2f67-42dc-9205-b67c3ffb5bdd"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> elevations and </span>", "ID": "d10bd5e6-e6ec-4551-b2e8-17e4ec1191d4", "Styles": "color:black", "Classes": "None", "Text": " elevations and ", "ParentId": "eec3bdf3-2f67-42dc-9205-b67c3ffb5bdd"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">re-emergence of HBV DNA</span>", "ID": "f2de3b38-4d20-4cab-ab6f-efe65d4de9c3", "Styles": "color:black", "Classes": "None", "Text": "re-emergence of HBV DNA", "ParentId": "eec3bdf3-2f67-42dc-9205-b67c3ffb5bdd"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">. In the controlled Phase III trials</span>", "ID": "a2e622ec-13de-4b01-a21f-38789578c9ff", "Styles": "color:black", "Classes": "None", "Text": ". In the controlled Phase III trials", "ParentId": "eec3bdf3-2f67-42dc-9205-b67c3ffb5bdd"}, {"Element": "<span lang=\"EN-GB\"> <span style=\"color:black\">with no-active-treatment follow-up, the\nincidence of post-treatment ALT elevations (more than 3 times baseline) was\nhigher in lamivudine-treated patients (21%) compared with those receiving\nplacebo (8%). However, the proportion of patients who had post-treatment\nelevations associated with bilirubin elevations was low and similar in both\ntreatment arms (see Table 3 in section 5.1). For lamivudine-treated patients,\nthe majority of post-treatment ALT elevations occurred between 8 and 12 weeks\npost-treatment. Most events have been self-limiting, however some fatalities\nhave been observed. If Lamivudine Teva is discontinued, patients should be\nperiodically monitored both clinically and by assessment of serum liver\nfunction tests (ALT and bilirubin levels), for at least four months, and then\nas clinically indicated. </span></span>", "ID": "192003e0-a17f-4d4f-994d-664c6186b885", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "eec3bdf3-2f67-42dc-9205-b67c3ffb5bdd"}, {"Element": "<span style=\"color:black\">with no-active-treatment follow-up, the\nincidence of post-treatment ALT elevations (more than 3 times baseline) was\nhigher in lamivudine-treated patients (21%) compared with those receiving\nplacebo (8%). However, the proportion of patients who had post-treatment\nelevations associated with bilirubin elevations was low and similar in both\ntreatment arms (see Table 3 in section 5.1). For lamivudine-treated patients,\nthe majority of post-treatment ALT elevations occurred between 8 and 12 weeks\npost-treatment. Most events have been self-limiting, however some fatalities\nhave been observed. If Lamivudine Teva is discontinued, patients should be\nperiodically monitored both clinically and by assessment of serum liver\nfunction tests (ALT and bilirubin levels), for at least four months, and then\nas clinically indicated. </span>", "ID": "a499c4ec-b136-4f38-9726-ed5552a64bf0", "Styles": "color:black", "Classes": "None", "Text": "with no-active-treatment follow-up, the incidence of post-treatment ALT elevations (more than 3 times baseline) was higher in lamivudine-treated patients (21%) compared with those receiving placebo (8%). However, the proportion of patients who had post-treatment elevations associated with bilirubin elevations was low and similar in both treatment arms (see Table 3 in section 5.1). For lamivudine-treated patients, the majority of post-treatment ALT elevations occurred between 8 and 12 weeks post-treatment. Most events have been self-limiting, however some fatalities have been observed. If Lamivudine Teva is discontinued, patients should be periodically monitored both clinically and by assessment of serum liver function tests (ALT and bilirubin levels), for at least four months, and then as clinically indicated. ", "ParentId": "192003e0-a17f-4d4f-994d-664c6186b885"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:yellow\">\u00a0</span></p>", "ID": "55998982-3701-4ec8-96aa-415fdd84d248", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:yellow\">\u00a0</span>", "ID": "458f5bd9-39cf-47b8-bdee-4a5a85d3c43c", "Styles": "color:black;background:yellow", "Classes": "None", "Text": "\u00a0", "ParentId": "55998982-3701-4ec8-96aa-415fdd84d248"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Transplantation\nrecipients are at greater risk from active viral replication. Due to the\nmarginal liver function in these patients, hepatitis reactivation at\ndiscontinuation of lamivudine or loss of efficacy during treatment may induce\nsevere and even fatal decompensation. These patients should be monitored for\nclinical, virological and serological parameters associated with hepatitis B,\nliver and renal function, and antiviral response during treatment (at least\nevery month), and, if treatment is discontinued for any reason, for at least 6\nmonths after treatment. Laboratory parameters to be monitored should include\n(as a minimum) serum ALT, bilirubin, albumin, blood urea nitrogen, creatinine,\nand virological status: HBV antigen/antibody, and serum HBV DNA concentrations when possible. Patients experiencing signs of hepatic insufficiency during or\npost-treatment should be monitored more frequently as appropriate.</span></p>", "ID": "ae88f0c0-6e1d-419b-89c3-eea4b8418128", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Transplantation\nrecipients are at greater risk from active viral replication. Due to the\nmarginal liver function in these patients, hepatitis reactivation at\ndiscontinuation of lamivudine or loss of efficacy during treatment may induce\nsevere and even fatal decompensation. These patients should be monitored for\nclinical, virological and serological parameters associated with hepatitis B,\nliver and renal function, and antiviral response during treatment (at least\nevery month), and, if treatment is discontinued for any reason, for at least 6\nmonths after treatment. Laboratory parameters to be monitored should include\n(as a minimum) serum ALT, bilirubin, albumin, blood urea nitrogen, creatinine,\nand virological status: HBV antigen/antibody, and serum HBV DNA concentrations when possible. Patients experiencing signs of hepatic insufficiency during or\npost-treatment should be monitored more frequently as appropriate.</span>", "ID": "6a56a57b-06d3-46b1-bd6c-21edd3f2d07a", "Styles": "color:black", "Classes": "None", "Text": "Transplantation recipients are at greater risk from active viral replication. Due to the marginal liver function in these patients, hepatitis reactivation at discontinuation of lamivudine or loss of efficacy during treatment may induce severe and even fatal decompensation. These patients should be monitored for clinical, virological and serological parameters associated with hepatitis B, liver and renal function, and antiviral response during treatment (at least every month), and, if treatment is discontinued for any reason, for at least 6 months after treatment. Laboratory parameters to be monitored should include (as a minimum) serum ALT, bilirubin, albumin, blood urea nitrogen, creatinine, and virological status: HBV antigen/antibody, and serum HBV DNA concentrations when possible. Patients experiencing signs of hepatic insufficiency during or post-treatment should be monitored more frequently as appropriate.", "ParentId": "ae88f0c0-6e1d-419b-89c3-eea4b8418128"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "89e19a36-7864-4149-a5cf-02eabd41e334", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "1bd7a131-bacf-43da-8abd-20154f80faaa", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "89e19a36-7864-4149-a5cf-02eabd41e334"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">For patients who\ndevelop evidence of recurrent hepatitis post-treatment, there are insufficient\ndata on the benefits of re-initiation of lamivudine treatment.</span></p>", "ID": "c4ce2bf5-a2f1-402a-9b2b-5fc9b6f9b225", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">For patients who\ndevelop evidence of recurrent hepatitis post-treatment, there are insufficient\ndata on the benefits of re-initiation of lamivudine treatment.</span>", "ID": "3c7ce99f-9b99-4ef7-9a41-04e0ad671b95", "Styles": "color:black", "Classes": "None", "Text": "For patients who develop evidence of recurrent hepatitis post-treatment, there are insufficient data on the benefits of re-initiation of lamivudine treatment.", "ParentId": "c4ce2bf5-a2f1-402a-9b2b-5fc9b6f9b225"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "24fef89a-4021-44b7-9ff1-307793ec8dd7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "ad2f72d0-2fcb-41a3-b2ee-f07eb7671ca9", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "24fef89a-4021-44b7-9ff1-307793ec8dd7"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Mitochondrial dysfunction</span></u></p>", "ID": "bc4e2973-52cb-4e1a-90af-4e7f11da47be", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Mitochondrial dysfunction</span></u>", "ID": "b329306c-9c29-4528-9443-c272a402e37e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc4e2973-52cb-4e1a-90af-4e7f11da47be"}, {"Element": "<span lang=\"EN-GB\">Mitochondrial dysfunction</span>", "ID": "b5c3e62a-2e99-4d93-8ac0-1befa5526dd4", "Styles": "None", "Classes": "None", "Text": "Mitochondrial dysfunction", "ParentId": "b329306c-9c29-4528-9443-c272a402e37e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Nucleoside and nucleotide analogues have\nbeen demonstrated <i>in vitro</i> and <i>in vivo</i> to cause a variable degree\nof mitochondrial damage. There have been reports of mitochondrial dysfunction\nin infants exposed in utero and/or post-natally to nucleoside analogues. </span><span lang=\"EN-GB\">The main adverse events reported are haematological disorders\n(anaemia, neutropenia), metabolic disorders (hyperlactatemia, hyperlipasemia). </span><span lang=\"EN-GB\">Some late-onset neurological disorders have been reported\n(hypertonia, convulsion, abnormal behaviour).</span><span lang=\"EN-GB\"> The neurological\ndisorders might be transient or permanent.</span><span lang=\"EN-GB\"> Any child\nexposed <i>in utero</i> to nucleoside and nucleotide analogues, should have\nclinical and laboratory follow-up and should be fully investigated for possible\nmitochondrial dysfunction in cases which have relevant signs or symptoms.</span></p>", "ID": "09114aa7-35fe-4bf8-81d2-be816c1e86d0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Nucleoside and nucleotide analogues have\nbeen demonstrated <i>in vitro</i> and <i>in vivo</i> to cause a variable degree\nof mitochondrial damage. There have been reports of mitochondrial dysfunction\nin infants exposed in utero and/or post-natally to nucleoside analogues. </span>", "ID": "a67fe876-8326-4d68-a1d8-52634324552d", "Styles": "None", "Classes": "None", "Text": "Nucleoside and nucleotide analogues have been demonstrated  and  to cause a variable degree of mitochondrial damage. There have been reports of mitochondrial dysfunction in infants exposed in utero and/or post-natally to nucleoside analogues. ", "ParentId": "09114aa7-35fe-4bf8-81d2-be816c1e86d0"}, {"Element": "<i>in vitro</i>", "ID": "f6552383-1d21-47ad-94c8-b8e7ab802f74", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "a67fe876-8326-4d68-a1d8-52634324552d"}, {"Element": "<i>in vivo</i>", "ID": "642badc3-bd48-49c0-be2c-6c152b839dde", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "a67fe876-8326-4d68-a1d8-52634324552d"}, {"Element": "<span lang=\"EN-GB\">The main adverse events reported are haematological disorders\n(anaemia, neutropenia), metabolic disorders (hyperlactatemia, hyperlipasemia). </span>", "ID": "770023ee-9258-436d-a2f2-1c9e15d3fb07", "Styles": "None", "Classes": "None", "Text": "The main adverse events reported are haematological disorders (anaemia, neutropenia), metabolic disorders (hyperlactatemia, hyperlipasemia). ", "ParentId": "09114aa7-35fe-4bf8-81d2-be816c1e86d0"}, {"Element": "<span lang=\"EN-GB\">Some late-onset neurological disorders have been reported\n(hypertonia, convulsion, abnormal behaviour).</span>", "ID": "63ed1eea-9639-4b03-80db-bb113bebf57a", "Styles": "None", "Classes": "None", "Text": "Some late-onset neurological disorders have been reported (hypertonia, convulsion, abnormal behaviour).", "ParentId": "09114aa7-35fe-4bf8-81d2-be816c1e86d0"}, {"Element": "<span lang=\"EN-GB\"> The neurological\ndisorders might be transient or permanent.</span>", "ID": "857c1bbf-e54b-4e07-b570-926f966bf397", "Styles": "None", "Classes": "None", "Text": " The neurological disorders might be transient or permanent.", "ParentId": "09114aa7-35fe-4bf8-81d2-be816c1e86d0"}, {"Element": "<span lang=\"EN-GB\"> Any child\nexposed <i>in utero</i> to nucleoside and nucleotide analogues, should have\nclinical and laboratory follow-up and should be fully investigated for possible\nmitochondrial dysfunction in cases which have relevant signs or symptoms.</span>", "ID": "62feece5-e140-4641-94f7-2ddff3270233", "Styles": "None", "Classes": "None", "Text": " Any child exposed  to nucleoside and nucleotide analogues, should have clinical and laboratory follow-up and should be fully investigated for possible mitochondrial dysfunction in cases which have relevant signs or symptoms.", "ParentId": "09114aa7-35fe-4bf8-81d2-be816c1e86d0"}, {"Element": "<i>in utero</i>", "ID": "d50b4b4d-f94a-423e-8a37-a3f2b5f701c3", "Styles": "None", "Classes": "None", "Text": "in utero", "ParentId": "62feece5-e140-4641-94f7-2ddff3270233"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "435c6ae3-7f5c-4c72-a312-cdceb6865897", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e1013982-6672-4bdf-b6af-88cf7e66c816", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "435c6ae3-7f5c-4c72-a312-cdceb6865897"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Paediatric patients</span></u></p>", "ID": "6662d5c5-5879-4ba1-8443-c528c1bf91ea", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Paediatric patients</span></u>", "ID": "a426b337-eee3-444d-874d-0a312dd888a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6662d5c5-5879-4ba1-8443-c528c1bf91ea"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Paediatric patients</span>", "ID": "f605d3d4-b8e8-4108-8035-6855eec8b327", "Styles": "color:black", "Classes": "None", "Text": "Paediatric patients", "ParentId": "a426b337-eee3-444d-874d-0a312dd888a9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine has been administered to\nchildren (2 years and above) and adolescents with compensated chronic hepatitis\nB. However, due to limitations of the data, the administration of lamivudine to\nthis patient population is not currently recommended (see section 5.1). </span></p>", "ID": "c2df5515-f4a2-49fd-b84b-9eb65a4a6a63", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine has been administered to\nchildren (2 years and above) and adolescents with compensated chronic hepatitis\nB. However, due to limitations of the data, the administration of lamivudine to\nthis patient population is not currently recommended (see section 5.1). </span>", "ID": "e1ac23d5-32b3-4e3b-ace0-1dc8b862e9a3", "Styles": "None", "Classes": "None", "Text": "Lamivudine has been administered to children (2 years and above) and adolescents with compensated chronic hepatitis B. However, due to limitations of the data, the administration of lamivudine to this patient population is not currently recommended (see section 5.1). ", "ParentId": "c2df5515-f4a2-49fd-b84b-9eb65a4a6a63"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "13cce3ff-ecca-4e64-8c52-2b8b1117b2df", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3c5d7161-07fa-4d88-b935-108a1e4b8b66", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "13cce3ff-ecca-4e64-8c52-2b8b1117b2df"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Delta hepatitis or\nhepatitis C</span></u></p>", "ID": "93ccf6df-437f-44e9-9fcb-4284f57e4243", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Delta hepatitis or\nhepatitis C</span></u>", "ID": "5f87b1a3-f7d2-4ab4-9db5-e0c7aa423794", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "93ccf6df-437f-44e9-9fcb-4284f57e4243"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Delta hepatitis or\nhepatitis C</span>", "ID": "1f3f4b04-02a1-4492-b1eb-44b67b40a30f", "Styles": "color:black", "Classes": "None", "Text": "Delta hepatitis or hepatitis C", "ParentId": "5f87b1a3-f7d2-4ab4-9db5-e0c7aa423794"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The efficacy of lamivudine in patients\nco-infected with Delta hepatitis or hepatitis C has not been established and\ncaution is advised. </span></p>", "ID": "bf6e9ebd-9b5d-4970-bec9-43c393bfc564", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The efficacy of lamivudine in patients\nco-infected with Delta hepatitis or hepatitis C has not been established and\ncaution is advised. </span>", "ID": "4ee6cd87-13da-4b81-a468-2666b28f60eb", "Styles": "None", "Classes": "None", "Text": "The efficacy of lamivudine in patients co-infected with Delta hepatitis or hepatitis C has not been established and caution is advised. ", "ParentId": "bf6e9ebd-9b5d-4970-bec9-43c393bfc564"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be996938-2c68-447e-aea7-95ae67da9293", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "27d7751e-cbde-41ed-964c-fd398bb7bc28", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be996938-2c68-447e-aea7-95ae67da9293"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Immunosuppressive\ntreatments</span></u></p>", "ID": "45f3a4ac-0f89-4e6d-974c-7dff88920057", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Immunosuppressive\ntreatments</span></u>", "ID": "c29fb1e0-c7a5-4437-84ba-9fc18f580d22", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45f3a4ac-0f89-4e6d-974c-7dff88920057"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Immunosuppressive\ntreatments</span>", "ID": "14413813-0746-4619-8941-7184d69cfdbd", "Styles": "color:black", "Classes": "None", "Text": "Immunosuppressive treatments", "ParentId": "c29fb1e0-c7a5-4437-84ba-9fc18f580d22"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Data are limited on the use of lamivudine\nin HBeAg negative (pre-core mutant) patients and in those receiving concurrent\nimmunosuppressive regimes, including cancer chemotherapy. </span><span lang=\"EN-GB\" style=\"color:black\">Lamivudine should be used with caution in these\npatients.</span></p>", "ID": "9858e6f3-43fe-469a-a8cc-f89d4dd38e96", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Data are limited on the use of lamivudine\nin HBeAg negative (pre-core mutant) patients and in those receiving concurrent\nimmunosuppressive regimes, including cancer chemotherapy. </span>", "ID": "11d9d45c-e72b-47d3-8ce4-9ce902998a11", "Styles": "None", "Classes": "None", "Text": "Data are limited on the use of lamivudine in HBeAg negative (pre-core mutant) patients and in those receiving concurrent immunosuppressive regimes, including cancer chemotherapy. ", "ParentId": "9858e6f3-43fe-469a-a8cc-f89d4dd38e96"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Lamivudine should be used with caution in these\npatients.</span>", "ID": "d90f4900-0091-45a9-b78f-b161f1b59c3f", "Styles": "color:black", "Classes": "None", "Text": "Lamivudine should be used with caution in these patients.", "ParentId": "9858e6f3-43fe-469a-a8cc-f89d4dd38e96"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec079c74-5982-4ff8-b591-ad749fb18bec", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0fa97d20-4ac3-4cdd-bebc-574fd42b9e29", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec079c74-5982-4ff8-b591-ad749fb18bec"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Monitoring</span></u></p>", "ID": "e8e7f5e8-6ac2-4319-a16e-63d0a08c42b6", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Monitoring</span></u>", "ID": "712469cc-e018-4618-8427-3a2961f5378f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e8e7f5e8-6ac2-4319-a16e-63d0a08c42b6"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Monitoring</span>", "ID": "618ace11-804f-4340-98a7-4fe6136e51f0", "Styles": "color:black", "Classes": "None", "Text": "Monitoring", "ParentId": "712469cc-e018-4618-8427-3a2961f5378f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">During treatment with Lamivudine Teva\npatients should be monitored regularly. Serum ALT </span><span lang=\"EN-GB\" style=\"color:black\">and HBV DNA</span><span lang=\"EN-GB\"> levels should be\nmonitored at 3 month intervals and </span><span lang=\"EN-GB\" style=\"color:black\">in\nHBeAg positive patients</span><span lang=\"EN-GB\"> HBeAg should be assessed every\n6 months. </span></p>", "ID": "f1cc22ee-12e2-4ac0-8384-0ea6473ce8be", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">During treatment with Lamivudine Teva\npatients should be monitored regularly. Serum ALT </span>", "ID": "55cc2aa9-612a-43c7-8cf4-564bd7975caa", "Styles": "None", "Classes": "None", "Text": "During treatment with Lamivudine Teva patients should be monitored regularly. Serum ALT ", "ParentId": "f1cc22ee-12e2-4ac0-8384-0ea6473ce8be"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">and HBV DNA</span>", "ID": "7d9f2cd5-8ff6-4e1d-a60b-d9db94d60607", "Styles": "color:black", "Classes": "None", "Text": "and HBV DNA", "ParentId": "f1cc22ee-12e2-4ac0-8384-0ea6473ce8be"}, {"Element": "<span lang=\"EN-GB\"> levels should be\nmonitored at 3 month intervals and </span>", "ID": "05c8f3d8-0880-4b9f-a0fa-029a8aa5addd", "Styles": "None", "Classes": "None", "Text": " levels should be monitored at 3 month intervals and ", "ParentId": "f1cc22ee-12e2-4ac0-8384-0ea6473ce8be"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">in\nHBeAg positive patients</span>", "ID": "8453036a-6c2c-4a0c-a492-1a72943a6b1b", "Styles": "color:black", "Classes": "None", "Text": "in HBeAg positive patients", "ParentId": "f1cc22ee-12e2-4ac0-8384-0ea6473ce8be"}, {"Element": "<span lang=\"EN-GB\"> HBeAg should be assessed every\n6 months. </span>", "ID": "541cb5e2-c0db-44c8-871b-76a1c555be07", "Styles": "None", "Classes": "None", "Text": " HBeAg should be assessed every 6 months. ", "ParentId": "f1cc22ee-12e2-4ac0-8384-0ea6473ce8be"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d868f3c0-0c13-4bc2-849c-e3791b49de81", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "49ba5477-c45c-4e23-8f93-7380aa25b5a7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d868f3c0-0c13-4bc2-849c-e3791b49de81"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">HIV co-infection</span></u></p>", "ID": "ec73138e-027f-4e90-a3af-f7e46b8b5ee2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">HIV co-infection</span></u>", "ID": "f3d6c164-ed3b-4e48-b424-35f6e309cef9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec73138e-027f-4e90-a3af-f7e46b8b5ee2"}, {"Element": "<span lang=\"EN-GB\">HIV co-infection</span>", "ID": "8f2b0395-deaf-4f1f-a247-8a8b746cf991", "Styles": "None", "Classes": "None", "Text": "HIV co-infection", "ParentId": "f3d6c164-ed3b-4e48-b424-35f6e309cef9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">For the treatment of patients who are\nco-infected with HIV and are currently receiving or plan to receive treatment\nwith lamivudine or the combination lamivudine-zidovudine, the dose of\nlamivudine prescribed for HIV infection (usually 150\u00a0mg/twice daily in\ncombination with other antiretrovirals) should be maintained. For HIV\nco-infected patients not requiring anti-retroviral therapy, there is a risk of\nHIV mutation when using lamivudine alone for treating chronic hepatitis B.</span></p>", "ID": "51f9e2ba-27ec-4651-adf1-35d4ff5a90d7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">For the treatment of patients who are\nco-infected with HIV and are currently receiving or plan to receive treatment\nwith lamivudine or the combination lamivudine-zidovudine, the dose of\nlamivudine prescribed for HIV infection (usually 150\u00a0mg/twice daily in\ncombination with other antiretrovirals) should be maintained. For HIV\nco-infected patients not requiring anti-retroviral therapy, there is a risk of\nHIV mutation when using lamivudine alone for treating chronic hepatitis B.</span>", "ID": "a001be79-fc46-4be1-a6d2-0f8e1ad1781d", "Styles": "None", "Classes": "None", "Text": "For the treatment of patients who are co-infected with HIV and are currently receiving or plan to receive treatment with lamivudine or the combination lamivudine-zidovudine, the dose of lamivudine prescribed for HIV infection (usually 150\u00a0mg/twice daily in combination with other antiretrovirals) should be maintained. For HIV co-infected patients not requiring anti-retroviral therapy, there is a risk of HIV mutation when using lamivudine alone for treating chronic hepatitis B.", "ParentId": "51f9e2ba-27ec-4651-adf1-35d4ff5a90d7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "598ce8e0-211a-477c-b35f-4e9044312be2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "19dc8808-63ab-4d3b-bbb4-8099fa36295f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "598ce8e0-211a-477c-b35f-4e9044312be2"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Transmission of hepatitis B </span></u></p>", "ID": "b5ee08b3-faa8-4988-ac67-cc7672599684", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Transmission of hepatitis B </span></u>", "ID": "e01ac942-6167-4219-b1d0-a211a4f6185e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5ee08b3-faa8-4988-ac67-cc7672599684"}, {"Element": "<span lang=\"EN-GB\">Transmission of hepatitis B </span>", "ID": "820af16a-3d4f-4afc-b041-78451773100b", "Styles": "None", "Classes": "None", "Text": "Transmission of hepatitis B ", "ParentId": "e01ac942-6167-4219-b1d0-a211a4f6185e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">There is no information available on\nmaternal-foetal transmission of hepatitis B virus in pregnant women receiving\ntreatment with lamivudine. The standard recommended procedures for hepatitis B\nvirus immunisation in infants should be followed. </span></p>", "ID": "b64d7e29-cbb0-4cfe-b529-ca96c6b85c51", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">There is no information available on\nmaternal-foetal transmission of hepatitis B virus in pregnant women receiving\ntreatment with lamivudine. The standard recommended procedures for hepatitis B\nvirus immunisation in infants should be followed. </span>", "ID": "b196a42f-c6fc-4095-b1b2-9023809adbb6", "Styles": "None", "Classes": "None", "Text": "There is no information available on maternal-foetal transmission of hepatitis B virus in pregnant women receiving treatment with lamivudine. The standard recommended procedures for hepatitis B virus immunisation in infants should be followed. ", "ParentId": "b64d7e29-cbb0-4cfe-b529-ca96c6b85c51"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e313fd95-9bbc-4e91-b7c1-cfe7b1ec31e1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "55b2d456-8375-405e-bb6b-5ba221ac8005", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e313fd95-9bbc-4e91-b7c1-cfe7b1ec31e1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Patients should be advised that therapy\nwith lamivudine has not been proven to reduce the risk of transmission of\nhepatitis B virus to others and therefore, appropriate precautions should still\nbe taken. </span></p>", "ID": "9ae25cc6-813c-4f91-8d03-495e865d0840", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Patients should be advised that therapy\nwith lamivudine has not been proven to reduce the risk of transmission of\nhepatitis B virus to others and therefore, appropriate precautions should still\nbe taken. </span>", "ID": "c9d6cbf7-aaeb-4d48-af85-52a9408181e8", "Styles": "None", "Classes": "None", "Text": "Patients should be advised that therapy with lamivudine has not been proven to reduce the risk of transmission of hepatitis B virus to others and therefore, appropriate precautions should still be taken. ", "ParentId": "9ae25cc6-813c-4f91-8d03-495e865d0840"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "91fa7d76-9cf9-4684-b0d6-f7b5923c13ac", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "af8f4cd7-cc8f-4ebe-9f23-4f7551177401", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "91fa7d76-9cf9-4684-b0d6-f7b5923c13ac"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Interactions with other medicinal\nproducts</span></u></p>", "ID": "7d55c8a7-3068-482e-9775-bd3d151a295e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Interactions with other medicinal\nproducts</span></u>", "ID": "b9bb8baa-1e03-48ba-88a9-9791b656a288", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7d55c8a7-3068-482e-9775-bd3d151a295e"}, {"Element": "<span lang=\"EN-GB\">Interactions with other medicinal\nproducts</span>", "ID": "f5ba22c1-318b-4858-98fb-654ad35c2786", "Styles": "None", "Classes": "None", "Text": "Interactions with other medicinal products", "ParentId": "b9bb8baa-1e03-48ba-88a9-9791b656a288"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva should not be taken with\nany other medicinal products containing lamivudine or medicinal products\ncontaining emtricitabine (see section 4.5).</span></p>", "ID": "d39133fb-f140-4094-9133-6d6a3e4c17db", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva should not be taken with\nany other medicinal products containing lamivudine or medicinal products\ncontaining emtricitabine (see section 4.5).</span>", "ID": "35be7c69-9e56-4074-a7a6-067e858070cf", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva should not be taken with any other medicinal products containing lamivudine or medicinal products containing emtricitabine (see section 4.5).", "ParentId": "d39133fb-f140-4094-9133-6d6a3e4c17db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ef86f5a-d257-4fe0-a77f-62f04202e32d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0f469824-7800-485f-9c8e-26e14b898430", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ef86f5a-d257-4fe0-a77f-62f04202e32d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The combination\nof lamivudine with cladribine is not recommended (see section 4.5).</span></p>", "ID": "1e98d02a-461e-4dfd-8896-e375977c9a27", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The combination\nof lamivudine with cladribine is not recommended (see section 4.5).</span>", "ID": "400a593a-6535-4e5e-a455-0c972d084004", "Styles": "None", "Classes": "None", "Text": "The combination of lamivudine with cladribine is not recommended (see section 4.5).", "ParentId": "1e98d02a-461e-4dfd-8896-e375977c9a27"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4a136dd9-8cb0-4b27-baa9-90cdeb37548e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c3f5418a-fdb0-4fcf-b575-8018f7a4eb1f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4a136dd9-8cb0-4b27-baa9-90cdeb37548e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span style=\"color:#222222;\nbackground:white\">Excipient(s)</span></u></p>", "ID": "1367b326-d5a1-4fe9-9f05-8773ae3c74aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span style=\"color:#222222;\nbackground:white\">Excipient(s)</span></u>", "ID": "c7595cc8-8696-4a77-8dc2-62fb6862c33d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1367b326-d5a1-4fe9-9f05-8773ae3c74aa"}, {"Element": "<span style=\"color:#222222;\nbackground:white\">Excipient(s)</span>", "ID": "daded82f-0202-471a-bef1-5ffd8cbcd64e", "Styles": "color:#222222;\nbackground:white", "Classes": "None", "Text": "Excipient(s)", "ParentId": "c7595cc8-8696-4a77-8dc2-62fb6862c33d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "53f1f4ed-2a1f-454c-af8a-4e3b89d460f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i>Sodium</i></p>", "ID": "177a1eb8-32bf-4da6-ae57-09aaefe3dde7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i>Sodium</i>", "ID": "200814b5-a910-4dbc-956c-30bbf673d892", "Styles": "None", "Classes": "None", "Text": "Sodium", "ParentId": "177a1eb8-32bf-4da6-ae57-09aaefe3dde7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">This medicinal product contains\nless than 1 mmol sodium (23 mg) per film-coated tablet, that is to say\nessentially \u201csodium-free\u201d.</p>", "ID": "b0f56f4c-bc67-497c-936e-d99282e7d6a3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "This medicinal product contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially \u201csodium-free\u201d.", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "ebba7301-48f3-4e7f-845f-ba998f490a56", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other\nmedicinal products and other forms of interaction</span></b></p>", "ID": "fc5c1629-a23c-45e7-aa56-8d15d25e52b1", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other\nmedicinal products and other forms of interaction</span></b>", "ID": "52496029-fdfe-4aaa-8d8d-65c217b99966", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fc5c1629-a23c-45e7-aa56-8d15d25e52b1"}, {"Element": "<span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other\nmedicinal products and other forms of interaction</span>", "ID": "aaf668f4-e917-4a43-b6e2-5e11931517ee", "Styles": "None", "Classes": "None", "Text": "4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal products and other forms of interaction", "ParentId": "52496029-fdfe-4aaa-8d8d-65c217b99966"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a99e7d35-0b0d-4cd2-8a81-a011237835a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a8a7f220-3629-4bc2-ad01-7d47ef9afd9a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a99e7d35-0b0d-4cd2-8a81-a011237835a7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Interaction studies have only been\nperformed in adults. </span></p>", "ID": "eef52590-a8d6-46b3-944a-eb1518ec56d9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Interaction studies have only been\nperformed in adults. </span>", "ID": "25e3d081-5ec2-4a50-90a6-28b2539b8f48", "Styles": "None", "Classes": "None", "Text": "Interaction studies have only been performed in adults. ", "ParentId": "eef52590-a8d6-46b3-944a-eb1518ec56d9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3bbfdf91-0345-412b-8b6b-177dc08af599", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9cbd67b7-85a8-43d3-9fab-804b66f1ec87", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3bbfdf91-0345-412b-8b6b-177dc08af599"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The likelihood of metabolic interactions is\nlow due to limited metabolism and plasma protein binding and almost complete\nrenal elimination of unchanged substance. </span></p>", "ID": "6b51e0f3-6c66-4c22-8dd0-f39745290a79", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The likelihood of metabolic interactions is\nlow due to limited metabolism and plasma protein binding and almost complete\nrenal elimination of unchanged substance. </span>", "ID": "f826b723-74f2-4cc6-8140-2b99cc125a9b", "Styles": "None", "Classes": "None", "Text": "The likelihood of metabolic interactions is low due to limited metabolism and plasma protein binding and almost complete renal elimination of unchanged substance. ", "ParentId": "6b51e0f3-6c66-4c22-8dd0-f39745290a79"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58320a33-1f55-410f-a51a-529c13560912", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "93996052-8bad-4f71-b493-b7d22fb716d3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58320a33-1f55-410f-a51a-529c13560912"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is predominantly eliminated by\nactive organic cationic secretion. The possibility of interactions with other\nmedicinal products administered concurrently should be considered, particularly\nwhen their main route of elimination is active renal secretion via the organic\ncationic transport system e.g. trimethoprim. Other medicinal products (e.g. ranitidine,\ncimetidine) are eliminated only in part by this mechanism and were shown not to\ninteract with lamivudine. </span></p>", "ID": "55460537-abdc-44e1-93ac-0421fd794164", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine is predominantly eliminated by\nactive organic cationic secretion. The possibility of interactions with other\nmedicinal products administered concurrently should be considered, particularly\nwhen their main route of elimination is active renal secretion via the organic\ncationic transport system e.g. trimethoprim. Other medicinal products (e.g. ranitidine,\ncimetidine) are eliminated only in part by this mechanism and were shown not to\ninteract with lamivudine. </span>", "ID": "26fb8290-8eab-452c-94a9-451fe46b8eff", "Styles": "None", "Classes": "None", "Text": "Lamivudine is predominantly eliminated by active organic cationic secretion. The possibility of interactions with other medicinal products administered concurrently should be considered, particularly when their main route of elimination is active renal secretion via the organic cationic transport system e.g. trimethoprim. Other medicinal products (e.g. ranitidine, cimetidine) are eliminated only in part by this mechanism and were shown not to interact with lamivudine. ", "ParentId": "55460537-abdc-44e1-93ac-0421fd794164"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4ff8d6e8-4ba8-4c6a-8053-bfab544e7c65", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b9883d1-bd43-47ac-b7d8-590582c04564", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4ff8d6e8-4ba8-4c6a-8053-bfab544e7c65"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Substances shown to be predominately\nexcreted either via the active organic anionic pathway, or by glomerular\nfiltration are unlikely to yield clinically significant interactions with\nlamivudine. </span></p>", "ID": "0a324393-6fe3-415b-ac0f-84e130006a2e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Substances shown to be predominately\nexcreted either via the active organic anionic pathway, or by glomerular\nfiltration are unlikely to yield clinically significant interactions with\nlamivudine. </span>", "ID": "a051bf80-5087-4842-a1e1-1b5293cbd57d", "Styles": "None", "Classes": "None", "Text": "Substances shown to be predominately excreted either via the active organic anionic pathway, or by glomerular filtration are unlikely to yield clinically significant interactions with lamivudine. ", "ParentId": "0a324393-6fe3-415b-ac0f-84e130006a2e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Administration of\ntrimethoprim/sulphamethoxazole 160\u00a0mg/800\u00a0mg increased lamivudine\nexposure by about 40\u00a0%. Lamivudine had no effect on the pharmacokinetics\nof trimethoprim or sulphamethoxazole. However, unless the patient has renal\nimpairment, no dosage adjustment of lamivudine is necessary. </span></p>", "ID": "b25c4467-9c08-40b8-8443-7460922b7299", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Administration of\ntrimethoprim/sulphamethoxazole 160\u00a0mg/800\u00a0mg increased lamivudine\nexposure by about 40\u00a0%. Lamivudine had no effect on the pharmacokinetics\nof trimethoprim or sulphamethoxazole. However, unless the patient has renal\nimpairment, no dosage adjustment of lamivudine is necessary. </span>", "ID": "904bb409-3245-4870-9961-c8022e18316e", "Styles": "None", "Classes": "None", "Text": "Administration of trimethoprim/sulphamethoxazole 160\u00a0mg/800\u00a0mg increased lamivudine exposure by about 40\u00a0%. Lamivudine had no effect on the pharmacokinetics of trimethoprim or sulphamethoxazole. However, unless the patient has renal impairment, no dosage adjustment of lamivudine is necessary. ", "ParentId": "b25c4467-9c08-40b8-8443-7460922b7299"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fbe54292-af40-4e72-ab78-4ffe73a1cfa3", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bd6434d0-4842-4696-9559-f4722c281185", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fbe54292-af40-4e72-ab78-4ffe73a1cfa3"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">A modest increase in Cmax (28\u00a0%) was\nobserved for zidovudine when administered with lamivudine, however overall\nexposure (AUC) was not significantly altered. Zidovudine had no effect on the\npharmacokinetics of lamivudine (see section 5.2). </span></p>", "ID": "0f823001-a0cb-488d-a39a-c5e20623122d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">A modest increase in Cmax (28\u00a0%) was\nobserved for zidovudine when administered with lamivudine, however overall\nexposure (AUC) was not significantly altered. Zidovudine had no effect on the\npharmacokinetics of lamivudine (see section 5.2). </span>", "ID": "85936e8c-2090-4b8f-b074-1bfda710ac4a", "Styles": "None", "Classes": "None", "Text": "A modest increase in Cmax (28\u00a0%) was observed for zidovudine when administered with lamivudine, however overall exposure (AUC) was not significantly altered. Zidovudine had no effect on the pharmacokinetics of lamivudine (see section 5.2). ", "ParentId": "0f823001-a0cb-488d-a39a-c5e20623122d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cacba968-6b98-4672-9902-05075406bf13", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f09471b-d482-43f3-a953-2d6a64a89fd6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cacba968-6b98-4672-9902-05075406bf13"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine has no pharmacokinetic\ninteraction with alpha-interferon when the two medicinal products are\nconcurrently administered. There were no observed clinically significant\nadverse interactions in patients taking lamivudine concurrently with commonly used\nimmunosuppressant medicinal products (e.g. cyclosporin A). However, formal\ninteraction studies have not been performed. </span></p>", "ID": "d7590127-39fe-4baf-911f-6e14cdc6066a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine has no pharmacokinetic\ninteraction with alpha-interferon when the two medicinal products are\nconcurrently administered. There were no observed clinically significant\nadverse interactions in patients taking lamivudine concurrently with commonly used\nimmunosuppressant medicinal products (e.g. cyclosporin A). However, formal\ninteraction studies have not been performed. </span>", "ID": "f910f023-7131-456b-b207-e81722aad4ad", "Styles": "None", "Classes": "None", "Text": "Lamivudine has no pharmacokinetic interaction with alpha-interferon when the two medicinal products are concurrently administered. There were no observed clinically significant adverse interactions in patients taking lamivudine concurrently with commonly used immunosuppressant medicinal products (e.g. cyclosporin A). However, formal interaction studies have not been performed. ", "ParentId": "d7590127-39fe-4baf-911f-6e14cdc6066a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eaeba5d2-8406-4d20-b60a-ebdc517e4a8b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "20ce2cab-c2ae-424c-aa8b-7da8e8d8966d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eaeba5d2-8406-4d20-b60a-ebdc517e4a8b"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Emtricitabine</span></i></p>", "ID": "9f551d97-b13d-4ea2-99de-d86fe88d2afe", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">Emtricitabine</span></i>", "ID": "59f7d16e-baf3-4dee-b866-0d5ecbdd5495", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9f551d97-b13d-4ea2-99de-d86fe88d2afe"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Emtricitabine</span>", "ID": "12027936-9058-4da5-80a6-6131bd1f7d96", "Styles": "color:black", "Classes": "None", "Text": "Emtricitabine", "ParentId": "59f7d16e-baf3-4dee-b866-0d5ecbdd5495"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Due to similarities, Lamivudine\nTeva should not be administered concomitantly with other cytidine analogues,\nsuch as emtricitabine. Moreover, Lamivudine Teva should not be taken with any\nother medicinal products containing lamivudine </span><span lang=\"EN-GB\">(</span><span lang=\"EN-GB\" style=\"color:black\">see section 4.4)</span><span lang=\"EN-GB\">.</span></p>", "ID": "e88b27a4-c0b6-4d1e-8f29-1b1d06dcad6b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Due to similarities, Lamivudine\nTeva should not be administered concomitantly with other cytidine analogues,\nsuch as emtricitabine. Moreover, Lamivudine Teva should not be taken with any\nother medicinal products containing lamivudine </span>", "ID": "2cc51505-e3e0-4c07-abb4-59edc635260c", "Styles": "color:black", "Classes": "None", "Text": "Due to similarities, Lamivudine Teva should not be administered concomitantly with other cytidine analogues, such as emtricitabine. Moreover, Lamivudine Teva should not be taken with any other medicinal products containing lamivudine ", "ParentId": "e88b27a4-c0b6-4d1e-8f29-1b1d06dcad6b"}, {"Element": "<span lang=\"EN-GB\">(</span>", "ID": "511b702c-b046-4335-9da5-63d33f2b90c6", "Styles": "None", "Classes": "None", "Text": "(", "ParentId": "e88b27a4-c0b6-4d1e-8f29-1b1d06dcad6b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">see section 4.4)</span>", "ID": "fbb92d04-9c41-4b6c-a798-48cbd5bced41", "Styles": "color:black", "Classes": "None", "Text": "see section 4.4)", "ParentId": "e88b27a4-c0b6-4d1e-8f29-1b1d06dcad6b"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "d3609d6c-6a2c-4b46-b939-452db0cd6757", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "e88b27a4-c0b6-4d1e-8f29-1b1d06dcad6b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f20c4655-865f-4c12-a3a7-d8f78b759f2e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78c76115-1fd3-4939-bc66-c3b53033a436", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f20c4655-865f-4c12-a3a7-d8f78b759f2e"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Cladribine </span></i></p>", "ID": "81582ff1-11ab-4e0b-a9d7-f1d1bf0985b2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">Cladribine </span></i>", "ID": "e6133d1e-4901-4cf4-a207-b39e25155a7e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81582ff1-11ab-4e0b-a9d7-f1d1bf0985b2"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Cladribine </span>", "ID": "8f09350a-b998-4bf6-8ff2-a354fdafbf1a", "Styles": "color:black", "Classes": "None", "Text": "Cladribine ", "ParentId": "e6133d1e-4901-4cf4-a207-b39e25155a7e"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">In vitro</span></i><span lang=\"EN-GB\" style=\"color:black\"> lamivudine inhibits the intracellular\nphosphorylation of cladribine leading to a potential risk of cladribine loss of\nefficacy in case of combination in the clinical setting. Some clinical findings\nalso support a possible interaction between lamivudine and cladribine. Therefore,\nthe concomitant use of lamivudine with cladribine is not recommended (see\nsection 4.4).</span></p>", "ID": "50d6a23a-a738-4def-89c8-8aa162a24fb3", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">In vitro</span></i>", "ID": "8d4b7df6-712b-4c7f-9c41-20936d3c9651", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50d6a23a-a738-4def-89c8-8aa162a24fb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">In vitro</span>", "ID": "c1136734-dd89-4efc-acb7-40655f945585", "Styles": "color:black", "Classes": "None", "Text": "In vitro", "ParentId": "8d4b7df6-712b-4c7f-9c41-20936d3c9651"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> lamivudine inhibits the intracellular\nphosphorylation of cladribine leading to a potential risk of cladribine loss of\nefficacy in case of combination in the clinical setting. Some clinical findings\nalso support a possible interaction between lamivudine and cladribine. Therefore,\nthe concomitant use of lamivudine with cladribine is not recommended (see\nsection 4.4).</span>", "ID": "7d65010c-6073-40ca-bfc6-4ccc6dc66e7e", "Styles": "color:black", "Classes": "None", "Text": " lamivudine inhibits the intracellular phosphorylation of cladribine leading to a potential risk of cladribine loss of efficacy in case of combination in the clinical setting. Some clinical findings also support a possible interaction between lamivudine and cladribine. Therefore, the concomitant use of lamivudine with cladribine is not recommended (see section 4.4).", "ParentId": "50d6a23a-a738-4def-89c8-8aa162a24fb3"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "14b2f470-36c1-4810-924d-ae861fa7d689", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "ee9608d0-9bfa-4144-b2f2-24f3dff95b4e", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "14b2f470-36c1-4810-924d-ae861fa7d689"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\" style=\"color:black\">Sorbitol</span></i></p>", "ID": "2617c78f-801e-4e4e-88fa-ea0f45b5ce7a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">Sorbitol</span></i>", "ID": "b53a2a44-5339-4c4f-8f7a-ce216f944109", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2617c78f-801e-4e4e-88fa-ea0f45b5ce7a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Sorbitol</span>", "ID": "8acc14af-64e6-494a-9446-11c28d813baa", "Styles": "color:black", "Classes": "None", "Text": "Sorbitol", "ParentId": "b53a2a44-5339-4c4f-8f7a-ce216f944109"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Co-administration of\nsorbitol solution (3.2 g, 10.2 g, 13.4 g) with a single 300 mg dose (Adult HIV\ndaily dose) of lamivudine oral solution resulted in dose-dependent decreases of\n14%, 32%, and 36% in lamivudine exposure (AUC</span><sub><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00a5</span></sub><span lang=\"EN-GB\" style=\"color:black\">) and 28%, 52%, and 55% in the Cmax of lamivudine in\nadults. When possible, avoid chronic co-administration of Lamivudine Teva with medicinal\nproducts containing sorbitol or other osmotic acting poly-alcohols or\nmonosaccharide alcohols (e.g. xylitol, mannitol, lactitol, maltitol). Consider\nmore frequent monitoring of HBV viral load when chronic co-administration\ncannot be avoided. </span></p>", "ID": "4862bbe3-b293-4220-b9eb-932e44eb3cd0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Co-administration of\nsorbitol solution (3.2 g, 10.2 g, 13.4 g) with a single 300 mg dose (Adult HIV\ndaily dose) of lamivudine oral solution resulted in dose-dependent decreases of\n14%, 32%, and 36% in lamivudine exposure (AUC</span>", "ID": "1db51bb9-f42e-4843-a623-fd71f0ad5d4e", "Styles": "color:black", "Classes": "None", "Text": "Co-administration of sorbitol solution (3.2 g, 10.2 g, 13.4 g) with a single 300 mg dose (Adult HIV daily dose) of lamivudine oral solution resulted in dose-dependent decreases of 14%, 32%, and 36% in lamivudine exposure (AUC", "ParentId": "4862bbe3-b293-4220-b9eb-932e44eb3cd0"}, {"Element": "<sub><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00a5</span></sub>", "ID": "f0c3f4d8-609b-4bab-bf59-c21dd1b50b61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4862bbe3-b293-4220-b9eb-932e44eb3cd0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00a5</span>", "ID": "453132ca-facf-47df-aa29-982ee1ddc906", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00a5", "ParentId": "f0c3f4d8-609b-4bab-bf59-c21dd1b50b61"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">) and 28%, 52%, and 55% in the Cmax of lamivudine in\nadults. When possible, avoid chronic co-administration of Lamivudine Teva with medicinal\nproducts containing sorbitol or other osmotic acting poly-alcohols or\nmonosaccharide alcohols (e.g. xylitol, mannitol, lactitol, maltitol). Consider\nmore frequent monitoring of HBV viral load when chronic co-administration\ncannot be avoided. </span>", "ID": "b7c3982f-9adc-4412-ad86-8f0a1b165a88", "Styles": "color:black", "Classes": "None", "Text": ") and 28%, 52%, and 55% in the Cmax of lamivudine in adults. When possible, avoid chronic co-administration of Lamivudine Teva with medicinal products containing sorbitol or other osmotic acting poly-alcohols or monosaccharide alcohols (e.g. xylitol, mannitol, lactitol, maltitol). Consider more frequent monitoring of HBV viral load when chronic co-administration cannot be avoided. ", "ParentId": "4862bbe3-b293-4220-b9eb-932e44eb3cd0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b6402c0a-08b2-4c69-876b-762976447135", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d89f19bc-21a6-402c-9c9f-3b39421287c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b6402c0a-08b2-4c69-876b-762976447135"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span></b></p>", "ID": "fe52a4cd-57a9-48d5-b4f1-a680fa4268ca", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span></b>", "ID": "2a77275f-1e80-4df0-800f-2484f5d97ebf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe52a4cd-57a9-48d5-b4f1-a680fa4268ca"}, {"Element": "<span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span>", "ID": "ea073147-83e6-447b-aad2-d9a05fbe03bb", "Styles": "None", "Classes": "None", "Text": "4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation", "ParentId": "2a77275f-1e80-4df0-800f-2484f5d97ebf"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "08193831-8abd-4c2a-8e21-4ff0ea35c114", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f807e4ac-4f07-4bbd-94ba-dec63665f714", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "08193831-8abd-4c2a-8e21-4ff0ea35c114"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f4098dd9-283c-40ba-8feb-ed618b6cb62c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f807e4ac-4f07-4bbd-94ba-dec63665f714"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>", "ID": "75a9b3bc-5954-4dcc-ab7a-3815b9a89a62", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Pregnancy</span></u>", "ID": "8b1b4098-b6e0-4dc4-b46a-4da9337483ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "75a9b3bc-5954-4dcc-ab7a-3815b9a89a62"}, {"Element": "<span lang=\"EN-GB\">Pregnancy</span>", "ID": "8eb85731-ffb2-4c93-86cd-cffd69ded567", "Styles": "None", "Classes": "None", "Text": "Pregnancy", "ParentId": "8b1b4098-b6e0-4dc4-b46a-4da9337483ed"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">A large amount of data on pregnant women\n(more than 1000 exposed outcomes) indicate no malformative toxicity. Lamivudine\nTeva can be used during pregnancy if clinically needed. </span></p>", "ID": "8014524a-9976-4032-a1fd-1cb3b65f4f9f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">A large amount of data on pregnant women\n(more than 1000 exposed outcomes) indicate no malformative toxicity. Lamivudine\nTeva can be used during pregnancy if clinically needed. </span>", "ID": "c1246bfc-ff08-4d2c-a4de-211a1e812c71", "Styles": "None", "Classes": "None", "Text": "A large amount of data on pregnant women (more than 1000 exposed outcomes) indicate no malformative toxicity. Lamivudine Teva can be used during pregnancy if clinically needed. ", "ParentId": "8014524a-9976-4032-a1fd-1cb3b65f4f9f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "acf6b53f-0a5b-4a29-b81b-f8d83c14d106", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "c04bb47d-e23f-4236-8024-064b99519b94", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "acf6b53f-0a5b-4a29-b81b-f8d83c14d106"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">For patients who are\nbeing treated with lamivudine and subsequently become pregnant consideration\nshould be given to the possibility of a recurrence of hepatitis on\ndiscontinuation of lamivudine.</span></p>", "ID": "09f23958-f923-4635-b474-1bccaf7398ce", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">For patients who are\nbeing treated with lamivudine and subsequently become pregnant consideration\nshould be given to the possibility of a recurrence of hepatitis on\ndiscontinuation of lamivudine.</span>", "ID": "a40115c0-fba1-4ebe-b648-13f4ab22ad83", "Styles": "color:black", "Classes": "None", "Text": "For patients who are being treated with lamivudine and subsequently become pregnant consideration should be given to the possibility of a recurrence of hepatitis on discontinuation of lamivudine.", "ParentId": "09f23958-f923-4635-b474-1bccaf7398ce"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "85914224-b4e2-4576-903a-a13a5033deca", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2ba63aaa-2364-4356-91dd-ad8fc23acacd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "85914224-b4e2-4576-903a-a13a5033deca"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Breast-feeding</span></u></p>", "ID": "3d639110-94ba-4527-aff2-d7e05ed97d23", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Breast-feeding</span></u>", "ID": "54b12c5d-beff-47fe-80a7-4a10401a1b9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d639110-94ba-4527-aff2-d7e05ed97d23"}, {"Element": "<span lang=\"EN-GB\">Breast-feeding</span>", "ID": "771c2ac9-c93e-40a9-8364-efd31745a517", "Styles": "None", "Classes": "None", "Text": "Breast-feeding", "ParentId": "54b12c5d-beff-47fe-80a7-4a10401a1b9e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Based on more than 200\nmother/child pairs treated for HIV, serum concentrations of lamivudine in\nbreastfed infants of mothers treated for HIV are very low ( less than 4% of\nmaternal serum concentrations) and progressively decrease to undetectable\nlevels when breastfed infants reach 24 weeks of age. The total amount of\nlamivudine ingested by a breastfed infant is very low and is therefore likely\nto result in exposures exerting a sub-optimal antiviral effect. Maternal\nhepatitis B is not a contraindication to breast-feeding if the newborn is\nadequately managed for hepatitis B prevention at birth, and there is no evidence\nthat the low concentration of lamivudine in human milk leads to adverse reactions\nin breastfed infants. Therefore breastfeeding may be considered in breast-\nfeeding mothers being treated with lamivudine for HBV taking into account the\nbenefit of breast feeding for the child and the benefit of therapy for the\nwoman. Where there is maternal transmission of HBV, despite adequate\nprophylaxis, consideration should be given to discontinuing breastfeeding to\nreduce the risk of the emergence of lamivudine resistant mutants in the infant.\n</span></p>", "ID": "4e229ef6-850f-4582-ad9f-28c1dbb6e659", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Based on more than 200\nmother/child pairs treated for HIV, serum concentrations of lamivudine in\nbreastfed infants of mothers treated for HIV are very low ( less than 4% of\nmaternal serum concentrations) and progressively decrease to undetectable\nlevels when breastfed infants reach 24 weeks of age. The total amount of\nlamivudine ingested by a breastfed infant is very low and is therefore likely\nto result in exposures exerting a sub-optimal antiviral effect. Maternal\nhepatitis B is not a contraindication to breast-feeding if the newborn is\nadequately managed for hepatitis B prevention at birth, and there is no evidence\nthat the low concentration of lamivudine in human milk leads to adverse reactions\nin breastfed infants. Therefore breastfeeding may be considered in breast-\nfeeding mothers being treated with lamivudine for HBV taking into account the\nbenefit of breast feeding for the child and the benefit of therapy for the\nwoman. Where there is maternal transmission of HBV, despite adequate\nprophylaxis, consideration should be given to discontinuing breastfeeding to\nreduce the risk of the emergence of lamivudine resistant mutants in the infant.\n</span>", "ID": "f6b49718-3a04-47bc-ab7a-38208906aefe", "Styles": "color:black", "Classes": "None", "Text": "Based on more than 200 mother/child pairs treated for HIV, serum concentrations of lamivudine in breastfed infants of mothers treated for HIV are very low ( less than 4% of maternal serum concentrations) and progressively decrease to undetectable levels when breastfed infants reach 24 weeks of age. The total amount of lamivudine ingested by a breastfed infant is very low and is therefore likely to result in exposures exerting a sub-optimal antiviral effect. Maternal hepatitis B is not a contraindication to breast-feeding if the newborn is adequately managed for hepatitis B prevention at birth, and there is no evidence that the low concentration of lamivudine in human milk leads to adverse reactions in breastfed infants. Therefore breastfeeding may be considered in breast- feeding mothers being treated with lamivudine for HBV taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. Where there is maternal transmission of HBV, despite adequate prophylaxis, consideration should be given to discontinuing breastfeeding to reduce the risk of the emergence of lamivudine resistant mutants in the infant. ", "ParentId": "4e229ef6-850f-4582-ad9f-28c1dbb6e659"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c327766b-f736-4317-be6f-e143313b3f2a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "441a5b82-36f0-4cfc-8a02-ddd9eee0e3ee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c327766b-f736-4317-be6f-e143313b3f2a"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Fertility</span></u></p>", "ID": "00d9282d-86e8-49e4-8476-f2fc3072bd9d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Fertility</span></u>", "ID": "1f18a2d7-dcd5-4680-8e20-9c1ff4c155a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00d9282d-86e8-49e4-8476-f2fc3072bd9d"}, {"Element": "<span lang=\"EN-GB\">Fertility</span>", "ID": "06b090af-bfe7-4bf6-99fa-19385aa76298", "Styles": "None", "Classes": "None", "Text": "Fertility", "ParentId": "1f18a2d7-dcd5-4680-8e20-9c1ff4c155a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Reproductive\nstudies in animals have shown no effect on male or female fertility (see\nsection 5.3).</span></p>", "ID": "ea0de3fd-0c16-4ff9-b574-2e55087856e4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Reproductive\nstudies in animals have shown no effect on male or female fertility (see\nsection 5.3).</span>", "ID": "fe0f84c7-54ac-42cf-834a-5dfe2d414eab", "Styles": "None", "Classes": "None", "Text": "Reproductive studies in animals have shown no effect on male or female fertility (see section 5.3).", "ParentId": "ea0de3fd-0c16-4ff9-b574-2e55087856e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e65190a-81ee-457e-9866-6829be68ccdf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "08aaf1f3-b790-4803-a06d-6b57ace1c0d7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e65190a-81ee-457e-9866-6829be68ccdf"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Mitochondrial\ndysfunction: </span></p>", "ID": "95d3904d-5d7b-4154-abf9-93db2a9f0e44", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Mitochondrial\ndysfunction: </span>", "ID": "fb70ea65-02ee-46c5-aaed-fd15681f401e", "Styles": "color:black", "Classes": "None", "Text": "Mitochondrial dysfunction: ", "ParentId": "95d3904d-5d7b-4154-abf9-93db2a9f0e44"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Nucleoside and\nnucleotide analogues have been demonstrated <i>in vitro</i> and <i>in vivo</i>\nto cause a variable degree of mitochondrial damage. There have been reports of\nmitochondrial dysfunction in infants exposed in utero and/or post-natally to\nnucleoside analogues (see section 4.4).</span></p>", "ID": "feaa6a9f-50b0-4a94-8482-2b90068b184b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Nucleoside and\nnucleotide analogues have been demonstrated <i>in vitro</i> and <i>in vivo</i>\nto cause a variable degree of mitochondrial damage. There have been reports of\nmitochondrial dysfunction in infants exposed in utero and/or post-natally to\nnucleoside analogues (see section 4.4).</span>", "ID": "f82c6637-b0fe-4dd0-8073-55a3b9663a07", "Styles": "color:black", "Classes": "None", "Text": "Nucleoside and nucleotide analogues have been demonstrated  and  to cause a variable degree of mitochondrial damage. There have been reports of mitochondrial dysfunction in infants exposed in utero and/or post-natally to nucleoside analogues (see section 4.4).", "ParentId": "feaa6a9f-50b0-4a94-8482-2b90068b184b"}, {"Element": "<i>in vitro</i>", "ID": "1d0eb9d0-6197-456c-aa2a-2e6eac49573d", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "f82c6637-b0fe-4dd0-8073-55a3b9663a07"}, {"Element": "<i>in vivo</i>", "ID": "f37cc46b-a57f-45fb-995e-64503eb2848a", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "f82c6637-b0fe-4dd0-8073-55a3b9663a07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c7a6087a-5a1f-4894-b33c-d0438dbf0d84", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "be53807e-ff6a-4ce4-80ec-3a26f2aedd10", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c7a6087a-5a1f-4894-b33c-d0438dbf0d84"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span></b></p>", "ID": "d324d4e8-5f1b-4507-8902-e45ab09e1652", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span></b>", "ID": "ce21e86f-9a62-4c37-a10e-05b792986dd5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d324d4e8-5f1b-4507-8902-e45ab09e1652"}, {"Element": "<span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span>", "ID": "45346ad2-d4dc-4741-803d-685ccd72d57b", "Styles": "None", "Classes": "None", "Text": "4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use machines", "ParentId": "ce21e86f-9a62-4c37-a10e-05b792986dd5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d5c3dffa-e0e7-4fda-81f6-db3c255dd380", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f7b118e-a867-47a8-adf7-2621c3e09720", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d5c3dffa-e0e7-4fda-81f6-db3c255dd380"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Patients should be\ninformed that malaise and fatigue have been reported during treatment with\nlamivudine. The clinical status of the patient and the adverse reaction profile\nof lamivudine should be borne in mind when considering the patient's ability to\ndrive or operate machinery.</span></p>", "ID": "f2c2be13-7657-44a0-8746-cc0b9ebe009a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Patients should be\ninformed that malaise and fatigue have been reported during treatment with\nlamivudine. The clinical status of the patient and the adverse reaction profile\nof lamivudine should be borne in mind when considering the patient's ability to\ndrive or operate machinery.</span>", "ID": "5c871854-91da-4ed5-ac2f-b82e8aaf8a37", "Styles": "color:black", "Classes": "None", "Text": "Patients should be informed that malaise and fatigue have been reported during treatment with lamivudine. The clinical status of the patient and the adverse reaction profile of lamivudine should be borne in mind when considering the patient's ability to drive or operate machinery.", "ParentId": "f2c2be13-7657-44a0-8746-cc0b9ebe009a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "92c50d23-d44a-4777-ae61-6028b3c583a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df3a2608-c5e7-4ffe-b470-fcc744db4397", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "92c50d23-d44a-4777-ae61-6028b3c583a7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">Undesirable effects</span></b></p>", "ID": "1bf7f52d-bbd6-4145-ac1f-f4f3ca75f0f8", "Styles": "margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b>", "ID": "e8ff9d63-e9c4-4fde-9689-6df4d32538fa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1bf7f52d-bbd6-4145-ac1f-f4f3ca75f0f8"}, {"Element": "<span lang=\"EN-GB\">4.8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ec3491d3-90c7-4f31-ac34-84d52c91ce2c", "Styles": "None", "Classes": "None", "Text": "4.8", "ParentId": "e8ff9d63-e9c4-4fde-9689-6df4d32538fa"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6f0d1cd2-db9f-4837-ae8d-4ddd3dd31232", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ec3491d3-90c7-4f31-ac34-84d52c91ce2c"}, {"Element": "<b><span lang=\"EN-GB\">Undesirable effects</span></b>", "ID": "e7f5b726-727f-4265-883e-c899022d3c65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1bf7f52d-bbd6-4145-ac1f-f4f3ca75f0f8"}, {"Element": "<span lang=\"EN-GB\">Undesirable effects</span>", "ID": "85ae103e-5da9-408b-81d6-29a8047912a5", "Styles": "None", "Classes": "None", "Text": "Undesirable effects", "ParentId": "e7f5b726-727f-4265-883e-c899022d3c65"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "a6b857bd-e6ad-4eec-93c7-fe261999827b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "db14e264-80ca-418a-af0d-e82d81ebb9c8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a6b857bd-e6ad-4eec-93c7-fe261999827b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "71be79b9-b645-4036-97b6-e71294fe19be", "Styles": "color:black", "Classes": "None", "Text": "", "ParentId": "db14e264-80ca-418a-af0d-e82d81ebb9c8"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "a12f6483-52ce-443f-a1d4-aea9a654def9", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "71be79b9-b645-4036-97b6-e71294fe19be"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Summary of the\nsafety profile</span></u></p>", "ID": "f8f4f42f-7af1-4954-b55b-9e6428ba2ac8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Summary of the\nsafety profile</span></u>", "ID": "5ff88e5b-a4fc-4c83-b1cd-f14ecc292fb5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f8f4f42f-7af1-4954-b55b-9e6428ba2ac8"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Summary of the\nsafety profile</span>", "ID": "585b26e1-2850-4a56-9e39-5f9572a98b5b", "Styles": "color:black", "Classes": "None", "Text": "Summary of the safety profile", "ParentId": "5ff88e5b-a4fc-4c83-b1cd-f14ecc292fb5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The incidence of adverse reactions and\nlaboratory abnormalities (with the exception of elevations of ALT and CPK, see\nbelow) were similar between placebo and lamivudine treated patients). The most\ncommon adverse reactions reported were malaise and fatigue, respiratory tract\ninfections, throat and tonsil discomfort, headache, abdominal discomfort and\npain, nausea, vomiting and diarrhoea. </span></p>", "ID": "9adcad65-cc69-4495-aebb-85671ac62e39", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The incidence of adverse reactions and\nlaboratory abnormalities (with the exception of elevations of ALT and CPK, see\nbelow) were similar between placebo and lamivudine treated patients). The most\ncommon adverse reactions reported were malaise and fatigue, respiratory tract\ninfections, throat and tonsil discomfort, headache, abdominal discomfort and\npain, nausea, vomiting and diarrhoea. </span>", "ID": "8a2a3db8-0b53-4dae-97ba-0d233640db77", "Styles": "None", "Classes": "None", "Text": "The incidence of adverse reactions and laboratory abnormalities (with the exception of elevations of ALT and CPK, see below) were similar between placebo and lamivudine treated patients). The most common adverse reactions reported were malaise and fatigue, respiratory tract infections, throat and tonsil discomfort, headache, abdominal discomfort and pain, nausea, vomiting and diarrhoea. ", "ParentId": "9adcad65-cc69-4495-aebb-85671ac62e39"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c9781774-d54f-4528-879a-44d79500c9a8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "58807fd2-a29f-4afb-8a75-a5f161b42c94", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c9781774-d54f-4528-879a-44d79500c9a8"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><u><span lang=\"EN-GB\">Tabulated\nlist of adverse reactions </span></u></p>", "ID": "bae569f2-3b67-4ee1-820e-3896f722fa06", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Tabulated\nlist of adverse reactions </span></u>", "ID": "c7cf30a8-e891-4a5e-a8e9-6940b12d7503", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bae569f2-3b67-4ee1-820e-3896f722fa06"}, {"Element": "<span lang=\"EN-GB\">Tabulated\nlist of adverse reactions </span>", "ID": "9288a54c-70a1-4dc9-a690-4a33c55775b9", "Styles": "None", "Classes": "None", "Text": "Tabulated list of adverse reactions ", "ParentId": "c7cf30a8-e891-4a5e-a8e9-6940b12d7503"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Adverse reactions are listed below by\nsystem organ class and frequency. Frequency categories are only assigned to\nthose adverse reactions considered to be at least possibly causally related to\nlamivudine. Frequencies are defined as: very common (\u2265 1/10), common\n(\u2265 1/100 to &lt; 1/10), uncommon (\u2265 1/1000 to &lt; 1/100), rare\n(\u2265 1/10,000 to &lt; 1/1000),very rare (&lt; 1/10,000)<span style=\"color:black\"> and n</span></span><span lang=\"EN-GB\">ot known (cannot be\nestimated from the available data)</span><span lang=\"EN-GB\" style=\"color:black\">.</span></p>", "ID": "a84f397c-6766-4c49-8434-2345abf71287", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Adverse reactions are listed below by\nsystem organ class and frequency. Frequency categories are only assigned to\nthose adverse reactions considered to be at least possibly causally related to\nlamivudine. Frequencies are defined as: very common (\u2265 1/10), common\n(\u2265 1/100 to &lt; 1/10), uncommon (\u2265 1/1000 to &lt; 1/100), rare\n(\u2265 1/10,000 to &lt; 1/1000),very rare (&lt; 1/10,000)<span style=\"color:black\"> and n</span></span>", "ID": "d987b497-2957-44d4-a63e-bb89e806e8ee", "Styles": "None", "Classes": "None", "Text": "Adverse reactions are listed below by system organ class and frequency. Frequency categories are only assigned to those adverse reactions considered to be at least possibly causally related to lamivudine. Frequencies are defined as: very common (\u2265 1/10), common (\u2265 1/100 to < 1/10), uncommon (\u2265 1/1000 to < 1/100), rare (\u2265 1/10,000 to < 1/1000),very rare (< 1/10,000)", "ParentId": "a84f397c-6766-4c49-8434-2345abf71287"}, {"Element": "<span style=\"color:black\"> and n</span>", "ID": "09a4fe38-4787-4379-9b7e-921ed11df525", "Styles": "color:black", "Classes": "None", "Text": " and n", "ParentId": "d987b497-2957-44d4-a63e-bb89e806e8ee"}, {"Element": "<span lang=\"EN-GB\">ot known (cannot be\nestimated from the available data)</span>", "ID": "ff5552ea-9688-4eb6-b7d2-5553062c1df5", "Styles": "None", "Classes": "None", "Text": "ot known (cannot be estimated from the available data)", "ParentId": "a84f397c-6766-4c49-8434-2345abf71287"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">.</span>", "ID": "af0f8ef6-be7d-4ba1-ab58-360cbf01d161", "Styles": "color:black", "Classes": "None", "Text": ".", "ParentId": "a84f397c-6766-4c49-8434-2345abf71287"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "013bcb7b-5b03-48d5-94e0-f4d986d96ef6", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb2cc950-2645-41ca-b75f-62e6b2ef917e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "013bcb7b-5b03-48d5-94e0-f4d986d96ef6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">The frequency\ncategories assigned to the adverse reactions are mainly based on experience\nfrom clinical trials including a total of 1,171 patients with chronic hepatitis\nB receiving lamivudine at 100\u00a0mg.</span></p>", "ID": "038d81f3-be33-43ca-b923-454dfc87dad1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">The frequency\ncategories assigned to the adverse reactions are mainly based on experience\nfrom clinical trials including a total of 1,171 patients with chronic hepatitis\nB receiving lamivudine at 100\u00a0mg.</span>", "ID": "f6bcd96f-024c-4dff-bfd7-a0be5c780c40", "Styles": "color:black", "Classes": "None", "Text": "The frequency categories assigned to the adverse reactions are mainly based on experience from clinical trials including a total of 1,171 patients with chronic hepatitis B receiving lamivudine at 100\u00a0mg.", "ParentId": "038d81f3-be33-43ca-b923-454dfc87dad1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2fa7c38c-e44a-47c3-a588-210a8196c093", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e5235ae3-d41a-4cd0-9130-6f45ab21149e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2fa7c38c-e44a-47c3-a588-210a8196c093"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Thrombocytopenia</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Immune system\n  disorders</span></b><span lang=\"EN-GB\" style=\"color:black\">:</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Angioedema</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Hepatobiliary\n  disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Very common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">ALT</span><span lang=\"EN-GB\" style=\"color:black\"> elevations (see section 4.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\n  hepatitis, primarily detected by serum ALT elevations, have been reported\n  \u2018on-treatment\u2019 and following lamivudine withdrawal. Most events\n  have been self-limited, however fatalities have been observed very rarely\n  (see section 4.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rash, pruritus</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Elevations of CPK</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Muscle disorders,\n  including myalgia and cramps* </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Rhabdomyolysis</span></p>\n</td>\n</tr>\n</table>", "ID": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845", "Styles": "width:100.0%;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "              ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>\n</tr>", "ID": "6bf78cdf-acb8-46cc-8e54-5246b2cf2e97", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>", "ID": "374009f4-d431-452f-850b-153043d0d1ea", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6bf78cdf-acb8-46cc-8e54-5246b2cf2e97"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>", "ID": "a6db51cc-7d46-4af5-b7d7-fb2954bd07c5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "374009f4-d431-452f-850b-153043d0d1ea"}, {"Element": "<b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b>", "ID": "ecb07d25-c9b6-48d1-943e-dabbd8900d22", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a6db51cc-7d46-4af5-b7d7-fb2954bd07c5"}, {"Element": "<span lang=\"EN-GB\">Blood and lymphatic system disorders</span>", "ID": "34435873-2732-4966-b54b-ab9dda80b67d", "Styles": "None", "Classes": "None", "Text": "Blood and lymphatic system disorders", "ParentId": "ecb07d25-c9b6-48d1-943e-dabbd8900d22"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Thrombocytopenia</span></p>\n</td>\n</tr>", "ID": "ee5bb9cb-537f-4290-b3b3-1a75a140e46b", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>", "ID": "ed82674e-7a2c-4779-8d2d-eb0861787bef", "Styles": "width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ee5bb9cb-537f-4290-b3b3-1a75a140e46b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>", "ID": "3502590c-9ae9-479f-9788-62736efc9512", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ed82674e-7a2c-4779-8d2d-eb0861787bef"}, {"Element": "<span lang=\"EN-GB\">Not known</span>", "ID": "46088441-4d52-46c3-9a20-aa18d59b81e1", "Styles": "None", "Classes": "None", "Text": "Not known", "ParentId": "3502590c-9ae9-479f-9788-62736efc9512"}, {"Element": "<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Thrombocytopenia</span></p>\n</td>", "ID": "2bdbb0b3-d136-4335-8fd0-347834a9d503", "Styles": "width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ee5bb9cb-537f-4290-b3b3-1a75a140e46b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Thrombocytopenia</span></p>", "ID": "c1aacf32-aee0-4c7e-9acc-f8415b784af5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2bdbb0b3-d136-4335-8fd0-347834a9d503"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Thrombocytopenia</span>", "ID": "0341b98b-f122-42e0-bd89-b1c6a5cc3753", "Styles": "color:black", "Classes": "None", "Text": "Thrombocytopenia", "ParentId": "c1aacf32-aee0-4c7e-9acc-f8415b784af5"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Immune system\n  disorders</span></b><span lang=\"EN-GB\" style=\"color:black\">:</span></p>\n</td>\n</tr>", "ID": "b395dcbb-5916-4d0b-ab79-a4a8f6af6e2d", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Immune system\n  disorders</span></b><span lang=\"EN-GB\" style=\"color:black\">:</span></p>\n</td>", "ID": "e62f165a-911b-41bc-b64a-c4a5ab2f49d1", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b395dcbb-5916-4d0b-ab79-a4a8f6af6e2d"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Immune system\n  disorders</span></b><span lang=\"EN-GB\" style=\"color:black\">:</span></p>", "ID": "4bdfed74-b4fb-427a-bb4f-d63800f5a686", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e62f165a-911b-41bc-b64a-c4a5ab2f49d1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Immune system\n  disorders</span></b>", "ID": "32eadc8f-d6fd-4cf8-99e7-a0052b41569c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4bdfed74-b4fb-427a-bb4f-d63800f5a686"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Immune system\n  disorders</span>", "ID": "aff7e9cb-1964-4f2b-b518-5c6c0c32fc54", "Styles": "color:black", "Classes": "None", "Text": "Immune system   disorders", "ParentId": "32eadc8f-d6fd-4cf8-99e7-a0052b41569c"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">:</span>", "ID": "5046cd10-c7d3-4dbc-b8dd-e1fad023b148", "Styles": "color:black", "Classes": "None", "Text": ":", "ParentId": "4bdfed74-b4fb-427a-bb4f-d63800f5a686"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Angioedema</span></p>\n</td>\n</tr>", "ID": "877376fc-31dc-4f88-b819-6644d489e043", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "0915030c-9c7b-4cbb-ad2e-18e39d279d2f", "Styles": "width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "877376fc-31dc-4f88-b819-6644d489e043"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "9e74a07e-6348-4ccd-aa7f-7366b44c286f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0915030c-9c7b-4cbb-ad2e-18e39d279d2f"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "247b8a11-5045-4f80-9d91-2f1ea9ce1fc3", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "9e74a07e-6348-4ccd-aa7f-7366b44c286f"}, {"Element": "<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Angioedema</span></p>\n</td>", "ID": "877c3e6f-4a0f-49fe-a900-6253b1f1838e", "Styles": "width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "877376fc-31dc-4f88-b819-6644d489e043"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Angioedema</span></p>", "ID": "0082c867-9f3b-4aed-9db7-fa8619b5e65f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "877c3e6f-4a0f-49fe-a900-6253b1f1838e"}, {"Element": "<span lang=\"EN-GB\">Angioedema</span>", "ID": "cbee357d-9e49-4b6f-b317-344cd181cd15", "Styles": "None", "Classes": "None", "Text": "Angioedema", "ParentId": "0082c867-9f3b-4aed-9db7-fa8619b5e65f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Hepatobiliary\n  disorders</span></b></p>\n</td>\n</tr>", "ID": "d9f76fe4-b795-48b4-bae8-d93f0da40e19", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Hepatobiliary\n  disorders</span></b></p>\n</td>", "ID": "f661cf2c-9714-466b-b28c-e92e8a38fb71", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d9f76fe4-b795-48b4-bae8-d93f0da40e19"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Hepatobiliary\n  disorders</span></b></p>", "ID": "2dc673b5-1918-4fb9-8241-8d076686ee7e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f661cf2c-9714-466b-b28c-e92e8a38fb71"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Hepatobiliary\n  disorders</span></b>", "ID": "45772e1c-6035-46ae-8ac8-28e43c11810b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2dc673b5-1918-4fb9-8241-8d076686ee7e"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Hepatobiliary\n  disorders</span>", "ID": "9190b607-cb26-450d-82dd-d5ae649f78a5", "Styles": "color:black", "Classes": "None", "Text": "Hepatobiliary   disorders", "ParentId": "45772e1c-6035-46ae-8ac8-28e43c11810b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Very common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">ALT</span><span lang=\"EN-GB\" style=\"color:black\"> elevations (see section 4.4)</span></p>\n</td>\n</tr>", "ID": "cddf5078-f156-422e-a373-18b655006bb6", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Very common</span></p>\n</td>", "ID": "bab61e58-1e02-43a0-9dee-de66822f894f", "Styles": "width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "cddf5078-f156-422e-a373-18b655006bb6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Very common</span></p>", "ID": "d22bd286-9692-4ac1-9b32-f964c60138cd", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bab61e58-1e02-43a0-9dee-de66822f894f"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Very common</span>", "ID": "12c937f8-4013-44d0-9948-07ae193ac1d2", "Styles": "color:black", "Classes": "None", "Text": "Very common", "ParentId": "d22bd286-9692-4ac1-9b32-f964c60138cd"}, {"Element": "<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">ALT</span><span lang=\"EN-GB\" style=\"color:black\"> elevations (see section 4.4)</span></p>\n</td>", "ID": "eb057727-af13-42ce-8f5c-7bd4151740ae", "Styles": "width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "cddf5078-f156-422e-a373-18b655006bb6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">ALT</span><span lang=\"EN-GB\" style=\"color:black\"> elevations (see section 4.4)</span></p>", "ID": "f784c951-5a1b-4eff-8c66-cb6e5e254e3d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb057727-af13-42ce-8f5c-7bd4151740ae"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">ALT</span>", "ID": "639011e7-2b9c-4d12-bbb0-b555e085742c", "Styles": "color:black", "Classes": "None", "Text": "ALT", "ParentId": "f784c951-5a1b-4eff-8c66-cb6e5e254e3d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> elevations (see section 4.4)</span>", "ID": "33582563-4aea-485a-b2b5-d6bd44e66e4e", "Styles": "color:black", "Classes": "None", "Text": " elevations (see section 4.4)", "ParentId": "f784c951-5a1b-4eff-8c66-cb6e5e254e3d"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\n  hepatitis, primarily detected by serum ALT elevations, have been reported\n  \u2018on-treatment\u2019 and following lamivudine withdrawal. Most events\n  have been self-limited, however fatalities have been observed very rarely\n  (see section 4.4).</span></p>\n</td>\n</tr>", "ID": "2395f9c8-3598-41b6-b32f-3235465789b1", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\n  hepatitis, primarily detected by serum ALT elevations, have been reported\n  \u2018on-treatment\u2019 and following lamivudine withdrawal. Most events\n  have been self-limited, however fatalities have been observed very rarely\n  (see section 4.4).</span></p>\n</td>", "ID": "f01eef2e-5c69-47b9-957f-63ed9b37115b", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2395f9c8-3598-41b6-b32f-3235465789b1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\n  hepatitis, primarily detected by serum ALT elevations, have been reported\n  \u2018on-treatment\u2019 and following lamivudine withdrawal. Most events\n  have been self-limited, however fatalities have been observed very rarely\n  (see section 4.4).</span></p>", "ID": "40e1cff6-1a1d-4146-9261-ade5a5579f56", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f01eef2e-5c69-47b9-957f-63ed9b37115b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Exacerbations of\n  hepatitis, primarily detected by serum ALT elevations, have been reported\n  \u2018on-treatment\u2019 and following lamivudine withdrawal. Most events\n  have been self-limited, however fatalities have been observed very rarely\n  (see section 4.4).</span>", "ID": "38ba9fa7-a671-431a-b1b0-5dbad93fc12b", "Styles": "color:black", "Classes": "None", "Text": "Exacerbations of   hepatitis, primarily detected by serum ALT elevations, have been reported   \u2018on-treatment\u2019 and following lamivudine withdrawal. Most events   have been self-limited, however fatalities have been observed very rarely   (see section 4.4).", "ParentId": "40e1cff6-1a1d-4146-9261-ade5a5579f56"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>\n</tr>", "ID": "694d592a-c4c3-4549-ad19-0f5eb44fb0d3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>", "ID": "8b8157b2-02ef-4617-b753-53c98342cb07", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "694d592a-c4c3-4549-ad19-0f5eb44fb0d3"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Skin and\n  subcutaneous tissue disorders</span></b></p>", "ID": "5aa1088a-a2fa-428a-86fc-4e117d0d1b57", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b8157b2-02ef-4617-b753-53c98342cb07"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Skin and\n  subcutaneous tissue disorders</span></b>", "ID": "e7ebadea-99ee-4455-b3de-e318e81a054f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5aa1088a-a2fa-428a-86fc-4e117d0d1b57"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Skin and\n  subcutaneous tissue disorders</span>", "ID": "cf3d1206-b227-4a29-9545-fb9036f7b4ea", "Styles": "color:black", "Classes": "None", "Text": "Skin and   subcutaneous tissue disorders", "ParentId": "e7ebadea-99ee-4455-b3de-e318e81a054f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rash, pruritus</span></p>\n</td>\n</tr>", "ID": "f5daeece-5303-4755-ac72-07e88a0a341b", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>", "ID": "16c07b2e-0f46-4d8c-96d4-d7c36f6806b7", "Styles": "width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f5daeece-5303-4755-ac72-07e88a0a341b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>", "ID": "2961b1fe-65b2-4bb4-a5a6-250e486e6cb0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16c07b2e-0f46-4d8c-96d4-d7c36f6806b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Common</span>", "ID": "04fd8869-f9ea-4965-a8fb-3d6b2681750a", "Styles": "color:black", "Classes": "None", "Text": "Common", "ParentId": "2961b1fe-65b2-4bb4-a5a6-250e486e6cb0"}, {"Element": "<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rash, pruritus</span></p>\n</td>", "ID": "a1efa5a8-d28e-4aee-a409-78b1e9008e02", "Styles": "width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f5daeece-5303-4755-ac72-07e88a0a341b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Rash, pruritus</span></p>", "ID": "98431d2e-83fb-43a9-9a59-5273160b264d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a1efa5a8-d28e-4aee-a409-78b1e9008e02"}, {"Element": "<span lang=\"EN-GB\">Rash, pruritus</span>", "ID": "8ffcce97-cfc0-473d-ac0a-7b261cdb81ee", "Styles": "None", "Classes": "None", "Text": "Rash, pruritus", "ParentId": "98431d2e-83fb-43a9-9a59-5273160b264d"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>\n</tr>", "ID": "98645b99-17b3-4447-bd08-2a64bbc9da79", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td colspan=\"2\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>", "ID": "8f0a577d-2e7e-4203-b08e-76ed8c6065f0", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "98645b99-17b3-4447-bd08-2a64bbc9da79"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"color:black\">Musculoskeletal\n  and connective tissue disorders</span></b></p>", "ID": "917c07e1-e689-476e-975b-5b0fb4adf50c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8f0a577d-2e7e-4203-b08e-76ed8c6065f0"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Musculoskeletal\n  and connective tissue disorders</span></b>", "ID": "e56ab509-7ae2-49dc-b549-5847286de923", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "917c07e1-e689-476e-975b-5b0fb4adf50c"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Musculoskeletal\n  and connective tissue disorders</span>", "ID": "125cf388-3170-4a98-9336-3071686aeaa5", "Styles": "color:black", "Classes": "None", "Text": "Musculoskeletal   and connective tissue disorders", "ParentId": "e56ab509-7ae2-49dc-b549-5847286de923"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Elevations of CPK</span></p>\n</td>\n</tr>", "ID": "8aaa4711-ff30-4a15-a46e-0b811d5123d3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>\n</td>", "ID": "a775eedd-95a7-4cb4-8e5c-4c3601d2b418", "Styles": "width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8aaa4711-ff30-4a15-a46e-0b811d5123d3"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Common</span></p>", "ID": "c95f62b3-3777-4580-a4fd-769486ea5d27", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a775eedd-95a7-4cb4-8e5c-4c3601d2b418"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Common</span>", "ID": "5ff3f683-496c-476e-a0f8-6f3701af3ec3", "Styles": "color:black", "Classes": "None", "Text": "Common", "ParentId": "c95f62b3-3777-4580-a4fd-769486ea5d27"}, {"Element": "<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Elevations of CPK</span></p>\n</td>", "ID": "1500d30e-3a5a-45a0-afa3-35fe57cf0b1e", "Styles": "width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8aaa4711-ff30-4a15-a46e-0b811d5123d3"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Elevations of CPK</span></p>", "ID": "1437e3b2-7462-4897-b2d2-b8588de2994c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1500d30e-3a5a-45a0-afa3-35fe57cf0b1e"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Elevations of CPK</span>", "ID": "9c40eaf9-873e-4ad6-ad09-ee22343718e0", "Styles": "color:black", "Classes": "None", "Text": "Elevations of CPK", "ParentId": "1437e3b2-7462-4897-b2d2-b8588de2994c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0Common</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Muscle disorders,\n  including myalgia and cramps* </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n</td>\n</tr>", "ID": "71ebdb6e-538f-4391-9717-14a960e96922", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0Common</span></p>\n</td>", "ID": "d7a071a7-00d6-4cbb-928c-ccfa9a5cf573", "Styles": "width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "71ebdb6e-538f-4391-9717-14a960e96922"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0Common</span></p>", "ID": "dfebbd72-e129-424e-acda-a1be384d9bba", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7a071a7-00d6-4cbb-928c-ccfa9a5cf573"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0Common</span>", "ID": "83867d26-3194-413a-96b1-710792da1910", "Styles": "color:black", "Classes": "None", "Text": "\u00a0Common", "ParentId": "dfebbd72-e129-424e-acda-a1be384d9bba"}, {"Element": "<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Muscle disorders,\n  including myalgia and cramps* </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n</td>", "ID": "4e22bb9e-6ebe-4bcb-9804-6a083ad1efbf", "Styles": "width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "71ebdb6e-538f-4391-9717-14a960e96922"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Muscle disorders,\n  including myalgia and cramps* </span></p>", "ID": "b3ea287d-594c-43ca-9cbb-cd378417a3b2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e22bb9e-6ebe-4bcb-9804-6a083ad1efbf"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Muscle disorders,\n  including myalgia and cramps* </span>", "ID": "29fb4537-0c58-4700-b314-40c92712f32d", "Styles": "color:black", "Classes": "None", "Text": "Muscle disorders,   including myalgia and cramps* ", "ParentId": "b3ea287d-594c-43ca-9cbb-cd378417a3b2"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "c5820dd9-0de2-4575-bd45-f8eee20f1bb7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e22bb9e-6ebe-4bcb-9804-6a083ad1efbf"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "a5ba028b-a153-433f-b506-74f95963340d", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "c5820dd9-0de2-4575-bd45-f8eee20f1bb7"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>\n<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Rhabdomyolysis</span></p>\n</td>\n</tr>", "ID": "27733ad8-d60a-4ece-8a36-2e2c86125219", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "5a1de684-c1b1-4ad9-b5aa-6bb2d3618845"}, {"Element": "<td style=\"width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"22%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>\n</td>", "ID": "3787b281-44b2-407a-a485-d131f641c66d", "Styles": "width:22.72%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "27733ad8-d60a-4ece-8a36-2e2c86125219"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not known</span></p>", "ID": "6b37cbad-516f-4ef3-bff8-e5168f739580", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3787b281-44b2-407a-a485-d131f641c66d"}, {"Element": "<span lang=\"EN-GB\">Not known</span>", "ID": "76afa56b-442e-498c-839e-b19df83465cf", "Styles": "None", "Classes": "None", "Text": "Not known", "ParentId": "6b37cbad-516f-4ef3-bff8-e5168f739580"}, {"Element": "<td style=\"width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"77%\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Rhabdomyolysis</span></p>\n</td>", "ID": "1302cc0a-d2e1-44b2-bdae-f1644880037e", "Styles": "width:77.28%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "27733ad8-d60a-4ece-8a36-2e2c86125219"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Rhabdomyolysis</span></p>", "ID": "5463c2c0-664c-438e-95ed-5e06500e8e89", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1302cc0a-d2e1-44b2-bdae-f1644880037e"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Rhabdomyolysis</span>", "ID": "78cddb58-dae3-484e-b327-bd1a06f992fa", "Styles": "color:black", "Classes": "None", "Text": "Rhabdomyolysis", "ParentId": "5463c2c0-664c-438e-95ed-5e06500e8e89"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">* In Phase III studies\nfrequency observed in the lamivudine treatment group was not greater than\nobserved in the placebo group</span></p>", "ID": "dc6586dd-474f-436d-af0b-dd7c30d6afae", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">* In Phase III studies\nfrequency observed in the lamivudine treatment group was not greater than\nobserved in the placebo group</span>", "ID": "1ce90d71-02d5-428e-a039-98f89334f030", "Styles": "color:black", "Classes": "None", "Text": "* In Phase III studies frequency observed in the lamivudine treatment group was not greater than observed in the placebo group", "ParentId": "dc6586dd-474f-436d-af0b-dd7c30d6afae"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6daf48e9-b558-4548-8807-25e9d8315d00", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f80ee3f1-23df-443b-baa1-5bb69e7b09ea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6daf48e9-b558-4548-8807-25e9d8315d00"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Paediatric\npopulation </span></u></p>", "ID": "9d789a3b-98fe-4466-98ae-cb4560089558", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Paediatric\npopulation </span></u>", "ID": "0de361c3-e9be-4af1-934f-37b75f2b220d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9d789a3b-98fe-4466-98ae-cb4560089558"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Paediatric\npopulation </span>", "ID": "4079ac96-1d59-4771-a84c-0bf19c8b5540", "Styles": "color:black", "Classes": "None", "Text": "Paediatric population ", "ParentId": "0de361c3-e9be-4af1-934f-37b75f2b220d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Based on limited data\nin children aged 2 to 17 years, there were no new safety issues identified\ncompared to adults.</span></p>", "ID": "7dfac998-994c-4528-8c90-41140c4cc40a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Based on limited data\nin children aged 2 to 17 years, there were no new safety issues identified\ncompared to adults.</span>", "ID": "2f531756-7c2d-4e94-870b-ab4edf93570a", "Styles": "color:black", "Classes": "None", "Text": "Based on limited data in children aged 2 to 17 years, there were no new safety issues identified compared to adults.", "ParentId": "7dfac998-994c-4528-8c90-41140c4cc40a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "84bd672b-cd6c-4372-bc76-19f5e31421ec", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "bd4ea80e-a8be-4dda-ad5b-9703efb52096", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "84bd672b-cd6c-4372-bc76-19f5e31421ec"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\" style=\"color:black\">Other special\npopulations</span></u></p>", "ID": "fbae9434-3150-438d-88cb-3783ee82354d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Other special\npopulations</span></u>", "ID": "ca63e779-aef7-4788-9bda-2934163c01b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbae9434-3150-438d-88cb-3783ee82354d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Other special\npopulations</span>", "ID": "1f870757-fa47-44a0-b9ff-6336ea9afd0b", "Styles": "color:black", "Classes": "None", "Text": "Other special populations", "ParentId": "ca63e779-aef7-4788-9bda-2934163c01b5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6b4bf3f2-62ba-406c-9089-b3e58d4e01b8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a59cbc12-fdbd-4a6b-98bf-e3ec761cedf2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6b4bf3f2-62ba-406c-9089-b3e58d4e01b8"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In patients with HIV infection, cases of\npancreatitis and peripheral neuropathy (or paresthesia) have been reported. In\npatients with chronic hepatitis B there was no observed difference in incidence\nof these events between placebo and lamivudine treated patients. </span></p>", "ID": "c577623a-18d7-468e-8af8-572b9959fbda", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In patients with HIV infection, cases of\npancreatitis and peripheral neuropathy (or paresthesia) have been reported. In\npatients with chronic hepatitis B there was no observed difference in incidence\nof these events between placebo and lamivudine treated patients. </span>", "ID": "226320f1-98b0-4657-a611-257fa0b8040a", "Styles": "None", "Classes": "None", "Text": "In patients with HIV infection, cases of pancreatitis and peripheral neuropathy (or paresthesia) have been reported. In patients with chronic hepatitis B there was no observed difference in incidence of these events between placebo and lamivudine treated patients. ", "ParentId": "c577623a-18d7-468e-8af8-572b9959fbda"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "62a13e23-872f-4aa8-87b3-0b1f1f0bf6a0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ee1ae0c-91ca-43e4-9540-b85b88a342cc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "62a13e23-872f-4aa8-87b3-0b1f1f0bf6a0"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Cases of lactic acidosis, sometimes fatal,\nusually associated with severe hepatomegaly and hepatic <br/>\nsteatosis, have been reported with the use of combination nucleoside analogue\ntherapy in patients with <br/>\nHIV. There have been rare reports of lactic acidosis in patients receiving\nlamivudine for hepatitis B. <br/>\n<br/>\n</span></p>", "ID": "d7073be6-2cb3-46c0-83f3-aceb83ebde81", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Cases of lactic acidosis, sometimes fatal,\nusually associated with severe hepatomegaly and hepatic <br/>\nsteatosis, have been reported with the use of combination nucleoside analogue\ntherapy in patients with <br/>\nHIV. There have been rare reports of lactic acidosis in patients receiving\nlamivudine for hepatitis B. <br/>\n<br/>\n</span>", "ID": "2b1ac2c9-85e7-44a0-ab3b-1ed2bab5d1c7", "Styles": "None", "Classes": "None", "Text": "Cases of lactic acidosis, sometimes fatal, usually associated with severe hepatomegaly and hepatic  steatosis, have been reported with the use of combination nucleoside analogue therapy in patients with  HIV. There have been rare reports of lactic acidosis in patients receiving lamivudine for hepatitis B.   ", "ParentId": "d7073be6-2cb3-46c0-83f3-aceb83ebde81"}, {"Element": "<br/>", "ID": "ac26168b-3e69-4453-b586-94dbcc061589", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2b1ac2c9-85e7-44a0-ab3b-1ed2bab5d1c7"}, {"Element": "<br/>", "ID": "5f83a2da-2328-48a7-8d66-d977e9f60a06", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2b1ac2c9-85e7-44a0-ab3b-1ed2bab5d1c7"}, {"Element": "<br/>", "ID": "3ac1c273-a2c2-47dc-995f-db9c6d4090b4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2b1ac2c9-85e7-44a0-ab3b-1ed2bab5d1c7"}, {"Element": "<br/>", "ID": "6427b329-bbbb-45d7-a24d-33b580bb42bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2b1ac2c9-85e7-44a0-ab3b-1ed2bab5d1c7"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><u><span lang=\"EN-GB\">Reporting of\nsuspected adverse reactions</span></u></p>", "ID": "b5b68010-0940-4c08-a4c4-89cf054065ee", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Reporting of\nsuspected adverse reactions</span></u>", "ID": "12053377-bfe2-40a7-bddc-6fb22673c11f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5b68010-0940-4c08-a4c4-89cf054065ee"}, {"Element": "<span lang=\"EN-GB\">Reporting of\nsuspected adverse reactions</span>", "ID": "293bde73-cf8d-4560-96d1-918e1b55408c", "Styles": "None", "Classes": "None", "Text": "Reporting of suspected adverse reactions", "ParentId": "12053377-bfe2-40a7-bddc-6fb22673c11f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after\nauthorisation of the medicinal product is important. It allows continued\nmonitoring of the benefit/risk balance of the medicinal product. Healthcare professionals\nare asked to report any suspected adverse reactions via <span style=\"background:\nlightgrey\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a></span></p>", "ID": "f637e04f-5d3a-43f3-bd35-44b0d0e94e00", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Reporting suspected adverse reactions after\nauthorisation of the medicinal product is important. It allows continued\nmonitoring of the benefit/risk balance of the medicinal product. Healthcare professionals\nare asked to report any suspected adverse reactions via <span style=\"background:\nlightgrey\">the national reporting system listed in </span></span>", "ID": "f5f329d9-7953-405e-8844-24f185238055", "Styles": "None", "Classes": "None", "Text": "Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via ", "ParentId": "f637e04f-5d3a-43f3-bd35-44b0d0e94e00"}, {"Element": "<span style=\"background:\nlightgrey\">the national reporting system listed in </span>", "ID": "9c28ccb1-96c6-4123-baa1-efedbe82f71b", "Styles": "background:\nlightgrey", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "f5f329d9-7953-405e-8844-24f185238055"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a></span>", "ID": "e3c1001a-0f76-42eb-afe5-737ddcc1c496", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f637e04f-5d3a-43f3-bd35-44b0d0e94e00"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a>", "ID": "4303fee8-431d-4850-a90d-d5f761559504", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e3c1001a-0f76-42eb-afe5-737ddcc1c496"}, {"Element": "<span style=\"background:lightgrey\">Appendix V</span>", "ID": "223419f5-17a0-46fb-a98b-768f9b03fa4c", "Styles": "background:lightgrey", "Classes": "None", "Text": "Appendix V", "ParentId": "4303fee8-431d-4850-a90d-d5f761559504"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "11f2e6b6-5b3c-4ad3-b1b9-5c1b09ca7300", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0b71a710-8b9a-4b84-b7ac-4cf35c79a157", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11f2e6b6-5b3c-4ad3-b1b9-5c1b09ca7300"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>", "ID": "7532c44c-3357-4c60-8f7c-d6b5a40844fa", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b>", "ID": "a8b2b71f-524f-43a0-9b0d-3ca349c54508", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7532c44c-3357-4c60-8f7c-d6b5a40844fa"}, {"Element": "<span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span>", "ID": "caed0b2d-1ea0-459b-9cef-903c3e21bfa8", "Styles": "None", "Classes": "None", "Text": "4.9\u00a0\u00a0\u00a0\u00a0 Overdose", "ParentId": "a8b2b71f-524f-43a0-9b0d-3ca349c54508"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a535ce0f-2ad0-4aef-9356-99d6a8a2c667", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "88b26238-d67b-49d9-9793-861992907ce0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a535ce0f-2ad0-4aef-9356-99d6a8a2c667"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Administration of lamivudine at very high\ndose levels in acute animal studies did not result in any organ toxicity.\nLimited data are available on the consequences of ingestion of acute overdoses\nin humans. No fatalities occurred, and the patients recovered. No specific\nsigns or symptoms have been identified following such overdose. </span></p>", "ID": "dd1e64c5-ceac-491d-a684-7c4d6ca2225e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Administration of lamivudine at very high\ndose levels in acute animal studies did not result in any organ toxicity.\nLimited data are available on the consequences of ingestion of acute overdoses\nin humans. No fatalities occurred, and the patients recovered. No specific\nsigns or symptoms have been identified following such overdose. </span>", "ID": "71e3e7d8-edb0-4232-8b91-26b240662d8e", "Styles": "None", "Classes": "None", "Text": "Administration of lamivudine at very high dose levels in acute animal studies did not result in any organ toxicity. Limited data are available on the consequences of ingestion of acute overdoses in humans. No fatalities occurred, and the patients recovered. No specific signs or symptoms have been identified following such overdose. ", "ParentId": "dd1e64c5-ceac-491d-a684-7c4d6ca2225e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2435f5e2-ba5c-4c88-9381-e8d37935fb7f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4fab1ec1-f6c9-475a-ba3b-472030d74d1f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2435f5e2-ba5c-4c88-9381-e8d37935fb7f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">If overdose occurs the patient should be\nmonitored and standard supportive treatment applied as required. Since\nlamivudine is dialysable, continuous haemodialysis could be used in the\ntreatment of overdose, although this has not been studied. </span></p>", "ID": "92f2264f-b904-47df-82aa-738fbfbc66c2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">If overdose occurs the patient should be\nmonitored and standard supportive treatment applied as required. Since\nlamivudine is dialysable, continuous haemodialysis could be used in the\ntreatment of overdose, although this has not been studied. </span>", "ID": "eb83c0b9-8e75-4380-9b7f-deef5b51bd77", "Styles": "None", "Classes": "None", "Text": "If overdose occurs the patient should be monitored and standard supportive treatment applied as required. Since lamivudine is dialysable, continuous haemodialysis could be used in the treatment of overdose, although this has not been studied. ", "ParentId": "92f2264f-b904-47df-82aa-738fbfbc66c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d710066b-8a2c-4aff-8a82-24c18357d6d4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "beb8a2c9-6489-4c7f-a785-6f8b3df895bd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d710066b-8a2c-4aff-8a82-24c18357d6d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f32344d8-f79d-41eb-9c2e-d9e271f2e38e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8cc6cb75-0ef8-46ac-bb16-27e1fc5db5d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f32344d8-f79d-41eb-9c2e-d9e271f2e38e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>", "ID": "1b3009c6-4f40-4a7b-89f9-053700edc73f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b>", "ID": "901f16d2-bab2-4e3f-804a-64b7749f6937", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b3009c6-4f40-4a7b-89f9-053700edc73f"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span>", "ID": "b84c9187-e345-454e-bf89-21d3877477b5", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES", "ParentId": "901f16d2-bab2-4e3f-804a-64b7749f6937"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e8822cbb-d6e2-40f0-b5fe-33d6aed884d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df4430d9-daba-48c6-a33d-4b7cd654f175", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e8822cbb-d6e2-40f0-b5fe-33d6aed884d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b></p>", "ID": "242d7b8f-83e4-49f9-851c-7baa5695811f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b>", "ID": "85d84de3-9150-42db-a535-bdf055957e26", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "242d7b8f-83e4-49f9-851c-7baa5695811f"}, {"Element": "<span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span>", "ID": "ee589ae0-1d61-4775-9dae-2a091d401979", "Styles": "None", "Classes": "None", "Text": "5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties", "ParentId": "85d84de3-9150-42db-a535-bdf055957e26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4f6fdefd-f47d-453f-adce-cd5ee6f3fec5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e913a010-8dee-48fa-873e-45d221499d86", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f6fdefd-f47d-453f-adce-cd5ee6f3fec5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Pharmacotherapeutic group - </span><span lang=\"EN-GB\" style=\"color:black\">Antivirals for systemic use, nucleoside and\nnucleotide reverse transcriptase inhibitors,</span><span lang=\"EN-GB\">ATC Code:\nJ05AF05. </span></p>", "ID": "8940031a-bcc9-47f3-8e27-737f3b2255e1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Pharmacotherapeutic group - </span>", "ID": "c466556f-0170-42ce-91d7-930f8df05a3d", "Styles": "None", "Classes": "None", "Text": "Pharmacotherapeutic group - ", "ParentId": "8940031a-bcc9-47f3-8e27-737f3b2255e1"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Antivirals for systemic use, nucleoside and\nnucleotide reverse transcriptase inhibitors,</span>", "ID": "9ba96dbf-a8bc-43b2-adb0-b888ab132275", "Styles": "color:black", "Classes": "None", "Text": "Antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors,", "ParentId": "8940031a-bcc9-47f3-8e27-737f3b2255e1"}, {"Element": "<span lang=\"EN-GB\">ATC Code:\nJ05AF05. </span>", "ID": "1dc3a305-11c4-4311-9718-06bd4ba1a53d", "Styles": "None", "Classes": "None", "Text": "ATC Code: J05AF05. ", "ParentId": "8940031a-bcc9-47f3-8e27-737f3b2255e1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a0ce07b1-fb87-4782-aaef-af26f3fcf693", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d6e2142f-f599-4fb0-9053-0299d5569fda", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0ce07b1-fb87-4782-aaef-af26f3fcf693"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is an antiviral agent which is\nactive against hepatitis B virus in all cell lines tested and in experimentally\ninfected animals. </span></p>", "ID": "ed764257-4f7e-4edc-b38c-012f47940a8f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine is an antiviral agent which is\nactive against hepatitis B virus in all cell lines tested and in experimentally\ninfected animals. </span>", "ID": "f278d5fa-2f34-4d53-9b5f-9d280423193e", "Styles": "None", "Classes": "None", "Text": "Lamivudine is an antiviral agent which is active against hepatitis B virus in all cell lines tested and in experimentally infected animals. ", "ParentId": "ed764257-4f7e-4edc-b38c-012f47940a8f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d34f1bd0-c737-44a0-926b-27f4df8d40e5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "830274f7-8ffc-4041-b4cf-54408c73e47c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d34f1bd0-c737-44a0-926b-27f4df8d40e5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is metabolised by both infected\nand uninfected cells to the triphosphate (TP) derivative which is the active\nform of the parent compound. The intracellular half life of the triphosphate in\nhepatocytes is 17\u201119 hours <i>in vitro</i>. Lamivudine-TP acts as a\nsubstrate for the HBV viral polymerase.</span></p>", "ID": "f00ccbb9-c6c2-45ed-8d0b-1a6a020e06af", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine is metabolised by both infected\nand uninfected cells to the triphosphate (TP) derivative which is the active\nform of the parent compound. The intracellular half life of the triphosphate in\nhepatocytes is 17\u201119 hours <i>in vitro</i>. Lamivudine-TP acts as a\nsubstrate for the HBV viral polymerase.</span>", "ID": "3d65fec7-ce3d-491c-a8e0-520d2bb57ee9", "Styles": "None", "Classes": "None", "Text": "Lamivudine is metabolised by both infected and uninfected cells to the triphosphate (TP) derivative which is the active form of the parent compound. The intracellular half life of the triphosphate in hepatocytes is 17\u201119 hours . Lamivudine-TP acts as a substrate for the HBV viral polymerase.", "ParentId": "f00ccbb9-c6c2-45ed-8d0b-1a6a020e06af"}, {"Element": "<i>in vitro</i>", "ID": "5a327d01-32e6-4f2a-83b2-fe04920bfc2f", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "3d65fec7-ce3d-491c-a8e0-520d2bb57ee9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8bd6fbb5-6ab9-47ab-bcc2-4c8a830ab18f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d3b1a4b1-67c3-408b-b75e-06dc1be74201", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8bd6fbb5-6ab9-47ab-bcc2-4c8a830ab18f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The formation of further viral DNA is\nblocked by incorporation of lamivudine-TP into the chain and subsequent chain\ntermination. </span></p>", "ID": "2fe903cb-164c-497b-9460-df364ecba506", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The formation of further viral DNA is\nblocked by incorporation of lamivudine-TP into the chain and subsequent chain\ntermination. </span>", "ID": "862994ac-f3c0-46b1-a860-8514a4297961", "Styles": "None", "Classes": "None", "Text": "The formation of further viral DNA is blocked by incorporation of lamivudine-TP into the chain and subsequent chain termination. ", "ParentId": "2fe903cb-164c-497b-9460-df364ecba506"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine-TP does not interfere with\nnormal cellular deoxynucleotide metabolism. It is also only a weak inhibitor of\nmammalian DNA polymerases alpha and beta. Furthermore, lamivudine-TP has little\neffect on mammalian cell DNA content. </span></p>", "ID": "3db2d170-6cd3-4105-bc83-0546f9f846bc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine-TP does not interfere with\nnormal cellular deoxynucleotide metabolism. It is also only a weak inhibitor of\nmammalian DNA polymerases alpha and beta. Furthermore, lamivudine-TP has little\neffect on mammalian cell DNA content. </span>", "ID": "557e4a93-b269-47fb-be9e-bc16ca0fe91c", "Styles": "None", "Classes": "None", "Text": "Lamivudine-TP does not interfere with normal cellular deoxynucleotide metabolism. It is also only a weak inhibitor of mammalian DNA polymerases alpha and beta. Furthermore, lamivudine-TP has little effect on mammalian cell DNA content. ", "ParentId": "3db2d170-6cd3-4105-bc83-0546f9f846bc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c653b7bb-6e67-4982-8e48-8376777f9455", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "15629b09-ed86-4eb7-9e43-800431e3206d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c653b7bb-6e67-4982-8e48-8376777f9455"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In assays relating to potential substance\neffects on mitochondrial structure and DNA content and function, lamivudine\nlacked appreciable toxic effects. It has a very low potential to decrease\nmitochondrial DNA content, is not permanently incorporated into mitochondrial\nDNA, and does not act as an inhibitor of mitochondrial DNA polymerase gamma. </span></p>", "ID": "d8b1b67a-22b9-432d-b84e-7cb8f77276cb", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In assays relating to potential substance\neffects on mitochondrial structure and DNA content and function, lamivudine\nlacked appreciable toxic effects. It has a very low potential to decrease\nmitochondrial DNA content, is not permanently incorporated into mitochondrial\nDNA, and does not act as an inhibitor of mitochondrial DNA polymerase gamma. </span>", "ID": "83336b7e-f1c2-4d21-bdc7-940da86ed64d", "Styles": "None", "Classes": "None", "Text": "In assays relating to potential substance effects on mitochondrial structure and DNA content and function, lamivudine lacked appreciable toxic effects. It has a very low potential to decrease mitochondrial DNA content, is not permanently incorporated into mitochondrial DNA, and does not act as an inhibitor of mitochondrial DNA polymerase gamma. ", "ParentId": "d8b1b67a-22b9-432d-b84e-7cb8f77276cb"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b88c8a88-8d97-4bfb-93a1-27c47553faac", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "27b3638b-80c2-49a8-a6ef-0d3f0bdcf040", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b88c8a88-8d97-4bfb-93a1-27c47553faac"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Clinical experience </span></u></p>", "ID": "78eeddfd-3fdc-4633-905c-d75aefb46297", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Clinical experience </span></u>", "ID": "6f6e0255-c610-429d-a9f5-7a3a44af1d41", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "78eeddfd-3fdc-4633-905c-d75aefb46297"}, {"Element": "<span lang=\"EN-GB\">Clinical experience </span>", "ID": "182ed988-fc18-405d-9d46-5a7f72c3d041", "Styles": "None", "Classes": "None", "Text": "Clinical experience ", "ParentId": "6f6e0255-c610-429d-a9f5-7a3a44af1d41"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6504b966-0a1e-449b-9682-6dbb9d59e54b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a85464f1-dd3e-4d47-9e3c-c833b37d122c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6504b966-0a1e-449b-9682-6dbb9d59e54b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">Experience in patients with HBeAg positive CHB and compensated liver\ndisease </span></i></p>", "ID": "cf7d3c18-dd5f-4f48-a181-1c519756a336", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Experience in patients with HBeAg positive CHB and compensated liver\ndisease </span></i>", "ID": "afd70272-e3d6-497a-911a-ce7b960119cd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf7d3c18-dd5f-4f48-a181-1c519756a336"}, {"Element": "<span lang=\"EN-GB\">Experience in patients with HBeAg positive CHB and compensated liver\ndisease </span>", "ID": "e4e97e2b-3348-4c04-960e-4bdc339a7af5", "Styles": "None", "Classes": "None", "Text": "Experience in patients with HBeAg positive CHB and compensated liver disease ", "ParentId": "afd70272-e3d6-497a-911a-ce7b960119cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In controlled studies, 1 year of lamivudine therapy significantly\nsuppressed HBV DNA replication [34\u201157\u00a0% of patients were below the\nassay detection limits (Abbott Genostics solution hybridization assay, LLOD\n&lt; 1.6\u00a0pg/ml)}, normalised ALT level (40\u201172\u00a0% of patients),\ninduced HBeAg seroconversion (HBeAg loss and HBeAb detection with HBV DNA loss\n[by conventional assay], 16\u201118\u00a0% of patients), improved histology\n(38\u201152\u00a0% of patients had a \u2265 2 point decrease in the Knodell\nHistologic Activity Index [HAI]) and reduced progression of fibrosis (in 3\u201117\u00a0%\nof patients) and progression to cirrhosis.</span></p>", "ID": "ad89a4fb-c3d3-4197-890a-b4cde646f05f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In controlled studies, 1 year of lamivudine therapy significantly\nsuppressed HBV DNA replication [34\u201157\u00a0% of patients were below the\nassay detection limits (Abbott Genostics solution hybridization assay, LLOD\n&lt; 1.6\u00a0pg/ml)}, normalised ALT level (40\u201172\u00a0% of patients),\ninduced HBeAg seroconversion (HBeAg loss and HBeAb detection with HBV DNA loss\n[by conventional assay], 16\u201118\u00a0% of patients), improved histology\n(38\u201152\u00a0% of patients had a \u2265 2 point decrease in the Knodell\nHistologic Activity Index [HAI]) and reduced progression of fibrosis (in 3\u201117\u00a0%\nof patients) and progression to cirrhosis.</span>", "ID": "1b4db931-6bf4-4867-b78d-c203704ca0c6", "Styles": "None", "Classes": "None", "Text": "In controlled studies, 1 year of lamivudine therapy significantly suppressed HBV DNA replication [34\u201157\u00a0% of patients were below the assay detection limits (Abbott Genostics solution hybridization assay, LLOD < 1.6\u00a0pg/ml)}, normalised ALT level (40\u201172\u00a0% of patients), induced HBeAg seroconversion (HBeAg loss and HBeAb detection with HBV DNA loss [by conventional assay], 16\u201118\u00a0% of patients), improved histology (38\u201152\u00a0% of patients had a \u2265 2 point decrease in the Knodell Histologic Activity Index [HAI]) and reduced progression of fibrosis (in 3\u201117\u00a0% of patients) and progression to cirrhosis.", "ParentId": "ad89a4fb-c3d3-4197-890a-b4cde646f05f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6bd36d7a-ff47-4ad7-aa6f-c602d010f2d5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ee3df801-7b99-48fa-bf7b-dd280b149e9b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6bd36d7a-ff47-4ad7-aa6f-c602d010f2d5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Continued lamivudine treatment for an\nadditional 2 years in patients who had failed to achieve HBeAg seroconversion\nin the initial 1 year controlled studies resulted in further improvement in\nbridging fibrosis. In patients with YMDD mutant HBV, 41/82 (50\u00a0%) patients\nhad improvement in liver inflammation and 40/56 (71\u00a0%) patients without\nYMDD mutant HBV had improvement. Improvement in bridging fibrosis occurred in\n19/30 (63\u00a0%) patients without YMDD mutant and 22/44 (50\u00a0%) patients\nwith the mutant. Five percent (3/56) of patients without the YMDD mutant and\n13\u00a0% (11/82) of patients with YMDD mutant showed worsening in liver\ninflammation compared to pre-treatment. Progression to cirrhosis occurred in\n4/68 (6\u00a0%) patients with the YMDD mutant, whereas no patients without the mutant\nprogressed to cirrhosis. </span></p>", "ID": "fe3fbb72-a40f-4994-9e01-5d4ef42c9e86", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Continued lamivudine treatment for an\nadditional 2 years in patients who had failed to achieve HBeAg seroconversion\nin the initial 1 year controlled studies resulted in further improvement in\nbridging fibrosis. In patients with YMDD mutant HBV, 41/82 (50\u00a0%) patients\nhad improvement in liver inflammation and 40/56 (71\u00a0%) patients without\nYMDD mutant HBV had improvement. Improvement in bridging fibrosis occurred in\n19/30 (63\u00a0%) patients without YMDD mutant and 22/44 (50\u00a0%) patients\nwith the mutant. Five percent (3/56) of patients without the YMDD mutant and\n13\u00a0% (11/82) of patients with YMDD mutant showed worsening in liver\ninflammation compared to pre-treatment. Progression to cirrhosis occurred in\n4/68 (6\u00a0%) patients with the YMDD mutant, whereas no patients without the mutant\nprogressed to cirrhosis. </span>", "ID": "0b017d2b-6bea-4097-b2b5-c6cad295c4ec", "Styles": "None", "Classes": "None", "Text": "Continued lamivudine treatment for an additional 2 years in patients who had failed to achieve HBeAg seroconversion in the initial 1 year controlled studies resulted in further improvement in bridging fibrosis. In patients with YMDD mutant HBV, 41/82 (50\u00a0%) patients had improvement in liver inflammation and 40/56 (71\u00a0%) patients without YMDD mutant HBV had improvement. Improvement in bridging fibrosis occurred in 19/30 (63\u00a0%) patients without YMDD mutant and 22/44 (50\u00a0%) patients with the mutant. Five percent (3/56) of patients without the YMDD mutant and 13\u00a0% (11/82) of patients with YMDD mutant showed worsening in liver inflammation compared to pre-treatment. Progression to cirrhosis occurred in 4/68 (6\u00a0%) patients with the YMDD mutant, whereas no patients without the mutant progressed to cirrhosis. ", "ParentId": "fe3fbb72-a40f-4994-9e01-5d4ef42c9e86"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1edca6dd-6023-4bb8-8a72-77e965611036", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d382098-886f-430d-a564-86a4d9a338f1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1edca6dd-6023-4bb8-8a72-77e965611036"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In an extended treatment study in Asian\npatients (NUCB3018) the HBeAg seroconversion rate and ALT normalisation rate at\nthe end of the 5 year treatment period was 48\u00a0% (28/58) and 47\u00a0%\n(15/32), respectively. HBeAg seroconversion was increased in patients with\nelevated ALT levels; 77\u00a0% (20/26) of patients with pre-treatment ALT &gt;\n2 x ULN seroconverted. At the end of 5 years, all patients had HBV DNA levels\nthat were undetectable or lower than pre-treatment levels. </span></p>", "ID": "4ea85d7a-f1a3-4c59-bff1-bfcfaddbdd34", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In an extended treatment study in Asian\npatients (NUCB3018) the HBeAg seroconversion rate and ALT normalisation rate at\nthe end of the 5 year treatment period was 48\u00a0% (28/58) and 47\u00a0%\n(15/32), respectively. HBeAg seroconversion was increased in patients with\nelevated ALT levels; 77\u00a0% (20/26) of patients with pre-treatment ALT &gt;\n2 x ULN seroconverted. At the end of 5 years, all patients had HBV DNA levels\nthat were undetectable or lower than pre-treatment levels. </span>", "ID": "f16a2fc3-0967-441f-8562-74d8ae804b0b", "Styles": "None", "Classes": "None", "Text": "In an extended treatment study in Asian patients (NUCB3018) the HBeAg seroconversion rate and ALT normalisation rate at the end of the 5 year treatment period was 48\u00a0% (28/58) and 47\u00a0% (15/32), respectively. HBeAg seroconversion was increased in patients with elevated ALT levels; 77\u00a0% (20/26) of patients with pre-treatment ALT > 2 x ULN seroconverted. At the end of 5 years, all patients had HBV DNA levels that were undetectable or lower than pre-treatment levels. ", "ParentId": "4ea85d7a-f1a3-4c59-bff1-bfcfaddbdd34"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "57b93c88-5936-4479-8e81-0f3e196f303d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "be2f32e7-e216-4a5a-b470-207c224b4669", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "57b93c88-5936-4479-8e81-0f3e196f303d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Further results from the trial by YMDD mutant\nstatus are summarised in Table 1. </span></p>", "ID": "c71fa72a-f6bd-4068-b09f-b7897b72411c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Further results from the trial by YMDD mutant\nstatus are summarised in Table 1. </span>", "ID": "a633eb7e-6ac2-4d23-ba10-6571977dfbbd", "Styles": "None", "Classes": "None", "Text": "Further results from the trial by YMDD mutant status are summarised in Table 1. ", "ParentId": "c71fa72a-f6bd-4068-b09f-b7897b72411c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "701e4786-b12a-41ab-b8f8-fcfa9076fda8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "51598469-0b5e-477d-9a14-5230f83a0364", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "701e4786-b12a-41ab-b8f8-fcfa9076fda8"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Table 1: Efficacy results 5 years by\nYMDD status (Asian Study) NUCB3018 </span></b></p>", "ID": "7c541f5d-5b81-4f5d-8cc9-10cee5bc54b3", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Table 1: Efficacy results 5 years by\nYMDD status (Asian Study) NUCB3018 </span></b>", "ID": "b2adeaa6-891a-48e7-bf69-1244dfdbe189", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c541f5d-5b81-4f5d-8cc9-10cee5bc54b3"}, {"Element": "<span lang=\"EN-GB\">Table 1: Efficacy results 5 years by\nYMDD status (Asian Study) NUCB3018 </span>", "ID": "bda5ed83-ca97-45ce-b045-c63a3b02908e", "Styles": "None", "Classes": "None", "Text": "Table 1: Efficacy results 5 years by YMDD status (Asian Study) NUCB3018 ", "ParentId": "b2adeaa6-891a-48e7-bf69-1244dfdbe189"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d5ea8b9c-14e3-4db3-aa94-aa923d96cfdc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "382cd5f6-c58e-43a6-ad52-1334dbf86cb1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d5ea8b9c-14e3-4db3-aa94-aa923d96cfdc"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:23.15pt;border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:139.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"186\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">Subjects,\u00a0% (no.)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><i><span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span></i></b></p>\n</td>\n<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">YMDD<sup>1</sup></span></p>\n</td>\n<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Non-YMDD<sup>1</sup></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- All patients </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT \u2264 1 x ULN</span><sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\">2</span></sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT &gt; 2 x ULN</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span></u></b><u><span lang=\"EN-GB\" style=\"color:black\"> </span></u></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline<sup>3</sup></span><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Week 260<sup>4</sup></span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 negative </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &lt; baseline </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span></u></b></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Baseline\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Week 260\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &lt;\n  baseline\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>\n<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">38\u00a0 (15/40)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">9\u00a0\u00a0\u00a0\u00a0 (1/11)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">60\u00a0\u00a0 (9/15)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(2/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  (2/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">92\u00a0\u00a0 (23/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">28\u00a0\u00a0 (11/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">73\u00a0\u00a0 (29/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">46\u00a0\u00a0 (13/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">21\u00a0\u00a0\u00a0 (6/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">32\u00a0\u00a0\u00a0 (9/28)</span></p>\n</td>\n<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">72\u00a0\u00a0\u00a0 (13/18)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">33\u00a0\u00a0\u00a0\u00a0 \u00a0(2/6)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">100\u00a0 (11/11)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">6<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(1/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">100\u00a0\u00a0\u00a0 (4/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">33\u00a0\u00a0\u00a0\u00a0 (6/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">67\u00a0\u00a0\u00a0 (12/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n</td>\n</tr>\n</table>", "ID": "973faa61-360c-4514-bef7-7a6feda7de20", "Styles": "margin-left:23.15pt;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "    ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:139.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"186\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">Subjects,\u00a0% (no.)</span></b></p>\n</td>\n</tr>", "ID": "7887c107-c64a-49e6-ad9e-c4e2ca8994e6", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "973faa61-360c-4514-bef7-7a6feda7de20"}, {"Element": "<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>", "ID": "e49a6a4a-874a-4f4d-8534-d9bb3250eed4", "Styles": "width:175.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7887c107-c64a-49e6-ad9e-c4e2ca8994e6"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "0d023595-5aee-4d1b-8ae4-169d0eb8dd60", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e49a6a4a-874a-4f4d-8534-d9bb3250eed4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "00161698-43b7-43ad-87a2-0b34a5882b9c", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "0d023595-5aee-4d1b-8ae4-169d0eb8dd60"}, {"Element": "<td colspan=\"2\" style=\"width:139.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"186\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">Subjects,\u00a0% (no.)</span></b></p>\n</td>", "ID": "cdc636b7-1512-44c6-a8d9-8468e06ecb4c", "Styles": "width:139.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7887c107-c64a-49e6-ad9e-c4e2ca8994e6"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">Subjects,\u00a0% (no.)</span></b></p>", "ID": "51c9daa2-8770-4aef-8544-521d2be5005b", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cdc636b7-1512-44c6-a8d9-8468e06ecb4c"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Subjects,\u00a0% (no.)</span></b>", "ID": "0e0d340d-dad7-4e1b-b5be-3e6e74c10a43", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "51c9daa2-8770-4aef-8544-521d2be5005b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Subjects,\u00a0% (no.)</span>", "ID": "c9b8de7e-4128-4aba-a899-5d8d097d2954", "Styles": "color:black", "Classes": "None", "Text": "Subjects,\u00a0% (no.)", "ParentId": "0e0d340d-dad7-4e1b-b5be-3e6e74c10a43"}, {"Element": "<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><i><span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span></i></b></p>\n</td>\n<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">YMDD<sup>1</sup></span></p>\n</td>\n<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Non-YMDD<sup>1</sup></span></p>\n</td>\n</tr>", "ID": "b09c46a6-12a9-44e4-9911-eb6ff938b1e2", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "973faa61-360c-4514-bef7-7a6feda7de20"}, {"Element": "<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><i><span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span></i></b></p>\n</td>", "ID": "d141aea9-5586-49e0-ba37-0fa9d9cf7f4f", "Styles": "width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b09c46a6-12a9-44e4-9911-eb6ff938b1e2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><i><span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span></i></b></p>", "ID": "f4436e67-4703-4565-bb4e-59550974c0a3", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d141aea9-5586-49e0-ba37-0fa9d9cf7f4f"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span></i></b>", "ID": "46db58be-5ba2-42c8-9f5a-553a3e24936f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f4436e67-4703-4565-bb4e-59550974c0a3"}, {"Element": "<i><span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span></i>", "ID": "a56ab5ee-c0fd-4b0d-a619-4417c42b2589", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46db58be-5ba2-42c8-9f5a-553a3e24936f"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">YMDD mutant HBV status</span>", "ID": "7db39961-2451-4a72-9ff9-bdabc43f67c6", "Styles": "color:black", "Classes": "None", "Text": "YMDD mutant HBV status", "ParentId": "a56ab5ee-c0fd-4b0d-a619-4417c42b2589"}, {"Element": "<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">YMDD<sup>1</sup></span></p>\n</td>", "ID": "fa25da69-d501-42e4-9cd6-70d247c8577e", "Styles": "width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b09c46a6-12a9-44e4-9911-eb6ff938b1e2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">YMDD<sup>1</sup></span></p>", "ID": "dedfc840-9a06-451f-8fdb-73310a6437ab", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa25da69-d501-42e4-9cd6-70d247c8577e"}, {"Element": "<span lang=\"EN-GB\">YMDD<sup>1</sup></span>", "ID": "c6a3f10a-39b5-48a5-85a5-1a7739256941", "Styles": "None", "Classes": "None", "Text": "YMDD", "ParentId": "dedfc840-9a06-451f-8fdb-73310a6437ab"}, {"Element": "<sup>1</sup>", "ID": "8f4fd486-09a6-452e-8cb7-1804450b223a", "Styles": "None", "Classes": "None", "Text": "1", "ParentId": "c6a3f10a-39b5-48a5-85a5-1a7739256941"}, {"Element": "<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Non-YMDD<sup>1</sup></span></p>\n</td>", "ID": "9abd3c88-2d52-4684-a98f-f47561b614a1", "Styles": "width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b09c46a6-12a9-44e4-9911-eb6ff938b1e2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Non-YMDD<sup>1</sup></span></p>", "ID": "4b615cc0-0edf-43db-be78-9a560769dd1a", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9abd3c88-2d52-4684-a98f-f47561b614a1"}, {"Element": "<span lang=\"EN-GB\">Non-YMDD<sup>1</sup></span>", "ID": "7ac35cca-e7a4-4dac-a432-e7168c022da9", "Styles": "None", "Classes": "None", "Text": "Non-YMDD", "ParentId": "4b615cc0-0edf-43db-be78-9a560769dd1a"}, {"Element": "<sup>1</sup>", "ID": "c55d3feb-96b0-40d5-afd0-d462d05e7e69", "Styles": "None", "Classes": "None", "Text": "1", "ParentId": "7ac35cca-e7a4-4dac-a432-e7168c022da9"}, {"Element": "<tr>\n<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- All patients </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT \u2264 1 x ULN</span><sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\">2</span></sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT &gt; 2 x ULN</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span></u></b><u><span lang=\"EN-GB\" style=\"color:black\"> </span></u></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline<sup>3</sup></span><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Week 260<sup>4</sup></span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 negative </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &lt; baseline </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span></u></b></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Baseline\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Week 260\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &lt;\n  baseline\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>\n<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">38\u00a0 (15/40)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">9\u00a0\u00a0\u00a0\u00a0 (1/11)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">60\u00a0\u00a0 (9/15)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(2/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  (2/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">92\u00a0\u00a0 (23/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">28\u00a0\u00a0 (11/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">73\u00a0\u00a0 (29/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">46\u00a0\u00a0 (13/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">21\u00a0\u00a0\u00a0 (6/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">32\u00a0\u00a0\u00a0 (9/28)</span></p>\n</td>\n<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">72\u00a0\u00a0\u00a0 (13/18)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">33\u00a0\u00a0\u00a0\u00a0 \u00a0(2/6)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">100\u00a0 (11/11)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">6<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(1/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">100\u00a0\u00a0\u00a0 (4/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">33\u00a0\u00a0\u00a0\u00a0 (6/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">67\u00a0\u00a0\u00a0 (12/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n</td>\n</tr>", "ID": "a6639d9d-733c-457e-a171-757e1e0837b5", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "973faa61-360c-4514-bef7-7a6feda7de20"}, {"Element": "<td style=\"width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span></u></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- All patients </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT \u2264 1 x ULN</span><sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\">2</span></sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT &gt; 2 x ULN</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span></u></b><u><span lang=\"EN-GB\" style=\"color:black\"> </span></u></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline<sup>3</sup></span><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Week 260<sup>4</sup></span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 negative </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &lt; baseline </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span></u></b></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Baseline\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Week 260\n  </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &lt;\n  baseline\u00a0\u00a0\u00a0 </span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &gt; baseline</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n</td>", "ID": "89718155-8d01-4649-bb2e-a7aa5f584257", "Styles": "width:175.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "                           ", "ParentId": "a6639d9d-733c-457e-a171-757e1e0837b5"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span></u></b></p>", "ID": "324330e1-dc30-4fae-81d6-2fe62b7e6367", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span></u></b>", "ID": "dd0b3207-a159-4dd4-88bd-a4489ecde5de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "324330e1-dc30-4fae-81d6-2fe62b7e6367"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span></u>", "ID": "d71bee6e-36d4-47ae-a843-ec7b54a12408", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd0b3207-a159-4dd4-88bd-a4489ecde5de"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">HBeAg seroconversion</span>", "ID": "64394b6e-9584-4369-9783-fa37985f5b9d", "Styles": "color:black", "Classes": "None", "Text": "HBeAg seroconversion", "ParentId": "d71bee6e-36d4-47ae-a843-ec7b54a12408"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>", "ID": "76c66b18-3613-49d2-98cd-33db8f72657a", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b>", "ID": "8ab6a07b-8ed9-44a7-9dfe-99eae8c5a9e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "76c66b18-3613-49d2-98cd-33db8f72657a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "9e040f5f-9571-409d-b7cd-880eb45ccbc8", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "8ab6a07b-8ed9-44a7-9dfe-99eae8c5a9e8"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">- All patients </span></p>", "ID": "715fb999-332d-4da1-a03a-c96a4fc82071", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">- All patients </span>", "ID": "38bd9839-ee2d-4729-83f1-730c85de16c2", "Styles": "None", "Classes": "None", "Text": "- All patients ", "ParentId": "715fb999-332d-4da1-a03a-c96a4fc82071"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT \u2264 1 x ULN</span><sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\">2</span></sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>", "ID": "443d896f-f8fd-4a68-a1ff-82c3792aab5a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">- Baseline ALT \u2264 1 x ULN</span>", "ID": "a1344c37-645f-4b34-89ce-93a82476a52a", "Styles": "None", "Classes": "None", "Text": "- Baseline ALT \u2264 1 x ULN", "ParentId": "443d896f-f8fd-4a68-a1ff-82c3792aab5a"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"font-size:7.0pt\">2</span></sup>", "ID": "66a9630b-c1ae-4d9f-8dfe-e3405365d996", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "443d896f-f8fd-4a68-a1ff-82c3792aab5a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\">2</span>", "ID": "c3f668ef-73f6-4359-b459-0e9e24f8efaa", "Styles": "font-size:7.0pt", "Classes": "None", "Text": "2", "ParentId": "66a9630b-c1ae-4d9f-8dfe-e3405365d996"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span>", "ID": "d8a68746-8e53-4b85-a191-a8b974b55808", "Styles": "font-size:7.0pt", "Classes": "None", "Text": " ", "ParentId": "443d896f-f8fd-4a68-a1ff-82c3792aab5a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline ALT &gt; 2 x ULN</span></p>", "ID": "88c08c20-59cf-4d48-99d3-9353c8e59c93", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">- Baseline ALT &gt; 2 x ULN</span>", "ID": "f3044592-4183-4636-9ae0-17eced442af7", "Styles": "None", "Classes": "None", "Text": "- Baseline ALT > 2 x ULN", "ParentId": "88c08c20-59cf-4d48-99d3-9353c8e59c93"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>", "ID": "589ac54c-4d82-4286-b720-2ec4f4d11046", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b>", "ID": "fd29cbdc-1fad-4908-ab32-0eec417e72e3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "589ac54c-4d82-4286-b720-2ec4f4d11046"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "83152297-022d-4998-a619-ba47b81e4b2b", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "fd29cbdc-1fad-4908-ab32-0eec417e72e3"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span></u></b><u><span lang=\"EN-GB\" style=\"color:black\"> </span></u></p>", "ID": "85adc6a4-dbe5-4046-94cc-f33dbb3fd50d", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span></u></b>", "ID": "0a6cd67c-d204-46c4-bd78-4c1b4121646d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "85adc6a4-dbe5-4046-94cc-f33dbb3fd50d"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span></u>", "ID": "a196be60-e57b-4eb9-8d38-1b442967c0c7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a6cd67c-d204-46c4-bd78-4c1b4121646d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Undetectable HBV DNA</span>", "ID": "2431f2be-da2d-48bb-b2a9-8ea73945910f", "Styles": "color:black", "Classes": "None", "Text": "Undetectable HBV DNA", "ParentId": "a196be60-e57b-4eb9-8d38-1b442967c0c7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\"> </span></u>", "ID": "76728674-7fb6-4b5b-adbc-afb7dd4cdc91", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "85adc6a4-dbe5-4046-94cc-f33dbb3fd50d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> </span>", "ID": "eeaa11ad-a7e4-4e60-bcac-fb6f1f604345", "Styles": "color:black", "Classes": "None", "Text": " ", "ParentId": "76728674-7fb6-4b5b-adbc-afb7dd4cdc91"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "409c088d-cd50-465b-80c3-768888de20b7", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "8808800c-befb-4e0f-a076-4856473aa8e1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "409c088d-cd50-465b-80c3-768888de20b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "55ae2e1d-79c9-471e-ba00-2e848df789d6", "Styles": "color:black", "Classes": "None", "Text": "", "ParentId": "8808800c-befb-4e0f-a076-4856473aa8e1"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "b9eacaff-720a-49f0-9868-5ab311a7d234", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "55ae2e1d-79c9-471e-ba00-2e848df789d6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Baseline<sup>3</sup></span><span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span></p>", "ID": "a3349d8a-5e2f-4abf-9848-76a1d6d39fc7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">- Baseline<sup>3</sup></span>", "ID": "ba823ed3-6f5b-47c8-82e1-0dc4f37c4691", "Styles": "None", "Classes": "None", "Text": "- Baseline", "ParentId": "a3349d8a-5e2f-4abf-9848-76a1d6d39fc7"}, {"Element": "<sup>3</sup>", "ID": "6e4002f4-1c07-4eaf-8796-0d83bed99397", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "ba823ed3-6f5b-47c8-82e1-0dc4f37c4691"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\"> </span>", "ID": "66a9ba88-f791-4879-89f4-7c1892a414a2", "Styles": "font-size:7.0pt", "Classes": "None", "Text": " ", "ParentId": "a3349d8a-5e2f-4abf-9848-76a1d6d39fc7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u00a0</span></p>", "ID": "cbd2f220-6a13-4afa-a03b-a9d0130ddf0c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u00a0</span>", "ID": "b02e6463-9058-4f1e-96cd-ad86b061843d", "Styles": "font-size:7.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "cbd2f220-6a13-4afa-a03b-a9d0130ddf0c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">- Week 260<sup>4</sup></span></p>", "ID": "de528e68-861e-4191-858b-0a0104d83415", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">- Week 260<sup>4</sup></span>", "ID": "3ee98392-e211-472f-b2ba-df1117cd12fb", "Styles": "None", "Classes": "None", "Text": "- Week 260", "ParentId": "de528e68-861e-4191-858b-0a0104d83415"}, {"Element": "<sup>4</sup>", "ID": "e53335c2-7087-4d14-8d6b-8433def844bf", "Styles": "None", "Classes": "None", "Text": "4", "ParentId": "3ee98392-e211-472f-b2ba-df1117cd12fb"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 negative </span></p>", "ID": "a9ebefc1-7962-476e-b021-c4f6b230e4b4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0 negative </span>", "ID": "0b6f25cd-d360-4610-985d-b2dded7fc3c8", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0 negative ", "ParentId": "a9ebefc1-7962-476e-b021-c4f6b230e4b4"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &lt; baseline </span></p>", "ID": "23afd21c-492e-4b54-82d1-a57043379cff", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0 positive &lt; baseline </span>", "ID": "5ac7e74d-688a-4c53-9678-794ee3c1d3e7", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0 positive < baseline ", "ParentId": "23afd21c-492e-4b54-82d1-a57043379cff"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0\u00a0 positive &gt; baseline</span></p>", "ID": "531cd639-7345-441b-b860-518fa17d08be", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0 positive &gt; baseline</span>", "ID": "373d5ea8-b82b-4c79-af0f-1291693c8f69", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0 positive > baseline", "ParentId": "531cd639-7345-441b-b860-518fa17d08be"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "f334be00-f91c-41fe-931d-22735004118d", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "052762d4-ed61-4da4-9e07-74394d4addfb", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "f334be00-f91c-41fe-931d-22735004118d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;text-autospace:none\"><b><u><span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span></u></b></p>", "ID": "d31ff4c0-26aa-48b8-8c31-fc75cada5993", "Styles": "text-align:center;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span></u></b>", "ID": "ad083ad3-b9a6-47be-8ecd-74378a6c49fe", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d31ff4c0-26aa-48b8-8c31-fc75cada5993"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span></u>", "ID": "93c896d6-d815-4602-899e-141d07df63f0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad083ad3-b9a6-47be-8ecd-74378a6c49fe"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">ALT normalisation</span>", "ID": "fa0485db-856f-472d-ba4c-c6f964962628", "Styles": "color:black", "Classes": "None", "Text": "ALT normalisation", "ParentId": "93c896d6-d815-4602-899e-141d07df63f0"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>", "ID": "0a3a8647-0dc2-4472-8e46-914b86c78e1a", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b>", "ID": "89b9b702-417b-4e56-8cf4-bd5924ceb97a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a3a8647-0dc2-4472-8e46-914b86c78e1a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "841f8340-55d3-4e69-8068-a64e8370478f", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "89b9b702-417b-4e56-8cf4-bd5924ceb97a"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Baseline\n  </span></p>", "ID": "35785c86-78ff-48a7-87bb-5d3ad1eac9cb", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><span lang=\"EN-GB\">- </span></b>", "ID": "c0575c05-023a-4339-bf26-05b2577471d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "35785c86-78ff-48a7-87bb-5d3ad1eac9cb"}, {"Element": "<span lang=\"EN-GB\">- </span>", "ID": "5154f482-d0d0-488e-9fa3-b67a90365374", "Styles": "None", "Classes": "None", "Text": "- ", "ParentId": "c0575c05-023a-4339-bf26-05b2577471d0"}, {"Element": "<span lang=\"EN-GB\">Baseline\n  </span>", "ID": "7382b9c7-58fb-4cdb-b4ef-c1738ddec468", "Styles": "None", "Classes": "None", "Text": "Baseline   ", "ParentId": "35785c86-78ff-48a7-87bb-5d3ad1eac9cb"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal </span></p>", "ID": "d200a2c2-a6c3-4c61-b0b4-a019cf1524fe", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0 normal </span>", "ID": "e71f5ee5-c7e9-4ed6-ab6d-b11859e222bc", "Styles": "None", "Classes": "None", "Text": "\u00a0 normal ", "ParentId": "d200a2c2-a6c3-4c61-b0b4-a019cf1524fe"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal </span></p>", "ID": "c5670028-3b08-472e-9255-ece1d2f14274", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0 above normal </span>", "ID": "3aa74877-fd41-459a-ac91-1cbeb96575d1", "Styles": "None", "Classes": "None", "Text": "\u00a0 above normal ", "ParentId": "c5670028-3b08-472e-9255-ece1d2f14274"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "428361f7-7e31-4f36-804f-c197f7d76d2d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "534de8b1-a52c-43b0-864b-7dd5e383d5b1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "428361f7-7e31-4f36-804f-c197f7d76d2d"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">- </span></b><span lang=\"EN-GB\">Week 260\n  </span></p>", "ID": "2061c362-5037-4c32-8fa6-3850ef0f4bcb", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<b><span lang=\"EN-GB\">- </span></b>", "ID": "9f86b22d-91eb-40ef-8b75-62dcf8914840", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2061c362-5037-4c32-8fa6-3850ef0f4bcb"}, {"Element": "<span lang=\"EN-GB\">- </span>", "ID": "e322611c-3fd9-4a58-87cf-20dcb82cbc6f", "Styles": "None", "Classes": "None", "Text": "- ", "ParentId": "9f86b22d-91eb-40ef-8b75-62dcf8914840"}, {"Element": "<span lang=\"EN-GB\">Week 260\n  </span>", "ID": "97535eb6-6052-480d-947b-428acea56945", "Styles": "None", "Classes": "None", "Text": "Week 260   ", "ParentId": "2061c362-5037-4c32-8fa6-3850ef0f4bcb"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 normal\u00a0\u00a0\u00a0 </span></p>", "ID": "c9571f79-b60a-431a-b905-2d79aa968469", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0 normal\u00a0\u00a0\u00a0 </span>", "ID": "9691c51b-7bd6-47e1-8fc4-c7cfd1c95e98", "Styles": "None", "Classes": "None", "Text": "\u00a0 normal\u00a0\u00a0\u00a0 ", "ParentId": "c9571f79-b60a-431a-b905-2d79aa968469"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &lt;\n  baseline\u00a0\u00a0\u00a0 </span></p>", "ID": "8c82e1ce-e1de-45db-a3e1-a130c00fa2ec", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0 above normal &lt;\n  baseline\u00a0\u00a0\u00a0 </span>", "ID": "fa007543-f3a6-4dbf-9260-d08fc42baf01", "Styles": "None", "Classes": "None", "Text": "\u00a0 above normal <   baseline\u00a0\u00a0\u00a0 ", "ParentId": "8c82e1ce-e1de-45db-a3e1-a130c00fa2ec"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0 above normal &gt; baseline</span></p>", "ID": "43386966-0af2-49cb-ab95-831f7b69b548", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\">\u00a0 above normal &gt; baseline</span>", "ID": "5af5ba76-8724-4d17-9dc0-254bf06bbe4c", "Styles": "None", "Classes": "None", "Text": "\u00a0 above normal > baseline", "ParentId": "43386966-0af2-49cb-ab95-831f7b69b548"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "21cbd59a-cb9d-460a-b543-29fe674e787e", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89718155-8d01-4649-bb2e-a7aa5f584257"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "bf7d2431-e31f-4dd8-888d-e7b097e47b7f", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "21cbd59a-cb9d-460a-b543-29fe674e787e"}, {"Element": "<td style=\"width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"91\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">38\u00a0 (15/40)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">9\u00a0\u00a0\u00a0\u00a0 (1/11)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">60\u00a0\u00a0 (9/15)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(2/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  (2/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">92\u00a0\u00a0 (23/25)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">28\u00a0\u00a0 (11/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">73\u00a0\u00a0 (29/40)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">46\u00a0\u00a0 (13/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">21\u00a0\u00a0\u00a0 (6/28)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">32\u00a0\u00a0\u00a0 (9/28)</span></p>\n</td>", "ID": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113", "Styles": "width:68.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "                          ", "ParentId": "a6639d9d-733c-457e-a171-757e1e0837b5"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "4619c174-4698-40e0-b069-9834885f76b3", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "5a47bd33-0de3-4882-b7ec-612b81c51b4d", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "4619c174-4698-40e0-b069-9834885f76b3"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "935a2aba-ffcb-4735-9aab-1f041812a9fc", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "736f0704-36dd-4827-9ec1-9bbf8faa3e2b", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "935a2aba-ffcb-4735-9aab-1f041812a9fc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">38\u00a0 (15/40)</span></p>", "ID": "bfd2cdf1-f84d-48c2-b8c0-1d8779834b73", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\">38\u00a0 (15/40)</span>", "ID": "5909551b-a1c0-4972-af0a-390f750ec8e1", "Styles": "None", "Classes": "None", "Text": "38\u00a0 (15/40)", "ParentId": "bfd2cdf1-f84d-48c2-b8c0-1d8779834b73"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">9\u00a0\u00a0\u00a0\u00a0 (1/11)</span></p>", "ID": "8e9df9af-4c31-4b5c-9beb-17ac69852344", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\">9\u00a0\u00a0\u00a0\u00a0 (1/11)</span>", "ID": "71bcccb7-f1c1-43aa-a39d-fe0bb4db2e31", "Styles": "None", "Classes": "None", "Text": "9\u00a0\u00a0\u00a0\u00a0 (1/11)", "ParentId": "8e9df9af-4c31-4b5c-9beb-17ac69852344"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">60\u00a0\u00a0 (9/15)</span></p>", "ID": "6a40187e-d21d-4b97-bbfb-0a877bcf5bb4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\">60\u00a0\u00a0 (9/15)</span>", "ID": "aebe037c-e41f-4e53-b8f4-89e9bd470080", "Styles": "None", "Classes": "None", "Text": "60\u00a0\u00a0 (9/15)", "ParentId": "6a40187e-d21d-4b97-bbfb-0a877bcf5bb4"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "54ecee24-d1fa-4915-bb4d-b4130671d8fd", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "f71c0334-5883-4fb0-b385-22d3c8348d28", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "54ecee24-d1fa-4915-bb4d-b4130671d8fd"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "b2055661-4101-473f-bb63-c331d7cf1fd2", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "657be548-ede5-4dbc-a4e7-b1eb58a72f0d", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "b2055661-4101-473f-bb63-c331d7cf1fd2"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "05245426-6f58-4ce4-ad97-71121af02056", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "f0b374e9-76ea-49f8-88e1-c915dcf813c3", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "05245426-6f58-4ce4-ad97-71121af02056"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(2/40)</span></p>", "ID": "fe9297f9-ad5e-46ab-b7a9-a74760bba25f", "Styles": "margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "2e5dc0a1-addf-4e7b-9b89-f9f5dc236b6c", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "5", "ParentId": "fe9297f9-ad5e-46ab-b7a9-a74760bba25f"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "84039437-3ee3-4880-aee1-c1885c0e2edb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "2e5dc0a1-addf-4e7b-9b89-f9f5dc236b6c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(2/40)</span>", "ID": "503ab695-be4c-4c3f-b3f4-41a47d47f1ef", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "(2/40)", "ParentId": "fe9297f9-ad5e-46ab-b7a9-a74760bba25f"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "68abe2c3-c05c-48b2-9869-2a7bcd9c70c0", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "d574b523-e623-47ea-a6e4-a97d68f576e6", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "68abe2c3-c05c-48b2-9869-2a7bcd9c70c0"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "e819ea68-0e5c-46cc-a4ae-e2e61f88ad6e", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "714367f1-4f1c-4ce5-aeb1-4406c955ead0", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "e819ea68-0e5c-46cc-a4ae-e2e61f88ad6e"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  (2/25)</span></p>", "ID": "3db940c6-2105-4e42-9946-705b73499d06", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  (2/25)</span>", "ID": "cb73955a-32f0-4b3a-a7a0-1652b5d47364", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   (2/25)", "ParentId": "3db940c6-2105-4e42-9946-705b73499d06"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">92\u00a0\u00a0 (23/25)</span></p>", "ID": "0ecfa888-19a9-40fb-8174-8625779bdc03", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">92\u00a0\u00a0 (23/25)</span>", "ID": "41cafbfe-0a0d-4baa-8511-2bc78de906a3", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "92\u00a0\u00a0 (23/25)", "ParentId": "0ecfa888-19a9-40fb-8174-8625779bdc03"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>", "ID": "5ec3f8f8-dccc-49ed-99f7-39572cb2fc25", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span>", "ID": "e77b03f7-dae1-4856-ad8a-e6af7b3bb508", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "0", "ParentId": "5ec3f8f8-dccc-49ed-99f7-39572cb2fc25"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "385cf06a-0c3f-455e-a3d3-bde0ca1b933f", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "cebcb127-3b34-4ed3-ba59-c0c7f50c9b5e", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "385cf06a-0c3f-455e-a3d3-bde0ca1b933f"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "44c72c23-0aee-49e7-8ea3-bc0525cb1057", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "4ab7c56b-c98d-469b-bf47-e0a26c815e7a", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "44c72c23-0aee-49e7-8ea3-bc0525cb1057"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "a0561737-84d1-4ce2-b5f9-b5b954298d89", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "c66cf927-fb0c-4ac8-b604-46a337866363", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "a0561737-84d1-4ce2-b5f9-b5b954298d89"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "bab75f80-1219-4397-a82c-ad8f76368f62", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "35ae5d8c-ad27-4a46-9cd7-7b5cb7167161", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "bab75f80-1219-4397-a82c-ad8f76368f62"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">28\u00a0\u00a0 (11/40)</span></p>", "ID": "2844cdc4-7f88-425e-8991-52b295874527", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">28\u00a0\u00a0 (11/40)</span>", "ID": "058d2b41-7daa-46c3-92e6-86e80f357355", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "28\u00a0\u00a0 (11/40)", "ParentId": "2844cdc4-7f88-425e-8991-52b295874527"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">73\u00a0\u00a0 (29/40)</span></p>", "ID": "c4510e8d-3c71-44f3-a4c4-9b1a39d4e97f", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">73\u00a0\u00a0 (29/40)</span>", "ID": "02b45f22-a1ed-482f-acc5-6a10a193e4f5", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "73\u00a0\u00a0 (29/40)", "ParentId": "c4510e8d-3c71-44f3-a4c4-9b1a39d4e97f"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "f89268ef-0ec9-4015-bae0-89273a6f3654", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "11c9e121-0549-4910-97ab-8c77bdecd7b2", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "f89268ef-0ec9-4015-bae0-89273a6f3654"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "eeb56af6-3ee9-4da5-a8d1-5689a706c0d8", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "5cb31e61-73b0-4c44-87d2-0ef728212a8f", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "eeb56af6-3ee9-4da5-a8d1-5689a706c0d8"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">46\u00a0\u00a0 (13/28)</span></p>", "ID": "2fee4b50-1386-4cdb-8b64-9fe0e3cc939a", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">46\u00a0\u00a0 (13/28)</span>", "ID": "2a06933a-f040-4c68-a23c-70dd2d8ae72a", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "46\u00a0\u00a0 (13/28)", "ParentId": "2fee4b50-1386-4cdb-8b64-9fe0e3cc939a"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">21\u00a0\u00a0\u00a0 (6/28)</span></p>", "ID": "02742e04-cb24-4ddd-86a2-45efd29dc9e8", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">21\u00a0\u00a0\u00a0 (6/28)</span>", "ID": "41d96612-f650-46bf-a5f3-4a7d1964ae0c", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "21\u00a0\u00a0\u00a0 (6/28)", "ParentId": "02742e04-cb24-4ddd-86a2-45efd29dc9e8"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">32\u00a0\u00a0\u00a0 (9/28)</span></p>", "ID": "81d2b2d8-e053-48cf-8e42-58c152680c74", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5b1f4b6-ad48-41e4-84eb-67d2153f9113"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">32\u00a0\u00a0\u00a0 (9/28)</span>", "ID": "b39ec5e6-2fc9-45af-b9f9-febea5d1b763", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "32\u00a0\u00a0\u00a0 (9/28)", "ParentId": "81d2b2d8-e053-48cf-8e42-58c152680c74"}, {"Element": "<td style=\"width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\">\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">72\u00a0\u00a0\u00a0 (13/18)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">33\u00a0\u00a0\u00a0\u00a0 \u00a0(2/6)</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">100\u00a0 (11/11)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">6<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(1/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">100\u00a0\u00a0\u00a0 (4/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">33\u00a0\u00a0\u00a0\u00a0 (6/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">67\u00a0\u00a0\u00a0 (12/18)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>\n</td>", "ID": "5a0497de-9e2c-405a-806e-002e738d78ae", "Styles": "width:70.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "                          ", "ParentId": "a6639d9d-733c-457e-a171-757e1e0837b5"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "3c38cb1a-cad2-4109-bf11-ed14a8a66722", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "15b3e69f-adb8-4413-86e5-0276b8c51eaa", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "3c38cb1a-cad2-4109-bf11-ed14a8a66722"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "2011ac7e-3f7b-43b8-8f5f-1347209d9fd8", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "d9eb37f3-fe5d-4192-8bee-3d4528528302", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "2011ac7e-3f7b-43b8-8f5f-1347209d9fd8"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">72\u00a0\u00a0\u00a0 (13/18)</span></p>", "ID": "082f9f23-85ef-4899-b094-d7bd91af1da7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\">72\u00a0\u00a0\u00a0 (13/18)</span>", "ID": "93d15396-48f8-4047-93e8-261d67db147f", "Styles": "None", "Classes": "None", "Text": "72\u00a0\u00a0\u00a0 (13/18)", "ParentId": "082f9f23-85ef-4899-b094-d7bd91af1da7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">33\u00a0\u00a0\u00a0\u00a0 \u00a0(2/6)</span></p>", "ID": "8671c015-2381-4d90-88b0-2e33901ec7a1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\">33\u00a0\u00a0\u00a0\u00a0 \u00a0(2/6)</span>", "ID": "e4b6366a-eda7-4a9d-b395-fe2140eba8aa", "Styles": "None", "Classes": "None", "Text": "33\u00a0\u00a0\u00a0\u00a0 \u00a0(2/6)", "ParentId": "8671c015-2381-4d90-88b0-2e33901ec7a1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">100\u00a0 (11/11)</span></p>", "ID": "56f4f525-b8fe-4898-8594-8000ad448a3f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\">100\u00a0 (11/11)</span>", "ID": "1fb03bf7-b7d9-4c73-8c72-69510e3282b3", "Styles": "None", "Classes": "None", "Text": "100\u00a0 (11/11)", "ParentId": "56f4f525-b8fe-4898-8594-8000ad448a3f"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "c3ebf053-cfed-4fb7-a272-3393102edbeb", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "4c8b521b-3b9d-424b-ac9f-2b385e852c42", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "c3ebf053-cfed-4fb7-a272-3393102edbeb"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "10d10ff6-83cf-49eb-a185-6aee2df49c85", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "cd48ec55-ea51-451d-b158-d7563a3569e5", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "10d10ff6-83cf-49eb-a185-6aee2df49c85"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "3ac0d53a-426c-46e1-ae84-ee47e7a01ad8", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "36ce058f-6503-4b85-940d-a145f3cc91ab", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "3ac0d53a-426c-46e1-ae84-ee47e7a01ad8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">6<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(1/18)</span></p>", "ID": "b2de2ea9-b2dd-4b2b-9703-ee5d2677bc6b", "Styles": "margin-left:28.5pt;text-indent:-28.5pt;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">6<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "c38bb9c3-65a3-4b27-9482-dfae889af180", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "6", "ParentId": "b2de2ea9-b2dd-4b2b-9703-ee5d2677bc6b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "9eeef140-0e94-4989-a5c1-9d9911f3ba04", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "c38bb9c3-65a3-4b27-9482-dfae889af180"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">(1/18)</span>", "ID": "3d500fd9-c0bb-4042-994a-11bec3b65df4", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "(1/18)", "ParentId": "b2de2ea9-b2dd-4b2b-9703-ee5d2677bc6b"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "bdb75e65-6a32-4749-88f8-1d6ae5e784be", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "4673511d-cefa-413d-ab5d-11f2d82dfa46", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "bdb75e65-6a32-4749-88f8-1d6ae5e784be"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "79ba1978-8d6e-45e2-9c69-71b72e92a785", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "739a9ee5-7626-4aed-9da6-f0f0b4c3f2a3", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "79ba1978-8d6e-45e2-9c69-71b72e92a785"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>", "ID": "3fac48e1-aff8-4312-aad5-0297d1214f3d", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span>", "ID": "02184f3c-1749-42e7-b42c-eb73a93cc48a", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "0", "ParentId": "3fac48e1-aff8-4312-aad5-0297d1214f3d"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">100\u00a0\u00a0\u00a0 (4/4)</span></p>", "ID": "60d33094-a119-4ad6-8b22-a3acdfebe8fc", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">100\u00a0\u00a0\u00a0 (4/4)</span>", "ID": "e696fd5f-a681-4ad6-8163-d3e0d5c460e3", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "100\u00a0\u00a0\u00a0 (4/4)", "ParentId": "60d33094-a119-4ad6-8b22-a3acdfebe8fc"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>", "ID": "d2946dcf-9674-448a-97a1-6667b3c17b91", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span>", "ID": "b22ae6e5-5ea3-4d94-8e2a-09b5e1a9e02e", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "0", "ParentId": "d2946dcf-9674-448a-97a1-6667b3c17b91"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "b44c2df5-7451-44ab-9819-ccac15ec504f", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "2d74d2f2-8c17-47ad-bb0a-ae727a64c334", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "b44c2df5-7451-44ab-9819-ccac15ec504f"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "67d1aacb-e2c8-441c-857f-2ebc76d64a83", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "ba192232-4c10-44b4-ad02-0d4da989e66b", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "67d1aacb-e2c8-441c-857f-2ebc76d64a83"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "ef760306-c9d1-46b6-a886-bd3eb04579a6", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "ed17a149-b6d3-4e00-b4e3-4d98ed7ffe47", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "ef760306-c9d1-46b6-a886-bd3eb04579a6"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "6bf33098-e251-474c-8da7-b47acbed047c", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "160eef30-6732-483f-ae38-d1111155b764", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "6bf33098-e251-474c-8da7-b47acbed047c"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">33\u00a0\u00a0\u00a0\u00a0 (6/18)</span></p>", "ID": "8f0807fd-2034-4e4d-9dcc-0263d6d5da46", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">33\u00a0\u00a0\u00a0\u00a0 (6/18)</span>", "ID": "b92b8038-7e58-42a9-92d2-fb505687f646", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "33\u00a0\u00a0\u00a0\u00a0 (6/18)", "ParentId": "8f0807fd-2034-4e4d-9dcc-0263d6d5da46"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">67\u00a0\u00a0\u00a0 (12/18)</span></p>", "ID": "5809e52d-ab2d-4075-af6c-6b4128e7c4d2", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">67\u00a0\u00a0\u00a0 (12/18)</span>", "ID": "1b62d3a8-08dc-4cc7-a510-a496f44cf092", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "67\u00a0\u00a0\u00a0 (12/18)", "ParentId": "5809e52d-ab2d-4075-af6c-6b4128e7c4d2"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "e7e8fb20-3990-46bb-bd41-de3ada533653", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "c6c26631-4adf-4b8a-aa50-ebfa9ea16a81", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "e7e8fb20-3990-46bb-bd41-de3ada533653"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span></p>", "ID": "8c27d21a-fb10-4b26-b000-0b2ac2249f65", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">\u00a0</span>", "ID": "49a34112-2bfb-4daa-92fa-dd20493be60b", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "8c27d21a-fb10-4b26-b000-0b2ac2249f65"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>", "ID": "59e3a779-25ef-4c6d-8b7c-ac23417e583c", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span>", "ID": "5e5365de-3e66-425a-8859-2b5b8c5295a2", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)", "ParentId": "59e3a779-25ef-4c6d-8b7c-ac23417e583c"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span></p>", "ID": "ed2ec42c-542d-4e5f-9636-129ba0bc7279", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">0</span>", "ID": "4b75472c-5bba-4d34-a04d-43fa990b7acc", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "0", "ParentId": "ed2ec42c-542d-4e5f-9636-129ba0bc7279"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span></p>", "ID": "6b0a5ed9-d8af-4705-ae64-2e0eb750c5f3", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a0497de-9e2c-405a-806e-002e738d78ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;color:black\">50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)</span>", "ID": "923a0c2c-ddbe-47fa-982f-a327c97c179f", "Styles": "font-size:12.0pt;color:black", "Classes": "None", "Text": "50\u00a0\u00a0\u00a0\u00a0\u00a0 (2/4)", "ParentId": "6b0a5ed9-d8af-4705-ae64-2e0eb750c5f3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span></p>", "ID": "97ba54c0-2fae-46dd-993a-8bcf0c731cfb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span>", "ID": "4693693d-debd-4f1e-8880-e12438f41ee8", "Styles": "font-size:12.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "97ba54c0-2fae-46dd-993a-8bcf0c731cfb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:8.0pt\">1 Patients designated as YMDD mutant were those with\n\u22655\u00a0% YMDD mutant HBV at any annual time-point during the 5-year\nperiod. Patients categorised as non-YMDD mutant were those with &gt; 95\u00a0%\nwild-type HBV at all annual time-points during the 5-year study period </span></p>", "ID": "ef0ac53e-0fe3-491d-9bf5-f4621310f55c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:8.0pt\">1 Patients designated as YMDD mutant were those with\n\u22655\u00a0% YMDD mutant HBV at any annual time-point during the 5-year\nperiod. Patients categorised as non-YMDD mutant were those with &gt; 95\u00a0%\nwild-type HBV at all annual time-points during the 5-year study period </span>", "ID": "74b6270b-f430-4cac-a365-94fccd483901", "Styles": "font-size:8.0pt", "Classes": "None", "Text": "1 Patients designated as YMDD mutant were those with \u22655\u00a0% YMDD mutant HBV at any annual time-point during the 5-year period. Patients categorised as non-YMDD mutant were those with > 95\u00a0% wild-type HBV at all annual time-points during the 5-year study period ", "ParentId": "ef0ac53e-0fe3-491d-9bf5-f4621310f55c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:8.0pt\">2 Upper limit of normal </span></p>", "ID": "4489620f-ccdf-4814-91df-42c4cb3e6dbf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:8.0pt\">2 Upper limit of normal </span>", "ID": "3f983284-1ede-4b9a-b840-c492e499dd49", "Styles": "font-size:8.0pt", "Classes": "None", "Text": "2 Upper limit of normal ", "ParentId": "4489620f-ccdf-4814-91df-42c4cb3e6dbf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:8.0pt\">3 Abbott Genostics solution hybridisation assay (LLOD\n&lt; 1.6\u00a0pg/ml </span></p>", "ID": "f2969aa6-d9e5-49fa-a1dc-488704409e0b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:8.0pt\">3 Abbott Genostics solution hybridisation assay (LLOD\n&lt; 1.6\u00a0pg/ml </span>", "ID": "8096cdf2-2d0e-4963-850b-37db00fb788c", "Styles": "font-size:8.0pt", "Classes": "None", "Text": "3 Abbott Genostics solution hybridisation assay (LLOD < 1.6\u00a0pg/ml ", "ParentId": "f2969aa6-d9e5-49fa-a1dc-488704409e0b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\" style=\"font-size:\n8.0pt\">4 Chiron Quantiplex assay (LLOD 0.7\u00a0Meq/ml) </span></p>", "ID": "4a81329d-a83a-4b5b-aeac-d6e51fdc6e0b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"FR\" style=\"font-size:\n8.0pt\">4 Chiron Quantiplex assay (LLOD 0.7\u00a0Meq/ml) </span>", "ID": "5bb2d087-e3ca-4428-bc03-0653dee6ad2d", "Styles": "font-size:\n8.0pt", "Classes": "None", "Text": "4 Chiron Quantiplex assay (LLOD 0.7\u00a0Meq/ml) ", "ParentId": "4a81329d-a83a-4b5b-aeac-d6e51fdc6e0b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"FR\" style=\"font-size:8.0pt\">\u00a0</span></p>", "ID": "573f24ec-5d97-4267-8996-ae3fa310a0f4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"FR\" style=\"font-size:8.0pt\">\u00a0</span>", "ID": "7e42a532-4bee-4716-95b8-475f3f49bef3", "Styles": "font-size:8.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "573f24ec-5d97-4267-8996-ae3fa310a0f4"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Comparative data according to YMDD status\nwere also available for histological assessment but only up to three years. In\npatients with YMDD mutant HBV, 18/39 (46\u00a0%) had improvements in\nnecroinflammatory activity and 9/39 (23\u00a0%) had worsening. In patients\nwithout the mutant, 20/27 (74\u00a0%) had improvements in necroinflammatory\nactivity and 2/27 (7\u00a0%) had worsening. </span></p>", "ID": "a47be21f-2074-49a3-9a55-68a3ecfbd87b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Comparative data according to YMDD status\nwere also available for histological assessment but only up to three years. In\npatients with YMDD mutant HBV, 18/39 (46\u00a0%) had improvements in\nnecroinflammatory activity and 9/39 (23\u00a0%) had worsening. In patients\nwithout the mutant, 20/27 (74\u00a0%) had improvements in necroinflammatory\nactivity and 2/27 (7\u00a0%) had worsening. </span>", "ID": "b90f3c9d-ac28-47d5-9eec-43f2bd8c0a1c", "Styles": "None", "Classes": "None", "Text": "Comparative data according to YMDD status were also available for histological assessment but only up to three years. In patients with YMDD mutant HBV, 18/39 (46\u00a0%) had improvements in necroinflammatory activity and 9/39 (23\u00a0%) had worsening. In patients without the mutant, 20/27 (74\u00a0%) had improvements in necroinflammatory activity and 2/27 (7\u00a0%) had worsening. ", "ParentId": "a47be21f-2074-49a3-9a55-68a3ecfbd87b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba97ef7a-ea4d-46bb-a487-98ac37d2c25a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e88b7c54-434c-4be4-beed-4a92a6022a66", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba97ef7a-ea4d-46bb-a487-98ac37d2c25a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Following HBeAg seroconversion, serologic\nresponse and clinical remission are generally durable after stopping\nlamivudine. However, relapse following seroconversion can occur. In a long-term\nfollow-up study of patients who had previously seroconverted and discontinued\nlamivudine, late virological relapse occurred in 39\u00a0% of the subjects.\nTherefore, following HBeAg seroconversion, patients should be periodically\nmonitored to determine that serologic and clinical responses are being\nmaintained. In patients who do not maintain a sustained serological response,\nconsideration should be given to retreatment with either lamivudine or an\nalternative antiviral agent for resumption of clinical control of HBV. </span></p>", "ID": "31862f93-42a6-4514-8cd9-21dd83b38c23", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Following HBeAg seroconversion, serologic\nresponse and clinical remission are generally durable after stopping\nlamivudine. However, relapse following seroconversion can occur. In a long-term\nfollow-up study of patients who had previously seroconverted and discontinued\nlamivudine, late virological relapse occurred in 39\u00a0% of the subjects.\nTherefore, following HBeAg seroconversion, patients should be periodically\nmonitored to determine that serologic and clinical responses are being\nmaintained. In patients who do not maintain a sustained serological response,\nconsideration should be given to retreatment with either lamivudine or an\nalternative antiviral agent for resumption of clinical control of HBV. </span>", "ID": "015d7563-6b61-4716-ad03-db4c180902cb", "Styles": "None", "Classes": "None", "Text": "Following HBeAg seroconversion, serologic response and clinical remission are generally durable after stopping lamivudine. However, relapse following seroconversion can occur. In a long-term follow-up study of patients who had previously seroconverted and discontinued lamivudine, late virological relapse occurred in 39\u00a0% of the subjects. Therefore, following HBeAg seroconversion, patients should be periodically monitored to determine that serologic and clinical responses are being maintained. In patients who do not maintain a sustained serological response, consideration should be given to retreatment with either lamivudine or an alternative antiviral agent for resumption of clinical control of HBV. ", "ParentId": "31862f93-42a6-4514-8cd9-21dd83b38c23"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "235b9753-f75d-43c6-adaf-49de570fbc53", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "844838d0-831c-4b4b-805c-1883a9e99b8d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "235b9753-f75d-43c6-adaf-49de570fbc53"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In patients followed for up to 16 weeks\nafter discontinuation of treatment at one year, post-treatment ALT elevations\nwere observed more frequently in patients who had received lamivudine than in\npatients who had received placebo. A comparison of post-treatment ALT\nelevations between weeks 52 and 68 in patients who discontinued lamivudine at\nweek 52 and patients in the same studies who received placebo throughout the\ntreatment course is shown in Table 2. The proportion of patients who had\npost-treatment ALT elevations in association with an increase in bilirubin\nlevels was low and similar in patients receiving either lamivudine or placebo. </span></p>", "ID": "0d5196de-0022-4b36-be6a-a61f022e63b6", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In patients followed for up to 16 weeks\nafter discontinuation of treatment at one year, post-treatment ALT elevations\nwere observed more frequently in patients who had received lamivudine than in\npatients who had received placebo. A comparison of post-treatment ALT\nelevations between weeks 52 and 68 in patients who discontinued lamivudine at\nweek 52 and patients in the same studies who received placebo throughout the\ntreatment course is shown in Table 2. The proportion of patients who had\npost-treatment ALT elevations in association with an increase in bilirubin\nlevels was low and similar in patients receiving either lamivudine or placebo. </span>", "ID": "a38aa324-c802-4886-b84e-54f0a193ff3f", "Styles": "None", "Classes": "None", "Text": "In patients followed for up to 16 weeks after discontinuation of treatment at one year, post-treatment ALT elevations were observed more frequently in patients who had received lamivudine than in patients who had received placebo. A comparison of post-treatment ALT elevations between weeks 52 and 68 in patients who discontinued lamivudine at week 52 and patients in the same studies who received placebo throughout the treatment course is shown in Table 2. The proportion of patients who had post-treatment ALT elevations in association with an increase in bilirubin levels was low and similar in patients receiving either lamivudine or placebo. ", "ParentId": "0d5196de-0022-4b36-be6a-a61f022e63b6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "87ade035-41bc-43e0-8685-21b3c1a21ee9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65f6b247-8638-4159-b0df-f064a75677e6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "87ade035-41bc-43e0-8685-21b3c1a21ee9"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Table 2: Post-treatment ALT Elevations\nin 2 Placebo-Controlled Studies in Adults </span></b></p>", "ID": "c78c25b4-cf66-406b-8087-26a7fc2a35e8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Table 2: Post-treatment ALT Elevations\nin 2 Placebo-Controlled Studies in Adults </span></b>", "ID": "dbfa0704-2836-46e8-8b0e-e9c9e775e288", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c78c25b4-cf66-406b-8087-26a7fc2a35e8"}, {"Element": "<span lang=\"EN-GB\">Table 2: Post-treatment ALT Elevations\nin 2 Placebo-Controlled Studies in Adults </span>", "ID": "1532508b-0d6b-42b8-b1d2-8d2f1a9569d6", "Styles": "None", "Classes": "None", "Text": "Table 2: Post-treatment ALT Elevations in 2 Placebo-Controlled Studies in Adults ", "ParentId": "dbfa0704-2836-46e8-8b0e-e9c9e775e288"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f471287d-b126-4a4a-9fdc-bde601306aa3", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0ebf23ae-5e7f-4f6d-96fb-c05bd0808ef8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f471287d-b126-4a4a-9fdc-bde601306aa3"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:469.75pt;border-collapse:collapse\" width=\"626\">\n<tr style=\"height:25.25pt\">\n<td rowspan=\"2\" style=\"width:239.25pt;border:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"bottom\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Abnormal Value </span></p>\n</td>\n<td colspan=\"2\" style=\"width:230.5pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"top\" width=\"307\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with ALT Elevation/ </span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with Observations*</span></p>\n</td>\n</tr>\n<tr style=\"height:12.5pt\">\n<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Lamivudine</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Placebo</span></p>\n</td>\n</tr>\n<tr style=\"height:13.25pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;border-top:none;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">37/137\n  (27\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">22/116 (19\u00a0%) </span></p>\n</td>\n</tr>\n<tr style=\"height:13.25pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 3 x baseline value</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u2020 </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">29/137\n  (21\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">9/116\n  (8\u00a0%)</span></p>\n</td>\n</tr>\n<tr style=\"height:25.9pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value and\n  absolute ALT &gt; 500 IU/l </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">21/137\n  (15\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">8/116\n  (7\u00a0%)</span></p>\n</td>\n</tr>\n<tr style=\"height:27.75pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u22652 x baseline value; and\n  bilirubin &gt;2 x ULN and \u22652 x baseline value </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/137\n  (0.7\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/116\n  (0.9\u00a0%)</span></p>\n</td>\n</tr>\n</table>", "ID": "d06e3ac1-5cd8-4527-94c9-39297584abde", "Styles": "width:469.75pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr style=\"height:25.25pt\">\n<td rowspan=\"2\" style=\"width:239.25pt;border:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"bottom\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Abnormal Value </span></p>\n</td>\n<td colspan=\"2\" style=\"width:230.5pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"top\" width=\"307\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with ALT Elevation/ </span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with Observations*</span></p>\n</td>\n</tr>", "ID": "68c4caa5-c593-4743-a7ec-9899a5086ef2", "Styles": "height:25.25pt", "Classes": "None", "Text": "   ", "ParentId": "d06e3ac1-5cd8-4527-94c9-39297584abde"}, {"Element": "<td rowspan=\"2\" style=\"width:239.25pt;border:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"bottom\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Abnormal Value </span></p>\n</td>", "ID": "eeb6fccb-309d-4836-a890-5f34f669905b", "Styles": "width:239.25pt;border:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.25pt", "Classes": "None", "Text": "  ", "ParentId": "68c4caa5-c593-4743-a7ec-9899a5086ef2"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Abnormal Value </span></p>", "ID": "1edab16b-a6d2-4cd2-9b49-5b57fb5ddf69", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eeb6fccb-309d-4836-a890-5f34f669905b"}, {"Element": "<span lang=\"EN-GB\">Abnormal Value </span>", "ID": "249e7911-974d-42f1-960e-44cdf2591c93", "Styles": "None", "Classes": "None", "Text": "Abnormal Value ", "ParentId": "1edab16b-a6d2-4cd2-9b49-5b57fb5ddf69"}, {"Element": "<td colspan=\"2\" style=\"width:230.5pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.25pt\" valign=\"top\" width=\"307\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with ALT Elevation/ </span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with Observations*</span></p>\n</td>", "ID": "9c08f5e5-cfb0-400d-992a-c04bb56adaaa", "Styles": "width:230.5pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.25pt", "Classes": "None", "Text": "   ", "ParentId": "68c4caa5-c593-4743-a7ec-9899a5086ef2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with ALT Elevation/ </span></p>", "ID": "118ee6f6-27f1-4b0f-9124-e1ce3fe8e7b7", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c08f5e5-cfb0-400d-992a-c04bb56adaaa"}, {"Element": "<span lang=\"EN-GB\">Patients\n  with ALT Elevation/ </span>", "ID": "f71262f5-7582-4a08-829e-5a8b85ba0383", "Styles": "None", "Classes": "None", "Text": "Patients   with ALT Elevation/ ", "ParentId": "118ee6f6-27f1-4b0f-9124-e1ce3fe8e7b7"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Patients\n  with Observations*</span></p>", "ID": "ac0ddcef-6a7e-45cf-8c4a-b17ca2b654b6", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c08f5e5-cfb0-400d-992a-c04bb56adaaa"}, {"Element": "<span lang=\"EN-GB\">Patients\n  with Observations*</span>", "ID": "1cbd83dd-2685-4845-abfd-3e30693bbc68", "Styles": "None", "Classes": "None", "Text": "Patients   with Observations*", "ParentId": "ac0ddcef-6a7e-45cf-8c4a-b17ca2b654b6"}, {"Element": "<tr style=\"height:12.5pt\">\n<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Lamivudine</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Placebo</span></p>\n</td>\n</tr>", "ID": "465411d6-4a90-4b02-90f0-5a2c9108d7bc", "Styles": "height:12.5pt", "Classes": "None", "Text": "   ", "ParentId": "d06e3ac1-5cd8-4527-94c9-39297584abde"}, {"Element": "<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Lamivudine</span></p>\n</td>", "ID": "fb61ac09-eb8a-4a7a-b893-26237ebeaf67", "Styles": "width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt", "Classes": "None", "Text": "  ", "ParentId": "465411d6-4a90-4b02-90f0-5a2c9108d7bc"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Lamivudine</span></p>", "ID": "d97ac6a8-7e33-4b16-931d-16f4f3e7a94e", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb61ac09-eb8a-4a7a-b893-26237ebeaf67"}, {"Element": "<span lang=\"EN-GB\">Lamivudine</span>", "ID": "56247511-335e-4984-9b80-ce5417f82662", "Styles": "None", "Classes": "None", "Text": "Lamivudine", "ParentId": "d97ac6a8-7e33-4b16-931d-16f4f3e7a94e"}, {"Element": "<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Placebo</span></p>\n</td>", "ID": "17c544f0-8f90-4639-8d45-262a4d9d8fd2", "Styles": "width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:12.5pt", "Classes": "None", "Text": "  ", "ParentId": "465411d6-4a90-4b02-90f0-5a2c9108d7bc"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">Placebo</span></p>", "ID": "7139e33b-8f65-470f-b0af-1203b0e1a402", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "17c544f0-8f90-4639-8d45-262a4d9d8fd2"}, {"Element": "<span lang=\"EN-GB\">Placebo</span>", "ID": "0cf2900d-2125-40c0-a4bc-1199b060ef5e", "Styles": "None", "Classes": "None", "Text": "Placebo", "ParentId": "7139e33b-8f65-470f-b0af-1203b0e1a402"}, {"Element": "<tr style=\"height:13.25pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;border-top:none;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">37/137\n  (27\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">22/116 (19\u00a0%) </span></p>\n</td>\n</tr>", "ID": "01f447de-c5bb-4cdd-b957-bcc3b00d9192", "Styles": "height:13.25pt", "Classes": "None", "Text": "    ", "ParentId": "d06e3ac1-5cd8-4527-94c9-39297584abde"}, {"Element": "<td style=\"width:239.25pt;border:solid black 1.0pt;border-top:none;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value </span></p>\n</td>", "ID": "d394b130-767e-4965-9267-b848f83b807d", "Styles": "width:239.25pt;border:solid black 1.0pt;border-top:none;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt", "Classes": "None", "Text": "  ", "ParentId": "01f447de-c5bb-4cdd-b957-bcc3b00d9192"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value </span></p>", "ID": "821c0456-ea50-4066-8cc4-6d879f96ba18", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d394b130-767e-4965-9267-b848f83b807d"}, {"Element": "<span lang=\"EN-GB\">ALT \u2265 2 x baseline value </span>", "ID": "d731ef05-061d-485b-9401-4408242bdbc8", "Styles": "None", "Classes": "None", "Text": "ALT \u2265 2 x baseline value ", "ParentId": "821c0456-ea50-4066-8cc4-6d879f96ba18"}, {"Element": "<td style=\"width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">37/137\n  (27\u00a0%)</span></p>\n</td>", "ID": "0dd51a7d-baf4-4a07-8bf4-12115df9542c", "Styles": "width:115.25pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt", "Classes": "None", "Text": "  ", "ParentId": "01f447de-c5bb-4cdd-b957-bcc3b00d9192"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">37/137\n  (27\u00a0%)</span></p>", "ID": "76e0843b-f6a5-422e-bf80-5fe9478147cc", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0dd51a7d-baf4-4a07-8bf4-12115df9542c"}, {"Element": "<span lang=\"EN-GB\">37/137\n  (27\u00a0%)</span>", "ID": "acb22896-47a8-4db2-b120-a4c8d20db48d", "Styles": "None", "Classes": "None", "Text": "37/137   (27\u00a0%)", "ParentId": "76e0843b-f6a5-422e-bf80-5fe9478147cc"}, {"Element": "<td style=\"width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">22/116 (19\u00a0%) </span></p>\n</td>", "ID": "4ffc4bb3-dac1-4849-bfe4-75f491d37d64", "Styles": "width:115.4pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:13.25pt", "Classes": "None", "Text": "  ", "ParentId": "01f447de-c5bb-4cdd-b957-bcc3b00d9192"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">22/116 (19\u00a0%) </span></p>", "ID": "b639ab79-1f65-48e7-bc4e-01e0e7c1a89c", "Styles": "text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4ffc4bb3-dac1-4849-bfe4-75f491d37d64"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">22/116 (19\u00a0%) </span>", "ID": "dfcce295-5ec9-4ddb-999a-e04d79f84295", "Styles": "color:black", "Classes": "None", "Text": "22/116 (19\u00a0%) ", "ParentId": "b639ab79-1f65-48e7-bc4e-01e0e7c1a89c"}, {"Element": "<tr style=\"height:13.25pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 3 x baseline value</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u2020 </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">29/137\n  (21\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">9/116\n  (8\u00a0%)</span></p>\n</td>\n</tr>", "ID": "a0c6094d-f266-44ee-b236-e4fd8a8c480c", "Styles": "height:13.25pt", "Classes": "None", "Text": "    ", "ParentId": "d06e3ac1-5cd8-4527-94c9-39297584abde"}, {"Element": "<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 3 x baseline value</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u2020 </span></p>\n</td>", "ID": "e87b39d5-cd97-4892-961d-c9c496ffffd6", "Styles": "width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:13.25pt", "Classes": "None", "Text": "  ", "ParentId": "a0c6094d-f266-44ee-b236-e4fd8a8c480c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 3 x baseline value</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u2020 </span></p>", "ID": "a061fcc7-f734-4041-87b4-ef43e6e22418", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e87b39d5-cd97-4892-961d-c9c496ffffd6"}, {"Element": "<span lang=\"EN-GB\">ALT \u2265 3 x baseline value</span>", "ID": "c8f16c3d-a296-42da-b686-14bae5d75b11", "Styles": "None", "Classes": "None", "Text": "ALT \u2265 3 x baseline value", "ParentId": "a061fcc7-f734-4041-87b4-ef43e6e22418"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\">\u2020 </span>", "ID": "5e85306a-96e3-4a5f-b27e-9fc226223a6b", "Styles": "font-size:7.0pt", "Classes": "None", "Text": "\u2020 ", "ParentId": "a061fcc7-f734-4041-87b4-ef43e6e22418"}, {"Element": "<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">29/137\n  (21\u00a0%)</span></p>\n</td>", "ID": "7da1155d-2b84-4db6-aa3d-d80befd2bbc6", "Styles": "width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt", "Classes": "None", "Text": "  ", "ParentId": "a0c6094d-f266-44ee-b236-e4fd8a8c480c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">29/137\n  (21\u00a0%)</span></p>", "ID": "d2c4292b-3d68-4054-97d6-3fda1e95dd7b", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7da1155d-2b84-4db6-aa3d-d80befd2bbc6"}, {"Element": "<span lang=\"EN-GB\">29/137\n  (21\u00a0%)</span>", "ID": "f3b97a56-7914-4bd0-9205-ed9fdaa28438", "Styles": "None", "Classes": "None", "Text": "29/137   (21\u00a0%)", "ParentId": "d2c4292b-3d68-4054-97d6-3fda1e95dd7b"}, {"Element": "<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt\" valign=\"top\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">9/116\n  (8\u00a0%)</span></p>\n</td>", "ID": "2fb6b107-c1d7-4bff-ad51-89bfa272205f", "Styles": "width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:13.25pt", "Classes": "None", "Text": "  ", "ParentId": "a0c6094d-f266-44ee-b236-e4fd8a8c480c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">9/116\n  (8\u00a0%)</span></p>", "ID": "b2192c9c-5e58-42ca-8d4d-6309b5aa7f9c", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2fb6b107-c1d7-4bff-ad51-89bfa272205f"}, {"Element": "<span lang=\"EN-GB\">9/116\n  (8\u00a0%)</span>", "ID": "19fcc59b-b34c-4743-aabb-0b69c94dba48", "Styles": "None", "Classes": "None", "Text": "9/116   (8\u00a0%)", "ParentId": "b2192c9c-5e58-42ca-8d4d-6309b5aa7f9c"}, {"Element": "<tr style=\"height:25.9pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value and\n  absolute ALT &gt; 500 IU/l </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">21/137\n  (15\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">8/116\n  (7\u00a0%)</span></p>\n</td>\n</tr>", "ID": "4b1a6739-f18a-4df4-a159-31a1d4897f3b", "Styles": "height:25.9pt", "Classes": "None", "Text": "    ", "ParentId": "d06e3ac1-5cd8-4527-94c9-39297584abde"}, {"Element": "<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value and\n  absolute ALT &gt; 500 IU/l </span></p>\n</td>", "ID": "4d6de6c0-d358-43d7-b177-77078cb57fec", "Styles": "width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:25.9pt", "Classes": "None", "Text": "  ", "ParentId": "4b1a6739-f18a-4df4-a159-31a1d4897f3b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u2265 2 x baseline value and\n  absolute ALT &gt; 500 IU/l </span></p>", "ID": "425e289c-3f1f-4632-af36-d6a5473bc6d6", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d6de6c0-d358-43d7-b177-77078cb57fec"}, {"Element": "<span lang=\"EN-GB\">ALT \u2265 2 x baseline value and\n  absolute ALT &gt; 500 IU/l </span>", "ID": "fa91667a-42b0-418f-a0e5-bd57b8ed5856", "Styles": "None", "Classes": "None", "Text": "ALT \u2265 2 x baseline value and   absolute ALT > 500 IU/l ", "ParentId": "425e289c-3f1f-4632-af36-d6a5473bc6d6"}, {"Element": "<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">21/137\n  (15\u00a0%)</span></p>\n</td>", "ID": "f7ed8cce-80fc-4d40-b463-ef5450220e8c", "Styles": "width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt", "Classes": "None", "Text": "  ", "ParentId": "4b1a6739-f18a-4df4-a159-31a1d4897f3b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">21/137\n  (15\u00a0%)</span></p>", "ID": "b1453a29-50b1-4b76-8d48-068e365b9a18", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7ed8cce-80fc-4d40-b463-ef5450220e8c"}, {"Element": "<span lang=\"EN-GB\">21/137\n  (15\u00a0%)</span>", "ID": "70d39c02-00f9-44cc-a7c6-b9e73d8d9733", "Styles": "None", "Classes": "None", "Text": "21/137   (15\u00a0%)", "ParentId": "b1453a29-50b1-4b76-8d48-068e365b9a18"}, {"Element": "<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">8/116\n  (7\u00a0%)</span></p>\n</td>", "ID": "0b30d4a9-d276-469a-806e-f6a804cbc6c8", "Styles": "width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.9pt", "Classes": "None", "Text": "  ", "ParentId": "4b1a6739-f18a-4df4-a159-31a1d4897f3b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">8/116\n  (7\u00a0%)</span></p>", "ID": "c06353b0-7e1b-483c-a83f-be57a03b5a7b", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b30d4a9-d276-469a-806e-f6a804cbc6c8"}, {"Element": "<span lang=\"EN-GB\">8/116\n  (7\u00a0%)</span>", "ID": "3735c901-32ff-49a0-8e71-43afa87ab34e", "Styles": "None", "Classes": "None", "Text": "8/116   (7\u00a0%)", "ParentId": "c06353b0-7e1b-483c-a83f-be57a03b5a7b"}, {"Element": "<tr style=\"height:27.75pt\">\n<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u22652 x baseline value; and\n  bilirubin &gt;2 x ULN and \u22652 x baseline value </span></p>\n</td>\n<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/137\n  (0.7\u00a0%)</span></p>\n</td>\n<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/116\n  (0.9\u00a0%)</span></p>\n</td>\n</tr>", "ID": "6cf2c43b-6b60-49f6-9b03-d58677db198a", "Styles": "height:27.75pt", "Classes": "None", "Text": "    ", "ParentId": "d06e3ac1-5cd8-4527-94c9-39297584abde"}, {"Element": "<td style=\"width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"top\" width=\"319\">\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u22652 x baseline value; and\n  bilirubin &gt;2 x ULN and \u22652 x baseline value </span></p>\n</td>", "ID": "e0e41988-8ba0-4feb-a05d-70e45e7f64a8", "Styles": "width:239.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:27.75pt", "Classes": "None", "Text": "  ", "ParentId": "6cf2c43b-6b60-49f6-9b03-d58677db198a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">ALT \u22652 x baseline value; and\n  bilirubin &gt;2 x ULN and \u22652 x baseline value </span></p>", "ID": "7a4bd820-d76a-4a64-929a-66efc93afdbc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0e41988-8ba0-4feb-a05d-70e45e7f64a8"}, {"Element": "<span lang=\"EN-GB\">ALT \u22652 x baseline value; and\n  bilirubin &gt;2 x ULN and \u22652 x baseline value </span>", "ID": "8bda852d-92be-4cab-9260-894795e3dc3b", "Styles": "None", "Classes": "None", "Text": "ALT \u22652 x baseline value; and   bilirubin >2 x ULN and \u22652 x baseline value ", "ParentId": "7a4bd820-d76a-4a64-929a-66efc93afdbc"}, {"Element": "<td style=\"width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/137\n  (0.7\u00a0%)</span></p>\n</td>", "ID": "cf72e731-1d09-46e4-9a77-862136daa585", "Styles": "width:115.25pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt", "Classes": "None", "Text": "  ", "ParentId": "6cf2c43b-6b60-49f6-9b03-d58677db198a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/137\n  (0.7\u00a0%)</span></p>", "ID": "d00a4473-883f-4581-a23e-44fedd40aae8", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf72e731-1d09-46e4-9a77-862136daa585"}, {"Element": "<span lang=\"EN-GB\">1/137\n  (0.7\u00a0%)</span>", "ID": "a76f6bab-3ac6-4ca9-b212-5400c6f22bec", "Styles": "None", "Classes": "None", "Text": "1/137   (0.7\u00a0%)", "ParentId": "d00a4473-883f-4581-a23e-44fedd40aae8"}, {"Element": "<td style=\"width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt\" valign=\"bottom\" width=\"154\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/116\n  (0.9\u00a0%)</span></p>\n</td>", "ID": "f9028575-fb7e-4da2-a6f8-813530fd2306", "Styles": "width:115.4pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:27.75pt", "Classes": "None", "Text": "  ", "ParentId": "6cf2c43b-6b60-49f6-9b03-d58677db198a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">1/116\n  (0.9\u00a0%)</span></p>", "ID": "d5e2ebaa-e603-4c70-96c5-608f26dfb817", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f9028575-fb7e-4da2-a6f8-813530fd2306"}, {"Element": "<span lang=\"EN-GB\">1/116\n  (0.9\u00a0%)</span>", "ID": "6b8a4e2b-ab3a-41b6-9615-2da4a4941201", "Styles": "None", "Classes": "None", "Text": "1/116   (0.9\u00a0%)", "ParentId": "d5e2ebaa-e603-4c70-96c5-608f26dfb817"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span></p>", "ID": "3a2b71dc-6383-4235-b978-d9a6860f00dd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span>", "ID": "9af26a0e-783d-4d33-99b3-d86fec64b4a9", "Styles": "font-size:12.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3a2b71dc-6383-4235-b978-d9a6860f00dd"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">*Each patient may be represented in one or\nmore category.</span></p>", "ID": "0dfe7e8d-66ca-4a6f-8ad4-666f1adb9f45", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">*Each patient may be represented in one or\nmore category.</span>", "ID": "abaef51e-eb02-452c-b564-80a2ddbd7415", "Styles": "None", "Classes": "None", "Text": "*Each patient may be represented in one or more category.", "ParentId": "0dfe7e8d-66ca-4a6f-8ad4-666f1adb9f45"}, {"Element": "<p class=\"MsoNormal\"><sup><span lang=\"EN-GB\" style=\"position:relative;top:-5.0pt\">\u2020</span></sup><span lang=\"EN-GB\">Comparable to a Grade 3 toxicity in accordance with modified WHO\ncriteria. </span></p>", "ID": "28bf0226-6e4b-476b-bd14-bbec1e7ca63c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"position:relative;top:-5.0pt\">\u2020</span></sup>", "ID": "f5acb4fd-931e-4673-8ed9-43c0848df5e7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "28bf0226-6e4b-476b-bd14-bbec1e7ca63c"}, {"Element": "<span lang=\"EN-GB\" style=\"position:relative;top:-5.0pt\">\u2020</span>", "ID": "0cd199ba-7298-41e0-aebb-cb66574836bb", "Styles": "position:relative;top:-5.0pt", "Classes": "None", "Text": "\u2020", "ParentId": "f5acb4fd-931e-4673-8ed9-43c0848df5e7"}, {"Element": "<span lang=\"EN-GB\">Comparable to a Grade 3 toxicity in accordance with modified WHO\ncriteria. </span>", "ID": "2f8f7ec5-aa6f-4b05-8804-cd2d3f2f8ad4", "Styles": "None", "Classes": "None", "Text": "Comparable to a Grade 3 toxicity in accordance with modified WHO criteria. ", "ParentId": "28bf0226-6e4b-476b-bd14-bbec1e7ca63c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">ULN = Upper limit of normal. </span></p>", "ID": "dbc3eee6-7758-4a75-97cd-98725d153bae", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">ULN = Upper limit of normal. </span>", "ID": "9ddbc0ee-3a92-4ecc-b084-ce65554369af", "Styles": "None", "Classes": "None", "Text": "ULN = Upper limit of normal. ", "ParentId": "dbc3eee6-7758-4a75-97cd-98725d153bae"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5feac244-c290-41e6-bf7a-620678983278", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "de24860e-ae65-45bd-b465-805281031beb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5feac244-c290-41e6-bf7a-620678983278"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Experience in patients with HBeAg\nnegative CHB: </span></i></p>", "ID": "a984c0aa-6820-4ae4-8a67-a1920de74f14", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Experience in patients with HBeAg\nnegative CHB: </span></i>", "ID": "b88174de-2a38-410b-b1ea-353f932455c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a984c0aa-6820-4ae4-8a67-a1920de74f14"}, {"Element": "<span lang=\"EN-GB\">Experience in patients with HBeAg\nnegative CHB: </span>", "ID": "c38480fd-99f1-4145-b8ec-fd8ee047e509", "Styles": "None", "Classes": "None", "Text": "Experience in patients with HBeAg negative CHB: ", "ParentId": "b88174de-2a38-410b-b1ea-353f932455c1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Initial data indicate the efficacy of\nlamivudine in patients with HBeAg negative CHB is similar to patients with\nHBeAg positive CHB, with 71\u00a0% of patients having HBV DNA suppressed below\nthe detection limit of the assay, 67\u00a0% ALT normalisation and 38\u00a0%\nwith improvement in HAI after one year of treatment. When lamivudine was\ndiscontinued, the majority of patients (70\u00a0%) had a return of viral\nreplication. Data is available from an extended treatment study in HBeAg\nnegative patients (NUCAB3017) treated with lamivudine. After two years of\ntreatment in this study, ALT normalisation and undetectable HBV DNA occurred in\n30/69 (43\u00a0%) and 32/68 (47\u00a0%) patients respectively and improvement\nin necroinflammatory score in 18/49 (37\u00a0%) patients. In patients without\nYMDD mutant HBV, 14/22 (64\u00a0%) showed improvement in necroinflammatory\nscore and 1/22 (5\u00a0%) patients worsened compared to pre-treatment. In\npatients with the mutant, 4/26 (15\u00a0%) patients showed improvement in\nnecroinflammatory score and 8/26 (31\u00a0%) patients worsened compared to\npre-treatment. No patients in either group progressed to cirrhosis. </span></p>", "ID": "269a85f3-4c02-4b31-8503-9f203f2b6a45", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Initial data indicate the efficacy of\nlamivudine in patients with HBeAg negative CHB is similar to patients with\nHBeAg positive CHB, with 71\u00a0% of patients having HBV DNA suppressed below\nthe detection limit of the assay, 67\u00a0% ALT normalisation and 38\u00a0%\nwith improvement in HAI after one year of treatment. When lamivudine was\ndiscontinued, the majority of patients (70\u00a0%) had a return of viral\nreplication. Data is available from an extended treatment study in HBeAg\nnegative patients (NUCAB3017) treated with lamivudine. After two years of\ntreatment in this study, ALT normalisation and undetectable HBV DNA occurred in\n30/69 (43\u00a0%) and 32/68 (47\u00a0%) patients respectively and improvement\nin necroinflammatory score in 18/49 (37\u00a0%) patients. In patients without\nYMDD mutant HBV, 14/22 (64\u00a0%) showed improvement in necroinflammatory\nscore and 1/22 (5\u00a0%) patients worsened compared to pre-treatment. In\npatients with the mutant, 4/26 (15\u00a0%) patients showed improvement in\nnecroinflammatory score and 8/26 (31\u00a0%) patients worsened compared to\npre-treatment. No patients in either group progressed to cirrhosis. </span>", "ID": "daf52c98-0938-4b60-a202-d5597ff2115a", "Styles": "None", "Classes": "None", "Text": "Initial data indicate the efficacy of lamivudine in patients with HBeAg negative CHB is similar to patients with HBeAg positive CHB, with 71\u00a0% of patients having HBV DNA suppressed below the detection limit of the assay, 67\u00a0% ALT normalisation and 38\u00a0% with improvement in HAI after one year of treatment. When lamivudine was discontinued, the majority of patients (70\u00a0%) had a return of viral replication. Data is available from an extended treatment study in HBeAg negative patients (NUCAB3017) treated with lamivudine. After two years of treatment in this study, ALT normalisation and undetectable HBV DNA occurred in 30/69 (43\u00a0%) and 32/68 (47\u00a0%) patients respectively and improvement in necroinflammatory score in 18/49 (37\u00a0%) patients. In patients without YMDD mutant HBV, 14/22 (64\u00a0%) showed improvement in necroinflammatory score and 1/22 (5\u00a0%) patients worsened compared to pre-treatment. In patients with the mutant, 4/26 (15\u00a0%) patients showed improvement in necroinflammatory score and 8/26 (31\u00a0%) patients worsened compared to pre-treatment. No patients in either group progressed to cirrhosis. ", "ParentId": "269a85f3-4c02-4b31-8503-9f203f2b6a45"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa62057e-712f-4c09-94cc-8f9acc083832", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "83424768-bb34-4740-82b7-0a3d510d4992", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa62057e-712f-4c09-94cc-8f9acc083832"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Frequency of emergence of YMDD mutant\nHBV and impact on the treatment response:</span></i><span lang=\"EN-GB\"> </span></p>", "ID": "8774ce12-e9bd-49ea-8231-887afe83b34c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Frequency of emergence of YMDD mutant\nHBV and impact on the treatment response:</span></i>", "ID": "ff1d0a9d-beaf-4a3f-b9bf-d476bb168658", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8774ce12-e9bd-49ea-8231-887afe83b34c"}, {"Element": "<span lang=\"EN-GB\">Frequency of emergence of YMDD mutant\nHBV and impact on the treatment response:</span>", "ID": "3aa4d613-c0df-41cc-b863-1e7b430d1d39", "Styles": "None", "Classes": "None", "Text": "Frequency of emergence of YMDD mutant HBV and impact on the treatment response:", "ParentId": "ff1d0a9d-beaf-4a3f-b9bf-d476bb168658"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "b6940283-abb8-4861-8d9a-2a1b4c7ec8d8", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "8774ce12-e9bd-49ea-8231-887afe83b34c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine monotherapy results in the\nselection of YMDD mutant HBV in approximately 24\u00a0% of patients following\none year of therapy, increasing to 69\u00a0% following 5 years of therapy.\nDevelopment of YMDD mutant HBV is associated with reduced treatment response in\nsome patients, as evidenced by increased HBV DNA levels and ALT elevations from\nprevious on-therapy levels, progression of signs and symptoms of hepatitis\ndisease and/or worsening of hepatic necroinflammatory findings. Given the risk\nof YMDD mutant HBV, maintenance of lamivudine monotherapy is not appropriate in\npatients with detectable serum HBV DNA at or beyond 24 weeks of treatment (see\nsection 4.4). </span></p>", "ID": "f0ea920f-7539-41ed-8381-a6a7ac9ce1ed", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine monotherapy results in the\nselection of YMDD mutant HBV in approximately 24\u00a0% of patients following\none year of therapy, increasing to 69\u00a0% following 5 years of therapy.\nDevelopment of YMDD mutant HBV is associated with reduced treatment response in\nsome patients, as evidenced by increased HBV DNA levels and ALT elevations from\nprevious on-therapy levels, progression of signs and symptoms of hepatitis\ndisease and/or worsening of hepatic necroinflammatory findings. Given the risk\nof YMDD mutant HBV, maintenance of lamivudine monotherapy is not appropriate in\npatients with detectable serum HBV DNA at or beyond 24 weeks of treatment (see\nsection 4.4). </span>", "ID": "8867e633-d9fd-4923-8aea-2cdce19521c5", "Styles": "None", "Classes": "None", "Text": "Lamivudine monotherapy results in the selection of YMDD mutant HBV in approximately 24\u00a0% of patients following one year of therapy, increasing to 69\u00a0% following 5 years of therapy. Development of YMDD mutant HBV is associated with reduced treatment response in some patients, as evidenced by increased HBV DNA levels and ALT elevations from previous on-therapy levels, progression of signs and symptoms of hepatitis disease and/or worsening of hepatic necroinflammatory findings. Given the risk of YMDD mutant HBV, maintenance of lamivudine monotherapy is not appropriate in patients with detectable serum HBV DNA at or beyond 24 weeks of treatment (see section 4.4). ", "ParentId": "f0ea920f-7539-41ed-8381-a6a7ac9ce1ed"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "45e7c1dc-695e-4c95-9986-7405d39d4309", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "240b3a94-61db-4719-897b-b6259daa0273", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "45e7c1dc-695e-4c95-9986-7405d39d4309"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In a retrospective study to determine the\nfactors associated with HBV DNA breakthrough, 159 Asian HBeAg-positive patients\nwere treated with lamivudine and followed up for a median period of almost 30\nmonths. Those with HBV DNA levels greater than 200 copies/mL at 6 months (24\nweeks) of lamivudine therapy had a 60\u00a0% chance of developing the YMDD\nmutant compared with 8\u00a0% of those with HBV DNA levels less than\n200\u00a0copies/mL at 24 weeks of lamivudine therapy. The risk for developing\nYMDD mutant was 63% versus 13% with a cut off of 1000 copies/ml (NUCB3009 and\nNUCB3018).</span></p>", "ID": "6e12e5a5-ed19-4b39-bd1a-a4436f596ca1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In a retrospective study to determine the\nfactors associated with HBV DNA breakthrough, 159 Asian HBeAg-positive patients\nwere treated with lamivudine and followed up for a median period of almost 30\nmonths. Those with HBV DNA levels greater than 200 copies/mL at 6 months (24\nweeks) of lamivudine therapy had a 60\u00a0% chance of developing the YMDD\nmutant compared with 8\u00a0% of those with HBV DNA levels less than\n200\u00a0copies/mL at 24 weeks of lamivudine therapy. The risk for developing\nYMDD mutant was 63% versus 13% with a cut off of 1000 copies/ml (NUCB3009 and\nNUCB3018).</span>", "ID": "f484c5d8-4832-4c00-bbb7-b08f7861cbb6", "Styles": "None", "Classes": "None", "Text": "In a retrospective study to determine the factors associated with HBV DNA breakthrough, 159 Asian HBeAg-positive patients were treated with lamivudine and followed up for a median period of almost 30 months. Those with HBV DNA levels greater than 200 copies/mL at 6 months (24 weeks) of lamivudine therapy had a 60\u00a0% chance of developing the YMDD mutant compared with 8\u00a0% of those with HBV DNA levels less than 200\u00a0copies/mL at 24 weeks of lamivudine therapy. The risk for developing YMDD mutant was 63% versus 13% with a cut off of 1000 copies/ml (NUCB3009 and NUCB3018).", "ParentId": "6e12e5a5-ed19-4b39-bd1a-a4436f596ca1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3b43c33a-3ce5-4164-851d-e6f5abd452f9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "85dfe3a4-73ad-4f04-ac27-f20594b2c17e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3b43c33a-3ce5-4164-851d-e6f5abd452f9"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><i><span lang=\"EN-GB\">Experience in\npatients with decompensated liver disease</span></i><span lang=\"EN-GB\">: </span></p>", "ID": "a989d07b-4604-4a7d-a9a6-298ccd79452b", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Experience in\npatients with decompensated liver disease</span></i>", "ID": "e1cdc320-f653-4d88-8844-0fe61fe77461", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a989d07b-4604-4a7d-a9a6-298ccd79452b"}, {"Element": "<span lang=\"EN-GB\">Experience in\npatients with decompensated liver disease</span>", "ID": "b912ead0-7169-458d-8545-9342e698d7cd", "Styles": "None", "Classes": "None", "Text": "Experience in patients with decompensated liver disease", "ParentId": "e1cdc320-f653-4d88-8844-0fe61fe77461"}, {"Element": "<span lang=\"EN-GB\">: </span>", "ID": "1a320cc2-d119-4c28-ba0e-f3f110c1b2d0", "Styles": "None", "Classes": "None", "Text": ": ", "ParentId": "a989d07b-4604-4a7d-a9a6-298ccd79452b"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">Placebo\ncontrolled studies have been regarded as inappropriate in patients with\ndecompensated liver disease, and have not been undertaken. In non\u2011controlled\nstudies, where lamivudine was administered prior to and during transplantation,\neffective HBV DNA suppression and ALT normalisation was demonstrated. When\nlamivudine therapy was continued post transplantation there was reduced graft\nre-infection by HBV, increased HBsAg loss and on one-year survival rate of 76\u2011100\u00a0%.\n</span></p>", "ID": "38ad541c-e8e0-4a4b-98a1-9465e88c0f70", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Placebo\ncontrolled studies have been regarded as inappropriate in patients with\ndecompensated liver disease, and have not been undertaken. In non\u2011controlled\nstudies, where lamivudine was administered prior to and during transplantation,\neffective HBV DNA suppression and ALT normalisation was demonstrated. When\nlamivudine therapy was continued post transplantation there was reduced graft\nre-infection by HBV, increased HBsAg loss and on one-year survival rate of 76\u2011100\u00a0%.\n</span>", "ID": "fcb71dad-bae1-4cac-98f9-ffe02749b835", "Styles": "None", "Classes": "None", "Text": "Placebo controlled studies have been regarded as inappropriate in patients with decompensated liver disease, and have not been undertaken. In non\u2011controlled studies, where lamivudine was administered prior to and during transplantation, effective HBV DNA suppression and ALT normalisation was demonstrated. When lamivudine therapy was continued post transplantation there was reduced graft re-infection by HBV, increased HBsAg loss and on one-year survival rate of 76\u2011100\u00a0%. ", "ParentId": "38ad541c-e8e0-4a4b-98a1-9465e88c0f70"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aa08aebf-23d6-463f-adb3-75ee0e2419b1", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7f74ab88-b3a3-4315-b3a0-5bf6db9f57f6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa08aebf-23d6-463f-adb3-75ee0e2419b1"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">As anticipated\ndue to the concomitant immunosuppression, the rate of emergence of YMDD mutant HBV\nafter 52 weeks treatment was higher (36\u00a0%\u201164\u00a0%) in the liver\ntransplant population than in the immunocompetent CHB patients (14\u00a0%\u201132\u00a0%).</span></p>", "ID": "64784455-8f60-4835-bccd-8a3e9992246f", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">As anticipated\ndue to the concomitant immunosuppression, the rate of emergence of YMDD mutant HBV\nafter 52 weeks treatment was higher (36\u00a0%\u201164\u00a0%) in the liver\ntransplant population than in the immunocompetent CHB patients (14\u00a0%\u201132\u00a0%).</span>", "ID": "705d85ba-a206-4896-8db5-369f0a6a1bb9", "Styles": "None", "Classes": "None", "Text": "As anticipated due to the concomitant immunosuppression, the rate of emergence of YMDD mutant HBV after 52 weeks treatment was higher (36\u00a0%\u201164\u00a0%) in the liver transplant population than in the immunocompetent CHB patients (14\u00a0%\u201132\u00a0%).", "ParentId": "64784455-8f60-4835-bccd-8a3e9992246f"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58a0a081-eaa9-4e49-a60f-1baae39c4090", "Styles": "text-align:justify", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a2127de6-c1bf-4ac4-adf7-bbaf8e9a41ee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58a0a081-eaa9-4e49-a60f-1baae39c4090"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Experience in CHB patients with advanced\nfibrosis or cirrhosis</span></i><span lang=\"EN-GB\">: </span></p>", "ID": "9f60f542-fcbf-4399-9bf6-2d8040994fc3", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Experience in CHB patients with advanced\nfibrosis or cirrhosis</span></i>", "ID": "735292c6-b451-4cd8-89dd-d0d78ab9dca7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9f60f542-fcbf-4399-9bf6-2d8040994fc3"}, {"Element": "<span lang=\"EN-GB\">Experience in CHB patients with advanced\nfibrosis or cirrhosis</span>", "ID": "d595ba35-f076-469a-a8a6-f3a31beb6d11", "Styles": "None", "Classes": "None", "Text": "Experience in CHB patients with advanced fibrosis or cirrhosis", "ParentId": "735292c6-b451-4cd8-89dd-d0d78ab9dca7"}, {"Element": "<span lang=\"EN-GB\">: </span>", "ID": "db7cf663-edcd-4561-b77f-dd3952a95b6d", "Styles": "None", "Classes": "None", "Text": ": ", "ParentId": "9f60f542-fcbf-4399-9bf6-2d8040994fc3"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In a placebo-controlled study in 651\npatients with clinically compensated chronic hepatitis B and histologically\nconfirmed fibrosis or cirrhosis, lamivudine treatment (median duration 32\nmonths) significantly reduced the rate of overall disease progression (34/436,\n7.8\u00a0% for lamivudine versus 38/215, 17.7\u00a0% for placebo, p=0.001),\ndemonstrated by a significant reduction in the proportion of patients having\nincreased Child-Pugh scores (15/436, 3.4\u00a0% versus 19/215, 8.8\u00a0%,\np=0.023) or developing hepatocellular carcinoma (17/436, 3.9\u00a0% versus\n16/215, 7.4\u00a0%, p=0.047). The rate of overall disease progression in the\nlamivudine group was higher for subjects with detectable YMDD mutant HBV DNA\n(23/209, 11\u00a0%) compared to those without detectable YMDD mutant HBV\n(11/221, 5\u00a0%). However, disease progression in YMDD subjects in the\nlamivudine group was lower than the disease progression in the placebo group\n(23/209, 11\u00a0% versus 38/214, 18\u00a0% respectively). Confirmed HBeAg\nseroconversion occurred in 47\u00a0% (118/252) of subjects treated with\nlamivudine and 93\u00a0% (320/345) of subjects receiving lamivudine became HBV\nDNA negative (VERSANT [version 1], bDNA assay, LLOD &lt; 0.7\u00a0MEq/ml)\nduring the study. </span></p>", "ID": "437753ac-0fe5-4adc-a7b6-b64bc8599766", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In a placebo-controlled study in 651\npatients with clinically compensated chronic hepatitis B and histologically\nconfirmed fibrosis or cirrhosis, lamivudine treatment (median duration 32\nmonths) significantly reduced the rate of overall disease progression (34/436,\n7.8\u00a0% for lamivudine versus 38/215, 17.7\u00a0% for placebo, p=0.001),\ndemonstrated by a significant reduction in the proportion of patients having\nincreased Child-Pugh scores (15/436, 3.4\u00a0% versus 19/215, 8.8\u00a0%,\np=0.023) or developing hepatocellular carcinoma (17/436, 3.9\u00a0% versus\n16/215, 7.4\u00a0%, p=0.047). The rate of overall disease progression in the\nlamivudine group was higher for subjects with detectable YMDD mutant HBV DNA\n(23/209, 11\u00a0%) compared to those without detectable YMDD mutant HBV\n(11/221, 5\u00a0%). However, disease progression in YMDD subjects in the\nlamivudine group was lower than the disease progression in the placebo group\n(23/209, 11\u00a0% versus 38/214, 18\u00a0% respectively). Confirmed HBeAg\nseroconversion occurred in 47\u00a0% (118/252) of subjects treated with\nlamivudine and 93\u00a0% (320/345) of subjects receiving lamivudine became HBV\nDNA negative (VERSANT [version 1], bDNA assay, LLOD &lt; 0.7\u00a0MEq/ml)\nduring the study. </span>", "ID": "d1bc4427-3332-4850-92d8-3d9214d6fb21", "Styles": "None", "Classes": "None", "Text": "In a placebo-controlled study in 651 patients with clinically compensated chronic hepatitis B and histologically confirmed fibrosis or cirrhosis, lamivudine treatment (median duration 32 months) significantly reduced the rate of overall disease progression (34/436, 7.8\u00a0% for lamivudine versus 38/215, 17.7\u00a0% for placebo, p=0.001), demonstrated by a significant reduction in the proportion of patients having increased Child-Pugh scores (15/436, 3.4\u00a0% versus 19/215, 8.8\u00a0%, p=0.023) or developing hepatocellular carcinoma (17/436, 3.9\u00a0% versus 16/215, 7.4\u00a0%, p=0.047). The rate of overall disease progression in the lamivudine group was higher for subjects with detectable YMDD mutant HBV DNA (23/209, 11\u00a0%) compared to those without detectable YMDD mutant HBV (11/221, 5\u00a0%). However, disease progression in YMDD subjects in the lamivudine group was lower than the disease progression in the placebo group (23/209, 11\u00a0% versus 38/214, 18\u00a0% respectively). Confirmed HBeAg seroconversion occurred in 47\u00a0% (118/252) of subjects treated with lamivudine and 93\u00a0% (320/345) of subjects receiving lamivudine became HBV DNA negative (VERSANT [version 1], bDNA assay, LLOD < 0.7\u00a0MEq/ml) during the study. ", "ParentId": "437753ac-0fe5-4adc-a7b6-b64bc8599766"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4b8d8438-c6c8-47b5-84b9-7ee386b7db62", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0980a25b-255f-40d5-bd69-8a1554e1ccda", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4b8d8438-c6c8-47b5-84b9-7ee386b7db62"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Experience in children and adolescents</span></i><span lang=\"EN-GB\">: </span></p>", "ID": "f145b9d2-44fb-45db-8c5b-456fe1365f18", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">Experience in children and adolescents</span></i>", "ID": "052f9148-229e-4a0b-9cdc-16ad82934926", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f145b9d2-44fb-45db-8c5b-456fe1365f18"}, {"Element": "<span lang=\"EN-GB\">Experience in children and adolescents</span>", "ID": "fe809100-636f-4a56-b8fe-1a814ddac095", "Styles": "None", "Classes": "None", "Text": "Experience in children and adolescents", "ParentId": "052f9148-229e-4a0b-9cdc-16ad82934926"}, {"Element": "<span lang=\"EN-GB\">: </span>", "ID": "35239a88-0fc6-4446-a528-fb39e3dbc128", "Styles": "None", "Classes": "None", "Text": ": ", "ParentId": "f145b9d2-44fb-45db-8c5b-456fe1365f18"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine has been administered to\nchildren and adolescents with compensated CHB in a placebo controlled study of\n286 patients aged 2 to 17 years. This population primarily consisted of\nchildren with minimal hepatitis B. A dose of 3\u00a0mg/kg once daily (up to a\nmaximum of 100\u00a0mg daily) was used in children aged 2 to 11 years and a\ndose of 100\u00a0mg once daily in adolescents aged 12 years and above. This\ndose needs to be further substantiated. The difference in the HBeAg\nseroconversion rates (HBeAg and HBV DNA loss with HBeAb detection) between\nplacebo and lamivudine was not statistically significant in this population\n(rates after one year were 13\u00a0% (12/95) for placebo versus 22\u00a0% (42/191)\nfor lamivudine; p=0.057). The incidence of YMDD mutant HBV was similar to that\nobserved in adults, ranging from 19\u00a0% at week 52 up to 45\u00a0% in\npatients treated continuously for 24 months.</span></p>", "ID": "93df8c26-3ee5-446a-8ae7-47b1ef63d701", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine has been administered to\nchildren and adolescents with compensated CHB in a placebo controlled study of\n286 patients aged 2 to 17 years. This population primarily consisted of\nchildren with minimal hepatitis B. A dose of 3\u00a0mg/kg once daily (up to a\nmaximum of 100\u00a0mg daily) was used in children aged 2 to 11 years and a\ndose of 100\u00a0mg once daily in adolescents aged 12 years and above. This\ndose needs to be further substantiated. The difference in the HBeAg\nseroconversion rates (HBeAg and HBV DNA loss with HBeAb detection) between\nplacebo and lamivudine was not statistically significant in this population\n(rates after one year were 13\u00a0% (12/95) for placebo versus 22\u00a0% (42/191)\nfor lamivudine; p=0.057). The incidence of YMDD mutant HBV was similar to that\nobserved in adults, ranging from 19\u00a0% at week 52 up to 45\u00a0% in\npatients treated continuously for 24 months.</span>", "ID": "9881b6a1-e977-4661-9b5d-33b35645993a", "Styles": "None", "Classes": "None", "Text": "Lamivudine has been administered to children and adolescents with compensated CHB in a placebo controlled study of 286 patients aged 2 to 17 years. This population primarily consisted of children with minimal hepatitis B. A dose of 3\u00a0mg/kg once daily (up to a maximum of 100\u00a0mg daily) was used in children aged 2 to 11 years and a dose of 100\u00a0mg once daily in adolescents aged 12 years and above. This dose needs to be further substantiated. The difference in the HBeAg seroconversion rates (HBeAg and HBV DNA loss with HBeAb detection) between placebo and lamivudine was not statistically significant in this population (rates after one year were 13\u00a0% (12/95) for placebo versus 22\u00a0% (42/191) for lamivudine; p=0.057). The incidence of YMDD mutant HBV was similar to that observed in adults, ranging from 19\u00a0% at week 52 up to 45\u00a0% in patients treated continuously for 24 months.", "ParentId": "93df8c26-3ee5-446a-8ae7-47b1ef63d701"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "027071e7-ddcb-4f84-9614-fa92b47c727a", "Styles": "margin-right:-.1pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4399bf1a-53f6-4206-9bba-39f606be0bd9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "027071e7-ddcb-4f84-9614-fa92b47c727a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b></p>", "ID": "4173ba5d-255a-4a14-8135-2c4d06b78f23", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b>", "ID": "53b53ac8-c071-4645-9bb0-69849de5e36c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4173ba5d-255a-4a14-8135-2c4d06b78f23"}, {"Element": "<span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span>", "ID": "147a8319-6917-4ee4-9689-f954162496ce", "Styles": "None", "Classes": "None", "Text": "5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties", "ParentId": "53b53ac8-c071-4645-9bb0-69849de5e36c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d999413-3b75-4e9b-ac75-b54cf11aa6cf", "Styles": "margin-right:-.1pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b3906ff8-3aab-4895-a4d2-490ad92e6ba4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d999413-3b75-4e9b-ac75-b54cf11aa6cf"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Absorption</span></u><span lang=\"EN-GB\"> </span></p>", "ID": "d5433dba-f711-46c0-ac32-55a913a928db", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Absorption</span></u>", "ID": "03933409-d8cf-4dbe-8d8e-b81e9f862479", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d5433dba-f711-46c0-ac32-55a913a928db"}, {"Element": "<span lang=\"EN-GB\">Absorption</span>", "ID": "4faaac5e-6068-488f-8fd2-ccb017fc813b", "Styles": "None", "Classes": "None", "Text": "Absorption", "ParentId": "03933409-d8cf-4dbe-8d8e-b81e9f862479"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "fdabf2b0-6dd9-41b6-9de0-a988c0460185", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "d5433dba-f711-46c0-ac32-55a913a928db"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "78396608-7071-4574-867f-e1e541de961c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9a92f9d-0633-496e-8222-a5d7e9b0cf3e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "78396608-7071-4574-867f-e1e541de961c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is well absorbed from the\ngastrointestinal tract, and the bioavailability of oral lamivudine in adults is\nnormally between 80 and 85\u00a0%. Following oral administration, the mean time\n(t</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span><span lang=\"EN-GB\">)\nto maximal serum concentrations (C</span><span lang=\"EN-GB\" style=\"font-size:\n7.0pt\">max</span><span lang=\"EN-GB\">) is about an hour. At therapeutic dose\nlevels i.e. 100\u00a0mg once daily, C</span><span lang=\"EN-GB\" style=\"font-size:\n7.0pt\">max</span><span lang=\"EN-GB\"> is in the order of 1.1\u20111.5\u00a0\u00b5g/ml\nand trough levels were 0.015\u20110.020\u00a0\u00b5g/ml. </span></p>", "ID": "a240a1cb-e6d4-4b4c-99e6-93116e287a25", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine is well absorbed from the\ngastrointestinal tract, and the bioavailability of oral lamivudine in adults is\nnormally between 80 and 85\u00a0%. Following oral administration, the mean time\n(t</span>", "ID": "b0d35025-b9d8-4a1d-8d0f-5fbd646b6d1c", "Styles": "None", "Classes": "None", "Text": "Lamivudine is well absorbed from the gastrointestinal tract, and the bioavailability of oral lamivudine in adults is normally between 80 and 85\u00a0%. Following oral administration, the mean time (t", "ParentId": "a240a1cb-e6d4-4b4c-99e6-93116e287a25"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span>", "ID": "50817720-cb28-4cf0-a687-aa99a5b6dd0c", "Styles": "font-size:7.0pt", "Classes": "None", "Text": "max", "ParentId": "a240a1cb-e6d4-4b4c-99e6-93116e287a25"}, {"Element": "<span lang=\"EN-GB\">)\nto maximal serum concentrations (C</span>", "ID": "69bfe9dd-19c1-4eab-8b25-140d0073181f", "Styles": "None", "Classes": "None", "Text": ") to maximal serum concentrations (C", "ParentId": "a240a1cb-e6d4-4b4c-99e6-93116e287a25"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n7.0pt\">max</span>", "ID": "3b30dfb5-83d9-4fec-af5f-59acd3ce79db", "Styles": "font-size:\n7.0pt", "Classes": "None", "Text": "max", "ParentId": "a240a1cb-e6d4-4b4c-99e6-93116e287a25"}, {"Element": "<span lang=\"EN-GB\">) is about an hour. At therapeutic dose\nlevels i.e. 100\u00a0mg once daily, C</span>", "ID": "03b97754-67d7-4ad3-bd9a-f3ea9da99b77", "Styles": "None", "Classes": "None", "Text": ") is about an hour. At therapeutic dose levels i.e. 100\u00a0mg once daily, C", "ParentId": "a240a1cb-e6d4-4b4c-99e6-93116e287a25"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n7.0pt\">max</span>", "ID": "4e05d753-b572-4606-a7f1-47af14188e34", "Styles": "font-size:\n7.0pt", "Classes": "None", "Text": "max", "ParentId": "a240a1cb-e6d4-4b4c-99e6-93116e287a25"}, {"Element": "<span lang=\"EN-GB\"> is in the order of 1.1\u20111.5\u00a0\u00b5g/ml\nand trough levels were 0.015\u20110.020\u00a0\u00b5g/ml. </span>", "ID": "b82d5715-4719-47c8-997e-8401d71f3867", "Styles": "None", "Classes": "None", "Text": " is in the order of 1.1\u20111.5\u00a0\u00b5g/ml and trough levels were 0.015\u20110.020\u00a0\u00b5g/ml. ", "ParentId": "a240a1cb-e6d4-4b4c-99e6-93116e287a25"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "21e4e14b-3e2e-4a7a-a92b-230dc5f34e9f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "58372259-b5ec-43e6-a56e-54d3c093602a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "21e4e14b-3e2e-4a7a-a92b-230dc5f34e9f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Co-administration of lamivudine with food\nresulted in a delay of t</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span><span lang=\"EN-GB\"> and a lower C</span><span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span><span lang=\"EN-GB\"> (decreased by up to 47\u00a0%). However, the extent (based on the\nAUC) of lamivudine absorbed was not influenced, therefore lamivudine can be\nadministered with or without food. </span></p>", "ID": "5d50eaf1-bed6-4b1f-bf10-578d20212eef", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Co-administration of lamivudine with food\nresulted in a delay of t</span>", "ID": "9241e011-06b7-4552-84ed-69d3e11d5ed0", "Styles": "None", "Classes": "None", "Text": "Co-administration of lamivudine with food resulted in a delay of t", "ParentId": "5d50eaf1-bed6-4b1f-bf10-578d20212eef"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span>", "ID": "49283bc3-c215-4e74-8ccd-8c58bc88caf7", "Styles": "font-size:7.0pt", "Classes": "None", "Text": "max", "ParentId": "5d50eaf1-bed6-4b1f-bf10-578d20212eef"}, {"Element": "<span lang=\"EN-GB\"> and a lower C</span>", "ID": "6ee15163-2e7e-4214-9d0d-163881c7b176", "Styles": "None", "Classes": "None", "Text": " and a lower C", "ParentId": "5d50eaf1-bed6-4b1f-bf10-578d20212eef"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:7.0pt\">max</span>", "ID": "8f5a4c98-5155-4449-9474-26f528f6f5bb", "Styles": "font-size:7.0pt", "Classes": "None", "Text": "max", "ParentId": "5d50eaf1-bed6-4b1f-bf10-578d20212eef"}, {"Element": "<span lang=\"EN-GB\"> (decreased by up to 47\u00a0%). However, the extent (based on the\nAUC) of lamivudine absorbed was not influenced, therefore lamivudine can be\nadministered with or without food. </span>", "ID": "f14f47a9-fd15-418b-8a17-df74bd3d98e2", "Styles": "None", "Classes": "None", "Text": " (decreased by up to 47\u00a0%). However, the extent (based on the AUC) of lamivudine absorbed was not influenced, therefore lamivudine can be administered with or without food. ", "ParentId": "5d50eaf1-bed6-4b1f-bf10-578d20212eef"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7678247f-bd5d-4326-8019-698dea4fc206", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6536d755-b169-407d-a10e-2345278daac9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7678247f-bd5d-4326-8019-698dea4fc206"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Distribution</span></u><span lang=\"EN-GB\">\n</span></p>", "ID": "f4d51585-d24c-4307-8b6d-bba4367e1458", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Distribution</span></u>", "ID": "e7b37511-3a0e-48a5-92d9-d238b63153ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f4d51585-d24c-4307-8b6d-bba4367e1458"}, {"Element": "<span lang=\"EN-GB\">Distribution</span>", "ID": "dfebded8-f6fe-4922-8a0d-aa292fe192f0", "Styles": "None", "Classes": "None", "Text": "Distribution", "ParentId": "e7b37511-3a0e-48a5-92d9-d238b63153ff"}, {"Element": "<span lang=\"EN-GB\">\n</span>", "ID": "ef173444-e3ae-427d-ac98-3e04af8aa192", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "f4d51585-d24c-4307-8b6d-bba4367e1458"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0fd56cd2-777e-4def-bd43-f6e4ef53329a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b660a6db-9b93-4b9c-ac33-47c6a18b7a82", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0fd56cd2-777e-4def-bd43-f6e4ef53329a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">From intravenous studies the mean volume of\ndistribution is 1.3\u00a0l/kg. Lamivudine exhibits linear pharmacokinetics over\nthe therapeutic dose range and displays low plasma protein binding to albumin. </span></p>", "ID": "d97cc622-8a18-4b9b-a41a-f84d914ff43d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">From intravenous studies the mean volume of\ndistribution is 1.3\u00a0l/kg. Lamivudine exhibits linear pharmacokinetics over\nthe therapeutic dose range and displays low plasma protein binding to albumin. </span>", "ID": "f573f7b0-54ea-46fd-915a-1bb4cafc66df", "Styles": "None", "Classes": "None", "Text": "From intravenous studies the mean volume of distribution is 1.3\u00a0l/kg. Lamivudine exhibits linear pharmacokinetics over the therapeutic dose range and displays low plasma protein binding to albumin. ", "ParentId": "d97cc622-8a18-4b9b-a41a-f84d914ff43d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Limited data shows lamivudine penetrates\nthe central nervous system and reaches the cerebro-spinal fluid (CSF). The mean\nlamivudine CSF/serum concentration ratio 2\u20114 hours after oral\nadministration was approximately 0.12. </span></p>", "ID": "333d9969-6bad-41d6-bd50-4d7f9dfad7ad", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Limited data shows lamivudine penetrates\nthe central nervous system and reaches the cerebro-spinal fluid (CSF). The mean\nlamivudine CSF/serum concentration ratio 2\u20114 hours after oral\nadministration was approximately 0.12. </span>", "ID": "4dc436c4-40f8-4a25-aa65-d61a8c86149a", "Styles": "None", "Classes": "None", "Text": "Limited data shows lamivudine penetrates the central nervous system and reaches the cerebro-spinal fluid (CSF). The mean lamivudine CSF/serum concentration ratio 2\u20114 hours after oral administration was approximately 0.12. ", "ParentId": "333d9969-6bad-41d6-bd50-4d7f9dfad7ad"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2925a31f-c95b-4554-a771-c8e688ab06de", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f585e42d-3800-43fa-8683-58f8ca5d038f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2925a31f-c95b-4554-a771-c8e688ab06de"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Biotransformation</span></u><span lang=\"EN-GB\"> </span></p>", "ID": "397670d9-92cf-4540-bc66-84cbad3e54b7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Biotransformation</span></u>", "ID": "15ecaabc-12cf-493b-9c22-eabad9c44677", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "397670d9-92cf-4540-bc66-84cbad3e54b7"}, {"Element": "<span lang=\"EN-GB\">Biotransformation</span>", "ID": "90b33289-82f7-46ff-a14c-44b3a3ad2cdd", "Styles": "None", "Classes": "None", "Text": "Biotransformation", "ParentId": "15ecaabc-12cf-493b-9c22-eabad9c44677"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "09e16f40-bb11-4638-a8f9-e6e95b37b3e5", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "397670d9-92cf-4540-bc66-84cbad3e54b7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a513aa43-da77-4fc4-9134-60b86de31843", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "53493dff-1ca2-4cb0-b455-0c2dafd5d467", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a513aa43-da77-4fc4-9134-60b86de31843"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine is predominately cleared by\nrenal excretion of unchanged substance. The likelihood of metabolic substance\ninteractions with lamivudine is low due to the small (5\u201110\u00a0%) extent\nof hepatic metabolism and the low plasma protein binding. </span></p>", "ID": "5a259393-d1f0-4503-9625-355e7c601c0a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine is predominately cleared by\nrenal excretion of unchanged substance. The likelihood of metabolic substance\ninteractions with lamivudine is low due to the small (5\u201110\u00a0%) extent\nof hepatic metabolism and the low plasma protein binding. </span>", "ID": "00f45717-3590-4b83-82f1-9d17542ec04c", "Styles": "None", "Classes": "None", "Text": "Lamivudine is predominately cleared by renal excretion of unchanged substance. The likelihood of metabolic substance interactions with lamivudine is low due to the small (5\u201110\u00a0%) extent of hepatic metabolism and the low plasma protein binding. ", "ParentId": "5a259393-d1f0-4503-9625-355e7c601c0a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f2ed75fc-d3ac-443d-a198-81927f2a9a7b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c313885-9bf5-456b-ab91-7f309fa3d174", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f2ed75fc-d3ac-443d-a198-81927f2a9a7b"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Elimination</span></u><span lang=\"EN-GB\"> </span></p>", "ID": "b96804be-eb67-4334-9930-669b1d1199ec", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Elimination</span></u>", "ID": "8f16443b-28f1-40cd-b1ca-7b322b9c851a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b96804be-eb67-4334-9930-669b1d1199ec"}, {"Element": "<span lang=\"EN-GB\">Elimination</span>", "ID": "3cf2affc-ef24-4c2e-9dcd-837ec3dc452e", "Styles": "None", "Classes": "None", "Text": "Elimination", "ParentId": "8f16443b-28f1-40cd-b1ca-7b322b9c851a"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "283c763f-e51c-48a4-92f4-515d419b6342", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "b96804be-eb67-4334-9930-669b1d1199ec"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0527f390-118c-4fa4-93c8-504d0ee850cb", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f374e6e2-af97-4393-b83c-5cd02d970931", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0527f390-118c-4fa4-93c8-504d0ee850cb"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The mean systemic clearance of lamivudine\nis approximately 0.3\u00a0l/h/kg. The observed half-life of elimination is 5 to\n7 hours. The majority of lamivudine is excreted unchanged in the urine via\nglomerular filtration and active secretion (organic cationic transport system).\nRenal clearance accounts for about 70\u00a0% of lamivudine elimination. </span></p>", "ID": "a4f28864-1245-4ff2-b706-a84fb605c5ed", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The mean systemic clearance of lamivudine\nis approximately 0.3\u00a0l/h/kg. The observed half-life of elimination is 5 to\n7 hours. The majority of lamivudine is excreted unchanged in the urine via\nglomerular filtration and active secretion (organic cationic transport system).\nRenal clearance accounts for about 70\u00a0% of lamivudine elimination. </span>", "ID": "c9b1ce02-6edf-4dff-9d7f-6207cebef064", "Styles": "None", "Classes": "None", "Text": "The mean systemic clearance of lamivudine is approximately 0.3\u00a0l/h/kg. The observed half-life of elimination is 5 to 7 hours. The majority of lamivudine is excreted unchanged in the urine via glomerular filtration and active secretion (organic cationic transport system). Renal clearance accounts for about 70\u00a0% of lamivudine elimination. ", "ParentId": "a4f28864-1245-4ff2-b706-a84fb605c5ed"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5e1f5e84-b52a-4c06-a27c-001464758c7b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "62e6c3ed-a106-4c42-b820-5c5adddf1730", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5e1f5e84-b52a-4c06-a27c-001464758c7b"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Special populations</span></u></p>", "ID": "527f8085-ab0a-4a1d-ba42-cd31e93e28ae", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Special populations</span></u>", "ID": "58386c8f-ef04-4154-b414-d641415df98c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "527f8085-ab0a-4a1d-ba42-cd31e93e28ae"}, {"Element": "<span lang=\"EN-GB\">Special populations</span>", "ID": "71613031-1485-4441-885f-0d54e2891263", "Styles": "None", "Classes": "None", "Text": "Special populations", "ParentId": "58386c8f-ef04-4154-b414-d641415df98c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "213e7cac-d829-415b-89d8-9330c529af08", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "71ccf8bb-01e0-4e3b-9b5d-fb62fa1d3564", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "213e7cac-d829-415b-89d8-9330c529af08"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Studies in patients with renal impairment\nshow lamivudine elimination is affected by renal dysfunction. Dose reduction in\npatients with a creatinine clearance of &lt; 50\u00a0ml/min is necessary (see\nsection 4.2). </span></p>", "ID": "d853dbd5-bd6a-4554-adeb-6f3396dba390", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Studies in patients with renal impairment\nshow lamivudine elimination is affected by renal dysfunction. Dose reduction in\npatients with a creatinine clearance of &lt; 50\u00a0ml/min is necessary (see\nsection 4.2). </span>", "ID": "fbf1775b-9b5c-4826-accc-087df744794c", "Styles": "None", "Classes": "None", "Text": "Studies in patients with renal impairment show lamivudine elimination is affected by renal dysfunction. Dose reduction in patients with a creatinine clearance of < 50\u00a0ml/min is necessary (see section 4.2). ", "ParentId": "d853dbd5-bd6a-4554-adeb-6f3396dba390"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "618e7200-bb1a-4aa8-9029-fe7b1e7b522e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "86bde652-a232-42bd-b0d2-716c94c6484c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "618e7200-bb1a-4aa8-9029-fe7b1e7b522e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The pharmacokinetics of lamivudine are\nunaffected by hepatic impairment. Limited data in patients undergoing liver\ntransplantation show that impairment of hepatic function does not impact\nsignificantly on the pharmacokinetics of lamivudine unless accompanied by renal\ndysfunction. </span></p>", "ID": "df751304-d51b-4859-a55c-2e0e5ffb018b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The pharmacokinetics of lamivudine are\nunaffected by hepatic impairment. Limited data in patients undergoing liver\ntransplantation show that impairment of hepatic function does not impact\nsignificantly on the pharmacokinetics of lamivudine unless accompanied by renal\ndysfunction. </span>", "ID": "f5eaa2c4-f220-44e5-b67d-f372bfa67d4a", "Styles": "None", "Classes": "None", "Text": "The pharmacokinetics of lamivudine are unaffected by hepatic impairment. Limited data in patients undergoing liver transplantation show that impairment of hepatic function does not impact significantly on the pharmacokinetics of lamivudine unless accompanied by renal dysfunction. ", "ParentId": "df751304-d51b-4859-a55c-2e0e5ffb018b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ce82ccc-b1fd-4b11-be5b-480b4deee456", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7653f0a-deda-423c-8b0e-876b296dcf8a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ce82ccc-b1fd-4b11-be5b-480b4deee456"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">In elderly patients the pharmacokinetic\nprofile of lamivudine suggests that normal ageing with accompanying renal\ndecline has no clinically significant effect on lamivudine exposure, except in\npatients with creatinine clearance of &lt; 50\u00a0ml/min (see section 4.2). </span></p>", "ID": "11407757-f40b-433f-8a4e-f6cab77f6620", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">In elderly patients the pharmacokinetic\nprofile of lamivudine suggests that normal ageing with accompanying renal\ndecline has no clinically significant effect on lamivudine exposure, except in\npatients with creatinine clearance of &lt; 50\u00a0ml/min (see section 4.2). </span>", "ID": "a005d856-b17d-4117-a921-1b178c97104c", "Styles": "None", "Classes": "None", "Text": "In elderly patients the pharmacokinetic profile of lamivudine suggests that normal ageing with accompanying renal decline has no clinically significant effect on lamivudine exposure, except in patients with creatinine clearance of < 50\u00a0ml/min (see section 4.2). ", "ParentId": "11407757-f40b-433f-8a4e-f6cab77f6620"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a8f5beae-b6d0-428b-ba2b-d0686e685ac0", "Styles": "margin-right:-.1pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "01e26ec0-b9d9-496c-83ea-8a86f220814a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a8f5beae-b6d0-428b-ba2b-d0686e685ac0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b></p>", "ID": "280695cc-a8fe-4705-88b0-58eee05628e3", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b>", "ID": "41584dc3-96bd-4a2f-9aaf-2cf320cb4517", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "280695cc-a8fe-4705-88b0-58eee05628e3"}, {"Element": "<span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span>", "ID": "41042753-91da-4325-98f3-528ae809eb02", "Styles": "None", "Classes": "None", "Text": "5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data", "ParentId": "41584dc3-96bd-4a2f-9aaf-2cf320cb4517"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6943736b-048d-4f85-8823-4447fc6396ff", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0251ac0d-b525-4e10-9de4-10d75ff0ebc5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6943736b-048d-4f85-8823-4447fc6396ff"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Administration of lamivudine in animal\ntoxicity studies at high doses was not associated with any major organ\ntoxicity. At the highest dosage levels, minor effects on indicators of liver\nand kidney function were seen together with occasional reduction in liver\nweights. Reduction of erythrocytes and neutrophil counts were identified as the\neffects most likely to be of clinical relevance. These events were seen\ninfrequently in clinical studies. </span></p>", "ID": "0649abc9-89a3-4ff4-9314-40b6bd6efa72", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Administration of lamivudine in animal\ntoxicity studies at high doses was not associated with any major organ\ntoxicity. At the highest dosage levels, minor effects on indicators of liver\nand kidney function were seen together with occasional reduction in liver\nweights. Reduction of erythrocytes and neutrophil counts were identified as the\neffects most likely to be of clinical relevance. These events were seen\ninfrequently in clinical studies. </span>", "ID": "fc1d82bf-e6c6-4c7c-8a39-4d7c62640594", "Styles": "None", "Classes": "None", "Text": "Administration of lamivudine in animal toxicity studies at high doses was not associated with any major organ toxicity. At the highest dosage levels, minor effects on indicators of liver and kidney function were seen together with occasional reduction in liver weights. Reduction of erythrocytes and neutrophil counts were identified as the effects most likely to be of clinical relevance. These events were seen infrequently in clinical studies. ", "ParentId": "0649abc9-89a3-4ff4-9314-40b6bd6efa72"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a0a6aeba-790c-4b2c-93b9-e967df9360b9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a9d9f5cd-2050-4a35-8efd-7fa0b12296b1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0a6aeba-790c-4b2c-93b9-e967df9360b9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine was not mutagenic in bacterial\ntests but, like many nucleoside analogues showed activity in an <i>in vitro</i>\ncytogenetic assay and the mouse lymphoma assay. Lamivudine was not genotoxic <i>in\nvivo </i>at doses that gave plasma concentrations around 60\u201170 times\nhigher than the anticipated clinical plasma levels. As the <i>in vitro</i>\nmutagenic activity of lamivudine could not be confirmed by <i>in vivo</i>\ntests, it is concluded that lamivudine should not represent a genotoxic hazard\nto patients undergoing treatment. </span></p>", "ID": "97465bab-db65-4bce-b4e2-3b08ca8da75e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine was not mutagenic in bacterial\ntests but, like many nucleoside analogues showed activity in an <i>in vitro</i>\ncytogenetic assay and the mouse lymphoma assay. Lamivudine was not genotoxic <i>in\nvivo </i>at doses that gave plasma concentrations around 60\u201170 times\nhigher than the anticipated clinical plasma levels. As the <i>in vitro</i>\nmutagenic activity of lamivudine could not be confirmed by <i>in vivo</i>\ntests, it is concluded that lamivudine should not represent a genotoxic hazard\nto patients undergoing treatment. </span>", "ID": "66c0d879-a67f-43da-9c67-7a3253e19f35", "Styles": "None", "Classes": "None", "Text": "Lamivudine was not mutagenic in bacterial tests but, like many nucleoside analogues showed activity in an  cytogenetic assay and the mouse lymphoma assay. Lamivudine was not genotoxic at doses that gave plasma concentrations around 60\u201170 times higher than the anticipated clinical plasma levels. As the  mutagenic activity of lamivudine could not be confirmed by  tests, it is concluded that lamivudine should not represent a genotoxic hazard to patients undergoing treatment. ", "ParentId": "97465bab-db65-4bce-b4e2-3b08ca8da75e"}, {"Element": "<i>in vitro</i>", "ID": "250c4033-2310-475d-9af8-ad36cd8e75f0", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "66c0d879-a67f-43da-9c67-7a3253e19f35"}, {"Element": "<i>in\nvivo </i>", "ID": "fe7bbcf7-fd1d-46f0-a46a-aa8f9870abbd", "Styles": "None", "Classes": "None", "Text": "in vivo ", "ParentId": "66c0d879-a67f-43da-9c67-7a3253e19f35"}, {"Element": "<i>in vitro</i>", "ID": "68493e72-3e18-4492-aa03-f93cbdae9cc0", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "66c0d879-a67f-43da-9c67-7a3253e19f35"}, {"Element": "<i>in vivo</i>", "ID": "fa9a39d9-2fd4-4468-b15f-5e53d83ce32a", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "66c0d879-a67f-43da-9c67-7a3253e19f35"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ca9020dc-2c07-4bf8-ad3a-166747c68213", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "486f6f03-d4bd-4b16-b9a3-d24bbf60bfb2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ca9020dc-2c07-4bf8-ad3a-166747c68213"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Reproductive studies in animals have not\nshown evidence of teratogenicity and showed no effect on male or female\nfertility. Lamivudine induces early embryolethality when administered to\npregnant rabbits at exposure levels comparable to those achieved in man, but\nnot in the rat even at very high systemic exposures. </span></p>", "ID": "2d68abeb-e981-4c59-aada-4a288b1035a5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Reproductive studies in animals have not\nshown evidence of teratogenicity and showed no effect on male or female\nfertility. Lamivudine induces early embryolethality when administered to\npregnant rabbits at exposure levels comparable to those achieved in man, but\nnot in the rat even at very high systemic exposures. </span>", "ID": "1340c60a-9521-40ca-8931-8e0abe0c4664", "Styles": "None", "Classes": "None", "Text": "Reproductive studies in animals have not shown evidence of teratogenicity and showed no effect on male or female fertility. Lamivudine induces early embryolethality when administered to pregnant rabbits at exposure levels comparable to those achieved in man, but not in the rat even at very high systemic exposures. ", "ParentId": "2d68abeb-e981-4c59-aada-4a288b1035a5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e2b3e539-e940-4a2e-b7a5-026cee114bf9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5edbc269-d705-4965-a326-f240625aefa7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e2b3e539-e940-4a2e-b7a5-026cee114bf9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The results of long term carcinogenicity\nstudies with lamivudine in rats and mice did not shown any carcinogenic\npotential. </span></p>", "ID": "0cc8a97d-573e-44f1-8351-107ea7a1ba80", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The results of long term carcinogenicity\nstudies with lamivudine in rats and mice did not shown any carcinogenic\npotential. </span>", "ID": "a9ceefbe-1071-43f7-a926-32c14c8c69c9", "Styles": "None", "Classes": "None", "Text": "The results of long term carcinogenicity studies with lamivudine in rats and mice did not shown any carcinogenic potential. ", "ParentId": "0cc8a97d-573e-44f1-8351-107ea7a1ba80"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "3a90e731-7f56-4fa0-9f77-24bcee685df1", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8d2dc2f1-92e9-41ae-b3f1-209181710973", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3a90e731-7f56-4fa0-9f77-24bcee685df1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "de7287c0-1199-41e0-9379-20ef4d4a1fa4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8d2dc2f1-92e9-41ae-b3f1-209181710973"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dd3f1b1e-9926-4c5d-8b2c-74676749ed95", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "077a1de8-5f28-48dc-9ad4-34c5ae8e7d3e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dd3f1b1e-9926-4c5d-8b2c-74676749ed95"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>", "ID": "00516622-36d8-4220-86c0-c4cf93f463ce", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b>", "ID": "812d7861-fbb8-4c22-9cb7-7d38e6b96454", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00516622-36d8-4220-86c0-c4cf93f463ce"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span>", "ID": "7fab5ae0-60db-48e2-8e5b-c5a951a19f19", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS", "ParentId": "812d7861-fbb8-4c22-9cb7-7d38e6b96454"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "017add0c-f523-491e-a9b4-2d3f71102f05", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7822127b-9c36-454c-9187-05832ace65ad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "017add0c-f523-491e-a9b4-2d3f71102f05"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>", "ID": "28484e3b-c15a-4633-9907-39c722430452", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b>", "ID": "80c31d0f-eea5-486c-b0ff-d85817ccea82", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "28484e3b-c15a-4633-9907-39c722430452"}, {"Element": "<span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span>", "ID": "a354d94c-2693-4e0b-924e-3dc01932b180", "Styles": "None", "Classes": "None", "Text": "6.1\u00a0\u00a0\u00a0\u00a0 List of excipients", "ParentId": "80c31d0f-eea5-486c-b0ff-d85817ccea82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa32563e-8225-425f-9726-654ca71abdbd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c28b261e-1413-431b-95e0-986a82d4823e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa32563e-8225-425f-9726-654ca71abdbd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><u><span lang=\"EN-GB\">Tablet core</span></u></p>", "ID": "d1546188-db8f-4d9b-8ca7-50f4b3f7c51b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Tablet core</span></u>", "ID": "a424a1dc-7339-405e-a870-809ff1324be8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d1546188-db8f-4d9b-8ca7-50f4b3f7c51b"}, {"Element": "<span lang=\"EN-GB\">Tablet core</span>", "ID": "8f509121-b8c4-4cd0-95ef-d8d8cba972d8", "Styles": "None", "Classes": "None", "Text": "Tablet core", "ParentId": "a424a1dc-7339-405e-a870-809ff1324be8"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Microcrystalline cellulose</span></p>", "ID": "81809dd8-cfd0-4cf9-ad67-5fc35d2a144e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Microcrystalline cellulose</span>", "ID": "4d34fb41-67b2-4c89-b560-1975f6751d33", "Styles": "None", "Classes": "None", "Text": "Microcrystalline cellulose", "ParentId": "81809dd8-cfd0-4cf9-ad67-5fc35d2a144e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Sodium starch glycolate (Type A)</span></p>", "ID": "91fe8ff6-886e-4fca-a892-c440f62de96e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Sodium starch glycolate (Type A)</span>", "ID": "493c285d-2225-4bc6-b886-e4990ca32db7", "Styles": "None", "Classes": "None", "Text": "Sodium starch glycolate (Type A)", "ParentId": "91fe8ff6-886e-4fca-a892-c440f62de96e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Magnesium stearate</span></p>", "ID": "0451a2fe-21b6-471e-b6e2-0d0a4efab326", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Magnesium stearate</span>", "ID": "981d8cf8-3736-4045-a5b2-ed24fe399d81", "Styles": "None", "Classes": "None", "Text": "Magnesium stearate", "ParentId": "0451a2fe-21b6-471e-b6e2-0d0a4efab326"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d187b6c2-abe1-4569-a4b5-a70894a56acd", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bbf4f53f-f644-4198-a00c-fd931e845dd4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d187b6c2-abe1-4569-a4b5-a70894a56acd"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Tablet film coat</span></u></p>", "ID": "29917e21-e855-4e9f-8d40-e4d27a241849", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Tablet film coat</span></u>", "ID": "032fafaf-ba9a-4af1-b99a-b64005574b3a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "29917e21-e855-4e9f-8d40-e4d27a241849"}, {"Element": "<span lang=\"EN-GB\">Tablet film coat</span>", "ID": "724f397a-a277-4b04-adcc-b055803af29e", "Styles": "None", "Classes": "None", "Text": "Tablet film coat", "ParentId": "032fafaf-ba9a-4af1-b99a-b64005574b3a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"NL\">Hypromellose 3cP</span></p>", "ID": "b74393b9-2662-49a5-b645-fa4dc2ab671c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"NL\">Hypromellose 3cP</span>", "ID": "495d9f1b-1bf5-415f-9459-87d0a4af806c", "Styles": "None", "Classes": "None", "Text": "Hypromellose 3cP", "ParentId": "b74393b9-2662-49a5-b645-fa4dc2ab671c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"NL\">Hypromellose 6cP</span></p>", "ID": "7101ce1a-ecdc-45e0-a07e-5d50f29741f9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"NL\">Hypromellose 6cP</span>", "ID": "fb36072e-fc04-4a97-a835-c6e9da20837a", "Styles": "None", "Classes": "None", "Text": "Hypromellose 6cP", "ParentId": "7101ce1a-ecdc-45e0-a07e-5d50f29741f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NL\">Titanium dioxide </span></p>", "ID": "db40b3ab-c22b-4dcd-a691-df360c609b1a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"NL\">Titanium dioxide </span>", "ID": "a2b88e49-c03c-4f3c-962d-eeba9a948882", "Styles": "None", "Classes": "None", "Text": "Titanium dioxide ", "ParentId": "db40b3ab-c22b-4dcd-a691-df360c609b1a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Macrogol 400</span></p>", "ID": "0f8a32c6-3f1a-4c44-9675-b9021a0cb6c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Macrogol 400</span>", "ID": "3fef0995-a2bf-4c5e-a442-f67a7162a676", "Styles": "None", "Classes": "None", "Text": "Macrogol 400", "ParentId": "0f8a32c6-3f1a-4c44-9675-b9021a0cb6c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Polysorbate 80</span></p>", "ID": "6ee58a8a-280d-49a7-aa62-c5ec4be77017", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Polysorbate 80</span>", "ID": "6e6e3fe9-295d-41af-839b-2084c49e93bb", "Styles": "None", "Classes": "None", "Text": "Polysorbate 80", "ParentId": "6ee58a8a-280d-49a7-aa62-c5ec4be77017"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Iron oxide\nyellow </span></p>", "ID": "2f28b94b-9ef8-40a1-bcb5-79b0b00548ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Iron oxide\nyellow </span>", "ID": "315b31e4-a56d-40a4-b7f2-4463aa5ae2f4", "Styles": "None", "Classes": "None", "Text": "Iron oxide yellow ", "ParentId": "2f28b94b-9ef8-40a1-bcb5-79b0b00548ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Iron oxide red </span></p>", "ID": "fb2312db-ea7e-42b0-be94-85abb74c8c92", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Iron oxide red </span>", "ID": "9ee335ee-2842-4925-afb4-9e56c9d71982", "Styles": "None", "Classes": "None", "Text": "Iron oxide red ", "ParentId": "fb2312db-ea7e-42b0-be94-85abb74c8c92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d9f3aab1-b22c-4f75-8c6a-0377c60367f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b8db9551-9823-4411-87ba-abd6e7326c18", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d9f3aab1-b22c-4f75-8c6a-0377c60367f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>", "ID": "b7faebea-d4ff-44d2-b51b-13cdfad4eecd", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b>", "ID": "46cd2a86-fc7a-4d6e-a4fc-08e2fc74e772", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b7faebea-d4ff-44d2-b51b-13cdfad4eecd"}, {"Element": "<span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span>", "ID": "8d8e2dda-5cd1-42af-aef8-a46f03a16e3b", "Styles": "None", "Classes": "None", "Text": "6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities", "ParentId": "46cd2a86-fc7a-4d6e-a4fc-08e2fc74e772"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f0416ddb-ab9d-439c-ad5f-343363834c96", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7328a22c-822b-49ae-af2a-eee458981c4c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f0416ddb-ab9d-439c-ad5f-343363834c96"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not applicable</span></p>", "ID": "43308936-bd97-4a0a-a818-40d3f2d39734", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Not applicable</span>", "ID": "d918efa0-6168-4e81-80de-6254f7856214", "Styles": "None", "Classes": "None", "Text": "Not applicable", "ParentId": "43308936-bd97-4a0a-a818-40d3f2d39734"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "74e9d6be-aa48-4c77-8bd4-d30b4abbf21f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7277b936-eae1-4eb7-afa9-22465e27b8a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "74e9d6be-aa48-4c77-8bd4-d30b4abbf21f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>", "ID": "f8c9c96b-ac59-485e-9de4-ea5a7d80c142", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b>", "ID": "f5d96860-1051-4f5c-af10-c5d51ee3a193", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f8c9c96b-ac59-485e-9de4-ea5a7d80c142"}, {"Element": "<span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span>", "ID": "5fa78375-d3cb-4783-bce9-0fa114a2a800", "Styles": "None", "Classes": "None", "Text": "6.3\u00a0\u00a0\u00a0\u00a0 Shelf life", "ParentId": "f5d96860-1051-4f5c-af10-c5d51ee3a193"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9f5893d9-0c4c-47a1-914d-03875269e580", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ca58610-0fa7-4bcb-840f-24faa242a84a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f5893d9-0c4c-47a1-914d-03875269e580"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">2 years</span></p>", "ID": "7a92d700-e714-4f90-b836-cd8b6a36e0f8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">2 years</span>", "ID": "7d17d16c-9619-415b-a607-add8feb70f1c", "Styles": "None", "Classes": "None", "Text": "2 years", "ParentId": "7a92d700-e714-4f90-b836-cd8b6a36e0f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ea3a5dd0-e5c4-4dac-90ff-740d3c4b1c4a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1be086f1-5b45-40e3-9c4b-296d7fa30f16", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ea3a5dd0-e5c4-4dac-90ff-740d3c4b1c4a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></b></p>", "ID": "4bf56ed5-7634-455f-b8d4-c9ed5db7fe36", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></b>", "ID": "afc97751-a973-4703-9625-80b61be5c7a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4bf56ed5-7634-455f-b8d4-c9ed5db7fe36"}, {"Element": "<span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span>", "ID": "5c493716-711b-409c-af2d-03f6410ff62b", "Styles": "None", "Classes": "None", "Text": "6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage", "ParentId": "afc97751-a973-4703-9625-80b61be5c7a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c2d0ea41-b557-41fd-87d3-f7e12e0dc4af", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a9b197c-ad80-42d7-9d43-26109cf04253", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c2d0ea41-b557-41fd-87d3-f7e12e0dc4af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct does not require any special storage conditions.</span></p>", "ID": "f61ac90b-f6a4-4f86-944b-48aa435c8f75", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">This medicinal\nproduct does not require any special storage conditions.</span>", "ID": "3eeaed70-d3ec-440b-a1d3-034f5f4eda34", "Styles": "None", "Classes": "None", "Text": "This medicinal product does not require any special storage conditions.", "ParentId": "f61ac90b-f6a4-4f86-944b-48aa435c8f75"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec92501e-90a3-4e8e-a3e8-d29ac62b0137", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7af7e07d-fd88-4184-9818-dbbe7a078d1a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec92501e-90a3-4e8e-a3e8-d29ac62b0137"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">Nature and contents of container</span></b></p>", "ID": "30b4f5e2-5249-4292-99fd-790d0aa27159", "Styles": "margin-left:28.5pt;text-indent:-28.5pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b>", "ID": "34976696-e857-4298-85b3-a61003bee433", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30b4f5e2-5249-4292-99fd-790d0aa27159"}, {"Element": "<span lang=\"EN-GB\">6.5<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "fcd8ebef-26ae-496a-bc72-e4370d209747", "Styles": "None", "Classes": "None", "Text": "6.5", "ParentId": "34976696-e857-4298-85b3-a61003bee433"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "371d5351-9dc4-4005-98c0-333f7fabd0c9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "fcd8ebef-26ae-496a-bc72-e4370d209747"}, {"Element": "<b><span lang=\"EN-GB\">Nature and contents of container</span></b>", "ID": "25e68090-eb2a-4a79-9f0d-84d61ddfe7ea", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30b4f5e2-5249-4292-99fd-790d0aa27159"}, {"Element": "<span lang=\"EN-GB\">Nature and contents of container</span>", "ID": "cb6d580e-dc16-4b5f-a781-dd7a6fe8725b", "Styles": "None", "Classes": "None", "Text": "Nature and contents of container", "ParentId": "25e68090-eb2a-4a79-9f0d-84d61ddfe7ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6005a6b8-5f3e-42cf-a9ad-c0acb634a0dd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3fc60fb2-6982-4f8a-90b7-f89228b8c53b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6005a6b8-5f3e-42cf-a9ad-c0acb634a0dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Blisters:</span></p>", "ID": "c6b8f205-7364-4210-85a4-3be4957c7c3c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Blisters:</span>", "ID": "243c1199-2ad4-41c5-bc9b-f52324f0380f", "Styles": "None", "Classes": "None", "Text": "Blisters:", "ParentId": "c6b8f205-7364-4210-85a4-3be4957c7c3c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7458574a-9bed-4a38-b1d5-56283791642d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dd441cea-242b-42e3-8e27-c2eb20f67569", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7458574a-9bed-4a38-b1d5-56283791642d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">White opaque\nPVC/PVdC \u2013 Aluminium blisters </span></p>", "ID": "90957242-dbb4-4423-aa37-f251c77ad3ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">White opaque\nPVC/PVdC \u2013 Aluminium blisters </span>", "ID": "67f9c6aa-f50d-437c-bd37-db2a02fb5b8a", "Styles": "None", "Classes": "None", "Text": "White opaque PVC/PVdC \u2013 Aluminium blisters ", "ParentId": "90957242-dbb4-4423-aa37-f251c77ad3ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack sizes of\n28, 30, 84 or 100 film-coated tablets</span></p>", "ID": "8fc74a29-b98f-44a1-b64a-59604751f7ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Pack sizes of\n28, 30, 84 or 100 film-coated tablets</span>", "ID": "763d8aab-a5f2-436c-ad39-a760c9268dee", "Styles": "None", "Classes": "None", "Text": "Pack sizes of 28, 30, 84 or 100 film-coated tablets", "ParentId": "8fc74a29-b98f-44a1-b64a-59604751f7ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6fbfdee0-76c7-4efa-8b8b-e7a02ae504c1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9119ca8c-62eb-45d4-bbee-2c7f25078545", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6fbfdee0-76c7-4efa-8b8b-e7a02ae504c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Containers:</span></p>", "ID": "6482cbd3-d77b-455b-ba6e-d27ea533d85e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Containers:</span>", "ID": "cd91ab26-9aa6-4e71-8beb-d50468b64db7", "Styles": "None", "Classes": "None", "Text": "Containers:", "ParentId": "6482cbd3-d77b-455b-ba6e-d27ea533d85e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b4457c8b-cee5-4dd0-b586-d84b3b7e78b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "36568373-e237-4758-9e8c-e58ac5e0021e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b4457c8b-cee5-4dd0-b586-d84b3b7e78b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">White opaque\nHDPE tablet containers with white opaque polyethylene child resistent screw cap\nwith induction seal </span></p>", "ID": "08f0c853-609a-46ca-957b-10c6063ad8c3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">White opaque\nHDPE tablet containers with white opaque polyethylene child resistent screw cap\nwith induction seal </span>", "ID": "c5178703-ce2a-49e5-813e-0781a4f601d2", "Styles": "None", "Classes": "None", "Text": "White opaque HDPE tablet containers with white opaque polyethylene child resistent screw cap with induction seal ", "ParentId": "08f0c853-609a-46ca-957b-10c6063ad8c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack size of 60\nfilm-coated tablets</span></p>", "ID": "31ea3936-45b6-45b1-8812-c8ecb49330b6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Pack size of 60\nfilm-coated tablets</span>", "ID": "46a8fe65-fc34-4498-b17e-dcf3fe9e5569", "Styles": "None", "Classes": "None", "Text": "Pack size of 60 film-coated tablets", "ParentId": "31ea3936-45b6-45b1-8812-c8ecb49330b6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d22c80b4-0f00-400a-9dc0-7b465f79d0c7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "46c119f6-cc65-4fdb-9947-48809b35898d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d22c80b4-0f00-400a-9dc0-7b465f79d0c7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">White opaque\nHDPE tablet containers with white opaque polypropylene child resistent,\ntamper-evident screw cap with induction seal</span></p>", "ID": "d4aa00b0-1d2e-4bd3-8d5e-b47ac5470eff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">White opaque\nHDPE tablet containers with white opaque polypropylene child resistent,\ntamper-evident screw cap with induction seal</span>", "ID": "0a4540d5-e6a2-4bb5-b6a3-1d270d8a2909", "Styles": "None", "Classes": "None", "Text": "White opaque HDPE tablet containers with white opaque polypropylene child resistent, tamper-evident screw cap with induction seal", "ParentId": "d4aa00b0-1d2e-4bd3-8d5e-b47ac5470eff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack size of 60 film-coated\ntablets</span></p>", "ID": "1abdac19-708d-4779-a211-6701d6dc8705", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Pack size of 60 film-coated\ntablets</span>", "ID": "fce129bc-c44d-4848-b949-f1d14bb5ee56", "Styles": "None", "Classes": "None", "Text": "Pack size of 60 film-coated tablets", "ParentId": "1abdac19-708d-4779-a211-6701d6dc8705"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "779cf6bd-9f45-4b4d-966c-9099c2069c4b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "adacbcbd-c2a6-48d7-b13c-388af8bc3f90", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "779cf6bd-9f45-4b4d-966c-9099c2069c4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not all pack\nsizes may be marketed.</span></p>", "ID": "c409013a-53f1-4283-9b85-c7582d5856fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Not all pack\nsizes may be marketed.</span>", "ID": "10b54ce6-2570-4e47-b32b-3f432a8de71c", "Styles": "None", "Classes": "None", "Text": "Not all pack sizes may be marketed.", "ParentId": "c409013a-53f1-4283-9b85-c7582d5856fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7bf5e4f4-3383-4943-b34b-1281f9eaba10", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9170c7c7-38ff-4ca5-807f-1ae1b6d0355d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7bf5e4f4-3383-4943-b34b-1281f9eaba10"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></b></p>", "ID": "16f0c693-b2d1-4cb7-84d9-f96d06952061", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></b>", "ID": "bc0f3064-ece6-47b0-bc93-d57743edd8b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16f0c693-b2d1-4cb7-84d9-f96d06952061"}, {"Element": "<span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span>", "ID": "ee73c7ef-116c-4795-b67e-707a96d69baf", "Styles": "None", "Classes": "None", "Text": "6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for disposal", "ParentId": "bc0f3064-ece6-47b0-bc93-d57743edd8b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7ea77603-bd0b-4d1b-a574-b014fcf2ee1f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "97cb3209-7b2b-423f-b293-b0b87e5f5c91", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7ea77603-bd0b-4d1b-a574-b014fcf2ee1f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Any unused </span><span lang=\"EN-GB\" style=\"color:black\">medicinal </span><span lang=\"EN-GB\">product or waste material\nshould be disposed of in accordance with local requirements. </span></p>", "ID": "2f3727cc-cff8-44a9-8380-ede40781fec9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Any unused </span>", "ID": "c7d0b069-3b64-48eb-99d4-269d76b38305", "Styles": "None", "Classes": "None", "Text": "Any unused ", "ParentId": "2f3727cc-cff8-44a9-8380-ede40781fec9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">medicinal </span>", "ID": "ecbc95c3-c319-4cd4-bcf9-dd0c1c541b8f", "Styles": "color:black", "Classes": "None", "Text": "medicinal ", "ParentId": "2f3727cc-cff8-44a9-8380-ede40781fec9"}, {"Element": "<span lang=\"EN-GB\">product or waste material\nshould be disposed of in accordance with local requirements. </span>", "ID": "76df7b90-bc24-41be-8c6a-459d31224b83", "Styles": "None", "Classes": "None", "Text": "product or waste material should be disposed of in accordance with local requirements. ", "ParentId": "2f3727cc-cff8-44a9-8380-ede40781fec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "69b61134-c554-4c95-ad98-b738cd3fba2f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "87004861-7277-4589-a098-3580aad8e028", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "69b61134-c554-4c95-ad98-b738cd3fba2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "086aad98-ad73-4f8b-a82c-da294ece54c3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e35cfc53-7a38-4b2f-ba59-f47f1befc2a5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "086aad98-ad73-4f8b-a82c-da294ece54c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "75feb73e-023c-4478-b301-46b298421061", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "ccecb3af-7c48-4871-8709-2f4d9e77e6f5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "75feb73e-023c-4478-b301-46b298421061"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span>", "ID": "87c35158-19a1-4096-9131-03c5ff7a8e8f", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION HOLDER", "ParentId": "ccecb3af-7c48-4871-8709-2f4d9e77e6f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "492ec79f-dcf7-475f-bc4d-a11c58b6b13f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "87a0b6a5-d4a2-448e-8421-dd43876f977b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "492ec79f-dcf7-475f-bc4d-a11c58b6b13f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva B.V.</span></p>", "ID": "a9b47584-2fd8-46c5-92e4-5c8ff697f831", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Teva B.V.</span>", "ID": "34c75220-f5f2-413d-a4a8-f503277b41ab", "Styles": "None", "Classes": "None", "Text": "Teva B.V.", "ParentId": "a9b47584-2fd8-46c5-92e4-5c8ff697f831"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Swensweg 5</span></p>", "ID": "f37f529d-6aee-4f43-8592-5c248cb44521", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">Swensweg 5</span>", "ID": "ffc69d70-be9e-41dd-8ae8-03a57321a247", "Styles": "None", "Classes": "None", "Text": "Swensweg 5", "ParentId": "f37f529d-6aee-4f43-8592-5c248cb44521"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">2031GA Haarlem</span></p>", "ID": "d39b8a9a-62df-4494-8569-a590c027b3e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">2031GA Haarlem</span>", "ID": "c6f0a8dc-b6bb-4843-aa5b-d4750dd15080", "Styles": "None", "Classes": "None", "Text": "2031GA Haarlem", "ParentId": "d39b8a9a-62df-4494-8569-a590c027b3e3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Netherlands</span></p>", "ID": "fc5552ee-c5b0-4f45-ae72-38894f66a977", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">Netherlands</span>", "ID": "3bd4c822-5fd7-4c95-bddd-75d9c01d122d", "Styles": "None", "Classes": "None", "Text": "Netherlands", "ParentId": "fc5552ee-c5b0-4f45-ae72-38894f66a977"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>", "ID": "38996a3b-3acd-4ae4-9704-fe4d4aebe324", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "71947a66-193a-4407-955c-256cfd25a7c7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "38996a3b-3acd-4ae4-9704-fe4d4aebe324"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>", "ID": "ed30ae1d-ac2e-4d16-bfbf-6f586e57d222", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "eafa7088-aeed-4f34-917e-1aa80c94050e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed30ae1d-ac2e-4d16-bfbf-6f586e57d222"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"DE\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "e0fcdb99-b281-4a22-91fe-24e2dfdfb469", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"DE\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "20d1c64f-538c-4a99-8372-3b0b09638bf5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e0fcdb99-b281-4a22-91fe-24e2dfdfb469"}, {"Element": "<span lang=\"DE\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "b0021056-0387-4525-9d5f-52af6f7dc62c", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "20d1c64f-538c-4a99-8372-3b0b09638bf5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>", "ID": "823f9e8e-61d7-4832-87d5-8bf03f243a92", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "43060965-516a-496a-a9e9-e143d7fc1d20", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "823f9e8e-61d7-4832-87d5-8bf03f243a92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/001\u2013\n28 Tablets</span></p>", "ID": "4589bd6b-cc93-42af-bf3c-ae4fdce79501", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">EU/1/09/566/001\u2013\n28 Tablets</span>", "ID": "f8955836-93c0-4104-8fb9-fa56fe4f5cf0", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/001\u2013 28 Tablets", "ParentId": "4589bd6b-cc93-42af-bf3c-ae4fdce79501"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/002\n\u2013 30 Tablets</span></p>", "ID": "50bfe464-9f41-4545-9060-10716b810c67", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">EU/1/09/566/002\n\u2013 30 Tablets</span>", "ID": "24ec1602-5b07-402f-9466-b40173af7a9e", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/002 \u2013 30 Tablets", "ParentId": "50bfe464-9f41-4545-9060-10716b810c67"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/003\n\u2013 84 Tablets</span></p>", "ID": "8498eb3d-171a-4a78-8f7a-f06908b0b424", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">EU/1/09/566/003\n\u2013 84 Tablets</span>", "ID": "c8535fbe-3973-4760-908d-a194e516563b", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/003 \u2013 84 Tablets", "ParentId": "8498eb3d-171a-4a78-8f7a-f06908b0b424"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/004\n\u2013 100 Tablets</span></p>", "ID": "54633b5c-e434-41b1-a14f-24cc58338c34", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">EU/1/09/566/004\n\u2013 100 Tablets</span>", "ID": "39407dbc-2a33-4d9e-a480-beeb02a15b54", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/004 \u2013 100 Tablets", "ParentId": "54633b5c-e434-41b1-a14f-24cc58338c34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/09/566/005\n\u2013 60 Tablets (bottle)</span></p>", "ID": "0443e266-da77-47ca-9d2f-e0b013c66f51", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">EU/1/09/566/005\n\u2013 60 Tablets (bottle)</span>", "ID": "df2efbe6-b46d-4196-a924-b08b5256c1be", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/005 \u2013 60 Tablets (bottle)", "ParentId": "0443e266-da77-47ca-9d2f-e0b013c66f51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/09/566/006 \u2013\n60 Tablets </span>(bottle with tamper evident cap)</p>", "ID": "0f884c1c-e3cf-4246-8390-510938119786", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "(bottle with tamper evident cap)", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">EU/1/09/566/006 \u2013\n60 Tablets </span>", "ID": "4072f900-99f6-4ea4-90fd-a8c8bf63bd89", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/006 \u2013 60 Tablets ", "ParentId": "0f884c1c-e3cf-4246-8390-510938119786"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "25f02a10-a550-4f66-8792-3b820c1869ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9a52109d-5892-4a10-9f43-28b389426431", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "25f02a10-a550-4f66-8792-3b820c1869ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3986e56f-baba-4b4e-b795-94ab118ef8de", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5b68f3ac-6a68-4a93-82f6-07438df8c105", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3986e56f-baba-4b4e-b795-94ab118ef8de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF\nFIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>", "ID": "7cc74413-a766-48db-b225-5799cede64de", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF\nFIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b>", "ID": "cbcdc6f4-1920-4921-874d-5740bfc74e04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7cc74413-a766-48db-b225-5799cede64de"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF\nFIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span>", "ID": "b41a0744-036a-4d5d-9807-bffd56250a19", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION", "ParentId": "cbcdc6f4-1920-4921-874d-5740bfc74e04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3e81b983-7faa-4f50-b598-c2ab1656558b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "84ec7540-83a5-4a68-a665-0085c1e80cca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3e81b983-7faa-4f50-b598-c2ab1656558b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of first\nauthorisation: 23 October 2009</span></p>", "ID": "700edad5-e721-4e2b-b194-e02af10bc62e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Date of first\nauthorisation: 23 October 2009</span>", "ID": "616802a9-2f43-46fb-8830-1068efdaa914", "Styles": "None", "Classes": "None", "Text": "Date of first authorisation: 23 October 2009", "ParentId": "700edad5-e721-4e2b-b194-e02af10bc62e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of latest\nrenewal: 09 September 2014 </span></p>", "ID": "f943735c-a54b-477e-9407-f0f22ebfd48a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Date of latest\nrenewal: 09 September 2014 </span>", "ID": "42196987-376d-4f05-918e-b747d7818ce6", "Styles": "None", "Classes": "None", "Text": "Date of latest renewal: 09 September 2014 ", "ParentId": "f943735c-a54b-477e-9407-f0f22ebfd48a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c841edc8-c73e-42ff-8a42-733bdfbf3a2e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d1bff694-d7b4-47c2-b539-698c8b3c9d4f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c841edc8-c73e-42ff-8a42-733bdfbf3a2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a98be102-995e-4c97-9bd2-d03a0849e69f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ed3c0fea-4d45-4ef1-9d97-8a151b79cff7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a98be102-995e-4c97-9bd2-d03a0849e69f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></b></p>", "ID": "4ab3c96f-ed7b-4fb9-a04b-5e0f8828a1ac", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></b>", "ID": "9841c3b7-2c77-4979-be08-e48b70e28b6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ab3c96f-ed7b-4fb9-a04b-5e0f8828a1ac"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span>", "ID": "286ded39-bbf7-470c-9f63-34991e329a4e", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT", "ParentId": "9841c3b7-2c77-4979-be08-e48b70e28b6d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicinal product is available on the website of the\nEuropean Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a><span style=\"color:black\"> </span></span></p>", "ID": "31355ec2-7768-47ac-843e-20652619da03", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Detailed\ninformation on this medicinal product is available on the website of the\nEuropean Medicines Agency </span>", "ID": "b1a74d4d-df7a-469d-9183-5db522f610ce", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency ", "ParentId": "31355ec2-7768-47ac-843e-20652619da03"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a><span style=\"color:black\"> </span></span>", "ID": "32b4786f-fafd-462e-afdd-29db63aa6fc9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "31355ec2-7768-47ac-843e-20652619da03"}, {"Element": "<a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a>", "ID": "1f7d6ce6-ca73-4918-92af-a80bdba1c093", "Styles": "None", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "32b4786f-fafd-462e-afdd-29db63aa6fc9"}, {"Element": "<span style=\"color:black\"> </span>", "ID": "919b1b7f-ebb2-42ae-8219-7c7b33a0c6a2", "Styles": "color:black", "Classes": "None", "Text": " ", "ParentId": "32b4786f-fafd-462e-afdd-29db63aa6fc9"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "a9a2be0a-63da-418e-9235-7af65085a72c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "9022e1c2-578c-45bf-a87f-52857a830ec6", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "a9a2be0a-63da-418e-9235-7af65085a72c"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "ff23304c-9176-4fe4-88ec-cd471fee62ca", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "9022e1c2-578c-45bf-a87f-52857a830ec6"}, {"Element": "<p class=\"MsoNormal\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>", "ID": "50017571-d0ed-41c0-be5d-1a35e1ac2c5f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b>", "ID": "af994447-7c04-42cc-a7aa-5c49e726b4bf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50017571-d0ed-41c0-be5d-1a35e1ac2c5f"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "846fd88a-78f8-4f33-897d-280a3fd5f455", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af994447-7c04-42cc-a7aa-5c49e726b4bf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "9d8a1a47-84ba-4804-8cbd-44d30d8ed139", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "", "ParentId": "846fd88a-78f8-4f33-897d-280a3fd5f455"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "16f243df-fab2-40d7-b643-412edcb93998", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "9d8a1a47-84ba-4804-8cbd-44d30d8ed139"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>", "ID": "3032b29e-2f44-4931-b71d-0c952d2cf95f", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b>", "ID": "42c86ddb-ebfc-4ce2-bea4-05d203a10b61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3032b29e-2f44-4931-b71d-0c952d2cf95f"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "8a98dc9d-4c4b-4b9c-875a-f61e28d1deb6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "42c86ddb-ebfc-4ce2-bea4-05d203a10b61"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "7b170a4a-b77b-41ee-b283-4d5318558728", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "", "ParentId": "8a98dc9d-4c4b-4b9c-875a-f61e28d1deb6"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "8aef8696-0643-4161-a5b1-11d2bedb1f84", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "7b170a4a-b77b-41ee-b283-4d5318558728"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>", "ID": "64446517-c991-4589-9f06-4e0004e5e19f", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b>", "ID": "f1ee59f1-2137-46fd-9505-fb0c512543fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "64446517-c991-4589-9f06-4e0004e5e19f"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "2906678f-ff3d-4489-bd2a-4a35d6355aee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1ee59f1-2137-46fd-9505-fb0c512543fb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "7daa7f85-44f9-4b04-abb5-43942a6952d2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "", "ParentId": "2906678f-ff3d-4489-bd2a-4a35d6355aee"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "667d4695-d7c5-4ed9-8fc6-86a7a4134e69", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "7daa7f85-44f9-4b04-abb5-43942a6952d2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>", "ID": "f4c01373-e671-4c11-9a86-dcda6a18bb0b", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b>", "ID": "6be27894-1ced-47a9-ad67-7e8f9d1a6915", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f4c01373-e671-4c11-9a86-dcda6a18bb0b"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "72bc7f77-fdc3-49b7-902a-b249e641430d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6be27894-1ced-47a9-ad67-7e8f9d1a6915"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "5f6cd33c-49ec-4162-abe6-5deb43709a60", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "", "ParentId": "72bc7f77-fdc3-49b7-902a-b249e641430d"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "5759a601-3e9f-4409-b393-890f2d216216", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "5f6cd33c-49ec-4162-abe6-5deb43709a60"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>", "ID": "6b30cdbf-d98d-4e6e-98a1-9db4b6fb48b9", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b>", "ID": "c62fc981-ec41-4e10-b2ef-8c1225c9ca66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b30cdbf-d98d-4e6e-98a1-9db4b6fb48b9"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "e02a5bca-5ada-44f9-ab86-40d42c565348", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c62fc981-ec41-4e10-b2ef-8c1225c9ca66"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "226fd14a-7fde-45f5-9484-80edb46e8b32", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "", "ParentId": "e02a5bca-5ada-44f9-ab86-40d42c565348"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "1400fc3e-3d7f-4e16-87f8-5db0fb10a7b9", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "226fd14a-7fde-45f5-9484-80edb46e8b32"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b></p>", "ID": "3650774a-b0df-4e6b-ade6-eaca11949636", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u></b>", "ID": "07f91de4-16c3-4de4-9936-a993ee515cc9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3650774a-b0df-4e6b-ade6-eaca11949636"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "1942903f-089b-4a38-aaf2-71689384043f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07f91de4-16c3-4de4-9936-a993ee515cc9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "c07332fd-b2a8-485c-8869-6815a9a6491f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "", "ParentId": "1942903f-089b-4a38-aaf2-71689384043f"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "0d0dbc5b-85a0-4c8b-9b0f-f40ed2e9bc74", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "c07332fd-b2a8-485c-8869-6815a9a6491f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "17315b27-d186-4536-b2f1-9cb61ca785d4", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e2b54af4-b6bc-4312-b555-dc5409b6a82a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "17315b27-d186-4536-b2f1-9cb61ca785d4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7bb6c790-4d66-4577-b88e-bd9ee06c59cd", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7f007347-e12f-4aeb-9d16-cdf3697bc846", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7bb6c790-4d66-4577-b88e-bd9ee06c59cd"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "46b77dbd-a269-44b8-a701-918301b0b76b", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4614f611-df7f-4f11-a80d-3f7e605839bb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "46b77dbd-a269-44b8-a701-918301b0b76b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8052adcb-2f11-4ea3-ac60-a22169d2f02b", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc16724a-93ec-41ff-82b1-b49cf8d063fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8052adcb-2f11-4ea3-ac60-a22169d2f02b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "abdd56e3-2354-425f-99f8-a04364ca456f", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92359f80-9eb1-4d8c-8411-666aed6f9004", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "abdd56e3-2354-425f-99f8-a04364ca456f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "129a2d48-d6f0-4d05-a4e1-b141aba7695d", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b72facc1-ddb1-4b9d-8e17-a44a32146b63", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "129a2d48-d6f0-4d05-a4e1-b141aba7695d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5ec19e7d-75a1-461a-adb5-1d5dbe9ae37f", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ff45be80-eb9f-4142-9afc-21864c87aa7d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5ec19e7d-75a1-461a-adb5-1d5dbe9ae37f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a85a5c38-095d-438f-a601-870c97fd45de", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "95caf2c2-51f9-461b-803c-ee22f5aa0d67", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a85a5c38-095d-438f-a601-870c97fd45de"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c6b2188d-4f60-41cc-8801-8ba9364d81d0", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "248f627b-3796-43a7-b06d-307815f33cce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c6b2188d-4f60-41cc-8801-8ba9364d81d0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a372b7f1-1ff3-4564-acb0-4e0c4b593ee5", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9d06f7ee-58ac-4398-8279-5847165c4116", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a372b7f1-1ff3-4564-acb0-4e0c4b593ee5"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "cd28ab44-b13e-45f8-8fb0-2e4fa57f6ed7", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "1dd99566-2b75-43c3-909d-eccbc939aa27", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd28ab44-b13e-45f8-8fb0-2e4fa57f6ed7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e49e68ba-f6de-4227-b71f-d1eac5176ae9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1dd99566-2b75-43c3-909d-eccbc939aa27"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "c856c420-be92-42cb-b87c-f6f0b3385739", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "7c01bded-3df2-44f7-9e41-69c1c7bffa10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c856c420-be92-42cb-b87c-f6f0b3385739"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2782f818-a871-40ad-ac9d-0387b8252dd7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7c01bded-3df2-44f7-9e41-69c1c7bffa10"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "ad39d60d-eb04-4959-81f7-bfc8f148fff1", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "5362809f-39d9-4f36-8bbb-db65833b40bc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad39d60d-eb04-4959-81f7-bfc8f148fff1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d45ae192-0b8d-4beb-9696-2581450a5e88", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5362809f-39d9-4f36-8bbb-db65833b40bc"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "2264138f-0af0-4111-83b3-60cbdd20e0e1", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "7d04b3f7-29e4-4b29-a47c-e5361a87cddf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2264138f-0af0-4111-83b3-60cbdd20e0e1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1e9e1662-4718-4d60-92f2-9b277de67650", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7d04b3f7-29e4-4b29-a47c-e5361a87cddf"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a53d11a4-10f9-4aef-8862-94c18be32153", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "7c98b0c7-307a-40c3-a2e8-091d2ff7f59a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a53d11a4-10f9-4aef-8862-94c18be32153"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c31cf879-4bcc-4600-b1f7-1b814a1c4344", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7c98b0c7-307a-40c3-a2e8-091d2ff7f59a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9ecd5c34-e4bd-4e9a-80b4-6c7e7ada4701", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d56718ad-2a6a-42f4-8cf0-00f40a5b2779", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9ecd5c34-e4bd-4e9a-80b4-6c7e7ada4701"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fc4e4c32-fec1-4c93-b4ff-d1d3e691c33f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d56718ad-2a6a-42f4-8cf0-00f40a5b2779"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center\"><b><span lang=\"EN-GB\">ANNEX\nII</span></b></p>", "ID": "5194b518-9691-4a12-9dbe-a664c8408a0a", "Styles": "text-align:center", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX\nII</span></b>", "ID": "e2496e3f-78c1-42da-8ec6-976bd8ec8391", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5194b518-9691-4a12-9dbe-a664c8408a0a"}, {"Element": "<span lang=\"EN-GB\">ANNEX\nII</span>", "ID": "45fb638c-5f82-486b-849a-06089fa13df6", "Styles": "None", "Classes": "None", "Text": "ANNEX II", "ParentId": "e2496e3f-78c1-42da-8ec6-976bd8ec8391"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9582ccbc-976e-4013-b752-b3b63f67cabe", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "66ce4781-0887-4632-8bc8-001eb19aec75", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9582ccbc-976e-4013-b752-b3b63f67cabe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S)\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>", "ID": "cbc4435b-0980-43df-ab48-486521ef707b", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S)\nRESPONSIBLE FOR BATCH RELEASE</span></b>", "ID": "6cdfe51a-368e-4851-8b91-1b82f0888860", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cbc4435b-0980-43df-ab48-486521ef707b"}, {"Element": "<span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S)\nRESPONSIBLE FOR BATCH RELEASE</span>", "ID": "431fc1ed-8ced-4bf5-b186-1e8a7fafe2a6", "Styles": "None", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE", "ParentId": "6cdfe51a-368e-4851-8b91-1b82f0888860"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "84570b3c-4aaf-44fa-9646-8f49aab1f2bc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c39a0560-fcf1-4538-94d5-261e89d00247", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "84570b3c-4aaf-44fa-9646-8f49aab1f2bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS </span></b><b><span style=\"layout-grid-mode:line\">OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>", "ID": "96d2618c-efa3-4e04-8773-e599ae3037a5", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS </span></b>", "ID": "38150c14-ed37-4a52-899b-14bd1a7e159d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "96d2618c-efa3-4e04-8773-e599ae3037a5"}, {"Element": "<span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS </span>", "ID": "76fe4494-255c-4aae-ba06-c5bc96073669", "Styles": "None", "Classes": "None", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS ", "ParentId": "38150c14-ed37-4a52-899b-14bd1a7e159d"}, {"Element": "<b><span style=\"layout-grid-mode:line\">OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b>", "ID": "9878d9d8-8031-48c1-a0ab-3a62c248bcce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "96d2618c-efa3-4e04-8773-e599ae3037a5"}, {"Element": "<span style=\"layout-grid-mode:line\">OR RESTRICTIONS REGARDING SUPPLY AND USE</span>", "ID": "dd126a19-ced3-4f94-b6b4-be9e4a6529b2", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "9878d9d8-8031-48c1-a0ab-3a62c248bcce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span style=\"layout-grid-mode:line\">\u00a0</span></b></p>", "ID": "eb70a7cc-3a53-4bec-bfa1-4685b5de7c68", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span style=\"layout-grid-mode:line\">\u00a0</span></b>", "ID": "c4a97c13-cbd4-48ef-9575-452c7ab9382f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb70a7cc-3a53-4bec-bfa1-4685b5de7c68"}, {"Element": "<span style=\"layout-grid-mode:line\">\u00a0</span>", "ID": "6e6b2a12-5325-40fa-828d-fb2a039855fe", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "c4a97c13-cbd4-48ef-9575-452c7ab9382f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span style=\"layout-grid-mode:line\">C. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS</span></b><b><span style='font-family:\"TimesNewRoman,Bold\",serif;\nlayout-grid-mode:line'> </span></b><b><span lang=\"EN-GB\">AND REQUIREMENTS OF </span></b><b><span style=\"layout-grid-mode:line\">THE MARKETING AUTHORISATION</span></b></p>", "ID": "89b61b4b-11b0-492a-8c3e-f2b407aa1780", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span style=\"layout-grid-mode:line\">C. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS</span></b>", "ID": "1aa6bf29-9290-434d-b388-2c92a5c7ed9b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89b61b4b-11b0-492a-8c3e-f2b407aa1780"}, {"Element": "<span style=\"layout-grid-mode:line\">C. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS</span>", "ID": "84136c7e-9862-4f63-8590-166b263c05bb", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "C. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS", "ParentId": "1aa6bf29-9290-434d-b388-2c92a5c7ed9b"}, {"Element": "<b><span style='font-family:\"TimesNewRoman,Bold\",serif;\nlayout-grid-mode:line'> </span></b>", "ID": "e54c2a45-3a9d-49e2-94fc-eeb963083d16", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89b61b4b-11b0-492a-8c3e-f2b407aa1780"}, {"Element": "<span style='font-family:\"TimesNewRoman,Bold\",serif;\nlayout-grid-mode:line'> </span>", "ID": "9423bb54-e194-4f3c-be2c-840d3aad956a", "Styles": "font-family:\"TimesNewRoman,Bold\",serif;\nlayout-grid-mode:line", "Classes": "None", "Text": " ", "ParentId": "e54c2a45-3a9d-49e2-94fc-eeb963083d16"}, {"Element": "<b><span lang=\"EN-GB\">AND REQUIREMENTS OF </span></b>", "ID": "ad3d36e4-5125-4cbc-9523-243eb1fe37aa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89b61b4b-11b0-492a-8c3e-f2b407aa1780"}, {"Element": "<span lang=\"EN-GB\">AND REQUIREMENTS OF </span>", "ID": "094c30d8-de9c-4115-bccc-c6947818f865", "Styles": "None", "Classes": "None", "Text": "AND REQUIREMENTS OF ", "ParentId": "ad3d36e4-5125-4cbc-9523-243eb1fe37aa"}, {"Element": "<b><span style=\"layout-grid-mode:line\">THE MARKETING AUTHORISATION</span></b>", "ID": "37b03409-2526-4b59-b812-5aaceb538e02", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89b61b4b-11b0-492a-8c3e-f2b407aa1780"}, {"Element": "<span style=\"layout-grid-mode:line\">THE MARKETING AUTHORISATION</span>", "ID": "fd55fccb-b9b0-4998-811c-ecc2e31de651", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "THE MARKETING AUTHORISATION", "ParentId": "37b03409-2526-4b59-b812-5aaceb538e02"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "2f0caa55-749c-4aa5-8ca7-5798f00a7a26", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d6e83437-d717-43d2-a2d2-e60a9a555313", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f0caa55-749c-4aa5-8ca7-5798f00a7a26"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c4774c3f-6ef0-4334-be29-a237eafc3d64", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d6e83437-d717-43d2-a2d2-e60a9a555313"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "4b86c14a-4c4c-45a3-88cf-49bc63f8892c", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:84.9pt;margin-bottom:.0001pt;text-indent:-35.25pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b>", "ID": "45bbbc40-5b98-4938-8cb4-bd3bda27bd5b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4b86c14a-4c4c-45a3-88cf-49bc63f8892c"}, {"Element": "<span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span>", "ID": "017a64bf-3762-4821-ad82-6d781c72b004", "Styles": "None", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT", "ParentId": "45bbbc40-5b98-4938-8cb4-bd3bda27bd5b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fb97db40-ff43-4ef7-9344-51500b94511c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1ba173c3-610a-43a4-8650-d68260b335c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fb97db40-ff43-4ef7-9344-51500b94511c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "0c0dfe59-c1da-4933-8da2-64a29115d187", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "cf74ab3b-cae8-4de3-a6b9-fe585b7e2fae", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "0c0dfe59-c1da-4933-8da2-64a29115d187"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "0d9f3575-fa63-46f5-827b-1c8b34fcad3e", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "cf74ab3b-cae8-4de3-a6b9-fe585b7e2fae"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S)\nRESPONSIBLE FOR BATCH RELEASE</span></p>", "ID": "b963365a-1869-49b7-bc1a-50f38804d10a", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S)\nRESPONSIBLE FOR BATCH RELEASE</span>", "ID": "e8e813d9-b50f-4e79-aa0e-45c27e761911", "Styles": "None", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE", "ParentId": "b963365a-1869-49b7-bc1a-50f38804d10a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:70.8pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7761693b-1d7e-4de8-88f8-38231dd36188", "Styles": "margin-right:70.8pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c2d7298d-3775-438f-a71e-a88ec91e23d6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7761693b-1d7e-4de8-88f8-38231dd36188"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Name and address of the manufacturer\nresponsible for batch release</span></u></p>", "ID": "ea8e6ccd-3b09-496f-a996-3ff910814653", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\">Name and address of the manufacturer\nresponsible for batch release</span></u>", "ID": "a8169d8a-417d-411c-a70a-6f3c678469dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea8e6ccd-3b09-496f-a996-3ff910814653"}, {"Element": "<span lang=\"EN-GB\">Name and address of the manufacturer\nresponsible for batch release</span>", "ID": "9887bbfb-2a5d-4833-859c-98162ea3ea6d", "Styles": "None", "Classes": "None", "Text": "Name and address of the manufacturer responsible for batch release", "ParentId": "a8169d8a-417d-411c-a70a-6f3c678469dc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2bc4b079-80b5-47d6-a463-743c045ee12c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9046163b-9e4e-42da-8117-ef93c9d59594", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2bc4b079-80b5-47d6-a463-743c045ee12c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Teva Pharmaceutical Works Private Limited\nCompany</span></p>", "ID": "ba0015f7-7b64-4ce9-9bd3-0bb0d80c3c0b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Teva Pharmaceutical Works Private Limited\nCompany</span>", "ID": "cc399c90-ce74-4306-8deb-86844b59aebf", "Styles": "None", "Classes": "None", "Text": "Teva Pharmaceutical Works Private Limited Company", "ParentId": "ba0015f7-7b64-4ce9-9bd3-0bb0d80c3c0b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Pallagi \u00fat 13</span></p>", "ID": "63fa0a7b-d3e5-4888-acfe-5f70ce56ab81", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Pallagi \u00fat 13</span>", "ID": "640401a3-f665-4943-ad13-ea3c272b9c48", "Styles": "None", "Classes": "None", "Text": "Pallagi \u00fat 13", "ParentId": "63fa0a7b-d3e5-4888-acfe-5f70ce56ab81"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Debrecen</span><span lang=\"EN-GB\"> H-4042</span></p>", "ID": "80042cef-6f10-4899-b6d6-a1fe610ae042", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Debrecen</span>", "ID": "0861e12a-0d5a-4a78-94ef-478c4e3c0f9d", "Styles": "None", "Classes": "None", "Text": "Debrecen", "ParentId": "80042cef-6f10-4899-b6d6-a1fe610ae042"}, {"Element": "<span lang=\"EN-GB\"> H-4042</span>", "ID": "7759bd88-4ad2-4b15-bc4b-6c0d99309c8d", "Styles": "None", "Classes": "None", "Text": " H-4042", "ParentId": "80042cef-6f10-4899-b6d6-a1fe610ae042"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hungary</span></p>", "ID": "389d109f-86d0-4113-8b64-fca04e269cec", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Hungary</span>", "ID": "c0ce608e-57c8-4c7c-8605-7ba5c6a7a04a", "Styles": "None", "Classes": "None", "Text": "Hungary", "ParentId": "389d109f-86d0-4113-8b64-fca04e269cec"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4b23ca11-3e58-4b7a-945a-1b440b793f82", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc05689e-dea1-4af0-8198-701858e8b45f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4b23ca11-3e58-4b7a-945a-1b440b793f82"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"DE\">Pharmachemie B.V.</span></p>", "ID": "d077746e-929d-4266-97ff-dab194230b24", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">Pharmachemie B.V.</span>", "ID": "df43df9e-f209-4d20-9785-bf393d2854cc", "Styles": "None", "Classes": "None", "Text": "Pharmachemie B.V.", "ParentId": "d077746e-929d-4266-97ff-dab194230b24"}, {"Element": "<p class=\"MsoNormal\">Swensweg 5</p>", "ID": "a31f6dce-830c-445b-a597-4b6c5ae45f2f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "Swensweg 5", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\">2031 GA Haarlem</p>", "ID": "ecab52d5-2b3d-47c3-a675-4a1c54929379", "Styles": "None", "Classes": "['MsoNormal']", "Text": "2031 GA Haarlem", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The Netherlands</span></p>", "ID": "0f96bccd-479d-4fb3-99fc-3f5421ef8c7b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The Netherlands</span>", "ID": "1e229771-c178-4a1b-bfb7-109d36e00371", "Styles": "None", "Classes": "None", "Text": "The Netherlands", "ParentId": "0f96bccd-479d-4fb3-99fc-3f5421ef8c7b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eee3a1ee-6528-4a30-af85-867c0355b343", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fdcf3720-9e8e-44c3-86c4-b462a81a026c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eee3a1ee-6528-4a30-af85-867c0355b343"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Teva Operations\nPoland Sp.z o. o.</span></p>", "ID": "04cea9d2-d68d-41b2-8929-c42c66abc9bc", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Teva Operations\nPoland Sp.z o. o.</span>", "ID": "c4fc240c-8abe-419e-9b16-c2c5f8a1ab13", "Styles": "None", "Classes": "None", "Text": "Teva Operations Poland Sp.z o. o.", "ParentId": "04cea9d2-d68d-41b2-8929-c42c66abc9bc"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Mogilska 80\nStr.</span></p>", "ID": "d702246a-5733-4f39-bd77-469a8ba62d16", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Mogilska 80\nStr.</span>", "ID": "97bfc05b-3998-45b5-8f66-db7599093fe2", "Styles": "None", "Classes": "None", "Text": "Mogilska 80 Str.", "ParentId": "d702246a-5733-4f39-bd77-469a8ba62d16"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">31-546\nKrak\u00f3w</span></p>", "ID": "425ae810-7a65-4fe9-86cd-6660b2bf5fb2", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">31-546\nKrak\u00f3w</span>", "ID": "c384c8e4-2027-4d73-a942-8038a19240b2", "Styles": "None", "Classes": "None", "Text": "31-546 Krak\u00f3w", "ParentId": "425ae810-7a65-4fe9-86cd-6660b2bf5fb2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">Poland</span></p>", "ID": "a1cfc27f-71c9-409d-a362-dacc20138d48", "Styles": "margin-right:-.1pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Poland</span>", "ID": "29b3e754-0c30-4e62-92bf-87600957e68e", "Styles": "None", "Classes": "None", "Text": "Poland", "ParentId": "a1cfc27f-71c9-409d-a362-dacc20138d48"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f7f86f21-8fdd-43f3-89a2-2f663af1c581", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4f8d5af-bad9-4fa5-ad52-fb24fc28e436", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f7f86f21-8fdd-43f3-89a2-2f663af1c581"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The printed package leaflet of the\nmedicinal product must state the name and address of the manufacturer\nresponsible for the release of the concerned batch.</span></p>", "ID": "d42cf5a9-88b6-4e4b-ab7f-0dd470db7e77", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The printed package leaflet of the\nmedicinal product must state the name and address of the manufacturer\nresponsible for the release of the concerned batch.</span>", "ID": "d50848b2-8f04-49dd-914e-f1ddef2fbe1c", "Styles": "None", "Classes": "None", "Text": "The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.", "ParentId": "d42cf5a9-88b6-4e4b-ab7f-0dd470db7e77"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "96fd5328-538d-415d-89bc-42180c5ad699", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9666dedd-40f4-4a42-a1e9-c87c45009957", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "96fd5328-538d-415d-89bc-42180c5ad699"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b14220cf-464c-484a-a738-c5e9c62ca780", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "59687f15-a283-4986-8fef-315a22dd8255", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b14220cf-464c-484a-a738-c5e9c62ca780"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></p>", "ID": "14d89c08-154a-4719-ac26-cf15e034245a", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span>", "ID": "2d5e34e3-0d5e-4a4b-8a24-496cea732dda", "Styles": "None", "Classes": "None", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "14d89c08-154a-4719-ac26-cf15e034245a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f6da1afa-70db-4157-81ec-a4e1dfd84bbc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "10470576-e4bf-4dfe-a660-015cc8d163e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f6da1afa-70db-4157-81ec-a4e1dfd84bbc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Medicinal product subject to restricted\nmedical prescription </span><span lang=\"EN-GB\">(See Annex I: Summary of Product\nCharacteristics, section 4.2).</span></p>", "ID": "81c89c93-bdd7-479a-9616-ec13a8d3eae0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Medicinal product subject to restricted\nmedical prescription </span>", "ID": "f5a73b79-d9f7-4107-9cf4-9379ee6b6b20", "Styles": "None", "Classes": "None", "Text": "Medicinal product subject to restricted medical prescription ", "ParentId": "81c89c93-bdd7-479a-9616-ec13a8d3eae0"}, {"Element": "<span lang=\"EN-GB\">(See Annex I: Summary of Product\nCharacteristics, section 4.2).</span>", "ID": "2fc13019-057b-4b28-aa2a-0a9985d13a95", "Styles": "None", "Classes": "None", "Text": "(See Annex I: Summary of Product Characteristics, section 4.2).", "ParentId": "81c89c93-bdd7-479a-9616-ec13a8d3eae0"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33835591-eafe-4c3d-a72d-026dbe6cbe76", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "79995a88-ba8d-4f66-81b5-95ad0b18e339", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33835591-eafe-4c3d-a72d-026dbe6cbe76"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a01a1000-3ba8-4408-90ef-4c54e1155e8a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f0395f1-83f2-4329-bbee-62f54ca350fa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a01a1000-3ba8-4408-90ef-4c54e1155e8a"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF </span><span style=\"layout-grid-mode:line\">THE\nMARKETING AUTHORISATION</span></p>", "ID": "272c5b65-f22e-4bb8-a0a3-13fba161b889", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF </span>", "ID": "ae988d9e-40e6-4fca-86e3-22347f3ce4fa", "Styles": "None", "Classes": "None", "Text": "C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF ", "ParentId": "272c5b65-f22e-4bb8-a0a3-13fba161b889"}, {"Element": "<span style=\"layout-grid-mode:line\">THE\nMARKETING AUTHORISATION</span>", "ID": "e4bc6d46-d8a3-4ab0-896c-68b3458bb3d9", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "THE MARKETING AUTHORISATION", "ParentId": "272c5b65-f22e-4bb8-a0a3-13fba161b889"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "8b2bcd00-9e49-449e-8481-d8667e282198", "Styles": "margin-right:-.05pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "4ac402e5-1930-4895-b35b-8567edcebf5b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8b2bcd00-9e49-449e-8481-d8667e282198"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "260c92d4-c39f-4899-b8f5-8620ab3e4909", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ac402e5-1930-4895-b35b-8567edcebf5b"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "744b6154-64c1-498e-8b84-360c6f6c6302", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "260c92d4-c39f-4899-b8f5-8620ab3e4909"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic Safety Report</span></b></p>", "ID": "154b8f1c-e720-43b4-a270-af8d061720d6", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5e9c8723-feac-459c-9cdb-924f12b1f9c1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "154b8f1c-e720-43b4-a270-af8d061720d6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8ca09d98-bd60-484a-a2fd-1f9d0ae36df9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5e9c8723-feac-459c-9cdb-924f12b1f9c1"}, {"Element": "<b><span lang=\"EN-GB\">Periodic Safety Report</span></b>", "ID": "072f85ab-2e4c-494e-900b-ff371b6188f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "154b8f1c-e720-43b4-a270-af8d061720d6"}, {"Element": "<span lang=\"EN-GB\">Periodic Safety Report</span>", "ID": "99901683-c50b-4576-8d4a-09dfc3703d08", "Styles": "None", "Classes": "None", "Text": "Periodic Safety Report", "ParentId": "072f85ab-2e4c-494e-900b-ff371b6188f8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt\"><span lang=\"EN-GB\" style=\"color:black\">The requirements for submission of periodic safety update\nreports for this medicinal products are set out in the list of Union reference\ndates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC\nand any subsequent updates published on the European medicines web-portal.</span></p>", "ID": "6e5cdd49-8a28-4b7d-bd02-3adbd37d7383", "Styles": "margin-right:-.05pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">The requirements for submission of periodic safety update\nreports for this medicinal products are set out in the list of Union reference\ndates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC\nand any subsequent updates published on the European medicines web-portal.</span>", "ID": "3ee90a8c-2921-48b3-918e-76f7362e798c", "Styles": "color:black", "Classes": "None", "Text": "The requirements for submission of periodic safety update reports for this medicinal products are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.", "ParentId": "6e5cdd49-8a28-4b7d-bd02-3adbd37d7383"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Tms Rmn\",serif'>\u00a0</span></p>", "ID": "2277f3f5-535d-4b34-9c5a-fb03ad27654f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Tms Rmn\",serif'>\u00a0</span>", "ID": "e6d34ea7-f874-4d6b-a184-9eae48c59339", "Styles": "font-size:12.0pt;font-family:\"Tms Rmn\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2277f3f5-535d-4b34-9c5a-fb03ad27654f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Tms Rmn\",serif'>\u00a0</span></p>", "ID": "21976f56-e1c7-433a-b2ae-7c08dfe567a6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Tms Rmn\",serif'>\u00a0</span>", "ID": "66e87a6b-040f-4f33-b950-3f77bcbb2537", "Styles": "font-size:12.0pt;font-family:\"Tms Rmn\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "21976f56-e1c7-433a-b2ae-7c08dfe567a6"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></p>", "ID": "92776240-95ef-4994-8c2b-50c37c1f7ba0", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span>", "ID": "b999eae9-3bbd-4103-b4e6-d7415874ebea", "Styles": "None", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT", "ParentId": "92776240-95ef-4994-8c2b-50c37c1f7ba0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "e7ad711b-d680-4d1b-9bdf-36aea3c30b7c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "66d7fb20-3de2-4b56-9271-fe5f86218a2e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e7ad711b-d680-4d1b-9bdf-36aea3c30b7c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cce214ce-7e45-47f4-8d11-eee77c0fe8e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "66d7fb20-3de2-4b56-9271-fe5f86218a2e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.5in;text-indent:-.5in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk Management Plan (RMP)</span></b></p>", "ID": "cb22e2f3-9609-4dae-b1f4-be7e53fb3891", "Styles": "margin-left:.5in;text-indent:-.5in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "25501b26-10e0-4282-9fa8-0db0e396e73f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cb22e2f3-9609-4dae-b1f4-be7e53fb3891"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "85d9e63f-0ce5-46f7-8de2-1923250a5a87", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "25501b26-10e0-4282-9fa8-0db0e396e73f"}, {"Element": "<b><span lang=\"EN-GB\">Risk Management Plan (RMP)</span></b>", "ID": "44588bb8-befd-423a-a9ec-3881990577b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb22e2f3-9609-4dae-b1f4-be7e53fb3891"}, {"Element": "<span lang=\"EN-GB\">Risk Management Plan (RMP)</span>", "ID": "49f14430-fd5d-495c-bc79-36197ce80f02", "Styles": "None", "Classes": "None", "Text": "Risk Management Plan (RMP)", "ParentId": "44588bb8-befd-423a-a9ec-3881990577b5"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "fa11b65c-e38e-4674-ab8c-21060daf1cbe", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "948a3f9b-82ce-4ea0-97db-614404600c4c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa11b65c-e38e-4674-ab8c-21060daf1cbe"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "1b7c9b8b-3c65-439e-92f1-e236325bfe27", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "948a3f9b-82ce-4ea0-97db-614404600c4c"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "1ee19eec-45be-41f6-86bf-d000b754d466", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "1b7c9b8b-3c65-439e-92f1-e236325bfe27"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Not applicable.</span></p>", "ID": "c04ff9c8-247a-48b9-802b-ea38c4bdd82e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Not applicable.</span>", "ID": "5c6d6bc0-37fb-439a-97ff-9d8c878515de", "Styles": "None", "Classes": "None", "Text": "Not applicable.", "ParentId": "c04ff9c8-247a-48b9-802b-ea38c4bdd82e"}, {"Element": "<p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "be53df18-9172-45e1-ba3f-cb96fc0ca7b8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "7e4084c7-1851-4bf0-9f04-7b00a22485f4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be53df18-9172-45e1-ba3f-cb96fc0ca7b8"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "8f1c1523-3017-4f84-96f3-2e64a2ed163f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7e4084c7-1851-4bf0-9f04-7b00a22485f4"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "a0f421d6-cc04-4ce5-b83e-f4b321d58067", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "8f1c1523-3017-4f84-96f3-2e64a2ed163f"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "ad38049d-ccdb-42c1-921c-5eef391527e7", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "d3fb9162-7adf-4bb0-bc36-0b43cb690a88", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "ad38049d-ccdb-42c1-921c-5eef391527e7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ceeaacd-7329-4ac2-b4d7-2e53513e1e3f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9980586c-b332-4fe7-aa36-0bd63bd16d52", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ceeaacd-7329-4ac2-b4d7-2e53513e1e3f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "19875f88-057b-4d53-9a0a-59848c971eeb", "Styles": "margin-right:28.3pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0606a56d-d4ea-4f51-9158-163326b58538", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "19875f88-057b-4d53-9a0a-59848c971eeb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34cb5dfe-41c9-48c2-855a-e72e6503ffff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "863b21d7-fb8e-43eb-ba2e-7bd77af3365a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34cb5dfe-41c9-48c2-855a-e72e6503ffff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7fa0a0e0-16b1-4f28-b360-4da5ca8b11dd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2fa4f198-2d22-409f-b59f-0d2b9cd99bf7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7fa0a0e0-16b1-4f28-b360-4da5ca8b11dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "029145d6-a584-4e5e-9701-a5c1e0220077", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d89bb4c8-c4af-478b-bc48-7a80a5119110", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "029145d6-a584-4e5e-9701-a5c1e0220077"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ae2d2ce9-f993-4031-b6f0-474306670762", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "68aff30f-f6e3-47f9-94a1-940d0b641648", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ae2d2ce9-f993-4031-b6f0-474306670762"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5bb8101a-a942-4137-8517-b5ae4d18535b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d18b7e9-abc1-45d7-9b09-1fd29ec7ca4c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5bb8101a-a942-4137-8517-b5ae4d18535b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eadb4072-e66f-4d18-a216-a01092a03a2e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d2e67698-260b-49a6-9a8c-4d10c9a780b6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eadb4072-e66f-4d18-a216-a01092a03a2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8503965b-972e-4168-b746-acdfac106205", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "adb36442-26b7-4ea1-8d21-215602739529", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8503965b-972e-4168-b746-acdfac106205"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33c0edba-39ca-4bf0-a86f-acb5ff74e220", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b29a78ee-cb63-492e-9a70-589f94967a6e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33c0edba-39ca-4bf0-a86f-acb5ff74e220"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f9bf0947-a9a1-4f49-b8c8-5be09a75eee4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da9aeb0f-6639-4d7e-a4fe-4962b88d0d3b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f9bf0947-a9a1-4f49-b8c8-5be09a75eee4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9ae52372-3bdd-45ec-aeca-eea2b9ed679a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "93b6102e-df86-4747-ad4c-fe1ebe62638a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ae52372-3bdd-45ec-aeca-eea2b9ed679a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d48fb900-3f57-4a7a-b8e2-02f8846486a2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a23ee62e-1a23-4074-a3b9-e9a90ced46a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d48fb900-3f57-4a7a-b8e2-02f8846486a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a26acba4-d393-43ae-a635-50819c89d5cf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "23b73278-a4ed-4cf2-b86b-7f7a3d180f57", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a26acba4-d393-43ae-a635-50819c89d5cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8682e325-8c9d-4809-b7ce-5c4a346672aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4942826-3ba9-4b9b-aa44-bf0716eb6c51", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8682e325-8c9d-4809-b7ce-5c4a346672aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6bb8b4ce-4080-4f0d-86ce-1851032a9c5d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ba7b2505-f03d-4804-ae25-6a40fba39757", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6bb8b4ce-4080-4f0d-86ce-1851032a9c5d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dfb460bb-16f7-4323-91d7-246433b9ad78", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b49cd07-7688-4b98-a5fc-5522f4b5e49b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dfb460bb-16f7-4323-91d7-246433b9ad78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b618deb5-8b2b-42c3-98d1-80eee2fc4354", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bd5a1786-2424-4b79-9c32-9acb8dd0621b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b618deb5-8b2b-42c3-98d1-80eee2fc4354"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cbc0602b-f326-4f96-bdca-e66c0304bae7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5fb04650-18b4-449c-aeae-60747dacd923", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cbc0602b-f326-4f96-bdca-e66c0304bae7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "085afd24-9f12-4f37-a2ee-6f593305d4e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "93a78e8c-4494-4d3a-b8f8-c231b2be74de", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "085afd24-9f12-4f37-a2ee-6f593305d4e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60f55b0f-e9ff-4edf-9d96-cadafcf62817", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "68ea7d37-077b-4f41-a957-7bd556acf521", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60f55b0f-e9ff-4edf-9d96-cadafcf62817"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aa3e3543-0935-49c0-ba03-9755c8ef68be", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e3364f4-e036-4b91-bada-66552030eaab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa3e3543-0935-49c0-ba03-9755c8ef68be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33b3ee2f-280f-49cb-a70b-127b19160f16", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "633da25a-636a-436c-8e6f-09d330b041fe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33b3ee2f-280f-49cb-a70b-127b19160f16"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c61735b0-750f-4bba-b73c-4b3aac8937f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b2723ebd-cae3-44d0-9955-e9390d61e777", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c61735b0-750f-4bba-b73c-4b3aac8937f6"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>", "ID": "30954293-2aea-4b35-8552-e19975de2529", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX III</span></b>", "ID": "1d221e0e-2f23-419d-8802-60818145a369", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30954293-2aea-4b35-8552-e19975de2529"}, {"Element": "<span lang=\"EN-GB\">ANNEX III</span>", "ID": "1dab90c8-cad7-4009-b08e-20038bef491b", "Styles": "None", "Classes": "None", "Text": "ANNEX III", "ParentId": "1d221e0e-2f23-419d-8802-60818145a369"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5d7604c3-3726-44a5-996c-eafc01430c68", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "2892bb74-6b6d-4306-b099-1e4b12c066a4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d7604c3-3726-44a5-996c-eafc01430c68"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "85786eea-5846-41f8-a63a-3cb45c9c3fe4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2892bb74-6b6d-4306-b099-1e4b12c066a4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>", "ID": "690d6ac6-20e0-42ce-b1cd-4b91cddc0957", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b>", "ID": "15e890d0-f180-4bf6-a734-06edccfae7af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "690d6ac6-20e0-42ce-b1cd-4b91cddc0957"}, {"Element": "<span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span>", "ID": "9b016e44-c89f-47d3-bf94-04b6fecb2ac3", "Styles": "None", "Classes": "None", "Text": "LABELLING AND PACKAGE LEAFLET", "ParentId": "15e890d0-f180-4bf6-a734-06edccfae7af"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "f7c2eaeb-764f-49ec-b710-f41b3c8aa45a", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "0bf23317-5cfd-4c13-92aa-82b907212ef7", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "f7c2eaeb-764f-49ec-b710-f41b3c8aa45a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "417a1b03-4ba1-4a12-ad44-27dab51336b4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "452ee1d8-0e76-4482-b265-331b53763200", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "417a1b03-4ba1-4a12-ad44-27dab51336b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "08195cb4-6da3-42ac-a9fa-8184cf8a664c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "67e0fcb4-fab9-44c6-afbe-75649612c572", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "08195cb4-6da3-42ac-a9fa-8184cf8a664c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dca53d90-5e99-495f-b1d8-77755eced881", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c39c2183-7a0f-410c-972f-3f7f61000b05", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dca53d90-5e99-495f-b1d8-77755eced881"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f1e89268-b261-4a22-ad40-7b49fb82e686", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c01e9835-4074-4320-8dea-ba786a7e9b13", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f1e89268-b261-4a22-ad40-7b49fb82e686"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0a1396c0-4ba7-4bc2-8d92-d02a1694f48f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "80247400-4155-4265-a622-1f62f8f38613", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0a1396c0-4ba7-4bc2-8d92-d02a1694f48f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "acab72a9-071c-4db1-bff6-53625d006e65", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b683a152-add0-403d-b1f3-2016b3752260", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "acab72a9-071c-4db1-bff6-53625d006e65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b22d19f7-c2a5-4e45-b2aa-d6ba7f13ea54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b3a5070-0d0d-4db0-8a74-9318fee2c884", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b22d19f7-c2a5-4e45-b2aa-d6ba7f13ea54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bba3ad94-2cc1-4c59-b3e4-5d3eac0f2768", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "acf28773-6e5b-4ecf-a79a-ab59f23e522a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bba3ad94-2cc1-4c59-b3e4-5d3eac0f2768"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "49f6a85b-8f2b-4136-99b8-308c12bcf053", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9ca40923-3d00-4258-b62f-ea7fa85d158b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "49f6a85b-8f2b-4136-99b8-308c12bcf053"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9843a7f5-df7f-4a9b-b51b-54069dfa46fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ffa9e84d-044e-4b4a-bbe9-536eed507c12", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9843a7f5-df7f-4a9b-b51b-54069dfa46fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4f4d85d0-3449-4e6d-adbc-8964a627ac13", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d8b1a0ce-4791-4e28-9268-a1efc5daeff2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f4d85d0-3449-4e6d-adbc-8964a627ac13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ae0f2e04-4d4e-49a9-9843-ca1353e334f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b28ba577-3361-47b2-a2aa-406fccea6e75", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ae0f2e04-4d4e-49a9-9843-ca1353e334f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a21dff40-a83f-431b-9f56-fb424aded251", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6d85a36c-c6bd-4aaa-b106-39e01d2d346e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a21dff40-a83f-431b-9f56-fb424aded251"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "31a242c8-1334-452f-963b-d2f187e62c54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5ad19a7b-c11a-43cb-b473-95dfd1dbf435", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "31a242c8-1334-452f-963b-d2f187e62c54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "51e0e4dd-7067-4933-88f8-c57a5fb37c43", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9966ac8b-b5a9-431e-bcd2-c4ded2acb63a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "51e0e4dd-7067-4933-88f8-c57a5fb37c43"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5f8d5d2f-e43c-451f-8e38-e132bca97c03", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "afe006a5-cbc4-4f60-91cd-48f3d195a828", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5f8d5d2f-e43c-451f-8e38-e132bca97c03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8ea17a29-b2ac-4787-960b-2a454953530e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f30c07d-3583-4777-86db-596842004e25", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8ea17a29-b2ac-4787-960b-2a454953530e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3a4765f8-3ed5-424b-8348-6e06fcc48aad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1b18c020-51c2-40b2-a58c-2b9f85280cdc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3a4765f8-3ed5-424b-8348-6e06fcc48aad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bd0e6b49-b5fa-47e5-bd77-51b08561c7df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c50fd204-9f25-4dfc-9ddb-2ddfd4a46868", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd0e6b49-b5fa-47e5-bd77-51b08561c7df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "137e5b82-b26d-4fe4-a356-e97227e8b824", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c352756d-fa1b-450e-8d36-9d7f5bc3ca34", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "137e5b82-b26d-4fe4-a356-e97227e8b824"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a95524de-4cf0-4187-82ed-e63999a6595d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "051cc340-92a9-4182-bbf6-093b1f5dabc5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a95524de-4cf0-4187-82ed-e63999a6595d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cc94d9ad-d555-43fc-9486-bfc2def202cb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "97312167-9286-49d2-9344-8790cc743e3f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc94d9ad-d555-43fc-9486-bfc2def202cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "672f375a-64f6-4bd9-8adb-5fcd9953b056", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ebccc693-2862-4277-955b-9254135e4910", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "672f375a-64f6-4bd9-8adb-5fcd9953b056"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">A. LABELLING</span></p>", "ID": "fbc44d16-3556-4dbe-b1a8-1c446e01e17b", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">A. LABELLING</span>", "ID": "46143215-256c-4301-90b7-db882dcde187", "Styles": "None", "Classes": "None", "Text": "A. LABELLING", "ParentId": "fbc44d16-3556-4dbe-b1a8-1c446e01e17b"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "8a22894f-e124-4093-b7f7-080d4fb0d815", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black", "Classes": "None", "Text": " ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "76f8dd92-ec69-4ab7-85e8-b5ea02fd58e8", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "8a22894f-e124-4093-b7f7-080d4fb0d815"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7d3f79b8-516f-4819-8a69-d62469086404", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f3ffc2e2-48f9-46ce-84c3-e15c9148ba7f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7d3f79b8-516f-4819-8a69-d62469086404"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">carton</span></b></p>\n</div>", "ID": "6b48fb1e-e85f-456b-a21c-a071de985b01", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>", "ID": "b3ab49d6-b6c2-407d-850d-848d027f58a8", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b48fb1e-e85f-456b-a21c-a071de985b01"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b>", "ID": "c12957ee-51d0-425b-a88e-63f6232c1c3e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b3ab49d6-b6c2-407d-850d-848d027f58a8"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span>", "ID": "14a3d5ee-bfad-494d-9640-b9c427a18919", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "ParentId": "c12957ee-51d0-425b-a88e-63f6232c1c3e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "38d3a66b-2555-4269-aced-1703fe75e7b4", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b48fb1e-e85f-456b-a21c-a071de985b01"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "65b33636-217f-4372-a3c7-e9d6b716c1f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "38d3a66b-2555-4269-aced-1703fe75e7b4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c9477fd-30ce-4280-b0b0-3dc53eb65ae9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65b33636-217f-4372-a3c7-e9d6b716c1f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">carton</span></b></p>", "ID": "469027c9-a61d-408a-892b-8f4bc1a21408", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b48fb1e-e85f-456b-a21c-a071de985b01"}, {"Element": "<b><span lang=\"EN-GB\">carton</span></b>", "ID": "11da5a48-f9ce-4ae8-9cf2-ec2755d45b75", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "469027c9-a61d-408a-892b-8f4bc1a21408"}, {"Element": "<span lang=\"EN-GB\">carton</span>", "ID": "8a923952-0e48-4dc5-9706-674be9bc4f0d", "Styles": "None", "Classes": "None", "Text": "carton", "ParentId": "11da5a48-f9ce-4ae8-9cf2-ec2755d45b75"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e240b48c-128f-4c53-bb9e-b2e9cae4c1d8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "762f277f-b8ef-454c-b505-6078a6cbcf6f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e240b48c-128f-4c53-bb9e-b2e9cae4c1d8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c050df3c-78fb-4288-b0c1-dbd3b51258a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2c555c1e-c83a-4d0e-91b4-0d25aa2a26d1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c050df3c-78fb-4288-b0c1-dbd3b51258a9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "2abfef6d-57a1-48ef-ad9d-e5f53fa43101", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "80df2cbe-7c8b-4102-a6de-036f6e2e4553", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2abfef6d-57a1-48ef-ad9d-e5f53fa43101"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "e20bda32-b8e8-44ec-b639-c6f6c3bcb2c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "80df2cbe-7c8b-4102-a6de-036f6e2e4553"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "0d3da71d-7f79-46a5-8b61-94fbb26c1929", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "e20bda32-b8e8-44ec-b639-c6f6c3bcb2c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "768d8f91-0daf-4fda-8b5c-406d0777d615", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "42e3b035-673f-4277-b343-ed24d48aa637", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "768d8f91-0daf-4fda-8b5c-406d0777d615"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span></p>", "ID": "dc69196f-2271-4ecc-8110-5b219b067610", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span>", "ID": "c32f85f7-c70d-4d34-bdb9-c6be31d1a80f", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg film\u2011coated tablets ", "ParentId": "dc69196f-2271-4ecc-8110-5b219b067610"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine </span></p>", "ID": "52c89b9d-fc7d-45d0-a060-bcfa6d29df92", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine </span>", "ID": "345ec2c2-3b5a-4574-aec1-b0a14ae2fb34", "Styles": "None", "Classes": "None", "Text": "Lamivudine ", "ParentId": "52c89b9d-fc7d-45d0-a060-bcfa6d29df92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b645d91f-fbc3-4ab9-98ca-1eea545d4f6b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "87497963-99ae-4908-b85e-24e7db3baa1e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b645d91f-fbc3-4ab9-98ca-1eea545d4f6b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "83ca8109-941f-4367-a192-3c22a456d6ac", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "03d5af28-b4a6-4932-acbc-cfedda55444f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "83ca8109-941f-4367-a192-3c22a456d6ac"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>\n</div>", "ID": "a53f4fbe-e258-4d5a-a55c-17afd3d0324f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>", "ID": "ec0aa010-f44c-4ed1-9ea8-84b07d4dcba4", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a53f4fbe-e258-4d5a-a55c-17afd3d0324f"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b>", "ID": "1963bdc6-3746-418c-a24f-170884a76e71", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec0aa010-f44c-4ed1-9ea8-84b07d4dcba4"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span>", "ID": "9573a8f2-cb0e-447c-b234-65920a471592", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "1963bdc6-3746-418c-a24f-170884a76e71"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "649e2ca8-7dba-4c0b-bc4a-e811e6d08715", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae900363-d6f4-4663-87b1-790172e73e9b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "649e2ca8-7dba-4c0b-bc4a-e811e6d08715"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Each film\u2011coated tablet contains 100\u00a0mg\nof lamivudine</span></p>", "ID": "1fa48426-f626-4cb4-912a-58bad3eb5cbe", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Each film\u2011coated tablet contains 100\u00a0mg\nof lamivudine</span>", "ID": "fc292d1d-583f-47e9-b2d5-ae1ab96d7248", "Styles": "None", "Classes": "None", "Text": "Each film\u2011coated tablet contains 100\u00a0mg of lamivudine", "ParentId": "1fa48426-f626-4cb4-912a-58bad3eb5cbe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e48a6a4-28aa-4749-b312-7b9e4014c06f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2496ff00-9e1f-499b-b3f5-6d0a884ada88", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e48a6a4-28aa-4749-b312-7b9e4014c06f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "058026f4-9865-4db6-8cfa-41257c20c768", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1bee42e1-70a2-4022-9bcf-89f1caa2c35d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "058026f4-9865-4db6-8cfa-41257c20c768"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "7f48bf35-3d8f-452b-bd22-aa001a7d1b73", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "80b98387-fe86-4da4-9922-23e1d17e6e6b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7f48bf35-3d8f-452b-bd22-aa001a7d1b73"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "dde4a056-7649-4c10-9ec4-dc0ef671610b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "80b98387-fe86-4da4-9922-23e1d17e6e6b"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "2e44e8c7-6502-4733-9480-0fc4c451c8e9", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "dde4a056-7649-4c10-9ec4-dc0ef671610b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3e1377db-0726-4ead-bb48-cc02b2c2055a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "edb14896-6add-4173-a803-1e0987d9d6a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3e1377db-0726-4ead-bb48-cc02b2c2055a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2e6bc39e-6e0e-4750-a948-1d88524fafd8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "57053def-cecb-43b3-a2d0-89aa67b77684", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2e6bc39e-6e0e-4750-a948-1d88524fafd8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "d6b8ac3c-81de-46a3-bda3-71e7fc5088c2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "29aa1063-0e00-4ab9-8114-55a153ce537a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d6b8ac3c-81de-46a3-bda3-71e7fc5088c2"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "aa705f43-5772-453e-965b-230fa0c92c79", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "29aa1063-0e00-4ab9-8114-55a153ce537a"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "1d42e607-c560-4377-9189-38cba76a4992", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "aa705f43-5772-453e-965b-230fa0c92c79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a03f7585-1df7-4841-ab0a-b28cf520d11f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a62fe704-434d-4f14-b175-033c43f1b9ef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a03f7585-1df7-4841-ab0a-b28cf520d11f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Blisters:</span></p>", "ID": "de5a3619-2737-4ea9-b881-a90b95f7c460", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Blisters:</span>", "ID": "4394dcd4-fe09-48ab-88fe-6cb3e3cbe493", "Styles": "None", "Classes": "None", "Text": "Blisters:", "ParentId": "de5a3619-2737-4ea9-b881-a90b95f7c460"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">28 film-coated\ntablets</span></p>", "ID": "6b9b0426-84c3-4f33-b15a-5226b24414fa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">28 film-coated\ntablets</span>", "ID": "444921ff-483c-4f27-99e5-d53c4a683090", "Styles": "None", "Classes": "None", "Text": "28 film-coated tablets", "ParentId": "6b9b0426-84c3-4f33-b15a-5226b24414fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">30 film-coated tablets</span></p>", "ID": "75f94ec8-3840-4c60-ae5e-5e34111fbb4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">30 film-coated tablets</span>", "ID": "0e66d814-cb38-4b34-b86c-09e13396a8d0", "Styles": "color:black;background:#A0A0A0", "Classes": "None", "Text": "30 film-coated tablets", "ParentId": "75f94ec8-3840-4c60-ae5e-5e34111fbb4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">84 film-coated tablets</span></p>", "ID": "fb0889e5-ab02-404f-ba3f-4bfe2581c9cb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">84 film-coated tablets</span>", "ID": "41f2b78c-8b04-4427-bf49-d1ddb51b963d", "Styles": "color:black;background:#A0A0A0", "Classes": "None", "Text": "84 film-coated tablets", "ParentId": "fb0889e5-ab02-404f-ba3f-4bfe2581c9cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">100 film-coated tablets</span></p>", "ID": "23a2cb02-dac3-45ec-bc27-a5e29bdce043", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#A0A0A0\">100 film-coated tablets</span>", "ID": "ece75441-fc89-4040-84e4-759ea33959d4", "Styles": "color:black;background:#A0A0A0", "Classes": "None", "Text": "100 film-coated tablets", "ParentId": "23a2cb02-dac3-45ec-bc27-a5e29bdce043"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d0e24c61-1d63-498e-b776-db9dd09e9b3e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6322f07d-acbf-4ead-a480-a08ea48a17af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d0e24c61-1d63-498e-b776-db9dd09e9b3e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3869c5ab-85ef-4c5b-bf38-c60b525f8667", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "25783be5-9977-4997-a9a2-9459e185509c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3869c5ab-85ef-4c5b-bf38-c60b525f8667"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "b23d8f8e-1a26-4d4a-bacf-1340ea2c5ae4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "6e4c140a-23e1-43e0-8fac-c76eed6aece0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b23d8f8e-1a26-4d4a-bacf-1340ea2c5ae4"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "4dea4ebc-3f90-4959-be04-ed988c7bcafb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6e4c140a-23e1-43e0-8fac-c76eed6aece0"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "170dc663-f9d8-40c1-9066-6c1a4f1e2308", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "4dea4ebc-3f90-4959-be04-ed988c7bcafb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "c94e8cd3-8e81-4999-95a9-b30dd5b1f690", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "0ce4d88e-948e-40e2-85da-6960ea428c50", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c94e8cd3-8e81-4999-95a9-b30dd5b1f690"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "18b3aac7-8ecd-48a5-ad1a-0731b3aff2fe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0ce4d88e-948e-40e2-85da-6960ea428c50"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Read the package leaflet before use</span></p>", "ID": "01c7dc58-0c73-424b-9759-d2cc58ffb737", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Read the package leaflet before use</span>", "ID": "89d6237c-87a0-4607-8571-8ea3de49d387", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use", "ParentId": "01c7dc58-0c73-424b-9759-d2cc58ffb737"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4f7af4c0-e295-4779-84b4-67234410370a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0df7f5f5-b72b-4789-8e28-a9c2c80f2b87", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f7af4c0-e295-4779-84b4-67234410370a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Oral use </span></p>", "ID": "ea2df67e-6f36-4169-9d54-80865a482159", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Oral use </span>", "ID": "7ef06e5a-4084-476a-8e83-46cfc035a35f", "Styles": "None", "Classes": "None", "Text": "Oral use ", "ParentId": "ea2df67e-6f36-4169-9d54-80865a482159"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4105a323-f670-48ba-ab71-91a1cec72698", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "73d5f9cb-48b0-4bc5-b5a0-97cf466011ff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4105a323-f670-48ba-ab71-91a1cec72698"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e3e8346-2918-4bb4-916c-51f9e379737b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5dca4b87-c929-413d-b914-7b92595af4d3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e3e8346-2918-4bb4-916c-51f9e379737b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span><span lang=\"EN-GB\">SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "9a71030f-8845-4ea6-b004-b3160d6149db", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span><span lang=\"EN-GB\">SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "5cef68d6-b026-4ad7-8a68-5558e4e741bf", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9a71030f-8845-4ea6-b004-b3160d6149db"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span><span lang=\"EN-GB\">SIGHT AND REACH OF CHILDREN</span></b>", "ID": "d67c63c7-81cd-40fa-ad51-243e858a2b2c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5cef68d6-b026-4ad7-8a68-5558e4e741bf"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span>", "ID": "2c13d771-a64a-4839-bb43-460e73947753", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE ", "ParentId": "d67c63c7-81cd-40fa-ad51-243e858a2b2c"}, {"Element": "<span lang=\"EN-GB\">SIGHT AND REACH OF CHILDREN</span>", "ID": "83a025aa-8b84-4bb6-bfce-f3d34c90e000", "Styles": "None", "Classes": "None", "Text": "SIGHT AND REACH OF CHILDREN", "ParentId": "d67c63c7-81cd-40fa-ad51-243e858a2b2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "57a39b31-6bdf-4f5a-b02f-f87cdf05aa29", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "85f68a3f-2451-45d6-b00c-d0ebb1d57c89", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "57a39b31-6bdf-4f5a-b02f-f87cdf05aa29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the sight\nand reach of children.</span></p>", "ID": "2f8d057b-0acb-4f19-adcb-a08d3f813811", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Keep out of the sight\nand reach of children.</span>", "ID": "f887fc3c-4af3-4c2b-a371-aaa7422c4038", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "2f8d057b-0acb-4f19-adcb-a08d3f813811"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6e2275c7-0022-4412-bdba-a9dda9ea7a4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ba5eb3b2-2ef8-4e25-a594-293a2a017cc4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6e2275c7-0022-4412-bdba-a9dda9ea7a4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "10dd7594-9da1-40a2-8bc5-e4358c37c1fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "691d9b71-15e5-45b7-99b8-34ec8fb8d90f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "10dd7594-9da1-40a2-8bc5-e4358c37c1fd"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "08efa8d9-8c9e-45be-a240-22c421aa08a7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "a4ef11e0-b7db-4081-b03b-94ad64a8506b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08efa8d9-8c9e-45be-a240-22c421aa08a7"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "de1d3461-f4b2-4219-bff9-79ee8d88dbbd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a4ef11e0-b7db-4081-b03b-94ad64a8506b"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "b2234148-faec-4da4-8481-684126315a4f", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "de1d3461-f4b2-4219-bff9-79ee8d88dbbd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4f317b82-39af-447c-be39-c0eb7851badc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f97a7bb3-9bc3-489f-a9fd-526464eda4ce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f317b82-39af-447c-be39-c0eb7851badc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "067aa9b1-0d42-4edb-bb1e-8deaa6f19c82", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d7ff1bf8-626a-42d7-b32e-df3baed8abbd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "067aa9b1-0d42-4edb-bb1e-8deaa6f19c82"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "937e9bc3-8967-4901-a850-b7d44409ac8c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "ab4179a2-a95b-48b4-91d0-94071329ccbd", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "937e9bc3-8967-4901-a850-b7d44409ac8c"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "bba180e5-1360-4294-a165-d9bdbf9ec111", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab4179a2-a95b-48b4-91d0-94071329ccbd"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "8aed6783-894b-4741-bac8-dfe27b5a2a8a", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "bba180e5-1360-4294-a165-d9bdbf9ec111"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5437735f-413d-4fc5-97ea-203136c89ec8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0918aa56-dabc-4fdd-8cb5-a27a7cd51243", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5437735f-413d-4fc5-97ea-203136c89ec8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "843cbc2e-86fd-462f-b9a5-db72fe1c42c6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "c8825ecc-af68-45d4-84c1-e77b11ecb86c", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "843cbc2e-86fd-462f-b9a5-db72fe1c42c6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7419879a-afd4-454b-994b-5d7715fce3e8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ba7073a-5662-465a-87e6-4c31e4e510ee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7419879a-afd4-454b-994b-5d7715fce3e8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "c5317ff4-d147-4075-b77e-3ec1f914d68e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "b965b11b-f23d-452c-a175-cdfd3b40c3ad", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c5317ff4-d147-4075-b77e-3ec1f914d68e"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "ec9d3db8-2195-4178-9f7a-a3ffa1b1f4c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b965b11b-f23d-452c-a175-cdfd3b40c3ad"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "a841abee-96e1-4e82-9aa2-4657c2a0f5a4", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "ec9d3db8-2195-4178-9f7a-a3ffa1b1f4c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f0a7827a-c8f1-47f7-b15f-b5a98035bc20", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c07f8c4c-9fbc-4f4d-97ea-bc1ceb168b2e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f0a7827a-c8f1-47f7-b15f-b5a98035bc20"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6b6dde30-0618-4557-817a-5275ce915160", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "496455b5-6d34-4262-8752-39780c5be43f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6b6dde30-0618-4557-817a-5275ce915160"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "0a2d8cb3-9fa9-48b2-947c-d450ccc0a8c1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "ecf2ec75-6442-4017-8829-95996e1808cc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0a2d8cb3-9fa9-48b2-947c-d450ccc0a8c1"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "835225c3-813d-49a1-af1b-e2c6dab46681", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ecf2ec75-6442-4017-8829-95996e1808cc"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "c9016f72-9f5b-4268-b0fa-9478b49c255c", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "835225c3-813d-49a1-af1b-e2c6dab46681"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f0c3c2d7-b17e-49b1-9a65-15ee74a6472e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ee178100-0f1f-4c7c-aa63-1623f341f0ac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f0c3c2d7-b17e-49b1-9a65-15ee74a6472e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "50757bfa-2e07-443c-be19-b0898dedbec8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8ef67e81-b2b4-4bb9-8938-cdf2d8b1f607", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50757bfa-2e07-443c-be19-b0898dedbec8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "e4c58d34-4f8a-4e39-a4c0-5a10118d0fa8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "e325cdda-7c15-495f-b093-d5a0703aae84", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e4c58d34-4f8a-4e39-a4c0-5a10118d0fa8"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "a4e7ffd4-1218-4ff6-b9c1-1b048708c4c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e325cdda-7c15-495f-b093-d5a0703aae84"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "bc9668c9-85e0-47a2-a42e-2ccc44f004e7", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "a4e7ffd4-1218-4ff6-b9c1-1b048708c4c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "55d719f8-2177-42ae-bf94-82a35f392532", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4dcd8c65-a2dc-4ca9-a619-450052c9fe5b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "55d719f8-2177-42ae-bf94-82a35f392532"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva B.V.</span></p>", "ID": "097ef48c-f6bc-4090-8f4b-2c46a4a906d4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">Teva B.V.</span>", "ID": "10079879-eaf1-4262-93b3-eb3e2aba5ac0", "Styles": "None", "Classes": "None", "Text": "Teva B.V.", "ParentId": "097ef48c-f6bc-4090-8f4b-2c46a4a906d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Swensweg 5</span></p>", "ID": "1f263837-9b64-471e-8b0d-0cce5e8fb361", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">Swensweg 5</span>", "ID": "feac62cf-e9a9-4266-a3bb-807ce492353e", "Styles": "None", "Classes": "None", "Text": "Swensweg 5", "ParentId": "1f263837-9b64-471e-8b0d-0cce5e8fb361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">2031GA Haarlem</span></p>", "ID": "cf456a7c-f75b-47ae-8b93-2dbea882d1d5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">2031GA Haarlem</span>", "ID": "415a6762-5f0d-4d0a-8b7f-1020f4e675c7", "Styles": "None", "Classes": "None", "Text": "2031GA Haarlem", "ParentId": "cf456a7c-f75b-47ae-8b93-2dbea882d1d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Netherlands</span></p>", "ID": "9a81e3f7-f269-4b68-b1c2-c4a69d04dd1d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Netherlands</span>", "ID": "ed93d2c2-1d83-434b-a332-e0543afc79af", "Styles": "None", "Classes": "None", "Text": "Netherlands", "ParentId": "9a81e3f7-f269-4b68-b1c2-c4a69d04dd1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bdbc4dbc-89d8-4a63-8458-136dae4c358d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6168e7e9-4da3-47bd-80c8-322c9fb5aadf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bdbc4dbc-89d8-4a63-8458-136dae4c358d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ed8f7bdb-a1d8-4525-9b01-fb7ce980050a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce233cfd-3dd3-449a-b3f8-aade05a49976", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed8f7bdb-a1d8-4525-9b01-fb7ce980050a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "99b3e7c8-8e4f-42d5-8f1f-773de6f5e44f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "cf544305-86f7-4bfd-9c5a-03702c701c4e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "99b3e7c8-8e4f-42d5-8f1f-773de6f5e44f"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "0178a9b0-bfe9-4ae4-94ae-8ee7c605894a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf544305-86f7-4bfd-9c5a-03702c701c4e"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "8984c468-71ce-4197-b762-9f0d1a9a3a33", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "0178a9b0-bfe9-4ae4-94ae-8ee7c605894a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "c0f8686b-10fd-4ddb-bfcb-b683ed1e3152", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">EU/1/09/566/001<span style=\"background:lightgrey\">\u2013 28 Tablets</span></span></p>", "ID": "97345fe7-9969-412d-b1e7-00970435e7f8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">EU/1/09/566/001<span style=\"background:lightgrey\">\u2013 28 Tablets</span></span>", "ID": "77e1e557-17a4-48ec-a321-1a4734e19eaf", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/001", "ParentId": "97345fe7-9969-412d-b1e7-00970435e7f8"}, {"Element": "<span style=\"background:lightgrey\">\u2013 28 Tablets</span>", "ID": "e7f299a5-6a38-4693-8b18-be78410337cf", "Styles": "background:lightgrey", "Classes": "None", "Text": "\u2013 28 Tablets", "ParentId": "77e1e557-17a4-48ec-a321-1a4734e19eaf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nlightgrey\">EU/1/09/566/002 \u2013 30 Tablets</span></p>", "ID": "2137d424-6c06-4f10-abd9-a19e59d4f7b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\" style=\"background:\nlightgrey\">EU/1/09/566/002 \u2013 30 Tablets</span>", "ID": "3e25f6a5-7b31-4094-b9c8-c246252fccfa", "Styles": "background:\nlightgrey", "Classes": "None", "Text": "EU/1/09/566/002 \u2013 30 Tablets", "ParentId": "2137d424-6c06-4f10-abd9-a19e59d4f7b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nlightgrey\">EU/1/09/566/003 \u2013 84 Tablets</span></p>", "ID": "eff7f8a9-cab4-4e85-8da6-a0a5555bcf83", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\" style=\"background:\nlightgrey\">EU/1/09/566/003 \u2013 84 Tablets</span>", "ID": "6bd35246-0db0-4e5f-823e-18f2f0816bc1", "Styles": "background:\nlightgrey", "Classes": "None", "Text": "EU/1/09/566/003 \u2013 84 Tablets", "ParentId": "eff7f8a9-cab4-4e85-8da6-a0a5555bcf83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">EU/1/09/566/004 \u2013 100 Tablets</span></p>", "ID": "9bbbad50-8f5a-4c25-b8f0-2a0f21437b41", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">EU/1/09/566/004 \u2013 100 Tablets</span>", "ID": "bfe1b8b2-f411-4584-b6bf-1cb4ca114d67", "Styles": "background:lightgrey", "Classes": "None", "Text": "EU/1/09/566/004 \u2013 100 Tablets", "ParentId": "9bbbad50-8f5a-4c25-b8f0-2a0f21437b41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "76b44868-b1e0-47b3-8540-17244d4bd1d4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "ad2b8d49-d4d6-48b0-ae0f-48c5fa7b860b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "bac2798b-adee-4e21-b930-463774fcc610", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "29845546-a3a6-456f-93aa-6ac74dd3bade", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac2798b-adee-4e21-b930-463774fcc610"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "e137a2a3-ec77-4281-a7da-2793d0cfede1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "29845546-a3a6-456f-93aa-6ac74dd3bade"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "4efa37e0-2e90-4269-983c-f6ea085ad039", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "e137a2a3-ec77-4281-a7da-2793d0cfede1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d6a784c1-c7d0-4eed-94e2-f4c3c77ae368", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f26bac91-1436-4137-ba83-467178cbdf96", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d6a784c1-c7d0-4eed-94e2-f4c3c77ae368"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "6767b56e-498d-4de0-bc25-f1f9c57b26e8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "4ca7bb9c-d0ef-43cd-8c8c-56a543a32648", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "6767b56e-498d-4de0-bc25-f1f9c57b26e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d3ba33ce-c5d8-4fb9-862e-d118f1ed18a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cc77df3e-ab2f-4bb3-88cc-24d3888a2adf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d3ba33ce-c5d8-4fb9-862e-d118f1ed18a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "16b2d5eb-60e8-4a26-94ce-41d0e2d1d7a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "19614ff4-558f-4a19-8721-c3544891cb8f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "16b2d5eb-60e8-4a26-94ce-41d0e2d1d7a4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "b0bf0f0b-e5ec-4566-a8ee-6e0167400620", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "9a20cc6c-025d-4114-9ba2-f670540fe92d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b0bf0f0b-e5ec-4566-a8ee-6e0167400620"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "8355b875-b8ab-40fc-98f8-fa64e78a871a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a20cc6c-025d-4114-9ba2-f670540fe92d"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "6b784ac3-30f6-4692-b7a3-5fc3444cd822", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "8355b875-b8ab-40fc-98f8-fa64e78a871a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a7dc5854-5447-4735-8607-0e3421dcdbcb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ca7090b7-8215-4196-838b-08892d02533a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a7dc5854-5447-4735-8607-0e3421dcdbcb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f4088d59-a91a-47be-aeff-0a69efe9240c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5e455b4d-1cbd-4335-bb87-76031277d059", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f4088d59-a91a-47be-aeff-0a69efe9240c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "9288a327-1f00-48ba-ab94-e2911e9f7ec5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "e6cb4e88-6552-4c14-96ac-25b25c4664b5", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9288a327-1f00-48ba-ab94-e2911e9f7ec5"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "7126842d-4f34-42ea-a1ec-f59705dc51a4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e6cb4e88-6552-4c14-96ac-25b25c4664b5"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "342a135c-e17f-4e48-80b8-5cbcc80c150b", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "7126842d-4f34-42ea-a1ec-f59705dc51a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "925a73ab-188e-4b59-a47c-e29f2b972cb9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f873b94e-2e21-4901-98e6-454d6f5b0562", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "925a73ab-188e-4b59-a47c-e29f2b972cb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7432d563-ead2-4eca-a8d5-17f656c60bf0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "533bb7b0-3d94-4ccc-ad99-48bc2c57fd76", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7432d563-ead2-4eca-a8d5-17f656c60bf0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "944aff6e-92bf-44e5-ad68-a6d7294ac691", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "b3692be4-e547-4380-948e-fab6d8113c7d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "944aff6e-92bf-44e5-ad68-a6d7294ac691"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "3e687374-e828-48cb-892f-09703de6d8aa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b3692be4-e547-4380-948e-fab6d8113c7d"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "cf6e8876-e6fc-4edf-8610-580e0892c061", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "3e687374-e828-48cb-892f-09703de6d8aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2919578f-9d59-4060-afb7-46d47cbad3cf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df3efcbf-3ccc-472b-9176-8e8c2aab7e37", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2919578f-9d59-4060-afb7-46d47cbad3cf"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg </span></p>", "ID": "d8a57a38-9bae-4f03-992c-9cadaa7cef2a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg </span>", "ID": "ec474cfe-7bd6-4781-b988-2db5c6b16c1c", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg ", "ParentId": "d8a57a38-9bae-4f03-992c-9cadaa7cef2a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dafa2edd-c447-4e64-8858-62044f6b964e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ee79b208-6db5-4f8c-85a4-fe63bfde6991", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dafa2edd-c447-4e64-8858-62044f6b964e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "792831fb-4e3f-4422-91ee-56c798c9990b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "56bfe4c0-b285-4765-a743-1d3c43ddbe8d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "792831fb-4e3f-4422-91ee-56c798c9990b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "27e11906-26de-427d-9009-5c156241c5af", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "0759dc94-5fb5-4e58-b2d9-892e700aa7b6", "Styles": "border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27e11906-26de-427d-9009-5c156241c5af"}, {"Element": "<b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "f1d810a7-9e3a-4c48-8580-9cbe1dff8867", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0759dc94-5fb5-4e58-b2d9-892e700aa7b6"}, {"Element": "<span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "b78f2468-bca5-4e2a-b5ea-06d18710cc04", "Styles": "None", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "f1d810a7-9e3a-4c48-8580-9cbe1dff8867"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c94c8615-7e64-40c3-af47-20168b3a8cf9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65564bd0-d0ec-43cc-900d-c2df55c56be0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c94c8615-7e64-40c3-af47-20168b3a8cf9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">2D\nbarcode carrying the unique identifier included.</span><span lang=\"EN-GB\" style=\"color:green\"> </span></p>", "ID": "05e3db3a-3fad-4544-977a-926a8547eab5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">2D\nbarcode carrying the unique identifier included.</span>", "ID": "b8f648de-68a6-4af1-8498-a4722a4dee12", "Styles": "color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "05e3db3a-3fad-4544-977a-926a8547eab5"}, {"Element": "<span lang=\"EN-GB\" style=\"color:green\"> </span>", "ID": "b218446e-8a85-45d8-9008-83c0ac766045", "Styles": "color:green", "Classes": "None", "Text": " ", "ParentId": "05e3db3a-3fad-4544-977a-926a8547eab5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a59fa952-1675-4575-9c7e-80c0078f7a50", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0ec347c4-2897-4602-8812-fd4e3297ba83", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a59fa952-1675-4575-9c7e-80c0078f7a50"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f5dff173-16a7-4c94-9a08-d45aa7114f75", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "54541094-a364-45ce-95bc-69b1276ff2ad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f5dff173-16a7-4c94-9a08-d45aa7114f75"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "326c0ade-91ee-481f-a79e-470b00688f7f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>", "ID": "f557ae78-916b-4cfe-b1db-3d31d4d79749", "Styles": "page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "326c0ade-91ee-481f-a79e-470b00688f7f"}, {"Element": "<b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b>", "ID": "cd2fe16f-5489-47d7-ad75-f9a8d1895ecf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f557ae78-916b-4cfe-b1db-3d31d4d79749"}, {"Element": "<span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span>", "ID": "ef20246a-1318-46ef-a1c5-7435b92f9019", "Styles": "None", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA", "ParentId": "cd2fe16f-5489-47d7-ad75-f9a8d1895ecf"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"display:none\">\u00a0</span></p>", "ID": "46ddd1db-1118-4e8a-947b-ab70b747d480", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"display:none\">\u00a0</span>", "ID": "9342dbbf-60fd-45ee-ae5b-866b5699dbfd", "Styles": "display:none", "Classes": "None", "Text": "\u00a0", "ParentId": "46ddd1db-1118-4e8a-947b-ab70b747d480"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">PC:</span></p>", "ID": "db8cc6ff-7717-4c57-bb2a-a89850592b7a", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">PC:</span>", "ID": "b15d2da0-575e-4c1b-95df-12fc72cf399a", "Styles": "None", "Classes": "None", "Text": "PC:", "ParentId": "db8cc6ff-7717-4c57-bb2a-a89850592b7a"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">SN:</span></p>", "ID": "c441163c-8685-4824-b00f-81a4b61e0b19", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">SN:</span>", "ID": "f7116feb-a100-46c5-abf4-caf0f8b5a24a", "Styles": "None", "Classes": "None", "Text": "SN:", "ParentId": "c441163c-8685-4824-b00f-81a4b61e0b19"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">NN:</span></p>", "ID": "a3b0b926-5744-483f-9f38-e714eb55b54f", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">NN:</span>", "ID": "88e5d23b-84f8-425f-8549-af36e11bd483", "Styles": "None", "Classes": "None", "Text": "NN:", "ParentId": "a3b0b926-5744-483f-9f38-e714eb55b54f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cb9e2de9-22d6-4ea1-9676-2a5ca164bf4a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "18dda2b9-43ac-4698-bc75-c1b224959381", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cb9e2de9-22d6-4ea1-9676-2a5ca164bf4a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "7989144b-7452-4054-b9c0-28d12870994f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "36572679-9751-4012-a0eb-4ef2f1e8d636", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "7989144b-7452-4054-b9c0-28d12870994f"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "cc0b5ced-fc40-48a4-aac2-355e11c9c412", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "36572679-9751-4012-a0eb-4ef2f1e8d636"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "be9aa07f-f80c-496c-935c-6aff75cdb0a8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "62362ba6-e0d5-45a1-9a0b-f9ddde081424", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be9aa07f-f80c-496c-935c-6aff75cdb0a8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "196d91d9-c91c-4b2a-9479-f6c513379f2a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "62362ba6-e0d5-45a1-9a0b-f9ddde081424"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr style=\"height:39.25pt\">\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:39.25pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON\n  BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Immediate packaging (blister foil)</span></b></p>\n</td>\n</tr>\n</table>", "ID": "8b85c8c0-db9a-4743-b0b2-d37030f4a5bd", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr style=\"height:39.25pt\">\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:39.25pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON\n  BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Immediate packaging (blister foil)</span></b></p>\n</td>\n</tr>", "ID": "f9f2d65b-c3d6-44a2-bb2b-a66b3bc3ed58", "Styles": "height:39.25pt", "Classes": "None", "Text": "  ", "ParentId": "8b85c8c0-db9a-4743-b0b2-d37030f4a5bd"}, {"Element": "<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:39.25pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON\n  BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Immediate packaging (blister foil)</span></b></p>\n</td>", "ID": "08fb552b-acdc-4533-8553-3e8b2ddce884", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:39.25pt", "Classes": "None", "Text": "    ", "ParentId": "f9f2d65b-c3d6-44a2-bb2b-a66b3bc3ed58"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON\n  BLISTERS OR STRIPS</span></b></p>", "ID": "8c146cb2-b24c-4665-a601-e38b5df62cfb", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08fb552b-acdc-4533-8553-3e8b2ddce884"}, {"Element": "<b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON\n  BLISTERS OR STRIPS</span></b>", "ID": "99504ac6-bee0-42d4-82eb-4ad36659a83f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8c146cb2-b24c-4665-a601-e38b5df62cfb"}, {"Element": "<span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON\n  BLISTERS OR STRIPS</span>", "ID": "c177afdc-c261-42b9-9625-a80644d58266", "Styles": "None", "Classes": "None", "Text": "MINIMUM PARTICULARS TO APPEAR ON   BLISTERS OR STRIPS", "ParentId": "99504ac6-bee0-42d4-82eb-4ad36659a83f"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "63fa8cea-1137-4de8-bdee-375066557c8a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08fb552b-acdc-4533-8553-3e8b2ddce884"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c481aede-a1bd-4448-8093-ccef5dbfe2be", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "63fa8cea-1137-4de8-bdee-375066557c8a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1c07174a-7cf8-4147-9b7c-07efdeee54f7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c481aede-a1bd-4448-8093-ccef5dbfe2be"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Immediate packaging (blister foil)</span></b></p>", "ID": "0fc3051d-9b65-4a80-9e85-dc73980b5ea2", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08fb552b-acdc-4533-8553-3e8b2ddce884"}, {"Element": "<b><span lang=\"EN-GB\">Immediate packaging (blister foil)</span></b>", "ID": "85d85be3-2789-47d8-82c9-6ae665491787", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0fc3051d-9b65-4a80-9e85-dc73980b5ea2"}, {"Element": "<span lang=\"EN-GB\">Immediate packaging (blister foil)</span>", "ID": "b477917c-2515-4543-aad8-5df214627fbc", "Styles": "None", "Classes": "None", "Text": "Immediate packaging (blister foil)", "ParentId": "85d85be3-2789-47d8-82c9-6ae665491787"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "e6ec67ce-68a9-4fa1-96b3-24083b7f145d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8e14b320-2e90-4914-a3cc-29ca656d54c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e6ec67ce-68a9-4fa1-96b3-24083b7f145d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d14b00f0-7500-4f96-b5fb-f50623f91421", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e14b320-2e90-4914-a3cc-29ca656d54c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9e7640b0-723f-4d47-a876-b78267c47e24", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "4dfea296-7494-499e-8b8f-93a511296718", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e7640b0-723f-4d47-a876-b78267c47e24"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5635e437-4a2e-432a-b9c4-1434b721b16c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4dfea296-7494-499e-8b8f-93a511296718"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MEDICINAL PRODUCT</span></b></p>\n</td>\n</tr>\n</table>", "ID": "1c8cfd1c-220c-41a4-8fa3-77773fff1a8e", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MEDICINAL PRODUCT</span></b></p>\n</td>\n</tr>", "ID": "db5a2980-1b5f-473c-a876-91c93c39a6e5", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "1c8cfd1c-220c-41a4-8fa3-77773fff1a8e"}, {"Element": "<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MEDICINAL PRODUCT</span></b></p>\n</td>", "ID": "c7dd2a87-7ecc-4612-ae44-9e34277bf9ed", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "db5a2980-1b5f-473c-a876-91c93c39a6e5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "58e90837-73ff-48b1-ab91-37d6d47a2fb4", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c7dd2a87-7ecc-4612-ae44-9e34277bf9ed"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MEDICINAL PRODUCT</span></b>", "ID": "e8c4dc9d-7b5e-4300-ad7b-82b8d652968c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58e90837-73ff-48b1-ab91-37d6d47a2fb4"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MEDICINAL PRODUCT</span>", "ID": "5205042f-bff1-4637-a024-a418ca23abc6", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME   OF THE MEDICINAL PRODUCT", "ParentId": "e8c4dc9d-7b5e-4300-ad7b-82b8d652968c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5517959f-22ce-4853-848f-b05527dcb5c5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8d7d863d-7d1d-4667-a5d4-4e17136163ae", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5517959f-22ce-4853-848f-b05527dcb5c5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span></p>", "ID": "03c1489e-050c-42ff-8bc8-6b2b0eec666c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span>", "ID": "5889c4be-c037-40b2-90ea-0714a5a31792", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg film\u2011coated tablets ", "ParentId": "03c1489e-050c-42ff-8bc8-6b2b0eec666c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine</span></p>", "ID": "ed4a1fb9-5de9-4c89-a692-dd57d8125689", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine</span>", "ID": "de4a973c-49bb-412d-aa4b-e948a4b5bbbd", "Styles": "None", "Classes": "None", "Text": "Lamivudine", "ParentId": "ed4a1fb9-5de9-4c89-a692-dd57d8125689"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b7792d32-972a-4fa4-8780-b4426066cb11", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "17e10ba7-4548-48d1-9cc1-02b5249b898f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b7792d32-972a-4fa4-8780-b4426066cb11"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cc16a4df-0495-4807-be25-334629d86f0b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "17e10ba7-4548-48d1-9cc1-02b5249b898f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "4f99ffd1-333c-4cbc-90e8-7ef2b723ef17", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8a0cc5b4-6c9f-404b-a6df-7ccc4e16aecf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f99ffd1-333c-4cbc-90e8-7ef2b723ef17"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f584a6e9-2ecd-4f01-a595-3572f9e5eca1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8a0cc5b4-6c9f-404b-a6df-7ccc4e16aecf"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</td>\n</tr>\n</table>", "ID": "4b5ab4fd-220b-4a7a-9313-8970a13b3a62", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</td>\n</tr>", "ID": "43965218-5e00-4141-a086-b78376c93d11", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "4b5ab4fd-220b-4a7a-9313-8970a13b3a62"}, {"Element": "<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</td>", "ID": "e6e93059-aec3-4d0d-833d-e3a03f3428d3", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "43965218-5e00-4141-a086-b78376c93d11"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "3ab58705-a9f0-4cea-a9c3-a0b8ea7dd9df", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e6e93059-aec3-4d0d-833d-e3a03f3428d3"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "59dece83-2c35-46c8-8ced-dfea56837207", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3ab58705-a9f0-4cea-a9c3-a0b8ea7dd9df"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\n  OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "96ee1c35-e056-4421-8300-2bbe390f270d", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME   OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "59dece83-2c35-46c8-8ced-dfea56837207"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "fbe515f3-12c3-4ad9-9e1c-e0a9d25be36b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "250ee06e-1ed9-4a09-a9dd-3c0f7d30c8c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbe515f3-12c3-4ad9-9e1c-e0a9d25be36b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "38b77ea1-d102-4bf6-9c7b-bba6d7e710b4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "250ee06e-1ed9-4a09-a9dd-3c0f7d30c8c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">TEVA B.V.</span></p>", "ID": "fa6316b1-fea9-46a4-bfe5-3f5322c3e4aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">TEVA B.V.</span>", "ID": "18bf509c-353e-4f80-8073-d91989fabc93", "Styles": "None", "Classes": "None", "Text": "TEVA B.V.", "ParentId": "fa6316b1-fea9-46a4-bfe5-3f5322c3e4aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "72a95262-23a6-4598-b4b0-1202e486c9ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "dc89e490-60ee-4603-9ff9-6019b84a541e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "72a95262-23a6-4598-b4b0-1202e486c9ef"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e15d3e11-a370-4bf2-ba29-cd5cc366a368", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc89e490-60ee-4603-9ff9-6019b84a541e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "e9aefb04-ead8-4008-9995-d4a1e071960b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "14820dea-70f0-4c37-8d9d-f25cda3e5c52", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e9aefb04-ead8-4008-9995-d4a1e071960b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b8399e2f-0cd2-4f6b-a0ca-1cb2e1461ac4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "14820dea-70f0-4c37-8d9d-f25cda3e5c52"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\n  DATE</span></b></p>\n</td>\n</tr>\n</table>", "ID": "4cafb4cc-8ff8-47c4-b88d-763e755e488f", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\n  DATE</span></b></p>\n</td>\n</tr>", "ID": "ee53ba0a-750f-4ada-824e-0bf498d62cfc", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "4cafb4cc-8ff8-47c4-b88d-763e755e488f"}, {"Element": "<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\n  DATE</span></b></p>\n</td>", "ID": "27886e92-6c3f-4503-95b7-5f24e3d9cc60", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ee53ba0a-750f-4ada-824e-0bf498d62cfc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\n  DATE</span></b></p>", "ID": "b037aff5-f2ee-4437-b405-442184b44162", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27886e92-6c3f-4503-95b7-5f24e3d9cc60"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\n  DATE</span></b>", "ID": "be952a66-ead0-489c-8f26-f132bd019ff7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b037aff5-f2ee-4437-b405-442184b44162"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\n  DATE</span>", "ID": "ec89ff64-2dea-4973-a2e5-c82529b8b95e", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY   DATE", "ParentId": "be952a66-ead0-489c-8f26-f132bd019ff7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67164a54-0e32-41e2-8e2c-d87a73396d79", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fe97a4c9-734b-4f48-8943-bd3d2263451e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67164a54-0e32-41e2-8e2c-d87a73396d79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "1e758457-42c6-45bd-8cb8-47ff71726fff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "9b2fa492-8bb3-4aa4-b9e5-98967c5342b1", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "1e758457-42c6-45bd-8cb8-47ff71726fff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2cf75cc9-06e2-44ac-a779-b856e9c99e63", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a9f3a92a-72e0-4786-99e2-4fdffe6fd157", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2cf75cc9-06e2-44ac-a779-b856e9c99e63"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cbec9468-af08-40a1-99e6-95ab1c7cafd2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "666bd5d1-222d-4cbb-b606-17649ff238e8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cbec9468-af08-40a1-99e6-95ab1c7cafd2"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\n  NUMBER</span></b></p>\n</td>\n</tr>\n</table>", "ID": "0c188b6d-d010-47fb-83b9-d3df83502698", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\n  NUMBER</span></b></p>\n</td>\n</tr>", "ID": "5af34aaa-421f-4b8e-8535-9b5766f3b93b", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "0c188b6d-d010-47fb-83b9-d3df83502698"}, {"Element": "<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\n  NUMBER</span></b></p>\n</td>", "ID": "30ba1aba-9d6d-486d-bf56-72456f2b7f0d", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5af34aaa-421f-4b8e-8535-9b5766f3b93b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\n  NUMBER</span></b></p>", "ID": "00a6b9db-f74b-4a08-8843-bf28bbb2ccbe", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "30ba1aba-9d6d-486d-bf56-72456f2b7f0d"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\n  NUMBER</span></b>", "ID": "dfe6c0ce-485e-4337-8a65-1dfcb7ca29a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00a6b9db-f74b-4a08-8843-bf28bbb2ccbe"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\n  NUMBER</span>", "ID": "7bf7b486-3660-4494-9993-33cd216e8a28", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH   NUMBER", "ParentId": "dfe6c0ce-485e-4337-8a65-1dfcb7ca29a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4bc5b305-449f-4dce-99fc-34fd8997e850", "Styles": "margin-right:5.65pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "63ad65d1-0f87-47cf-849b-92c01495e74a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4bc5b305-449f-4dce-99fc-34fd8997e850"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "a246fcb4-c38a-4843-850a-76e8b0282be9", "Styles": "margin-right:5.65pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "66807fea-3fe4-4442-910e-d8768fbcfdd8", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "a246fcb4-c38a-4843-850a-76e8b0282be9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8bf05a19-10b0-451f-81bf-f66461c41dba", "Styles": "margin-right:5.65pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b1a3f0f3-0cc6-45ab-9e0f-859a32e35c92", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8bf05a19-10b0-451f-81bf-f66461c41dba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "75cd5433-115b-43c8-a667-8706daf42d13", "Styles": "margin-right:5.65pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e1bc1d4e-0188-4fdd-b9b8-4fa7c53c6616", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "75cd5433-115b-43c8-a667-8706daf42d13"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</td>\n</tr>\n</table>", "ID": "7d4302d9-2f84-49fa-b281-54a574f21c3e", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr>\n<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</td>\n</tr>", "ID": "67cdde2a-e39d-4394-acbf-f73de496bd4d", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "7d4302d9-2f84-49fa-b281-54a574f21c3e"}, {"Element": "<td style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</td>", "ID": "d79bdf39-53b2-4f5f-bffd-bb633d51215e", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "67cdde2a-e39d-4394-acbf-f73de496bd4d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>", "ID": "6fcee67a-44b0-45e4-9286-4470e7bfa0ca", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d79bdf39-53b2-4f5f-bffd-bb633d51215e"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b>", "ID": "7e5f2e37-ffe5-42cf-82a5-7482431ec348", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6fcee67a-44b0-45e4-9286-4470e7bfa0ca"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span>", "ID": "a41a6a14-61d2-4b7d-9c19-457f5b8ed32c", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER", "ParentId": "7e5f2e37-ffe5-42cf-82a5-7482431ec348"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ae39069a-afe7-4c25-a18d-ddcedfd711b4", "Styles": "margin-right:5.65pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "56d61284-f253-47cb-850d-2348d7348750", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ae39069a-afe7-4c25-a18d-ddcedfd711b4"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "40bca918-29d9-42d8-82e4-2919bee06322", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "3f3242de-393b-412c-a14f-beee57a12f81", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "40bca918-29d9-42d8-82e4-2919bee06322"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">Tablet container</span></b></p>\n</div>", "ID": "afed3f70-4f04-44aa-827f-6ca1d4bdf1f0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING</span></b></p>", "ID": "f39beed5-59f5-4093-839f-dad6c762f7b8", "Styles": "border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "afed3f70-4f04-44aa-827f-6ca1d4bdf1f0"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING</span></b>", "ID": "fc1d3f37-dd41-4ea2-bd09-863ec15557d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f39beed5-59f5-4093-839f-dad6c762f7b8"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING</span>", "ID": "0ef2c031-3bde-40a1-9a93-da12cf0218b8", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING", "ParentId": "fc1d3f37-dd41-4ea2-bd09-863ec15557d2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "179e9e9c-751d-4526-8cdf-3e6bae1e73a8", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "afed3f70-4f04-44aa-827f-6ca1d4bdf1f0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d5e68284-26b0-40b2-bb9c-7000c41f1c43", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "179e9e9c-751d-4526-8cdf-3e6bae1e73a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">Tablet container</span></b></p>", "ID": "5f9c0243-ed65-404b-9475-6abe0fcfe417", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "afed3f70-4f04-44aa-827f-6ca1d4bdf1f0"}, {"Element": "<b><span lang=\"EN-GB\">Tablet container</span></b>", "ID": "906b6fd4-1099-4434-94a4-cc5a57f75543", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5f9c0243-ed65-404b-9475-6abe0fcfe417"}, {"Element": "<span lang=\"EN-GB\">Tablet container</span>", "ID": "b5b5285b-5b4d-4721-bada-86e08347ca86", "Styles": "None", "Classes": "None", "Text": "Tablet container", "ParentId": "906b6fd4-1099-4434-94a4-cc5a57f75543"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d97c377b-6f49-4945-b422-2ff2edb6d37f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f1101594-544c-47ac-9edb-88e7ed52228c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d97c377b-6f49-4945-b422-2ff2edb6d37f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "203af7fe-dfce-42be-b809-e55ba6a108e0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a157b272-b712-41cd-88d3-6323c6f0818a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "203af7fe-dfce-42be-b809-e55ba6a108e0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "4c2a326f-7d70-4ff7-9f0a-d353fc517670", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "ebafc107-1829-4f84-b72e-b8e363d6876b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c2a326f-7d70-4ff7-9f0a-d353fc517670"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "9a178db7-a61f-46f5-b1ef-5d54280eadc2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ebafc107-1829-4f84-b72e-b8e363d6876b"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "f64f34db-76c5-4b0a-b4a6-69172ba437a5", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "9a178db7-a61f-46f5-b1ef-5d54280eadc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "326e9b3a-4df1-4aef-a044-5feb9ae015f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1021d366-68b9-4ebc-98d8-6e0868dd0210", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "326e9b3a-4df1-4aef-a044-5feb9ae015f6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span></p>", "ID": "7731595d-7499-4030-9ddf-73f4be1f47c4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film\u2011coated\ntablets </span>", "ID": "11514950-cc6d-40d9-ab11-a6aae9824d1a", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg film\u2011coated tablets ", "ParentId": "7731595d-7499-4030-9ddf-73f4be1f47c4"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine </span></p>", "ID": "a91a04c9-f817-4988-8d09-c9e0d07eb495", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine </span>", "ID": "101630b8-ad53-42b7-8613-119d8290f061", "Styles": "None", "Classes": "None", "Text": "Lamivudine ", "ParentId": "a91a04c9-f817-4988-8d09-c9e0d07eb495"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eca619a3-6557-430b-b05d-90e3b3d19d7e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "577a2092-d863-4072-b388-1d0d8368090e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eca619a3-6557-430b-b05d-90e3b3d19d7e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ebe6363-83f9-4b55-803c-87d5e770495e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "af07e294-0393-4090-ba17-d3ea9ae9fb89", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ebe6363-83f9-4b55-803c-87d5e770495e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>\n</div>", "ID": "ce267964-cb36-4e3b-b628-0f5c985947ee", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>", "ID": "650d023a-3b49-4394-a319-cf12c8cf993a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ce267964-cb36-4e3b-b628-0f5c985947ee"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b>", "ID": "4aa2abef-4865-4b63-8da0-6ea9be4e915f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "650d023a-3b49-4394-a319-cf12c8cf993a"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span>", "ID": "a35e1b01-c37a-4256-bd95-49a3b1c7b68b", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "4aa2abef-4865-4b63-8da0-6ea9be4e915f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6a7b2b1d-9def-4529-990a-1fc9a673f631", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "deeb51b7-3fc5-4c34-8921-401362d13c62", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6a7b2b1d-9def-4529-990a-1fc9a673f631"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Each film\u2011coated tablet contains 100\u00a0mg\nof lamivudine</span></p>", "ID": "aa6a9ece-3d76-433d-98ff-75442dfb7e21", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Each film\u2011coated tablet contains 100\u00a0mg\nof lamivudine</span>", "ID": "e82e6b76-29e8-4eeb-823d-57cea39d02ae", "Styles": "None", "Classes": "None", "Text": "Each film\u2011coated tablet contains 100\u00a0mg of lamivudine", "ParentId": "aa6a9ece-3d76-433d-98ff-75442dfb7e21"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f204d06a-604d-4511-9f23-b43931000841", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "86a59725-db22-4858-96ea-e1c6596c2369", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f204d06a-604d-4511-9f23-b43931000841"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9318d8e8-8324-4560-bff9-ef29f1cf5c4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9f830002-6815-4ad0-95d5-e5fc7ce6b360", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9318d8e8-8324-4560-bff9-ef29f1cf5c4e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "d7e2208e-b6d0-4961-97ae-8118dc25ff49", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "de967a6c-5692-43f4-8c07-ae6812827f51", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7e2208e-b6d0-4961-97ae-8118dc25ff49"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "7caa52ac-5855-4b66-941d-4aa7f2780f82", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de967a6c-5692-43f4-8c07-ae6812827f51"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "fb0c5a6f-f8d5-4483-b969-78c0807393b2", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "7caa52ac-5855-4b66-941d-4aa7f2780f82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b3c1498a-3964-44b9-8cc0-6508928eb582", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5375a343-00d6-432e-9077-e28f90b63eec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b3c1498a-3964-44b9-8cc0-6508928eb582"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c10a1754-d612-4038-8384-e280ffaa01a3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "342cc98c-2836-42c6-9999-46f82d8ae780", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c10a1754-d612-4038-8384-e280ffaa01a3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "ac33dcb2-8d11-40b0-bc71-eeef0db72862", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "39d8eec5-87d9-47f7-aad9-0ba7a93c12e9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ac33dcb2-8d11-40b0-bc71-eeef0db72862"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "88e05b09-6a4c-4bbb-ac5a-e1777f677f18", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "39d8eec5-87d9-47f7-aad9-0ba7a93c12e9"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "2cc693e7-3789-4492-b6a5-427e390020c9", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "88e05b09-6a4c-4bbb-ac5a-e1777f677f18"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f4d702c-ab2f-4d75-9293-2cbed7a2f0a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1de4dbe0-f5f2-4984-a3e8-dabd41b79d33", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f4d702c-ab2f-4d75-9293-2cbed7a2f0a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Tablet container:</span></p>", "ID": "f5a8a1d0-e62c-4a99-9886-f4ae7f70de8c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">Tablet container:</span>", "ID": "5120637b-079b-4e13-a6ef-e22b4c8d5410", "Styles": "background:lightgrey", "Classes": "None", "Text": "Tablet container:", "ParentId": "f5a8a1d0-e62c-4a99-9886-f4ae7f70de8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">60 film-coated\ntablets</span></p>", "ID": "9d4b5a02-4541-4962-916b-7f7df4975924", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">60 film-coated\ntablets</span>", "ID": "0adbac0b-b500-40bd-93f8-a310c02da85a", "Styles": "None", "Classes": "None", "Text": "60 film-coated tablets", "ParentId": "9d4b5a02-4541-4962-916b-7f7df4975924"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a1bb0193-4861-4d7f-874c-d9146cf7fc84", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8527f7a1-5f49-44e5-808d-44ccc60e9c4e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a1bb0193-4861-4d7f-874c-d9146cf7fc84"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5adb8b2d-d67b-4fa6-913d-e040d667d8b3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a00914a8-898c-4af2-b919-f541e7f51a17", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5adb8b2d-d67b-4fa6-913d-e040d667d8b3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "e09e2985-b75a-4788-8693-1f0876fad03b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "4d07fd38-7529-4658-b1e2-e36a53d1a28f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e09e2985-b75a-4788-8693-1f0876fad03b"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "3fb06ef5-8dfa-48e4-90e6-1895c1d89ece", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d07fd38-7529-4658-b1e2-e36a53d1a28f"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "94ec588e-d7cd-4937-acfb-725c9ddadccc", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "3fb06ef5-8dfa-48e4-90e6-1895c1d89ece"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "31a45b77-119c-4309-a50d-6d69042222be", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "3796a188-1333-43b5-96c3-c782347cf743", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "31a45b77-119c-4309-a50d-6d69042222be"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b007c222-1492-4bfa-8264-d5b8920e11ac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3796a188-1333-43b5-96c3-c782347cf743"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Read the package leaflet before use </span></p>", "ID": "00193689-66b6-46bd-a4d7-c3e6213ea413", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Read the package leaflet before use </span>", "ID": "db056987-dfdc-424d-b528-cac552ad5349", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use ", "ParentId": "00193689-66b6-46bd-a4d7-c3e6213ea413"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "97ac4919-6694-42f7-9739-6f6f01f6e507", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "52a02db2-cf57-4423-8cef-4e2cf936a99e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "97ac4919-6694-42f7-9739-6f6f01f6e507"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Oral use </span></p>", "ID": "b80056f3-e382-4695-bcd4-320390b76d09", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Oral use </span>", "ID": "f9ad80fd-329e-4d8e-a6ba-1f85ba70f0a6", "Styles": "None", "Classes": "None", "Text": "Oral use ", "ParentId": "b80056f3-e382-4695-bcd4-320390b76d09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b0a025ce-7fda-4a89-95f0-435f15207c9c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "033ea0b1-4e2b-4c1c-ac2d-315145274501", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b0a025ce-7fda-4a89-95f0-435f15207c9c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3d7e6466-2bf7-475a-a15b-c03bc8ac1762", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eb1a82d0-5089-4ca7-8e3a-c3d4b1462cec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3d7e6466-2bf7-475a-a15b-c03bc8ac1762"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span lang=\"EN-GB\">SIGHT AND </span></b><b><span lang=\"EN-GB\">REACH OF CHILDREN</span></b></p>\n</div>", "ID": "8f6d86e7-02b3-4f4f-b3e7-08edfb477621", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b><b><span lang=\"EN-GB\">SIGHT AND </span></b><b><span lang=\"EN-GB\">REACH OF CHILDREN</span></b></p>", "ID": "6707a9a6-f93d-4ea7-9068-0abfdebe85b7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8f6d86e7-02b3-4f4f-b3e7-08edfb477621"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span></b>", "ID": "633e27d8-42e1-4f3e-9624-326d9a4d4105", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6707a9a6-f93d-4ea7-9068-0abfdebe85b7"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE </span>", "ID": "dc9d5c44-9c63-4b0c-998c-8a81498f78c6", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE ", "ParentId": "633e27d8-42e1-4f3e-9624-326d9a4d4105"}, {"Element": "<b><span lang=\"EN-GB\">SIGHT AND </span></b>", "ID": "7fc718f0-12c5-492a-9c80-b3cbee971162", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6707a9a6-f93d-4ea7-9068-0abfdebe85b7"}, {"Element": "<span lang=\"EN-GB\">SIGHT AND </span>", "ID": "897a5d49-ccfa-4119-b47e-8ccbc0e234bf", "Styles": "None", "Classes": "None", "Text": "SIGHT AND ", "ParentId": "7fc718f0-12c5-492a-9c80-b3cbee971162"}, {"Element": "<b><span lang=\"EN-GB\">REACH OF CHILDREN</span></b>", "ID": "9cceb0df-ebb9-4304-bb2a-e4810574112e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6707a9a6-f93d-4ea7-9068-0abfdebe85b7"}, {"Element": "<span lang=\"EN-GB\">REACH OF CHILDREN</span>", "ID": "a0089421-1896-4ff0-8acd-cc896ffcead5", "Styles": "None", "Classes": "None", "Text": "REACH OF CHILDREN", "ParentId": "9cceb0df-ebb9-4304-bb2a-e4810574112e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0f18ea8c-d94d-4b90-85ad-3bc14eeeaf7d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "464a2ef6-d59e-454f-b913-99d2f178e4d3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0f18ea8c-d94d-4b90-85ad-3bc14eeeaf7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the sight\nand reach of children.</span></p>", "ID": "32e02910-65ac-42e0-9683-6cebdcf9325a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Keep out of the sight\nand reach of children.</span>", "ID": "f4968af0-d7ab-44be-9041-3eb85a07639b", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "32e02910-65ac-42e0-9683-6cebdcf9325a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "50ded113-c853-4213-b9cd-17c7b263655b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b9028d33-94cb-4088-9410-dfc0994616b7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50ded113-c853-4213-b9cd-17c7b263655b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "65aafae1-29c2-46f1-8cdf-df1e82961715", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d47a724c-738c-4811-bfb3-2ed2e8946a17", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65aafae1-29c2-46f1-8cdf-df1e82961715"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "d96de4c4-ad37-4a50-a313-2efd31ae3ed0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "bc7e62d3-ca57-4fea-892f-0bc38e2b4fdc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d96de4c4-ad37-4a50-a313-2efd31ae3ed0"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "1c734557-9b5a-4a26-a825-7148bb43edf2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc7e62d3-ca57-4fea-892f-0bc38e2b4fdc"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "c0ea5c0e-802a-4894-b16c-d45a88037d36", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "1c734557-9b5a-4a26-a825-7148bb43edf2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e21b36b0-64ac-42b1-8b15-4491ab80fdce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d73a924c-10b7-4cf4-8934-94593726f318", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e21b36b0-64ac-42b1-8b15-4491ab80fdce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "55f114a4-c894-46db-9cb7-e4ff862e9149", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "668ac719-6734-4769-99e3-22970e098530", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "55f114a4-c894-46db-9cb7-e4ff862e9149"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "397077fe-4399-4332-bea1-d44c1376e278", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "2ff0bc57-a64d-49af-bf3f-a00f106d7693", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "397077fe-4399-4332-bea1-d44c1376e278"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "9afce58f-711e-4932-b6b6-4cceecb24312", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ff0bc57-a64d-49af-bf3f-a00f106d7693"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "e39f5041-64df-443e-8c2d-16e6d0d6f5ee", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "9afce58f-711e-4932-b6b6-4cceecb24312"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bb42ff79-b983-4ced-aa6c-246479fb6ab0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a5d03250-6347-4c78-976d-91821221f0e0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bb42ff79-b983-4ced-aa6c-246479fb6ab0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "ba79ee5d-693f-4579-98e8-13a40ecab8e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "7e8088dd-4978-43c7-851e-0d51c37f28bb", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "ba79ee5d-693f-4579-98e8-13a40ecab8e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c8e20909-1244-4915-9e75-80236eb6f89c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65a18fe9-9b3d-4bf6-aaf3-8c46a76e942e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c8e20909-1244-4915-9e75-80236eb6f89c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "48b46373-b4fa-4dd2-828f-f127504b7665", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "6f541f51-7f7f-4881-881d-4b428da9b19a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48b46373-b4fa-4dd2-828f-f127504b7665"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "c9ade249-1428-437e-8382-fcb1814a5269", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6f541f51-7f7f-4881-881d-4b428da9b19a"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "59dbbd68-e1bd-41e9-834e-efe536a7d323", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "c9ade249-1428-437e-8382-fcb1814a5269"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "460d4c36-bfc6-4b6e-9245-01f0d3a29cd0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75227200-b2a7-446b-8b1c-185cf58af7bb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "460d4c36-bfc6-4b6e-9245-01f0d3a29cd0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3916996e-6ba1-4bcf-9768-fc17aa9ffdfe", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "30f946de-81f1-4bea-a6c8-ee5704d6991f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3916996e-6ba1-4bcf-9768-fc17aa9ffdfe"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "276c6b87-ddb7-47d8-9568-b05ff6ac7dbd", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "8598736a-1726-4a1a-aa94-bb5f0d73a14f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "276c6b87-ddb7-47d8-9568-b05ff6ac7dbd"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "8df62f9e-5fed-4dc8-8b35-f6133e85350c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8598736a-1726-4a1a-aa94-bb5f0d73a14f"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "00519777-8d95-4f78-acb3-5e123ecddae6", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "8df62f9e-5fed-4dc8-8b35-f6133e85350c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dccde97d-24bc-4e2d-9d3b-cbcdc04d3610", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3d619134-1932-424f-a92d-4635bd528bc4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dccde97d-24bc-4e2d-9d3b-cbcdc04d3610"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "274e2983-1199-40ff-ad00-58458d7a55c7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5b5ff783-5494-47d9-977d-d5d469ac7541", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "274e2983-1199-40ff-ad00-58458d7a55c7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "62690bc5-8531-4a22-add3-aa3ae3418b8f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "7151f6ae-7134-444c-aa14-cade74efb23d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "62690bc5-8531-4a22-add3-aa3ae3418b8f"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "d860e5f8-9c60-4c95-addc-570911e23487", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7151f6ae-7134-444c-aa14-cade74efb23d"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "29557ce5-b0c1-4f60-8b29-5217b7d9e45c", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "d860e5f8-9c60-4c95-addc-570911e23487"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "52a0ec41-24a8-4578-a9bb-67251f5790bb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e251d4a-7420-484e-af71-e8884ed26b63", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "52a0ec41-24a8-4578-a9bb-67251f5790bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva B.V.</span></p>", "ID": "b91c0db5-fa54-40ab-8378-f375cc3a13b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">Teva B.V.</span>", "ID": "6de2de72-f679-4145-a90b-de1aed62d75f", "Styles": "None", "Classes": "None", "Text": "Teva B.V.", "ParentId": "b91c0db5-fa54-40ab-8378-f375cc3a13b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Swensweg 5</span></p>", "ID": "6ea88e7b-e3ba-4041-8670-d57bc9010003", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">Swensweg 5</span>", "ID": "1468dd1e-307c-413f-b746-2e88058c1af2", "Styles": "None", "Classes": "None", "Text": "Swensweg 5", "ParentId": "6ea88e7b-e3ba-4041-8670-d57bc9010003"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">2031GA Haarlem</span></p>", "ID": "29651266-0c75-4bb7-a9e6-f9103ab55807", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"DE\">2031GA Haarlem</span>", "ID": "7334beb2-1ca5-40de-b919-f34d702a4f8c", "Styles": "None", "Classes": "None", "Text": "2031GA Haarlem", "ParentId": "29651266-0c75-4bb7-a9e6-f9103ab55807"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Netherlands</span></p>", "ID": "b6f2f758-2241-4b54-9080-dbb02778ce82", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Netherlands</span>", "ID": "754ef823-ca34-429a-8726-9ce2b8a7d5f6", "Styles": "None", "Classes": "None", "Text": "Netherlands", "ParentId": "b6f2f758-2241-4b54-9080-dbb02778ce82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3465af0-7e1a-4eb7-9c0f-cca9b3cf5762", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8f173454-e095-4af2-8d2a-c6f90c7c06b4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3465af0-7e1a-4eb7-9c0f-cca9b3cf5762"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "45c31406-0bfb-4c74-baff-9ed5c541df48", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6e3f2611-291a-425d-b177-191ce8efef02", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "45c31406-0bfb-4c74-baff-9ed5c541df48"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "8fad5297-8630-4f36-9f89-f4a842f1fef9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "eea6a783-0dca-4971-bce7-f9757c8fea2d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fad5297-8630-4f36-9f89-f4a842f1fef9"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "ad3974fb-9bfa-413e-a218-959e0209b08f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eea6a783-0dca-4971-bce7-f9757c8fea2d"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "172b6b19-2dcc-439e-8d91-1d9a93b99a63", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "ad3974fb-9bfa-413e-a218-959e0209b08f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "541ada17-d037-4a04-9e9f-f6a0dea9bcc9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/09/566/005</span></p>", "ID": "8a85d6ee-85f9-49b7-8aec-5b3f220962dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">EU/1/09/566/005</span>", "ID": "40faa555-843d-4f0c-88ed-7d002db5bf0b", "Styles": "None", "Classes": "None", "Text": "EU/1/09/566/005", "ParentId": "8a85d6ee-85f9-49b7-8aec-5b3f220962dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">EU/1/09/566/006 </span></p>", "ID": "cbfcdf4f-6b5f-4876-810e-bbde325af839", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">EU/1/09/566/006 </span>", "ID": "5b265a78-1a90-4f1a-bb68-b211b6c2d070", "Styles": "background:lightgrey", "Classes": "None", "Text": "EU/1/09/566/006 ", "ParentId": "cbfcdf4f-6b5f-4876-810e-bbde325af839"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "68ea584d-b412-4e8d-af47-d7986f96e108", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "a3db0c20-409a-4555-a810-df83f2105c2b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "6ea1ddcc-7b6f-4ab0-aa70-487620a7cff4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "b485cdf3-58ed-4511-989f-c84f5238ec3b", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ea1ddcc-7b6f-4ab0-aa70-487620a7cff4"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "9df41444-4313-4f2a-a69b-b5c868a90c39", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b485cdf3-58ed-4511-989f-c84f5238ec3b"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "c6a551a0-3caa-4b07-8811-68b1bc901609", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "9df41444-4313-4f2a-a69b-b5c868a90c39"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "16ab6d17-833b-4056-998a-d9c16c7e3e33", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "51ac5803-348a-4c98-953c-255d639afacf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "16ab6d17-833b-4056-998a-d9c16c7e3e33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "a9b4a646-c3a5-4f8a-8f1a-8b54d370acef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "6573a806-d872-41bf-b678-158dd0ee144c", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "a9b4a646-c3a5-4f8a-8f1a-8b54d370acef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d87854ad-a39b-42cf-a555-39c6f7ed7965", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1ed8567d-b4e5-499c-a685-1da51d9ec5d7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d87854ad-a39b-42cf-a555-39c6f7ed7965"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6e82c1a2-2ca0-47a1-8423-2afb92ac93dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bb4130e3-7187-45b4-baa1-f907655ed199", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6e82c1a2-2ca0-47a1-8423-2afb92ac93dc"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "5f06b424-08a5-4b1c-a790-4e2ca458f9a3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "0db74fad-8635-47a4-b331-471385f2e05b", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f06b424-08a5-4b1c-a790-4e2ca458f9a3"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "2c4a95e0-4683-4414-9442-d4a7af9da0b2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0db74fad-8635-47a4-b331-471385f2e05b"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "ae6915d3-1abd-4ec9-a9fb-7ab32c567f84", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "2c4a95e0-4683-4414-9442-d4a7af9da0b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "61a23fee-312f-4af7-82ca-df080805705e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75ce94d3-f041-455e-ae31-10cbca4546a5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "61a23fee-312f-4af7-82ca-df080805705e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f38f3769-a6a5-4f44-b9c8-390f698c8fe8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d3aed9ec-1d26-4a5d-beb2-faee70d22ed0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f38f3769-a6a5-4f44-b9c8-390f698c8fe8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "1afb9906-3e10-4ef9-bf3f-308ea47e7e01", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "01a86b16-1ad3-43f2-8e79-eb6df33daa1e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1afb9906-3e10-4ef9-bf3f-308ea47e7e01"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "e10e7f26-5932-4565-b4d7-05f14cfc4525", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "01a86b16-1ad3-43f2-8e79-eb6df33daa1e"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "8f68dd10-2c0d-4371-8c1f-f11341f49137", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "e10e7f26-5932-4565-b4d7-05f14cfc4525"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44cd474b-3d8b-4807-9440-180b3bd0838a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b9915797-152f-4e77-89b3-f4d24fcb8701", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44cd474b-3d8b-4807-9440-180b3bd0838a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2917ba2d-1120-4198-9ee3-4fefb8e6bfe5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5bd18f42-ad0b-41e5-9845-1e98cc3de7c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2917ba2d-1120-4198-9ee3-4fefb8e6bfe5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "de7548e6-ec00-4d82-a56a-0a77cea829c0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "84cad433-4fb3-417c-a39e-6a2783d12535", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "de7548e6-ec00-4d82-a56a-0a77cea829c0"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "8d8734cc-f81b-4464-91d5-4283bc0ccfdd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84cad433-4fb3-417c-a39e-6a2783d12535"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "b9a65449-cc46-4abd-9c62-333600d5804d", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "8d8734cc-f81b-4464-91d5-4283bc0ccfdd"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "af4dd08b-f64f-4fd5-ae41-e8a023ae718b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "33ad7db4-71a7-409b-be8b-df0e5f855d43", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "af4dd08b-f64f-4fd5-ae41-e8a023ae718b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span></p>", "ID": "ea26ce40-95d0-4cc7-bb6b-4909e1ea277b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span>", "ID": "d59a7af0-f11a-40a6-9ff6-d607cf34e365", "Styles": "background:lightgrey", "Classes": "None", "Text": "Outer packaging (carton):", "ParentId": "ea26ce40-95d0-4cc7-bb6b-4909e1ea277b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg</span></p>", "ID": "57f92fcc-19e2-43b7-8f86-879c96347f4c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg</span>", "ID": "d6783750-f8cb-4c4c-9d8c-19cc597fc6a8", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg", "ParentId": "57f92fcc-19e2-43b7-8f86-879c96347f4c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dc8c1846-0db5-407e-8d0f-3dad8277cbbb", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2d921e7b-c9e6-4d44-8587-89d641b4f272", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc8c1846-0db5-407e-8d0f-3dad8277cbbb"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate\npackaging (bottle label):</span></p>", "ID": "d6a06ed4-3bb9-415c-b323-325128471c57", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate\npackaging (bottle label):</span>", "ID": "d0ef77f9-1cd5-4713-83ae-f61cfc051c87", "Styles": "background:lightgrey", "Classes": "None", "Text": "Immediate packaging (bottle label):", "ParentId": "d6a06ed4-3bb9-415c-b323-325128471c57"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span></b></p>", "ID": "623183f3-c228-4429-aa18-16777214b536", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span></b>", "ID": "84060d54-2962-41b7-8154-bd35b1564291", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "623183f3-c228-4429-aa18-16777214b536"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span>", "ID": "f9bc11d2-8cfa-426a-9dc1-5207b2c82c37", "Styles": "background:lightgrey", "Classes": "None", "Text": "In case no outer packaging is used", "ParentId": "84060d54-2962-41b7-8154-bd35b1564291"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg</span></p>", "ID": "da01a6d2-29ed-404e-a6ad-a531955540c8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg</span>", "ID": "de1cad39-120c-49ac-bf79-fd4fb993882e", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg", "ParentId": "da01a6d2-29ed-404e-a6ad-a531955540c8"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1ea4a9cb-e46c-409d-a0e6-b9b35fbb981e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4888f886-34e0-4e98-9748-72fdbd18eb2c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1ea4a9cb-e46c-409d-a0e6-b9b35fbb981e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8d4a906b-8e22-4180-bb5d-b17a2bddc735", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cc867c14-989e-49ed-83be-09c030841b7a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8d4a906b-8e22-4180-bb5d-b17a2bddc735"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "671f5490-b345-4214-817d-3112c20625b8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "9b57d4a1-a49b-459e-aa39-4e9f6997f387", "Styles": "border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "671f5490-b345-4214-817d-3112c20625b8"}, {"Element": "<b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "83eb3b78-bc97-4e49-bf5a-4bd2417fa85c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b57d4a1-a49b-459e-aa39-4e9f6997f387"}, {"Element": "<span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "91b33e88-a4b0-41f2-a438-02196c5422e2", "Styles": "None", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "83eb3b78-bc97-4e49-bf5a-4bd2417fa85c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1e6d2613-7e9d-484a-8bfa-4e671442c6df", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "af1d89af-d924-40d1-947c-04822941d7ac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1e6d2613-7e9d-484a-8bfa-4e671442c6df"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span></p>", "ID": "fc495575-a811-40ae-8153-20e5fc95a27c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span>", "ID": "6114c641-754d-4f75-bff7-670ffd0ef7b3", "Styles": "background:lightgrey", "Classes": "None", "Text": "Outer packaging (carton):", "ParentId": "fc495575-a811-40ae-8153-20e5fc95a27c"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">2D\nbarcode carrying the unique identifier included.</span><span lang=\"EN-GB\" style=\"color:green\"> </span></p>", "ID": "63ea4355-8a3f-46bf-81a2-23d6b6ff5043", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">2D\nbarcode carrying the unique identifier included.</span>", "ID": "8c113c39-8fe8-4e4e-b34b-730b7254afb1", "Styles": "color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "63ea4355-8a3f-46bf-81a2-23d6b6ff5043"}, {"Element": "<span lang=\"EN-GB\" style=\"color:green\"> </span>", "ID": "21795e20-ea8c-42f3-9f20-7c82d5bfdfe0", "Styles": "color:green", "Classes": "None", "Text": " ", "ParentId": "63ea4355-8a3f-46bf-81a2-23d6b6ff5043"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "20f8e701-c9bc-4065-b6da-f97dbba9d1c5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f6c21ff7-a8f7-4179-91c1-c98a8d44c7f6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "20f8e701-c9bc-4065-b6da-f97dbba9d1c5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate\npackaging (bottle label):</span></p>", "ID": "5723c184-e607-4f17-8aa8-712fa6073780", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate\npackaging (bottle label):</span>", "ID": "f5f22d09-9446-4a6d-a390-5332466bbb44", "Styles": "background:lightgrey", "Classes": "None", "Text": "Immediate packaging (bottle label):", "ParentId": "5723c184-e607-4f17-8aa8-712fa6073780"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span></b></p>", "ID": "9a9d6014-5414-4b4d-afa0-d14d444d5ee7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span></b>", "ID": "8dc02b43-f271-420a-8602-6ee5f698ca65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a9d6014-5414-4b4d-afa0-d14d444d5ee7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">In case no\nouter packaging is used</span>", "ID": "f43d2fb8-6714-43fd-8c56-78a94ca66075", "Styles": "background:lightgrey", "Classes": "None", "Text": "In case no outer packaging is used", "ParentId": "8dc02b43-f271-420a-8602-6ee5f698ca65"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">&lt;2D\nbarcode carrying the unique identifier included.&gt;</span></p>", "ID": "8f098964-abc1-475c-8045-413f4b2a124f", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">&lt;2D\nbarcode carrying the unique identifier included.&gt;</span>", "ID": "7ec05b38-9d4e-4d2d-a579-4ea34c6d4cb8", "Styles": "color:black;background:#CCCCCC", "Classes": "None", "Text": "<2D barcode carrying the unique identifier included.>", "ParentId": "8f098964-abc1-475c-8045-413f4b2a124f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "63a44f3e-8c50-4ead-b902-02e150bde069", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d0d7801-a61c-4600-b625-79898eedf3cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "63a44f3e-8c50-4ead-b902-02e150bde069"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "17fe2d1c-23c7-491c-8ec5-9af492c2ae58", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3dfd1397-c1e6-436b-a241-0163f6ba73a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "17fe2d1c-23c7-491c-8ec5-9af492c2ae58"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "2e1f508e-42ad-4001-a2ab-6727b72a7208", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b></p>", "ID": "7794acb1-2de1-441e-892d-65b50fec089d", "Styles": "border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e1f508e-42ad-4001-a2ab-6727b72a7208"}, {"Element": "<b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b>", "ID": "316b3c94-11a6-4fbb-a9ee-3c2b7aed1b78", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7794acb1-2de1-441e-892d-65b50fec089d"}, {"Element": "<span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span>", "ID": "87c9595c-af2c-45c6-9a3b-895eebe67535", "Styles": "None", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA", "ParentId": "316b3c94-11a6-4fbb-a9ee-3c2b7aed1b78"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"display:none\">\u00a0</span></p>", "ID": "83ed52be-e18f-44da-aed0-c4776555a7c7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"display:none\">\u00a0</span>", "ID": "08796020-a106-4283-a093-e6b4b0db7f0e", "Styles": "display:none", "Classes": "None", "Text": "\u00a0", "ParentId": "83ed52be-e18f-44da-aed0-c4776555a7c7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span></p>", "ID": "2b1c1959-045e-439f-ab37-6ec0fc3360da", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">Outer\npackaging (carton):</span>", "ID": "5d9431f4-2d0e-4272-a3dd-9f5494ae8f26", "Styles": "background:lightgrey", "Classes": "None", "Text": "Outer packaging (carton):", "ParentId": "2b1c1959-045e-439f-ab37-6ec0fc3360da"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">PC:</span></p>", "ID": "50d3b8a5-f9bc-46f3-8245-6e53cd6c7e7e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">PC:</span>", "ID": "999681fc-0d36-44c4-a953-7bdad77ee5aa", "Styles": "None", "Classes": "None", "Text": "PC:", "ParentId": "50d3b8a5-f9bc-46f3-8245-6e53cd6c7e7e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">SN:</span></p>", "ID": "b03c36d4-2690-4fe1-aa8d-49e850e2456e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">SN:</span>", "ID": "3843774c-28f5-4d40-8007-06e82731659b", "Styles": "None", "Classes": "None", "Text": "SN:", "ParentId": "b03c36d4-2690-4fe1-aa8d-49e850e2456e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">NN:</span></p>", "ID": "58d84223-381f-4973-98e7-cf1eb711b854", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">NN:</span>", "ID": "98c7e75c-fef3-4c0c-aa04-a2a731c80f82", "Styles": "None", "Classes": "None", "Text": "NN:", "ParentId": "58d84223-381f-4973-98e7-cf1eb711b854"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ff5082b7-2e6f-40ef-925b-a4d8e77f1014", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "939c2e72-afe4-4c15-848e-470e40ab1f2a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ff5082b7-2e6f-40ef-925b-a4d8e77f1014"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate packaging (bottle label):</span></p>", "ID": "66b6a085-94ae-4e22-bfb8-3c8a9f43f9ed", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">Immediate packaging (bottle label):</span>", "ID": "4a574256-7788-4c9a-a27d-f307cedb4e28", "Styles": "background:lightgrey", "Classes": "None", "Text": "Immediate packaging (bottle label):", "ParentId": "66b6a085-94ae-4e22-bfb8-3c8a9f43f9ed"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no outer packaging is used</span></b></p>", "ID": "d7494bd8-1dcc-47b6-afd9-e44b4d59e2d4", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"background:lightgrey\">In case no outer packaging is used</span></b>", "ID": "8fdb81cc-80c1-41bb-bd07-fb09fc0b7b03", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7494bd8-1dcc-47b6-afd9-e44b4d59e2d4"}, {"Element": "<span lang=\"EN-GB\" style=\"background:lightgrey\">In case no outer packaging is used</span>", "ID": "74c7eb31-0fcb-42e3-b7eb-3ee420deea92", "Styles": "background:lightgrey", "Classes": "None", "Text": "In case no outer packaging is used", "ParentId": "8fdb81cc-80c1-41bb-bd07-fb09fc0b7b03"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">&lt;PC:</span></p>", "ID": "d2a6faef-08d9-464e-ba44-6f1000d23e53", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">&lt;PC:</span>", "ID": "9484ba0e-0692-4fc2-9ff4-9e571d2a45a8", "Styles": "None", "Classes": "None", "Text": "<PC:", "ParentId": "d2a6faef-08d9-464e-ba44-6f1000d23e53"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">SN:</span></p>", "ID": "cebf7b96-7e29-4c75-b3d7-ddfcd755fa2b", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">SN:</span>", "ID": "2ee2ff4b-fe5e-4f3d-a582-996605e56991", "Styles": "None", "Classes": "None", "Text": "SN:", "ParentId": "cebf7b96-7e29-4c75-b3d7-ddfcd755fa2b"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">NN:&gt;</span></p>", "ID": "7a8877b2-971c-4e89-8637-5a835c6280aa", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">NN:&gt;</span>", "ID": "b9fda8d3-ef61-47d7-a1a7-330afac7c518", "Styles": "None", "Classes": "None", "Text": "NN:>", "ParentId": "7a8877b2-971c-4e89-8637-5a835c6280aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "163ea671-6ad5-4a73-bdb0-86567bc0c355", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "32f52e34-aa4a-4016-897a-b69106b81c03", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "163ea671-6ad5-4a73-bdb0-86567bc0c355"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span></p>", "ID": "7af4b39d-b1f1-4cf1-8e45-9652d8173861", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt\">\u00a0</span>", "ID": "aea231b3-113c-4eac-b2d9-dd56b47ced45", "Styles": "font-size:12.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "7af4b39d-b1f1-4cf1-8e45-9652d8173861"}, {"Element": "<b><u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></u></b>", "ID": "3ccea37f-2f6f-4657-9194-a147f4621b6a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></u>", "ID": "583ee37d-35ba-4845-8ac9-9f70b28a347c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3ccea37f-2f6f-4657-9194-a147f4621b6a"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "e951ade7-fc34-4e89-8424-fce1f365effe", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "583ee37d-35ba-4845-8ac9-9f70b28a347c"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "ae0b1702-9d61-474a-b7e4-9e4d5b975eb4", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "e951ade7-fc34-4e89-8424-fce1f365effe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "871694f7-d089-427a-9836-56136f38a72a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fc4fa42d-7fee-419d-9cef-7fe02ceaa251", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "871694f7-d089-427a-9836-56136f38a72a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a241e4c9-aff7-43a2-8ff4-e7573ec06117", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "110f1107-3115-42a6-b740-535eea9b73e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a241e4c9-aff7-43a2-8ff4-e7573ec06117"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cd61186c-f1fb-4458-9b4c-35dbb26eadf6", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d01c830-3b1c-4b16-ad10-c1861a9a4503", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cd61186c-f1fb-4458-9b4c-35dbb26eadf6"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b9a832ce-968c-4694-8a4c-8062ff4f3882", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "036601d9-cd32-4dcb-956c-b0e835e9040c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b9a832ce-968c-4694-8a4c-8062ff4f3882"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "40643006-c607-4555-9f13-7cb9d0d0a960", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc4fbbd6-4c67-4b63-9d27-c647fc2594a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "40643006-c607-4555-9f13-7cb9d0d0a960"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d1693cb9-4b20-498a-9b33-75aa8aa4e308", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "de4a3b62-d6af-4192-b15a-4a7f37143414", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d1693cb9-4b20-498a-9b33-75aa8aa4e308"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "50696590-854b-4029-b0de-a21f40c27889", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6259b878-713d-4b71-99d5-57429297587c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50696590-854b-4029-b0de-a21f40c27889"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7338b796-3610-43d6-babf-06169ab44315", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1863a1b3-8aed-4717-a8b1-df0ae354d70b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7338b796-3610-43d6-babf-06169ab44315"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "af9a2334-d682-4d97-952e-db98ba063c48", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b51700f-5718-4441-aea5-6c733a357381", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "af9a2334-d682-4d97-952e-db98ba063c48"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3be8e931-d4d4-483e-8dbf-a2729d9d3f2c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48727f1c-cd23-4bc6-ad4c-376aebff9f92", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3be8e931-d4d4-483e-8dbf-a2729d9d3f2c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f8337c54-54b4-4a8d-ade8-acfebea306c9", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6c42a8a2-ded2-4330-ba20-653bc8ab72f7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f8337c54-54b4-4a8d-ade8-acfebea306c9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a801c830-22c9-49a4-98dc-8dbfaab7093b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "47ee3aa9-e4c6-4399-a8ee-3a106edbf8f1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a801c830-22c9-49a4-98dc-8dbfaab7093b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0ffff3e2-e985-4f34-b423-1bf6bf5f8e43", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3feb18ff-78a2-4c7a-b438-d2ad6c98a90e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0ffff3e2-e985-4f34-b423-1bf6bf5f8e43"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7485fcb2-ab5c-49be-8d95-2118c59cef2f", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0cffa234-2882-4d2f-aa56-43496a81ed60", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7485fcb2-ab5c-49be-8d95-2118c59cef2f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b323ea80-d74c-4ecb-88e5-028d6cde6ee9", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce47ca0f-3442-42c4-b13b-b658ede14944", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b323ea80-d74c-4ecb-88e5-028d6cde6ee9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0426fcec-be42-4dce-95c5-91fd7f560a1e", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7797e6df-b20d-410e-b8eb-8f7f2a68ded6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0426fcec-be42-4dce-95c5-91fd7f560a1e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c85ac6cc-dcb4-463f-8ba1-7bf25ab74e7d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bede0545-b9c0-4ee7-b400-000a65205696", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c85ac6cc-dcb4-463f-8ba1-7bf25ab74e7d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6d021289-249a-44a5-9fd7-00a5464549de", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5796a6d6-45f6-4c2e-913b-1fc6306014e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6d021289-249a-44a5-9fd7-00a5464549de"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a99bbdf1-7fa9-4233-84be-41d2a3a1d10d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "317d5323-7919-427d-a6e8-11fbfb1ae6e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a99bbdf1-7fa9-4233-84be-41d2a3a1d10d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3c975800-cd19-4d6a-963d-27c36fbc74bd", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d2aa5199-c2dd-4035-b730-6e7525761e0e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3c975800-cd19-4d6a-963d-27c36fbc74bd"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34531c61-cbb5-493a-8cd2-50510f4e639f", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e324c9bf-e88f-4545-92d3-eebd5120a6d0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34531c61-cbb5-493a-8cd2-50510f4e639f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "100e6075-495c-49af-93e2-461046ceee03", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "485bb95f-398d-4572-a5bf-ab9efe115746", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "100e6075-495c-49af-93e2-461046ceee03"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "da9895f4-187c-4c17-8d0c-d0c86504f700", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "654fdd23-7388-4abb-b3df-d2cd6dc4a85d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "da9895f4-187c-4c17-8d0c-d0c86504f700"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></p>", "ID": "f635329d-1c88-4038-a6ad-53d31ff2f373", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">B. PACKAGE LEAFLET</span>", "ID": "024ecf4b-db35-4db7-8c0a-7e4b06994ebb", "Styles": "None", "Classes": "None", "Text": "B. PACKAGE LEAFLET", "ParentId": "f635329d-1c88-4038-a6ad-53d31ff2f373"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0ecb839a-a41d-48de-9553-61d82955aa39", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cd4f4d1e-588e-4e3d-909d-65c50b20f61d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0ecb839a-a41d-48de-9553-61d82955aa39"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "8d670b4c-0cc7-4d8a-ac36-cdaf1b75d7d8", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "529b977a-e39d-4bd7-bd03-572284c5926a", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "8d670b4c-0cc7-4d8a-ac36-cdaf1b75d7d8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Package leaflet: Information for the patient</span></b></p>", "ID": "361bca2d-4011-428b-87eb-9215fa6f6c6e", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Package leaflet: Information for the patient</span></b>", "ID": "313e3dab-bc97-40b9-8d63-aba1d1aa0b16", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "361bca2d-4011-428b-87eb-9215fa6f6c6e"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Package leaflet: Information for the patient</span>", "ID": "e1942fc3-060a-433f-842b-9cf9f74b5359", "Styles": "color:black", "Classes": "None", "Text": "Package leaflet: Information for the patient", "ParentId": "313e3dab-bc97-40b9-8d63-aba1d1aa0b16"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0bac7603-a4dd-4b64-bb5e-896b9746a415", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e72aca11-d4d9-4e0e-beb6-e65462235a17", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0bac7603-a4dd-4b64-bb5e-896b9746a415"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "453049b7-3255-40e5-93bb-fe41c6cec5d4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e72aca11-d4d9-4e0e-beb6-e65462235a17"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film-coated tablets</span></b></p>", "ID": "c7c0d10b-dda5-48a9-ba0e-2ae83a6cf0a2", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film-coated tablets</span></b>", "ID": "95a67fa0-ff4b-44da-94a3-2df16bc8d3eb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c7c0d10b-dda5-48a9-ba0e-2ae83a6cf0a2"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva 100\u00a0mg film-coated tablets</span>", "ID": "311534c4-cbc9-496c-a6b7-faffbcad6aba", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva 100\u00a0mg film-coated tablets", "ParentId": "95a67fa0-ff4b-44da-94a3-2df16bc8d3eb"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">lamivudine</span></p>", "ID": "a0e552d9-1d7e-4542-82ec-52c97d89221f", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">lamivudine</span>", "ID": "b5c2d9f0-a6e2-4cd1-890a-95d148cb16ce", "Styles": "None", "Classes": "None", "Text": "lamivudine", "ParentId": "a0e552d9-1d7e-4542-82ec-52c97d89221f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d79f1302-85a7-4f90-acfc-cbf68ff86296", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e8ae04b8-f61e-4108-b458-591cacf8d174", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d79f1302-85a7-4f90-acfc-cbf68ff86296"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you start taking this medicine </span><span lang=\"EN-GB\" style=\"color:black\">because it contains important information for\nyou</span><span lang=\"EN-GB\">.</span></b></p>", "ID": "4d676625-af0b-401f-98fe-a95c8d81d3aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you start taking this medicine </span><span lang=\"EN-GB\" style=\"color:black\">because it contains important information for\nyou</span><span lang=\"EN-GB\">.</span></b>", "ID": "7648ee79-96f3-4209-a168-30d42fba3816", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d676625-af0b-401f-98fe-a95c8d81d3aa"}, {"Element": "<span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you start taking this medicine </span>", "ID": "e8ac6f21-6469-4195-8ade-61d59176b759", "Styles": "None", "Classes": "None", "Text": "Read all of this leaflet carefully before you start taking this medicine ", "ParentId": "7648ee79-96f3-4209-a168-30d42fba3816"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">because it contains important information for\nyou</span>", "ID": "f09f01fe-7833-4fc4-950b-3195727d8b47", "Styles": "color:black", "Classes": "None", "Text": "because it contains important information for you", "ParentId": "7648ee79-96f3-4209-a168-30d42fba3816"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "95eb136f-856b-4d28-9952-0e95ade9b1fd", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "7648ee79-96f3-4209-a168-30d42fba3816"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain.</span></p>", "ID": "c9508eb8-5abe-4cd9-afd6-e024f54116f8", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e9119d33-e806-49ef-8355-f803074db8f5", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "c9508eb8-5abe-4cd9-afd6-e024f54116f8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0c89ad01-f955-494e-b970-c5b2ce337431", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e9119d33-e806-49ef-8355-f803074db8f5"}, {"Element": "<span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain.</span>", "ID": "50b36497-6094-4be5-ba10-5ec261139b33", "Styles": "None", "Classes": "None", "Text": "Keep this leaflet. You may need to read it again.", "ParentId": "c9508eb8-5abe-4cd9-afd6-e024f54116f8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor or pharmacist.</span></p>", "ID": "fb00f250-be33-4bf4-bfc8-f1ec6fa91c85", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "85f0dd2a-8ab8-4216-a67f-894a0a5df0ac", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "fb00f250-be33-4bf4-bfc8-f1ec6fa91c85"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e356a37b-d38d-4d94-8d91-a8e0ee388451", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "85f0dd2a-8ab8-4216-a67f-894a0a5df0ac"}, {"Element": "<span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor or pharmacist.</span>", "ID": "3fa4061e-0793-41ad-b409-25e08098d0c8", "Styles": "None", "Classes": "None", "Text": "If you have any further questions, ask your doctor or pharmacist.", "ParentId": "fb00f250-be33-4bf4-bfc8-f1ec6fa91c85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">This medicine has been prescribed for you only.\nDo not pass it on to others. It may harm them, even if their signs of illness\nare the same as yours.</span></p>", "ID": "3ed0b4da-0b71-4662-aee9-29d847bc956a", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "dba944b1-a5b4-42fb-b573-ffc5c1f7749d", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "3ed0b4da-0b71-4662-aee9-29d847bc956a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f9cf998d-9d28-421d-97eb-daf23227c976", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "dba944b1-a5b4-42fb-b573-ffc5c1f7749d"}, {"Element": "<span lang=\"EN-GB\">This medicine has been prescribed for you only.\nDo not pass it on to others. It may harm them, even if their signs of illness\nare the same as yours.</span>", "ID": "bed2c2ec-343d-407d-9780-239ca8b29a10", "Styles": "None", "Classes": "None", "Text": "This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.", "ParentId": "3ed0b4da-0b71-4662-aee9-29d847bc956a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you get any of the side effects </span><span lang=\"EN-GB\" style=\"color:black\">talk to your doctor or pharmacist. This includes\n</span><span lang=\"EN-GB\">any possible side effects not listed in this leaflet.\nSee section 4.</span></p>", "ID": "1f0d7ee8-e8de-424c-b11b-270137b0c7ec", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "617598f9-5e18-40d3-92bc-12a2b0e60774", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "1f0d7ee8-e8de-424c-b11b-270137b0c7ec"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "1cbd9cd7-34f0-4e22-9f4a-54a8d5960bb2", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "617598f9-5e18-40d3-92bc-12a2b0e60774"}, {"Element": "<span lang=\"EN-GB\">If you get any of the side effects </span>", "ID": "7706f188-24e1-435b-afc7-147acf050626", "Styles": "None", "Classes": "None", "Text": "If you get any of the side effects ", "ParentId": "1f0d7ee8-e8de-424c-b11b-270137b0c7ec"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">talk to your doctor or pharmacist. This includes\n</span>", "ID": "0c72e41a-2d17-46e5-a1d0-10170a61fb70", "Styles": "color:black", "Classes": "None", "Text": "talk to your doctor or pharmacist. This includes ", "ParentId": "1f0d7ee8-e8de-424c-b11b-270137b0c7ec"}, {"Element": "<span lang=\"EN-GB\">any possible side effects not listed in this leaflet.\nSee section 4.</span>", "ID": "8466460a-5709-4352-8241-2e6a79101373", "Styles": "None", "Classes": "None", "Text": "any possible side effects not listed in this leaflet. See section 4.", "ParentId": "1f0d7ee8-e8de-424c-b11b-270137b0c7ec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26629a82-037e-41cd-9988-f872964d967a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b0f29989-d2a5-46ec-8fe6-6100708a0956", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26629a82-037e-41cd-9988-f872964d967a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d50930da-5ee9-4c9f-a19f-be280f9de451", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae5416d9-c6b1-4f71-8b3e-00ef2cb60857", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d50930da-5ee9-4c9f-a19f-be280f9de451"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b><span lang=\"EN-GB\">: </span></p>", "ID": "8359cc16-484e-40ca-a335-b4d542795d71", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">What is in this leaflet</span></b>", "ID": "342ad31b-30bc-4df4-ba80-ee5691ba13fc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8359cc16-484e-40ca-a335-b4d542795d71"}, {"Element": "<span lang=\"EN-GB\">What is in this leaflet</span>", "ID": "70a897e1-b664-44ad-9489-780210544605", "Styles": "None", "Classes": "None", "Text": "What is in this leaflet", "ParentId": "342ad31b-30bc-4df4-ba80-ee5691ba13fc"}, {"Element": "<span lang=\"EN-GB\">: </span>", "ID": "7f908607-c00e-45b1-a120-0e93fa63ea8c", "Styles": "None", "Classes": "None", "Text": ": ", "ParentId": "8359cc16-484e-40ca-a335-b4d542795d71"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Lamivudine Teva is and\nwhat it is used for</span></p>", "ID": "e38f9ecd-f238-4f45-9cde-49fe18145dd3", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Lamivudine Teva is and\nwhat it is used for</span>", "ID": "8ece712e-1364-4cab-94d8-ce88cdb448c2", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Lamivudine Teva is and what it is used for", "ParentId": "e38f9ecd-f238-4f45-9cde-49fe18145dd3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style=\"color:black\">What you need to know </span><span lang=\"EN-GB\">before you\ntake Lamivudine Teva</span></p>", "ID": "33ff354a-44dc-4f20-b3bc-c1efb174bd17", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "7c535615-b4c9-4d03-ae76-c954f5bc045a", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "33ff354a-44dc-4f20-b3bc-c1efb174bd17"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">What you need to know </span>", "ID": "35bc9b17-122e-40ea-a218-168a7fcb47a3", "Styles": "color:black", "Classes": "None", "Text": "What you need to know ", "ParentId": "33ff354a-44dc-4f20-b3bc-c1efb174bd17"}, {"Element": "<span lang=\"EN-GB\">before you\ntake Lamivudine Teva</span>", "ID": "35fd66c5-de4d-4fdf-8754-d6c33a3508e6", "Styles": "None", "Classes": "None", "Text": "before you take Lamivudine Teva", "ParentId": "33ff354a-44dc-4f20-b3bc-c1efb174bd17"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Lamivudine Teva</span></p>", "ID": "ad03b9a2-cd11-4265-974b-3c47d627c0c9", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Lamivudine Teva</span>", "ID": "ab1d5873-f1ea-4b6e-9b6b-eddb25637571", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Lamivudine Teva", "ParentId": "ad03b9a2-cd11-4265-974b-3c47d627c0c9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects</span></p>", "ID": "235f3f75-c08b-49f9-a286-8b0900503d6d", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects</span>", "ID": "2e46eefe-c84e-4672-a83e-b4f1b635cec8", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "235f3f75-c08b-49f9-a286-8b0900503d6d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\">5.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">How to store Lamivudine Teva</span></p>", "ID": "ff0502e6-ef23-416a-989f-6e07c5a2bfd7", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;text-indent:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">5.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2e84d81f-ac55-40c0-81bc-a51b20160334", "Styles": "None", "Classes": "None", "Text": "5.", "ParentId": "ff0502e6-ef23-416a-989f-6e07c5a2bfd7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "3e272765-5902-4102-93d0-1fc7667b1997", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2e84d81f-ac55-40c0-81bc-a51b20160334"}, {"Element": "<span lang=\"EN-GB\">How to store Lamivudine Teva</span>", "ID": "37cbf064-98af-49e7-b89d-d23535d14619", "Styles": "None", "Classes": "None", "Text": "How to store Lamivudine Teva", "ParentId": "ff0502e6-ef23-416a-989f-6e07c5a2bfd7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style=\"color:black\">Contents of the pack and other</span><span lang=\"EN-GB\">\ninformation</span></p>", "ID": "c47186d1-9fa3-457f-b4f9-bae4d0f52a5e", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "0d924769-93ce-4b7e-a650-2002ca18d6eb", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c47186d1-9fa3-457f-b4f9-bae4d0f52a5e"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Contents of the pack and other</span>", "ID": "565b9ad8-bb58-43cf-aeb1-cc20c5ac41b5", "Styles": "color:black", "Classes": "None", "Text": "Contents of the pack and other", "ParentId": "c47186d1-9fa3-457f-b4f9-bae4d0f52a5e"}, {"Element": "<span lang=\"EN-GB\">\ninformation</span>", "ID": "d0032466-d07d-4408-8cb2-e1bf5ea15840", "Styles": "None", "Classes": "None", "Text": " information", "ParentId": "c47186d1-9fa3-457f-b4f9-bae4d0f52a5e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "92aa660a-d5f9-4ed1-aaff-794d85b262be", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b07e47ab-e6a5-469e-b415-3e0200efae95", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "92aa660a-d5f9-4ed1-aaff-794d85b262be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "785552f6-4638-4c63-96fc-766491d4da12", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "28ef404b-bbee-41f0-a6b1-aeaaf52401b7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "785552f6-4638-4c63-96fc-766491d4da12"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal\"><b><span lang=\"EN-GB\">1.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">What Lamivudine Teva is and what it is\nused for</span></b></p>", "ID": "cf9d931a-b97c-4d77-aa1d-b395bd8a6a2b", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">1.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b>", "ID": "fc2c15ba-3e2b-450b-aad6-aefc293e1bf9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf9d931a-b97c-4d77-aa1d-b395bd8a6a2b"}, {"Element": "<span lang=\"EN-GB\">1.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "11a85b8a-4441-4a09-a0cb-aa618ae6dfd4", "Styles": "None", "Classes": "None", "Text": "1.", "ParentId": "fc2c15ba-3e2b-450b-aad6-aefc293e1bf9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "32ab0f39-1ae8-4c6b-b6a7-03c797e072b9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "11a85b8a-4441-4a09-a0cb-aa618ae6dfd4"}, {"Element": "<b><span lang=\"EN-GB\">What Lamivudine Teva is and what it is\nused for</span></b>", "ID": "0ab8efe2-1ede-482f-9cf8-f975370ad429", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf9d931a-b97c-4d77-aa1d-b395bd8a6a2b"}, {"Element": "<span lang=\"EN-GB\">What Lamivudine Teva is and what it is\nused for</span>", "ID": "e63105cc-bc91-46bf-b53e-1308b4bf861d", "Styles": "None", "Classes": "None", "Text": "What Lamivudine Teva is and what it is used for", "ParentId": "0ab8efe2-1ede-482f-9cf8-f975370ad429"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f46e58c1-7af3-462f-85d2-92a168fc1f4b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "24a0fa25-41fe-45f1-bd6d-4bd02b70e7cb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f46e58c1-7af3-462f-85d2-92a168fc1f4b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The active ingredient in Lamivudine Teva is\nlamivudine.</span></p>", "ID": "04768463-fa9d-4e3c-a235-2ceec1e947c0", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The active ingredient in Lamivudine Teva is\nlamivudine.</span>", "ID": "aa058c8a-fd79-4a22-a4bc-aa00794722d6", "Styles": "None", "Classes": "None", "Text": "The active ingredient in Lamivudine Teva is lamivudine.", "ParentId": "04768463-fa9d-4e3c-a235-2ceec1e947c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3643de10-c913-4fe4-b0ec-f8198992ff5b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d987e858-f8fb-45eb-9293-00266a440b34", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3643de10-c913-4fe4-b0ec-f8198992ff5b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lamivudine\nTeva is used to treat long term (chronic) hepatitis B infection in adults.</span></b></p>", "ID": "c62da973-f58c-43b3-b2a4-76391e6797f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Lamivudine\nTeva is used to treat long term (chronic) hepatitis B infection in adults.</span></b>", "ID": "05d7351a-6924-4174-acdf-e9204978b2ab", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c62da973-f58c-43b3-b2a4-76391e6797f6"}, {"Element": "<span lang=\"EN-GB\">Lamivudine\nTeva is used to treat long term (chronic) hepatitis B infection in adults.</span>", "ID": "9728fdbe-0a8e-43b7-bc97-2a8fab83ac58", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva is used to treat long term (chronic) hepatitis B infection in adults.", "ParentId": "05d7351a-6924-4174-acdf-e9204978b2ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2afcafdc-6c16-421e-bd50-27a2314609bb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9778b3a4-ed56-4928-b362-251150284e7f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2afcafdc-6c16-421e-bd50-27a2314609bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">Lamivudine Teva\n</span><span lang=\"EN-GB\">is an antiviral medicine that suppresses the hepatitis\nB virus and belongs to a group of medicines called <i>nucleoside analogue\nreverse transcriptase inhibitors (NRTIs)</i>.</span></p>", "ID": "077b8d53-7cca-4aa7-8c40-53817f044bf5", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva\n</span>", "ID": "d3b6291d-7f82-4b70-8d35-6d1b4daae106", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva ", "ParentId": "077b8d53-7cca-4aa7-8c40-53817f044bf5"}, {"Element": "<span lang=\"EN-GB\">is an antiviral medicine that suppresses the hepatitis\nB virus and belongs to a group of medicines called <i>nucleoside analogue\nreverse transcriptase inhibitors (NRTIs)</i>.</span>", "ID": "140607b4-f21e-411b-acbc-51163994490f", "Styles": "None", "Classes": "None", "Text": "is an antiviral medicine that suppresses the hepatitis B virus and belongs to a group of medicines called .", "ParentId": "077b8d53-7cca-4aa7-8c40-53817f044bf5"}, {"Element": "<i>nucleoside analogue\nreverse transcriptase inhibitors (NRTIs)</i>", "ID": "4b2d2eaa-c7b0-4cf0-ba98-fcc99de908a2", "Styles": "None", "Classes": "None", "Text": "nucleoside analogue reverse transcriptase inhibitors (NRTIs)", "ParentId": "140607b4-f21e-411b-acbc-51163994490f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fe0c2310-0c78-4a41-98fa-d9db5b171ed6", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2ebd55bb-9133-45f9-9877-4a1b25daab7a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fe0c2310-0c78-4a41-98fa-d9db5b171ed6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">Hepatitis B is\na virus that infects the liver </span><span lang=\"EN-GB\">causes long term\n(chronic) infection, and can lead to liver damage. Lamivudine Teva <span style=\"color:black\">can be used in people whose liver is damaged but still\nfunctions </span>normally<span style=\"color:black\"> (<i>compensated liver\ndisease</i>).</span></span></p>", "ID": "44752722-2fc7-4f67-b81f-f234d1221127", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Hepatitis B is\na virus that infects the liver </span>", "ID": "f1b3a2a3-af2d-4d37-b68f-0776e2278ad8", "Styles": "None", "Classes": "None", "Text": "Hepatitis B is a virus that infects the liver ", "ParentId": "44752722-2fc7-4f67-b81f-f234d1221127"}, {"Element": "<span lang=\"EN-GB\">causes long term\n(chronic) infection, and can lead to liver damage. Lamivudine Teva <span style=\"color:black\">can be used in people whose liver is damaged but still\nfunctions </span>normally<span style=\"color:black\"> (<i>compensated liver\ndisease</i>).</span></span>", "ID": "a81a50d2-def1-455c-89ad-1b2cb445acc7", "Styles": "None", "Classes": "None", "Text": "causes long term (chronic) infection, and can lead to liver damage. Lamivudine Teva normally", "ParentId": "44752722-2fc7-4f67-b81f-f234d1221127"}, {"Element": "<span style=\"color:black\">can be used in people whose liver is damaged but still\nfunctions </span>", "ID": "16c6c3ec-ce73-4242-927e-1a5e6c2a3828", "Styles": "color:black", "Classes": "None", "Text": "can be used in people whose liver is damaged but still functions ", "ParentId": "a81a50d2-def1-455c-89ad-1b2cb445acc7"}, {"Element": "<span style=\"color:black\"> (<i>compensated liver\ndisease</i>).</span>", "ID": "c6ba196d-36ba-4c88-863a-157bb2538b07", "Styles": "color:black", "Classes": "None", "Text": " ().", "ParentId": "a81a50d2-def1-455c-89ad-1b2cb445acc7"}, {"Element": "<i>compensated liver\ndisease</i>", "ID": "da770a2f-9e3a-475c-b520-9487ff51c20f", "Styles": "None", "Classes": "None", "Text": "compensated liver disease", "ParentId": "c6ba196d-36ba-4c88-863a-157bb2538b07"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fff7fcea-ddc0-4e54-89c2-c7ce449dde0e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d8f0eb7-c90c-45d2-8b53-046db0fa7959", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fff7fcea-ddc0-4e54-89c2-c7ce449dde0e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">Treatment with\nLamivudine Teva can reduce the amount of hepatitis B virus in your body. This\nshould lead to a reduction in liver damage and an improvement in your liver\nfunction. </span><span lang=\"EN-GB\" style=\"color:black\">Not everyone responds to\ntreatment with Lamivudine Teva in the same way. Your doctor will monitor the\neffectiveness of your treatment with regular blood tests.</span></p>", "ID": "c0e72724-8a2a-4b9e-9f43-3c4e6384cfad", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Treatment with\nLamivudine Teva can reduce the amount of hepatitis B virus in your body. This\nshould lead to a reduction in liver damage and an improvement in your liver\nfunction. </span>", "ID": "77860500-09bc-45f5-8c2b-4fa4b3c4cb83", "Styles": "None", "Classes": "None", "Text": "Treatment with Lamivudine Teva can reduce the amount of hepatitis B virus in your body. This should lead to a reduction in liver damage and an improvement in your liver function. ", "ParentId": "c0e72724-8a2a-4b9e-9f43-3c4e6384cfad"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Not everyone responds to\ntreatment with Lamivudine Teva in the same way. Your doctor will monitor the\neffectiveness of your treatment with regular blood tests.</span>", "ID": "0bec828b-c0cc-40d3-aeb9-eed97055350d", "Styles": "color:black", "Classes": "None", "Text": "Not everyone responds to treatment with Lamivudine Teva in the same way. Your doctor will monitor the effectiveness of your treatment with regular blood tests.", "ParentId": "c0e72724-8a2a-4b9e-9f43-3c4e6384cfad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c250bb7d-e992-4220-bc9f-735ecfb1ddd4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d081d1bc-c164-4b15-aeb2-1f7d7c3f8230", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c250bb7d-e992-4220-bc9f-735ecfb1ddd4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e841e5d-2b60-4f0c-a3cc-45f4097bf9d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "55efd0fc-c3ea-4bd8-9bdd-564c7b05e42a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e841e5d-2b60-4f0c-a3cc-45f4097bf9d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal\"><b><span lang=\"EN-GB\">2.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\" style=\"color:black\">What you need to know\n</span><span lang=\"EN-GB\">before you take Lamivudine Teva</span></b></p>", "ID": "5e126a79-67c1-4a9d-b7b8-5ff84cc8dcc9", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">2.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b>", "ID": "9f8efc5d-c0a0-4720-b005-0b054118a2d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5e126a79-67c1-4a9d-b7b8-5ff84cc8dcc9"}, {"Element": "<span lang=\"EN-GB\">2.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b21e949c-4b32-4c13-b413-5c430fd419b1", "Styles": "None", "Classes": "None", "Text": "2.", "ParentId": "9f8efc5d-c0a0-4720-b005-0b054118a2d2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8ff32bda-ff5c-42b5-a697-324b7df56f02", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b21e949c-4b32-4c13-b413-5c430fd419b1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">What you need to know\n</span><span lang=\"EN-GB\">before you take Lamivudine Teva</span></b>", "ID": "c2040126-a17c-4858-9574-73eadef630f4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5e126a79-67c1-4a9d-b7b8-5ff84cc8dcc9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">What you need to know\n</span>", "ID": "4e543d38-5ea5-4ae3-bfd3-250e6f4d993c", "Styles": "color:black", "Classes": "None", "Text": "What you need to know ", "ParentId": "c2040126-a17c-4858-9574-73eadef630f4"}, {"Element": "<span lang=\"EN-GB\">before you take Lamivudine Teva</span>", "ID": "f4f14af0-03c6-49e2-990d-f42934a5f912", "Styles": "None", "Classes": "None", "Text": "before you take Lamivudine Teva", "ParentId": "c2040126-a17c-4858-9574-73eadef630f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be917f5a-72e7-4c74-8632-71a3c9d5af49", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4e078b9a-b600-4619-9b90-44bd9edcbfb3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be917f5a-72e7-4c74-8632-71a3c9d5af49"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Do not take\nLamivudine Teva</span></b></p>", "ID": "8c95337f-575f-4bb2-86f5-b76d898157f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Do not take\nLamivudine Teva</span></b>", "ID": "8b84f692-c6d1-4280-b7ac-cdc675ddcd88", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8c95337f-575f-4bb2-86f5-b76d898157f4"}, {"Element": "<span lang=\"EN-GB\">Do not take\nLamivudine Teva</span>", "ID": "9a8f2700-2313-4e3c-99b8-b8426d83b160", "Styles": "None", "Classes": "None", "Text": "Do not take Lamivudine Teva", "ParentId": "8b84f692-c6d1-4280-b7ac-cdc675ddcd88"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "02284fcf-ae5e-4ec0-9b33-660333758c87", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c9429ddd-4152-48eb-8e69-9650cebdca08", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "02284fcf-ae5e-4ec0-9b33-660333758c87"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you are <b>allergic </b>to lamivudine or any\nof the other ingredients of </span><span lang=\"EN-GB\" style=\"color:black\">this\nmedicine </span><i><span lang=\"EN-GB\">(listed in Section 6).</span></i></p>", "ID": "a14a983c-5b4a-43c0-8e25-1b117004e09a", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "88bfb117-dbb5-4afb-bb18-0e9533a6b94f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a14a983c-5b4a-43c0-8e25-1b117004e09a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0cf585bb-3379-4a47-b17b-39477baedb52", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "88bfb117-dbb5-4afb-bb18-0e9533a6b94f"}, {"Element": "<span lang=\"EN-GB\">if you are <b>allergic </b>to lamivudine or any\nof the other ingredients of </span>", "ID": "6d364467-b38e-473c-8161-1ce73570c7de", "Styles": "None", "Classes": "None", "Text": "if you are to lamivudine or any of the other ingredients of ", "ParentId": "a14a983c-5b4a-43c0-8e25-1b117004e09a"}, {"Element": "<b>allergic </b>", "ID": "0532a3bb-1bf4-4e4c-bddf-7203912862e2", "Styles": "None", "Classes": "None", "Text": "allergic ", "ParentId": "6d364467-b38e-473c-8161-1ce73570c7de"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">this\nmedicine </span>", "ID": "6065e018-ee35-44c8-9532-51bca4e7973a", "Styles": "color:black", "Classes": "None", "Text": "this medicine ", "ParentId": "a14a983c-5b4a-43c0-8e25-1b117004e09a"}, {"Element": "<i><span lang=\"EN-GB\">(listed in Section 6).</span></i>", "ID": "05936f08-f3cf-4267-92e6-6ad860638f5f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a14a983c-5b4a-43c0-8e25-1b117004e09a"}, {"Element": "<span lang=\"EN-GB\">(listed in Section 6).</span>", "ID": "82fe0818-1afd-4154-b011-202763694f01", "Styles": "None", "Classes": "None", "Text": "(listed in Section 6).", "ParentId": "05936f08-f3cf-4267-92e6-6ad860638f5f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Check\nwith your doctor</span></b><span lang=\"EN-GB\"> if you think this applies to you.</span></p>", "ID": "d0bc55a8-eb62-4e22-9168-332c9970c679", "Styles": "margin-left:21.3pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "7bb92333-afb9-4784-b449-8fe5aa9b7094", "Styles": "font-family:Wingdings;color:black", "Classes": "None", "Text": "\u00e8", "ParentId": "d0bc55a8-eb62-4e22-9168-332c9970c679"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "54dcfbea-1554-4190-bab3-4411585b1d66", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "7bb92333-afb9-4784-b449-8fe5aa9b7094"}, {"Element": "<b><span lang=\"EN-GB\">Check\nwith your doctor</span></b>", "ID": "9c73edbd-3f27-4608-8872-653a4b46ce25", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d0bc55a8-eb62-4e22-9168-332c9970c679"}, {"Element": "<span lang=\"EN-GB\">Check\nwith your doctor</span>", "ID": "2cdc4a0b-3e9b-42d7-b4cd-ca2e63579bb2", "Styles": "None", "Classes": "None", "Text": "Check with your doctor", "ParentId": "9c73edbd-3f27-4608-8872-653a4b46ce25"}, {"Element": "<span lang=\"EN-GB\"> if you think this applies to you.</span>", "ID": "534932c6-125d-4a98-b88c-d14c0c783d14", "Styles": "None", "Classes": "None", "Text": " if you think this applies to you.", "ParentId": "d0bc55a8-eb62-4e22-9168-332c9970c679"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dc134d2a-9fc4-4f16-83a0-c649be5a92bf", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "31d76f28-982f-4f34-8ce2-e87fc14b6d24", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc134d2a-9fc4-4f16-83a0-c649be5a92bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span></b></p>", "ID": "8ce192c3-aa14-4085-9b63-cfd853fe96d3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span></b>", "ID": "52209ea1-ff60-432b-946a-a310382e39ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8ce192c3-aa14-4085-9b63-cfd853fe96d3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Warnings and precautions</span>", "ID": "9b2750cb-1e9a-42e1-aff9-56f2f3910035", "Styles": "color:black", "Classes": "None", "Text": "Warnings and precautions", "ParentId": "52209ea1-ff60-432b-946a-a310382e39ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Some people taking Lamivudine Teva or other similar medicines are\nmore at risk of serious side effects. You need to be aware of the extra risks:</span></p>", "ID": "52bfe3a8-c179-4254-b322-1b934ad4f18f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Some people taking Lamivudine Teva or other similar medicines are\nmore at risk of serious side effects. You need to be aware of the extra risks:</span>", "ID": "f05a168d-ba7b-4765-af10-c7851f24480d", "Styles": "None", "Classes": "None", "Text": "Some people taking Lamivudine Teva or other similar medicines are more at risk of serious side effects. You need to be aware of the extra risks:", "ParentId": "52bfe3a8-c179-4254-b322-1b934ad4f18f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you have ever had other types of <b>liver\ndisease</b>, such as hepatitis C.</span></p>", "ID": "ba6eefbf-d87b-481c-afd9-aa10a4347fd2", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6b1cd309-0029-47f4-8f17-ef75c883e557", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ba6eefbf-d87b-481c-afd9-aa10a4347fd2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a21c190a-b65f-40bd-af78-75954049becc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6b1cd309-0029-47f4-8f17-ef75c883e557"}, {"Element": "<span lang=\"EN-GB\">if you have ever had other types of <b>liver\ndisease</b>, such as hepatitis C.</span>", "ID": "95f907d4-eadd-42b3-90e7-97e89f9d522a", "Styles": "None", "Classes": "None", "Text": "if you have ever had other types of , such as hepatitis C.", "ParentId": "ba6eefbf-d87b-481c-afd9-aa10a4347fd2"}, {"Element": "<b>liver\ndisease</b>", "ID": "76bfeaef-b2fd-404b-a008-a99161efea5d", "Styles": "None", "Classes": "None", "Text": "liver disease", "ParentId": "95f907d4-eadd-42b3-90e7-97e89f9d522a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you are seriously <b>overweight</b>\n(especially if you are a woman).</span></p>", "ID": "b3638ca6-8558-4cef-84c3-d792d537bc71", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f0cd0a45-6bf4-4239-9d57-5b35a1e25af7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b3638ca6-8558-4cef-84c3-d792d537bc71"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "eb0b1041-03da-4c0a-9344-17c1af96f7e5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f0cd0a45-6bf4-4239-9d57-5b35a1e25af7"}, {"Element": "<span lang=\"EN-GB\">if you are seriously <b>overweight</b>\n(especially if you are a woman).</span>", "ID": "e6b94c9b-3b42-4e8a-ab9e-3fcf2be0a111", "Styles": "None", "Classes": "None", "Text": "if you are seriously  (especially if you are a woman).", "ParentId": "b3638ca6-8558-4cef-84c3-d792d537bc71"}, {"Element": "<b>overweight</b>", "ID": "427d4c45-09e2-4e35-ade3-2ecd2eba1931", "Styles": "None", "Classes": "None", "Text": "overweight", "ParentId": "e6b94c9b-3b42-4e8a-ab9e-3fcf2be0a111"}, {"Element": "<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">Talk to your doctor if any of these apply to\nyou</span></b><span lang=\"EN-GB\">. You may need extra check-ups, including blood\ntests, while you are taking your medication. <b>See Section 4 </b>for more\ninformation about the risks. </span></p>", "ID": "ca66a148-e3cc-4992-886d-a255948b3853", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal", "Classes": "['Action']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span>", "ID": "3e8508d2-a0dc-4d6f-9f45-9e38156a3a8b", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e8", "ParentId": "ca66a148-e3cc-4992-886d-a255948b3853"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span>", "ID": "08d69759-1d16-41a3-8ccc-1e42abed6128", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "3e8508d2-a0dc-4d6f-9f45-9e38156a3a8b"}, {"Element": "<b><span lang=\"EN-GB\">Talk to your doctor if any of these apply to\nyou</span></b>", "ID": "02f18ebc-3068-4905-8065-7f9f9aaa126f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ca66a148-e3cc-4992-886d-a255948b3853"}, {"Element": "<span lang=\"EN-GB\">Talk to your doctor if any of these apply to\nyou</span>", "ID": "8aac3317-4627-4539-89e3-0ddeec11bdb4", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor if any of these apply to you", "ParentId": "02f18ebc-3068-4905-8065-7f9f9aaa126f"}, {"Element": "<span lang=\"EN-GB\">. You may need extra check-ups, including blood\ntests, while you are taking your medication. <b>See Section 4 </b>for more\ninformation about the risks. </span>", "ID": "134a34d7-9133-4982-8d8f-7ca8c2adf37b", "Styles": "None", "Classes": "None", "Text": ". You may need extra check-ups, including blood tests, while you are taking your medication. for more information about the risks. ", "ParentId": "ca66a148-e3cc-4992-886d-a255948b3853"}, {"Element": "<b>See Section 4 </b>", "ID": "39cf9f80-6cea-4cf9-81a1-e83544d4e159", "Styles": "None", "Classes": "None", "Text": "See Section 4 ", "ParentId": "134a34d7-9133-4982-8d8f-7ca8c2adf37b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "878db176-12a9-4cef-be8a-5210358f56b4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ad848f01-030d-40f0-ae6d-a13d6c2c1731", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "878db176-12a9-4cef-be8a-5210358f56b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\">Do not stop\ntaking Lamivudine Teva</span></b><span lang=\"EN-GB\"> without your doctor\u2019s\nadvice, as there is a risk of your hepatitis getting worse. When you stop\ntaking Lamivudine Teva your doctor will monitor you for at least four months to\ncheck for any problems. This will mean taking blood samples to check for any raised\nliver enzyme levels, which may indicate liver damage.</span><span lang=\"EN-GB\" style=\"color:black\"> See section 3 for more information about how to take </span><span lang=\"EN-GB\">Lamivudine Teva</span><span lang=\"EN-GB\" style=\"color:black\">.</span></p>", "ID": "92d6ad9e-33de-49a9-a200-6bcac76294b1", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Do not stop\ntaking Lamivudine Teva</span></b>", "ID": "84068187-c89f-45bf-ba62-4ffd4d4a265d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92d6ad9e-33de-49a9-a200-6bcac76294b1"}, {"Element": "<span lang=\"EN-GB\">Do not stop\ntaking Lamivudine Teva</span>", "ID": "86f08eaf-8c14-4ea9-8ef1-4dcd6f96e457", "Styles": "None", "Classes": "None", "Text": "Do not stop taking Lamivudine Teva", "ParentId": "84068187-c89f-45bf-ba62-4ffd4d4a265d"}, {"Element": "<span lang=\"EN-GB\"> without your doctor\u2019s\nadvice, as there is a risk of your hepatitis getting worse. When you stop\ntaking Lamivudine Teva your doctor will monitor you for at least four months to\ncheck for any problems. This will mean taking blood samples to check for any raised\nliver enzyme levels, which may indicate liver damage.</span>", "ID": "8167588d-bc8d-4f38-adb3-3922b49befe3", "Styles": "None", "Classes": "None", "Text": " without your doctor\u2019s advice, as there is a risk of your hepatitis getting worse. When you stop taking Lamivudine Teva your doctor will monitor you for at least four months to check for any problems. This will mean taking blood samples to check for any raised liver enzyme levels, which may indicate liver damage.", "ParentId": "92d6ad9e-33de-49a9-a200-6bcac76294b1"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> See section 3 for more information about how to take </span>", "ID": "4c962e5b-695e-4e02-952a-126be349de7e", "Styles": "color:black", "Classes": "None", "Text": " See section 3 for more information about how to take ", "ParentId": "92d6ad9e-33de-49a9-a200-6bcac76294b1"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva</span>", "ID": "8de995cd-709c-430d-ac80-503b4c255cec", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva", "ParentId": "92d6ad9e-33de-49a9-a200-6bcac76294b1"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">.</span>", "ID": "1a452f13-2f2e-46ee-9c1e-1be0e8de6c93", "Styles": "color:black", "Classes": "None", "Text": ".", "ParentId": "92d6ad9e-33de-49a9-a200-6bcac76294b1"}, {"Element": "<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Look out for important symptoms</span></h2>", "ID": "ec794c2f-bed1-4a84-a979-980aaad4a30b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Look out for important symptoms</span>", "ID": "6a52ca6e-0feb-460e-b785-24fbf22c91c1", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal", "Classes": "None", "Text": "Look out for important symptoms", "ParentId": "ec794c2f-bed1-4a84-a979-980aaad4a30b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Some people taking medicines for hepatitis\nB infection develop other conditions, which can be serious. You need to know\nabout important signs and symptoms to look out for while you are taking\nLamivudine Teva.</span></p>", "ID": "8c032345-d0c2-4603-bb65-589f59136212", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Some people taking medicines for hepatitis\nB infection develop other conditions, which can be serious. You need to know\nabout important signs and symptoms to look out for while you are taking\nLamivudine Teva.</span>", "ID": "dc3f64ff-ad99-4559-8a1b-01363558a8f4", "Styles": "None", "Classes": "None", "Text": "Some people taking medicines for hepatitis B infection develop other conditions, which can be serious. You need to know about important signs and symptoms to look out for while you are taking Lamivudine Teva.", "ParentId": "8c032345-d0c2-4603-bb65-589f59136212"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><span lang=\"EN-GB\">Read\nthe information \u2018Other possible side effects of therapy for Hepatitis\nB\u2019 in Section\u00a04 of this leaflet.</span></p>", "ID": "b36badd7-70f5-4b5b-8294-b0ab797641b4", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "14dc26d6-9072-4b2a-b411-eefda23a6f46", "Styles": "font-family:Wingdings;color:black", "Classes": "None", "Text": "\u00e8", "ParentId": "b36badd7-70f5-4b5b-8294-b0ab797641b4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "6ce977f8-6d72-44b8-8af9-858ec68670bc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "14dc26d6-9072-4b2a-b411-eefda23a6f46"}, {"Element": "<span lang=\"EN-GB\">Read\nthe information \u2018Other possible side effects of therapy for Hepatitis\nB\u2019 in Section\u00a04 of this leaflet.</span>", "ID": "e2206cb7-37a7-499a-a639-bc4ea2f5d48d", "Styles": "None", "Classes": "None", "Text": "Read the information \u2018Other possible side effects of therapy for Hepatitis B\u2019 in Section\u00a04 of this leaflet.", "ParentId": "b36badd7-70f5-4b5b-8294-b0ab797641b4"}, {"Element": "<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Protect other people</span></h2>", "ID": "2474a47c-b80d-4272-a3fd-b9987752a9a5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Protect other people</span>", "ID": "071b761c-f9bc-4af0-860e-48f47f06901f", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal", "Classes": "None", "Text": "Protect other people", "ParentId": "2474a47c-b80d-4272-a3fd-b9987752a9a5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hepatitis B infection is spread by sexual\ncontact with someone who has the infection, or by transfer of infected blood\n(for example, by sharing injection needles). Lamivudine Teva will not stop you\npassing hepatitis B infection on to other people. To protect other people from\nbecoming infected with hepatitis B:</span></p>", "ID": "ed01d4ab-1ed7-44b0-bba2-660ba3e69510", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Hepatitis B infection is spread by sexual\ncontact with someone who has the infection, or by transfer of infected blood\n(for example, by sharing injection needles). Lamivudine Teva will not stop you\npassing hepatitis B infection on to other people. To protect other people from\nbecoming infected with hepatitis B:</span>", "ID": "75dce1cf-2c8b-422f-a958-fcc0d5b454a1", "Styles": "None", "Classes": "None", "Text": "Hepatitis B infection is spread by sexual contact with someone who has the infection, or by transfer of infected blood (for example, by sharing injection needles). Lamivudine Teva will not stop you passing hepatitis B infection on to other people. To protect other people from becoming infected with hepatitis B:", "ParentId": "ed01d4ab-1ed7-44b0-bba2-660ba3e69510"}, {"Element": "<p class=\"Bullet\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;font-family:Wingdings;color:black\">\u0178<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span></span><b><span lang=\"EN-GB\">Use a condom</span></b><span lang=\"EN-GB\"> when you have oral or\npenetrative sex.</span></p>", "ID": "e16e9f1b-c191-4046-a918-b244d1239810", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;font-family:Wingdings;color:black\">\u0178<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span></span>", "ID": "0e0bf517-7512-42c9-99d8-22f914d889cb", "Styles": "font-size:12.0pt;font-family:Wingdings;color:black", "Classes": "None", "Text": "\u0178", "ParentId": "e16e9f1b-c191-4046-a918-b244d1239810"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span>", "ID": "cd867ccc-7bf0-41c1-aa7b-b7451e2d2f4d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0 ", "ParentId": "0e0bf517-7512-42c9-99d8-22f914d889cb"}, {"Element": "<b><span lang=\"EN-GB\">Use a condom</span></b>", "ID": "78e8c09c-4ddc-4778-9e40-29b994841b47", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e16e9f1b-c191-4046-a918-b244d1239810"}, {"Element": "<span lang=\"EN-GB\">Use a condom</span>", "ID": "e7b604a2-47b6-49ce-bb3e-e92fc8917b0a", "Styles": "None", "Classes": "None", "Text": "Use a condom", "ParentId": "78e8c09c-4ddc-4778-9e40-29b994841b47"}, {"Element": "<span lang=\"EN-GB\"> when you have oral or\npenetrative sex.</span>", "ID": "97a97658-66b6-473b-9ca7-ccd6d35eafcb", "Styles": "None", "Classes": "None", "Text": " when you have oral or penetrative sex.", "ParentId": "e16e9f1b-c191-4046-a918-b244d1239810"}, {"Element": "<p class=\"Bullet\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:12.0pt;font-family:Wingdings;color:black\">\u0178<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span></span><b><span lang=\"EN-GB\">Do not risk blood transfer</span></b><span lang=\"EN-GB\"> \u2014 for\nexample, do not share needles.</span></p>", "ID": "de7bd754-532b-48ca-8e68-146edafd3b34", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:12.0pt;font-family:Wingdings;color:black\">\u0178<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span></span>", "ID": "54daefad-7afb-4693-89e7-69f3095b3a1e", "Styles": "font-size:12.0pt;font-family:Wingdings;color:black", "Classes": "None", "Text": "\u0178", "ParentId": "de7bd754-532b-48ca-8e68-146edafd3b34"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0 </span>", "ID": "055dc030-914e-43d8-a2ee-6b6211ad975c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0 ", "ParentId": "54daefad-7afb-4693-89e7-69f3095b3a1e"}, {"Element": "<b><span lang=\"EN-GB\">Do not risk blood transfer</span></b>", "ID": "5e337351-5a63-44ba-b5cd-e5002f4eca4c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de7bd754-532b-48ca-8e68-146edafd3b34"}, {"Element": "<span lang=\"EN-GB\">Do not risk blood transfer</span>", "ID": "0b2f1c06-3f96-49f3-a823-9d99632c5670", "Styles": "None", "Classes": "None", "Text": "Do not risk blood transfer", "ParentId": "5e337351-5a63-44ba-b5cd-e5002f4eca4c"}, {"Element": "<span lang=\"EN-GB\"> \u2014 for\nexample, do not share needles.</span>", "ID": "b702ff49-c5d1-472f-884e-6ee2af03f313", "Styles": "None", "Classes": "None", "Text": " \u2014 for example, do not share needles.", "ParentId": "de7bd754-532b-48ca-8e68-146edafd3b34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "55834862-506f-4bcb-b444-80a589661dff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5f8936a0-93a8-4e65-8af0-c4c3a2a8c7ba", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "55834862-506f-4bcb-b444-80a589661dff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Other medicines and Lamivudine Teva</span></b></p>", "ID": "ded4ff5f-1b6f-404c-8d19-8b4048e2e16e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Other medicines and Lamivudine Teva</span></b>", "ID": "e4dad74f-15e9-40fe-8e63-4e03d969b6f6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ded4ff5f-1b6f-404c-8d19-8b4048e2e16e"}, {"Element": "<span lang=\"EN-GB\">Other medicines and Lamivudine Teva</span>", "ID": "d95ddf36-4699-4be8-ad1d-cba33c1ab040", "Styles": "None", "Classes": "None", "Text": "Other medicines and Lamivudine Teva", "ParentId": "e4dad74f-15e9-40fe-8e63-4e03d969b6f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;page-break-after:avoid\"><span lang=\"EN-GB\">Tell your doctor or pharmacist if you are taking, </span><span lang=\"EN-GB\">have recently taken or might take</span><span lang=\"EN-GB\"> any other\nmedicines, including herbal medicines or other medicines you bought without a\nprescription. </span></p>", "ID": "524bc720-3c4a-4413-a76a-c49105b9b410", "Styles": "margin-top:6.0pt;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Tell your doctor or pharmacist if you are taking, </span>", "ID": "414f8e61-c5f4-405b-b63d-dba6fe1a73f6", "Styles": "None", "Classes": "None", "Text": "Tell your doctor or pharmacist if you are taking, ", "ParentId": "524bc720-3c4a-4413-a76a-c49105b9b410"}, {"Element": "<span lang=\"EN-GB\">have recently taken or might take</span>", "ID": "2ba1fd18-610a-4c9b-b2bc-8d0755e8e517", "Styles": "None", "Classes": "None", "Text": "have recently taken or might take", "ParentId": "524bc720-3c4a-4413-a76a-c49105b9b410"}, {"Element": "<span lang=\"EN-GB\"> any other\nmedicines, including herbal medicines or other medicines you bought without a\nprescription. </span>", "ID": "bd62db72-2a9a-4730-b7f2-0bdd039aa5f7", "Styles": "None", "Classes": "None", "Text": " any other medicines, including herbal medicines or other medicines you bought without a prescription. ", "ParentId": "524bc720-3c4a-4413-a76a-c49105b9b410"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:6.0pt;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "675ffd02-e77f-43ed-9a49-96a4eac1164d", "Styles": "margin-top:6.0pt;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:0in;margin-bottom:.0001pt;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3453bd9e-a886-47e5-8897-74cdb3741897", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "675ffd02-e77f-43ed-9a49-96a4eac1164d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt;line-height:normal\"><span lang=\"EN-GB\">Remember to tell your doctor or pharmacist if you begin taking a new\nmedicine while you are taking Lamivudine Teva.</span></p>", "ID": "98113c2e-1849-41ed-b20e-f1eb6a391d49", "Styles": "margin-right:-1.7pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Remember to tell your doctor or pharmacist if you begin taking a new\nmedicine while you are taking Lamivudine Teva.</span>", "ID": "1823ee56-b162-4069-8042-c1e6580bc2e6", "Styles": "None", "Classes": "None", "Text": "Remember to tell your doctor or pharmacist if you begin taking a new medicine while you are taking Lamivudine Teva.", "ParentId": "98113c2e-1849-41ed-b20e-f1eb6a391d49"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "841cb9bb-9d53-408f-bcb6-7131e2eccaf0", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "87fd2eac-8106-41d0-b7bf-aa6e3ebe6061", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "841cb9bb-9d53-408f-bcb6-7131e2eccaf0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">These medicines should not be used with </span><span lang=\"EN-GB\">Lamivudine Teva</span><span lang=\"EN-GB\" style=\"color:black\">:</span></b></p>", "ID": "675f62ae-e091-4462-b0f1-eb866b6f55d8", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">These medicines should not be used with </span><span lang=\"EN-GB\">Lamivudine Teva</span><span lang=\"EN-GB\" style=\"color:black\">:</span></b>", "ID": "ea3567f1-c44a-4b7a-8321-5541e3775673", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "675f62ae-e091-4462-b0f1-eb866b6f55d8"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">These medicines should not be used with </span>", "ID": "a6f2fabc-cc27-4684-9ba1-08f404fc9a93", "Styles": "color:black", "Classes": "None", "Text": "These medicines should not be used with ", "ParentId": "ea3567f1-c44a-4b7a-8321-5541e3775673"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva</span>", "ID": "92ed80d5-3b9f-4f9f-83d0-0cac1b9c3d79", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva", "ParentId": "ea3567f1-c44a-4b7a-8321-5541e3775673"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">:</span>", "ID": "996cf6eb-9117-4971-bd21-4ac45269bc68", "Styles": "color:black", "Classes": "None", "Text": ":", "ParentId": "ea3567f1-c44a-4b7a-8321-5541e3775673"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">medicines (usually liquids)\ncontaining sorbitol and other sugar alcohols (such as xylitol, mannitol,\nlactitol or maltitol), if taken regularly</span></p>", "ID": "727440b9-aba8-4bf7-b4fb-553ccf108910", "Styles": "margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c6dc5c40-19c5-4a37-a975-2aa4438691dc", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "727440b9-aba8-4bf7-b4fb-553ccf108910"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "636c3643-5de7-4b0c-b415-e32aec2dc10b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c6dc5c40-19c5-4a37-a975-2aa4438691dc"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">medicines (usually liquids)\ncontaining sorbitol and other sugar alcohols (such as xylitol, mannitol,\nlactitol or maltitol), if taken regularly</span>", "ID": "ba467bcd-440c-4de9-9ebc-37204b6fadbd", "Styles": "color:black", "Classes": "None", "Text": "medicines (usually liquids) containing sorbitol and other sugar alcohols (such as xylitol, mannitol, lactitol or maltitol), if taken regularly", "ParentId": "727440b9-aba8-4bf7-b4fb-553ccf108910"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">other medicines containing lamivudine,\nused to treat HIV infection </span><span lang=\"EN-GB\">(sometimes called the AIDS\nvirus)</span></p>", "ID": "a6d4051f-0a6c-4773-b997-b8a48ecb6ac9", "Styles": "margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8041c31d-41fa-49d5-b281-6715b2fb9ac0", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "a6d4051f-0a6c-4773-b997-b8a48ecb6ac9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4ad5c531-66c4-4945-a42b-407e5ed7042f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8041c31d-41fa-49d5-b281-6715b2fb9ac0"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">other medicines containing lamivudine,\nused to treat HIV infection </span>", "ID": "2d44c8d1-3571-4f97-a778-1d1b66ce6f8d", "Styles": "color:black", "Classes": "None", "Text": "other medicines containing lamivudine, used to treat HIV infection ", "ParentId": "a6d4051f-0a6c-4773-b997-b8a48ecb6ac9"}, {"Element": "<span lang=\"EN-GB\">(sometimes called the AIDS\nvirus)</span>", "ID": "155d2e3a-4dee-4909-8e93-06db371d71a3", "Styles": "None", "Classes": "None", "Text": "(sometimes called the AIDS virus)", "ParentId": "a6d4051f-0a6c-4773-b997-b8a48ecb6ac9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">emtricitabine (used to treat\nHIV or hepatitis B infection)</span></p>", "ID": "db0f50d7-b484-4d87-ade5-0b7cf793f26f", "Styles": "margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "956915fe-ecca-49ea-965d-540d2be60a02", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "db0f50d7-b484-4d87-ade5-0b7cf793f26f"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6c2cb453-3df3-41ab-bfad-8fd3f31aa6ec", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "956915fe-ecca-49ea-965d-540d2be60a02"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">emtricitabine (used to treat\nHIV or hepatitis B infection)</span>", "ID": "afacd60b-9b18-479e-a4ab-04b226a10a87", "Styles": "color:black", "Classes": "None", "Text": "emtricitabine (used to treat HIV or hepatitis B infection)", "ParentId": "db0f50d7-b484-4d87-ade5-0b7cf793f26f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">cladribine, used to treat <b>hairy\ncell leukaemia</b></span></p>", "ID": "67419dd4-34ee-48d2-96b2-d581fa32bbbf", "Styles": "margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "58416138-d2a7-46d6-9eef-9bc62c23965b", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "67419dd4-34ee-48d2-96b2-d581fa32bbbf"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7d434f96-967e-4f91-8d12-c7db6abdb268", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "58416138-d2a7-46d6-9eef-9bc62c23965b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">cladribine, used to treat <b>hairy\ncell leukaemia</b></span>", "ID": "e8398367-6609-4f3e-a70e-ca871729d69d", "Styles": "color:black", "Classes": "None", "Text": "cladribine, used to treat ", "ParentId": "67419dd4-34ee-48d2-96b2-d581fa32bbbf"}, {"Element": "<b>hairy\ncell leukaemia</b>", "ID": "febd4347-9b04-4c7a-8673-ba461f7f8642", "Styles": "None", "Classes": "None", "Text": "hairy cell leukaemia", "ParentId": "e8398367-6609-4f3e-a70e-ca871729d69d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Tell\nyour doctor</span></b><span lang=\"EN-GB\"> if you are being treated with any of\nthese.</span></p>", "ID": "2534bbe4-2540-4c60-b8c8-fbb56a195bc8", "Styles": "margin-left:21.3pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "ff049e7b-66e8-4115-bbf8-bda93d9777d7", "Styles": "font-family:Wingdings;color:black", "Classes": "None", "Text": "\u00e8", "ParentId": "2534bbe4-2540-4c60-b8c8-fbb56a195bc8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "751b350e-b0d0-4fae-a3b3-59f5fe98be95", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "ff049e7b-66e8-4115-bbf8-bda93d9777d7"}, {"Element": "<b><span lang=\"EN-GB\">Tell\nyour doctor</span></b>", "ID": "5a05e02b-89f4-4587-ac3d-d6f7009c3d2c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2534bbe4-2540-4c60-b8c8-fbb56a195bc8"}, {"Element": "<span lang=\"EN-GB\">Tell\nyour doctor</span>", "ID": "5856ed00-e0cd-4603-a418-c9a0ed7ef6fb", "Styles": "None", "Classes": "None", "Text": "Tell your doctor", "ParentId": "5a05e02b-89f4-4587-ac3d-d6f7009c3d2c"}, {"Element": "<span lang=\"EN-GB\"> if you are being treated with any of\nthese.</span>", "ID": "382c0520-6bdd-42d5-ac06-7293d5866ab2", "Styles": "None", "Classes": "None", "Text": " if you are being treated with any of these.", "ParentId": "2534bbe4-2540-4c60-b8c8-fbb56a195bc8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8345573e-b6fa-43b7-822d-48fa3ca58e2d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1c4a8e9a-35d6-45e8-9bab-f30090ac3fe6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8345573e-b6fa-43b7-822d-48fa3ca58e2d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Pregnancy </span></b></p>", "ID": "e2b63228-dbe6-490d-8621-932ba52dc9f3", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Pregnancy </span></b>", "ID": "6d900890-1e77-457c-a95e-b63ff49ff814", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e2b63228-dbe6-490d-8621-932ba52dc9f3"}, {"Element": "<span lang=\"EN-GB\">Pregnancy </span>", "ID": "cc040f3e-1454-4331-b9ff-201f58f2f3cd", "Styles": "None", "Classes": "None", "Text": "Pregnancy ", "ParentId": "6d900890-1e77-457c-a95e-b63ff49ff814"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are\npregnant, </span><span lang=\"EN-GB\" style=\"color:black\">think you may be </span><span lang=\"EN-GB\">pregnant,<span style=\"color:black\"> </span>or are planning to have a\nbaby:</span></p>", "ID": "37431969-160f-46a5-987d-de526bef59b0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">If you are\npregnant, </span>", "ID": "2e75b254-75f0-46d4-b38f-c0915fc55135", "Styles": "None", "Classes": "None", "Text": "If you are pregnant, ", "ParentId": "37431969-160f-46a5-987d-de526bef59b0"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">think you may be </span>", "ID": "00725b9a-9ad1-4459-aef9-844c9629d112", "Styles": "color:black", "Classes": "None", "Text": "think you may be ", "ParentId": "37431969-160f-46a5-987d-de526bef59b0"}, {"Element": "<span lang=\"EN-GB\">pregnant,<span style=\"color:black\"> </span>or are planning to have a\nbaby:</span>", "ID": "ca61ba24-5c81-4609-bb79-13e8960a9b2a", "Styles": "None", "Classes": "None", "Text": "pregnant,or are planning to have a baby:", "ParentId": "37431969-160f-46a5-987d-de526bef59b0"}, {"Element": "<span style=\"color:black\"> </span>", "ID": "1bc3d664-dde3-48b5-908e-4db6a19dc753", "Styles": "color:black", "Classes": "None", "Text": " ", "ParentId": "ca61ba24-5c81-4609-bb79-13e8960a9b2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Talk\nto your doctor </span></b><span lang=\"EN-GB\">about the risks and benefits of\ntaking Lamivudine Teva during your pregnancy.</span></p>", "ID": "e5e42299-90fd-4a71-86ed-b82ceb1fbbe9", "Styles": "margin-left:21.3pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "47317b7e-d5a1-497c-88d6-4539d251d4c5", "Styles": "font-family:Wingdings;color:black", "Classes": "None", "Text": "\u00e8", "ParentId": "e5e42299-90fd-4a71-86ed-b82ceb1fbbe9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "1d07b1cd-8946-4681-ab18-bb1539bb1cf9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "47317b7e-d5a1-497c-88d6-4539d251d4c5"}, {"Element": "<b><span lang=\"EN-GB\">Talk\nto your doctor </span></b>", "ID": "74341ff1-0072-4793-9d44-52cccb76e38d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e5e42299-90fd-4a71-86ed-b82ceb1fbbe9"}, {"Element": "<span lang=\"EN-GB\">Talk\nto your doctor </span>", "ID": "5c426811-b939-482e-a887-acb4eb9d9c3b", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor ", "ParentId": "74341ff1-0072-4793-9d44-52cccb76e38d"}, {"Element": "<span lang=\"EN-GB\">about the risks and benefits of\ntaking Lamivudine Teva during your pregnancy.</span>", "ID": "445dac0f-8977-40a9-8213-4950ca090610", "Styles": "None", "Classes": "None", "Text": "about the risks and benefits of taking Lamivudine Teva during your pregnancy.", "ParentId": "e5e42299-90fd-4a71-86ed-b82ceb1fbbe9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not stop\ntreatment with Lamivudine Teva without your doctor\u2019s advice.</span></p>", "ID": "583373b8-5b53-4d72-98c6-46536be44b3f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Do not stop\ntreatment with Lamivudine Teva without your doctor\u2019s advice.</span>", "ID": "f20d3d45-acd1-44b5-9c43-00033a136bc5", "Styles": "None", "Classes": "None", "Text": "Do not stop treatment with Lamivudine Teva without your doctor\u2019s advice.", "ParentId": "583373b8-5b53-4d72-98c6-46536be44b3f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2acf5456-5016-45c5-a1c9-44822333a918", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8dec5b47-a6ac-4935-be59-6695357ace9d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2acf5456-5016-45c5-a1c9-44822333a918"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">Breast-feeding</span></b><span lang=\"EN-GB\" style=\"color:\nblack\"> </span></p>", "ID": "c0a991ba-ebf0-42fa-ac20-299e45269d6e", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Breast-feeding</span></b>", "ID": "0a584c94-531b-4fb4-a425-06ee8fd66179", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c0a991ba-ebf0-42fa-ac20-299e45269d6e"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Breast-feeding</span>", "ID": "0d5f019b-2fc0-4fc7-89ec-e38354afb87e", "Styles": "color:black", "Classes": "None", "Text": "Breast-feeding", "ParentId": "0a584c94-531b-4fb4-a425-06ee8fd66179"}, {"Element": "<span lang=\"EN-GB\" style=\"color:\nblack\"> </span>", "ID": "17af8520-1572-4c1e-bdeb-8aa0e522fc51", "Styles": "color:\nblack", "Classes": "None", "Text": " ", "ParentId": "c0a991ba-ebf0-42fa-ac20-299e45269d6e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Lamivudine Teva</span><span lang=\"EN-GB\" style=\"color:black\"> can pass\ninto breast-milk. If you are breast-feeding, </span><span lang=\"EN-GB\">or\nthinking about breast-feeding:</span></p>", "ID": "45dee3ba-da8f-40d3-a8a1-f4ce35cfabdc", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva</span>", "ID": "28e81808-835c-4a30-86e7-7ce8a9cfedfd", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva", "ParentId": "45dee3ba-da8f-40d3-a8a1-f4ce35cfabdc"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> can pass\ninto breast-milk. If you are breast-feeding, </span>", "ID": "8b520a75-6b2a-4b0f-b0d7-622c4d1e85a0", "Styles": "color:black", "Classes": "None", "Text": " can pass into breast-milk. If you are breast-feeding, ", "ParentId": "45dee3ba-da8f-40d3-a8a1-f4ce35cfabdc"}, {"Element": "<span lang=\"EN-GB\">or\nthinking about breast-feeding:</span>", "ID": "d156954a-26a5-43b3-85be-1659d6630ca2", "Styles": "None", "Classes": "None", "Text": "or thinking about breast-feeding:", "ParentId": "45dee3ba-da8f-40d3-a8a1-f4ce35cfabdc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">Talk to your doctor </span></b><span lang=\"EN-GB\">before you take Lamivudine Teva.</span></p>", "ID": "141106b1-4c84-47eb-ba13-4cad0d914384", "Styles": "margin-left:0in;text-indent:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span>", "ID": "13ee72e8-5769-4020-ba57-323f0003a389", "Styles": "font-family:Wingdings;color:black", "Classes": "None", "Text": "\u00e8", "ParentId": "141106b1-4c84-47eb-ba13-4cad0d914384"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span>", "ID": "71281661-bb49-4443-8577-884f30b90256", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "13ee72e8-5769-4020-ba57-323f0003a389"}, {"Element": "<b><span lang=\"EN-GB\">Talk to your doctor </span></b>", "ID": "95176d0b-42ad-41f8-bcc2-8f505f7f65a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "141106b1-4c84-47eb-ba13-4cad0d914384"}, {"Element": "<span lang=\"EN-GB\">Talk to your doctor </span>", "ID": "8cfd1ea1-1bfd-4591-ab03-98182d548a74", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor ", "ParentId": "95176d0b-42ad-41f8-bcc2-8f505f7f65a1"}, {"Element": "<span lang=\"EN-GB\">before you take Lamivudine Teva.</span>", "ID": "c75bc264-819d-43f7-af01-f498e2426918", "Styles": "None", "Classes": "None", "Text": "before you take Lamivudine Teva.", "ParentId": "141106b1-4c84-47eb-ba13-4cad0d914384"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "35bf3dad-a126-4811-bcfa-f228a0a6bb9e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "896f4e83-2ff2-4e40-8f5a-894bfdf76c41", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "35bf3dad-a126-4811-bcfa-f228a0a6bb9e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3ec0514c-aec4-4ef9-af28-0335072f49c2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "896f4e83-2ff2-4e40-8f5a-894bfdf76c41"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>", "ID": "1b4247fa-7895-4d57-b487-8d2e9fbd81d5", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Driving and using machines</span></b>", "ID": "7453cef3-0fdf-4977-97d9-9d9fd98e4970", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b4247fa-7895-4d57-b487-8d2e9fbd81d5"}, {"Element": "<span lang=\"EN-GB\">Driving and using machines</span>", "ID": "b8db6226-87d8-4d6b-880d-d50c29463afe", "Styles": "None", "Classes": "None", "Text": "Driving and using machines", "ParentId": "7453cef3-0fdf-4977-97d9-9d9fd98e4970"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva </span><span lang=\"EN-GB\">may make you feel\ntired, which could <span style=\"color:black\">affect your ability to drive or\nuse machines</span>. </span></p>", "ID": "ab38d61b-6127-4717-a2b0-d14ab483c560", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva </span>", "ID": "41aee274-6583-4c6e-9029-ac1a30e5e1ff", "Styles": "color:black", "Classes": "None", "Text": "Lamivudine Teva ", "ParentId": "ab38d61b-6127-4717-a2b0-d14ab483c560"}, {"Element": "<span lang=\"EN-GB\">may make you feel\ntired, which could <span style=\"color:black\">affect your ability to drive or\nuse machines</span>. </span>", "ID": "31cb39d3-2b82-4ed1-8d60-148d800eea83", "Styles": "None", "Classes": "None", "Text": "may make you feel tired, which could . ", "ParentId": "ab38d61b-6127-4717-a2b0-d14ab483c560"}, {"Element": "<span style=\"color:black\">affect your ability to drive or\nuse machines</span>", "ID": "e6f94f2e-20bc-47dc-a542-269cc4a92cea", "Styles": "color:black", "Classes": "None", "Text": "affect your ability to drive or use machines", "ParentId": "31cb39d3-2b82-4ed1-8d60-148d800eea83"}, {"Element": "<p class=\"Action\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><span lang=\"EN-GB\">Don\u2019t drive or use machines unless you are\nsure you\u2019re not affected.</span></p>", "ID": "5811e7e0-38ef-4547-aede-b203c0aa1230", "Styles": "margin-top:0in;margin-right:-1.7pt;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:normal", "Classes": "['Action']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span>", "ID": "79e5fc7f-b854-4bbc-a0ff-4cda2689db8d", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e8", "ParentId": "5811e7e0-38ef-4547-aede-b203c0aa1230"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span>", "ID": "afd64188-ca68-4ff9-b503-291119a9ac0d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "79e5fc7f-b854-4bbc-a0ff-4cda2689db8d"}, {"Element": "<span lang=\"EN-GB\">Don\u2019t drive or use machines unless you are\nsure you\u2019re not affected.</span>", "ID": "251dcc55-716f-44d1-baa3-d457d549fdce", "Styles": "None", "Classes": "None", "Text": "Don\u2019t drive or use machines unless you are sure you\u2019re not affected.", "ParentId": "5811e7e0-38ef-4547-aede-b203c0aa1230"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>", "ID": "a84cd840-ce32-4c06-948e-2fc816b519fd", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b>", "ID": "8282c0ac-275a-472c-ae03-0aa744104cf8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a84cd840-ce32-4c06-948e-2fc816b519fd"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "5700da0b-d9e5-47d8-ab51-ba9dca5b12e9", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "8282c0ac-275a-472c-ae03-0aa744104cf8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lamivudine\nTeva</span></b><b> contains sodium</b></p>", "ID": "f70f2c32-96db-4d1b-9c15-9b1f918343dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Lamivudine\nTeva</span></b>", "ID": "c77fd2fd-1cad-4ef3-b318-ef14ade78bd2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f70f2c32-96db-4d1b-9c15-9b1f918343dc"}, {"Element": "<span lang=\"EN-GB\">Lamivudine\nTeva</span>", "ID": "d1e9344a-01a2-4c2b-9887-5eff51a9b0b7", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva", "ParentId": "c77fd2fd-1cad-4ef3-b318-ef14ade78bd2"}, {"Element": "<b> contains sodium</b>", "ID": "be60475c-a0df-47d9-a967-e2c60ec82214", "Styles": "None", "Classes": "None", "Text": " contains sodium", "ParentId": "f70f2c32-96db-4d1b-9c15-9b1f918343dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">This medicine contains less than\n1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially\n\u201csodium-free\u201d.</p>", "ID": "0f912e8e-1b1f-44fa-baf9-f2a136062843", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially \u201csodium-free\u201d.", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\">\u00a0</p>", "ID": "15b81226-176b-4474-a9d7-b7f6c12068ec", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal\"><b><span lang=\"EN-GB\">3.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b><b><span lang=\"EN-GB\">How to take Lamivudine Teva </span></b></p>", "ID": "07475ef7-9f3e-4dd4-91af-de29d8c690e9", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">3.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></b>", "ID": "a0c64150-9ed3-40b3-a2a0-2bd78dbab0b3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07475ef7-9f3e-4dd4-91af-de29d8c690e9"}, {"Element": "<span lang=\"EN-GB\">3.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "58915379-c79c-4f18-8006-fc3fa2e31d41", "Styles": "None", "Classes": "None", "Text": "3.", "ParentId": "a0c64150-9ed3-40b3-a2a0-2bd78dbab0b3"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5c1025ee-a0b7-466d-a8b2-c553baab3e23", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "58915379-c79c-4f18-8006-fc3fa2e31d41"}, {"Element": "<b><span lang=\"EN-GB\">How to take Lamivudine Teva </span></b>", "ID": "5167ec73-4e14-4bba-a6d0-6eea900675d3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07475ef7-9f3e-4dd4-91af-de29d8c690e9"}, {"Element": "<span lang=\"EN-GB\">How to take Lamivudine Teva </span>", "ID": "1ec6ee0f-24b7-4101-a3ef-374e31c4620c", "Styles": "None", "Classes": "None", "Text": "How to take Lamivudine Teva ", "ParentId": "5167ec73-4e14-4bba-a6d0-6eea900675d3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dcf32c19-b759-4be1-8b05-1d5ef1524b90", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4bc2f3f-8a23-4939-926e-ab03ad0a495f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dcf32c19-b759-4be1-8b05-1d5ef1524b90"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Always take this medicine exactly as your doctor has told you to</span></b><span lang=\"EN-GB\">. Check with your doctor or pharmacist if you are not sure. </span></p>", "ID": "d38a81c3-1618-457a-9d14-95babced1dc3", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Always take this medicine exactly as your doctor has told you to</span></b>", "ID": "ee9fafaf-b645-4f70-a9d8-f9bdc6e9c3af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d38a81c3-1618-457a-9d14-95babced1dc3"}, {"Element": "<span lang=\"EN-GB\">Always take this medicine exactly as your doctor has told you to</span>", "ID": "9237c41b-6eff-492d-bdf9-9dfc2034315c", "Styles": "None", "Classes": "None", "Text": "Always take this medicine exactly as your doctor has told you to", "ParentId": "ee9fafaf-b645-4f70-a9d8-f9bdc6e9c3af"}, {"Element": "<span lang=\"EN-GB\">. Check with your doctor or pharmacist if you are not sure. </span>", "ID": "beb08972-1260-4edf-b10e-db478aba28cd", "Styles": "None", "Classes": "None", "Text": ". Check with your doctor or pharmacist if you are not sure. ", "ParentId": "d38a81c3-1618-457a-9d14-95babced1dc3"}, {"Element": "<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Stay in regular contact with your doctor</span></h2>", "ID": "067d2d91-41cb-4836-9617-6824540760dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>Stay in regular contact with your doctor</span>", "ID": "efbc7680-58e6-4a13-a644-4c422e920da8", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal", "Classes": "None", "Text": "Stay in regular contact with your doctor", "ParentId": "067d2d91-41cb-4836-9617-6824540760dc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Lamivudine Teva helps to control your\nhepatitis B infection. You need to keep taking it every day to control your\ninfection and stop your illness getting worse.</span></p>", "ID": "fe15aa79-ff1d-4ab3-95e4-af9d89d4f40b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva helps to control your\nhepatitis B infection. You need to keep taking it every day to control your\ninfection and stop your illness getting worse.</span>", "ID": "71bd2015-91e7-4f1d-b651-b1ace4239ba9", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva helps to control your hepatitis B infection. You need to keep taking it every day to control your infection and stop your illness getting worse.", "ParentId": "fe15aa79-ff1d-4ab3-95e4-af9d89d4f40b"}, {"Element": "<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">Keep in touch with your doctor, and do not\nstop taking Lamivudine Teva</span></b><span lang=\"EN-GB\"> without your\ndoctor\u2019s advice.</span></p>", "ID": "ff5f979a-8afc-48e3-a070-edc07fcf11b3", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt", "Classes": "['Action']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span>", "ID": "0ff880d8-15ae-475f-820a-8abdfd9450e2", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e8", "ParentId": "ff5f979a-8afc-48e3-a070-edc07fcf11b3"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span>", "ID": "4c29f315-75f3-425e-953b-702237e45a6c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "0ff880d8-15ae-475f-820a-8abdfd9450e2"}, {"Element": "<b><span lang=\"EN-GB\">Keep in touch with your doctor, and do not\nstop taking Lamivudine Teva</span></b>", "ID": "9187297a-f424-450e-a661-963340f19e3e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff5f979a-8afc-48e3-a070-edc07fcf11b3"}, {"Element": "<span lang=\"EN-GB\">Keep in touch with your doctor, and do not\nstop taking Lamivudine Teva</span>", "ID": "72458f0d-5421-4f2c-82f0-ebc188d1d69e", "Styles": "None", "Classes": "None", "Text": "Keep in touch with your doctor, and do not stop taking Lamivudine Teva", "ParentId": "9187297a-f424-450e-a661-963340f19e3e"}, {"Element": "<span lang=\"EN-GB\"> without your\ndoctor\u2019s advice.</span>", "ID": "ab0cf2e6-7988-4689-9c35-c50439b30f9f", "Styles": "None", "Classes": "None", "Text": " without your doctor\u2019s advice.", "ParentId": "ff5f979a-8afc-48e3-a070-edc07fcf11b3"}, {"Element": "<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>How much to take</span></h2>", "ID": "3ba58b3b-5d7e-4378-b567-f3f0d75edee5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>How much to take</span>", "ID": "005fccf7-8a5d-4c48-8045-04c2181632b3", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal", "Classes": "None", "Text": "How much to take", "ParentId": "3ba58b3b-5d7e-4378-b567-f3f0d75edee5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">The usual dose\nof Lamivudine Teva is one tablet (100\u00a0mg lamivudine) once a day. </span></p>", "ID": "66630970-a742-400e-8b8c-e5fe7421fcca", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The usual dose\nof Lamivudine Teva is one tablet (100\u00a0mg lamivudine) once a day. </span>", "ID": "3c5ad592-8ac6-4bc8-96e7-7949a7ba9142", "Styles": "None", "Classes": "None", "Text": "The usual dose of Lamivudine Teva is one tablet (100\u00a0mg lamivudine) once a day. ", "ParentId": "66630970-a742-400e-8b8c-e5fe7421fcca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "070084e9-576e-46d1-a1de-988b4d47dcca", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "06df6585-a003-4697-ba2d-4878095fdfed", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "070084e9-576e-46d1-a1de-988b4d47dcca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Your doctor may prescribe a lower dose if you have problems with your\nkidneys. An <span style=\"color:black\">oral solution</span> of Lamivudine is\navailable for people who need a lower than usual dose, or who can\u2019t take\ntablets.</span></p>", "ID": "c88ce69e-82c9-4c39-be99-8bd2c11dabe2", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Your doctor may prescribe a lower dose if you have problems with your\nkidneys. An <span style=\"color:black\">oral solution</span> of Lamivudine is\navailable for people who need a lower than usual dose, or who can\u2019t take\ntablets.</span>", "ID": "2cc15739-3650-4e32-8803-f784de2bce28", "Styles": "None", "Classes": "None", "Text": "Your doctor may prescribe a lower dose if you have problems with your kidneys. An  of Lamivudine is available for people who need a lower than usual dose, or who can\u2019t take tablets.", "ParentId": "c88ce69e-82c9-4c39-be99-8bd2c11dabe2"}, {"Element": "<span style=\"color:black\">oral solution</span>", "ID": "dc355a63-bf62-45ab-8ff6-3d7f9690e33f", "Styles": "color:black", "Classes": "None", "Text": "oral solution", "ParentId": "2cc15739-3650-4e32-8803-f784de2bce28"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5cb53370-c40b-42bc-9313-93717f63e2f3", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0edbf60d-2ee9-4695-aa3e-b5d75aeee4fb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5cb53370-c40b-42bc-9313-93717f63e2f3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor </span></b><span lang=\"EN-GB\" style=\"color:black\">if this applies to you.</span></p>", "ID": "aa84d990-cb5e-492c-9179-05635e3fd69c", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "de216701-175f-41d0-a206-1329fb6270b6", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e8", "ParentId": "aa84d990-cb5e-492c-9179-05635e3fd69c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "0656f708-4c52-413c-b61b-929e1978dac8", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "de216701-175f-41d0-a206-1329fb6270b6"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor </span></b>", "ID": "9f6cb867-8e17-401a-ac47-29642cdca045", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa84d990-cb5e-492c-9179-05635e3fd69c"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Talk to your doctor </span>", "ID": "6796669f-7205-4f8e-adb4-1456501296c7", "Styles": "color:black", "Classes": "None", "Text": "Talk to your doctor ", "ParentId": "9f6cb867-8e17-401a-ac47-29642cdca045"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">if this applies to you.</span>", "ID": "b914d5d5-6ab6-4e3c-9f24-0843111814a3", "Styles": "color:black", "Classes": "None", "Text": "if this applies to you.", "ParentId": "aa84d990-cb5e-492c-9179-05635e3fd69c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "61498cf7-1217-4cfd-bad4-0a74acc6ff94", "Styles": "margin-right:-1.7pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "f46ba431-059b-4b51-9a12-5e035e5aa0f6", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "61498cf7-1217-4cfd-bad4-0a74acc6ff94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are\nalready taking another medicine that contains lamivudine for HIV infection,\nyour doctor will continue to treat you with the higher dose, (usually\n150\u00a0mg twice a day), because the dose of lamivudine in Lamivudine Teva\n(100\u00a0mg) is not enough to treat HIV infection. If you are planning to\nchange your HIV treatment, discuss this change with your doctor first.</span></p>", "ID": "011e2074-0fef-4e59-8f69-3ee6e517b447", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">If you are\nalready taking another medicine that contains lamivudine for HIV infection,\nyour doctor will continue to treat you with the higher dose, (usually\n150\u00a0mg twice a day), because the dose of lamivudine in Lamivudine Teva\n(100\u00a0mg) is not enough to treat HIV infection. If you are planning to\nchange your HIV treatment, discuss this change with your doctor first.</span>", "ID": "a08fdff3-5351-472a-9de8-cfb16e6021c3", "Styles": "None", "Classes": "None", "Text": "If you are already taking another medicine that contains lamivudine for HIV infection, your doctor will continue to treat you with the higher dose, (usually 150\u00a0mg twice a day), because the dose of lamivudine in Lamivudine Teva (100\u00a0mg) is not enough to treat HIV infection. If you are planning to change your HIV treatment, discuss this change with your doctor first.", "ParentId": "011e2074-0fef-4e59-8f69-3ee6e517b447"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d3c5dec3-dbd7-40fb-a388-151f112917cc", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "946e4a19-9cb0-4853-9726-9e6473955b4e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d3c5dec3-dbd7-40fb-a388-151f112917cc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Swallow the tablet whole, with some water. Lamivudine\nTeva can be taken with or without food.</span></p>", "ID": "7ec1e3f0-32f4-4249-81ac-625501ed39af", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Swallow the tablet whole, with some water. Lamivudine\nTeva can be taken with or without food.</span>", "ID": "1c4b2365-1ef3-4dfc-b0d5-3dbb213bed12", "Styles": "None", "Classes": "None", "Text": "Swallow the tablet whole, with some water. Lamivudine Teva can be taken with or without food.", "ParentId": "7ec1e3f0-32f4-4249-81ac-625501ed39af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ae9281e4-d427-40f7-977a-4b0baf46dce6", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fac93673-f6fa-4c94-a7b2-04d15cc2021b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ae9281e4-d427-40f7-977a-4b0baf46dce6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">If you take more Lamivudine Teva than you should</span></b></p>", "ID": "8fc97102-3514-4ec8-b5ca-6e7100d3095b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">If you take more Lamivudine Teva than you should</span></b>", "ID": "73b42f03-fd98-4e95-a80f-47d07beaf129", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8fc97102-3514-4ec8-b5ca-6e7100d3095b"}, {"Element": "<span lang=\"EN-GB\">If you take more Lamivudine Teva than you should</span>", "ID": "d51dd35f-f3b9-4383-ad25-0951ebf854a6", "Styles": "None", "Classes": "None", "Text": "If you take more Lamivudine Teva than you should", "ParentId": "73b42f03-fd98-4e95-a80f-47d07beaf129"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Accidentally\ntaking too much Lamivudine Teva is unlikely to cause any serious problems.</span><span lang=\"EN-GB\"> If you accidentally take too much, tell your doctor or pharmacist,\nor contact your nearest hospital emergency department for further advice.</span></p>", "ID": "0834645c-ed6f-43a3-a03b-5506ffe50c4d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Accidentally\ntaking too much Lamivudine Teva is unlikely to cause any serious problems.</span>", "ID": "9f8753ab-144e-4968-b268-afbd284dd273", "Styles": "None", "Classes": "None", "Text": "Accidentally taking too much Lamivudine Teva is unlikely to cause any serious problems.", "ParentId": "0834645c-ed6f-43a3-a03b-5506ffe50c4d"}, {"Element": "<span lang=\"EN-GB\"> If you accidentally take too much, tell your doctor or pharmacist,\nor contact your nearest hospital emergency department for further advice.</span>", "ID": "ec463e0f-5d68-47ed-84bb-58cada5c643e", "Styles": "None", "Classes": "None", "Text": " If you accidentally take too much, tell your doctor or pharmacist, or contact your nearest hospital emergency department for further advice.", "ParentId": "0834645c-ed6f-43a3-a03b-5506ffe50c4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "72aead86-fee3-4573-9504-94dfc7126839", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c7b02819-d4ed-4780-8b4d-8d579a832e22", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "72aead86-fee3-4573-9504-94dfc7126839"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">If you forget to take Lamivudine Teva</span></b></p>", "ID": "8ca88cee-b6cf-40d1-9af6-4afdeac08037", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">If you forget to take Lamivudine Teva</span></b>", "ID": "a771f25d-6f9d-48b3-8219-0b6d83ea2084", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8ca88cee-b6cf-40d1-9af6-4afdeac08037"}, {"Element": "<span lang=\"EN-GB\">If you forget to take Lamivudine Teva</span>", "ID": "e7d30d6c-ecb4-4122-9469-ec0b1bd9c41e", "Styles": "None", "Classes": "None", "Text": "If you forget to take Lamivudine Teva", "ParentId": "a771f25d-6f9d-48b3-8219-0b6d83ea2084"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">If you forget to take a dose, take it as soon as you remember. Then\ncontinue </span><span lang=\"EN-GB\">your treatment as before.</span></p>", "ID": "b413b85d-9f3b-4a57-bb8d-26633ec739da", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">If you forget to take a dose, take it as soon as you remember. Then\ncontinue </span>", "ID": "33e09196-f43e-4d05-8b0d-a45a81405089", "Styles": "None", "Classes": "None", "Text": "If you forget to take a dose, take it as soon as you remember. Then continue ", "ParentId": "b413b85d-9f3b-4a57-bb8d-26633ec739da"}, {"Element": "<span lang=\"EN-GB\">your treatment as before.</span>", "ID": "b2668679-4409-44a8-a713-61817e450fd1", "Styles": "None", "Classes": "None", "Text": "your treatment as before.", "ParentId": "b413b85d-9f3b-4a57-bb8d-26633ec739da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not take a double dose to make up for a missed dose.</span></p>", "ID": "a8aed43c-f51d-4db8-9429-7f5f7c527de2", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Do not take a double dose to make up for a missed dose.</span>", "ID": "18955066-2f01-4efe-a6ca-05c1fb32c21d", "Styles": "None", "Classes": "None", "Text": "Do not take a double dose to make up for a missed dose.", "ParentId": "a8aed43c-f51d-4db8-9429-7f5f7c527de2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c75ad56-e53a-4fbb-aedf-12e6c7d1f641", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3e8f832e-82ba-4786-9557-18a00d08ae46", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c75ad56-e53a-4fbb-aedf-12e6c7d1f641"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Do not stop taking Lamivudine Teva</span></b></p>", "ID": "bf540eb4-120d-4ec4-aae4-5f2c67a79ac9", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Do not stop taking Lamivudine Teva</span></b>", "ID": "66170068-5496-4fb4-b35f-9f8fb71b636c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bf540eb4-120d-4ec4-aae4-5f2c67a79ac9"}, {"Element": "<span lang=\"EN-GB\">Do not stop taking Lamivudine Teva</span>", "ID": "5d118804-3a12-4295-a893-aeca25f20a6f", "Styles": "None", "Classes": "None", "Text": "Do not stop taking Lamivudine Teva", "ParentId": "66170068-5496-4fb4-b35f-9f8fb71b636c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">You must not\nstop taking Lamivudine Teva without consulting your doctor. </span><span lang=\"EN-GB\">There is a risk of your hepatitis getting worse (see section 2).<span style=\"color:black\"> When you stop taking Lamivudine Teva your doctor will\nmonitor you for at least four months to check for any problems. This will mean\ntaking blood samples to check for any raised liver enzyme levels, which may\nindicate liver damage.</span></span></p>", "ID": "058bfbb6-c2ad-4e68-b162-38b0f0863d1f", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">You must not\nstop taking Lamivudine Teva without consulting your doctor. </span>", "ID": "ecab0399-3ee4-4c5a-bbc5-19b89857f70a", "Styles": "None", "Classes": "None", "Text": "You must not stop taking Lamivudine Teva without consulting your doctor. ", "ParentId": "058bfbb6-c2ad-4e68-b162-38b0f0863d1f"}, {"Element": "<span lang=\"EN-GB\">There is a risk of your hepatitis getting worse (see section 2).<span style=\"color:black\"> When you stop taking Lamivudine Teva your doctor will\nmonitor you for at least four months to check for any problems. This will mean\ntaking blood samples to check for any raised liver enzyme levels, which may\nindicate liver damage.</span></span>", "ID": "d2a1ec76-e2fb-49cc-957c-c2c637e0504b", "Styles": "None", "Classes": "None", "Text": "There is a risk of your hepatitis getting worse (see section 2).", "ParentId": "058bfbb6-c2ad-4e68-b162-38b0f0863d1f"}, {"Element": "<span style=\"color:black\"> When you stop taking Lamivudine Teva your doctor will\nmonitor you for at least four months to check for any problems. This will mean\ntaking blood samples to check for any raised liver enzyme levels, which may\nindicate liver damage.</span>", "ID": "49be24ea-7269-4d37-8b43-537fac649482", "Styles": "color:black", "Classes": "None", "Text": " When you stop taking Lamivudine Teva your doctor will monitor you for at least four months to check for any problems. This will mean taking blood samples to check for any raised liver enzyme levels, which may indicate liver damage.", "ParentId": "d2a1ec76-e2fb-49cc-957c-c2c637e0504b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df06f483-0d3a-4032-a034-10444c856907", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8fa9c9f2-f342-479a-88b2-1e54c50fa538", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df06f483-0d3a-4032-a034-10444c856907"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a8e32895-179a-40ca-bd86-3a4332a11eae", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0344d947-8dc6-417c-a31c-8371574917c2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a8e32895-179a-40ca-bd86-3a4332a11eae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span></b></p>", "ID": "7d4b630f-5b3f-4367-9904-431bf5e5ea7e", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span></b>", "ID": "4b58c3ed-ac87-4a67-8f17-8388a153cd5d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7d4b630f-5b3f-4367-9904-431bf5e5ea7e"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span>", "ID": "1a05045c-94de-4d19-bb89-66f22d849db2", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "4b58c3ed-ac87-4a67-8f17-8388a153cd5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5de8f30b-3352-4da4-9abc-d03759565ca4", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6c5d43f-9961-4855-aabf-56263b905a7a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5de8f30b-3352-4da4-9abc-d03759565ca4"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Like all medicines, this\nmedicine can cause side effects, but not everyone gets them. </span></p>", "ID": "78882cd3-2ff2-41af-8487-f85c5f7bc961", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Like all medicines, this\nmedicine can cause side effects, but not everyone gets them. </span>", "ID": "37c321f3-3527-42fe-9e89-c95b69273a59", "Styles": "color:black", "Classes": "None", "Text": "Like all medicines, this medicine can cause side effects, but not everyone gets them. ", "ParentId": "78882cd3-2ff2-41af-8487-f85c5f7bc961"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d8e31dcc-7063-496c-bb62-5c5bf8fa49d4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "5a06e816-66a2-4a5d-aa27-4470066a4210", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d8e31dcc-7063-496c-bb62-5c5bf8fa49d4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1284a3c3-afc2-4b37-9490-94d2d653a6ad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5a06e816-66a2-4a5d-aa27-4470066a4210"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">As well as\nthe side effects listed below for Lamivudine Teva</span></b><span lang=\"EN-GB\">,\nother conditions can develop during therapy for\u00a0hepatitis B. </span></p>", "ID": "843d8174-15d8-47ea-a5da-28253047d311", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">As well as\nthe side effects listed below for Lamivudine Teva</span></b>", "ID": "b0125567-4083-420d-be68-8b6c19f94ae6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "843d8174-15d8-47ea-a5da-28253047d311"}, {"Element": "<span lang=\"EN-GB\">As well as\nthe side effects listed below for Lamivudine Teva</span>", "ID": "563e62e5-eff3-433f-8589-1da8e99a207e", "Styles": "None", "Classes": "None", "Text": "As well as the side effects listed below for Lamivudine Teva", "ParentId": "b0125567-4083-420d-be68-8b6c19f94ae6"}, {"Element": "<span lang=\"EN-GB\">,\nother conditions can develop during therapy for\u00a0hepatitis B. </span>", "ID": "d1203784-1a51-45e3-83e4-1a8cc63965c9", "Styles": "None", "Classes": "None", "Text": ", other conditions can develop during therapy for\u00a0hepatitis B. ", "ParentId": "843d8174-15d8-47ea-a5da-28253047d311"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><span lang=\"EN-GB\">It\nis important to read the information under \u2018Other possible side effects\nof therapy for\u00a0hepatitis B\u2019.</span></p>", "ID": "c4f13fd6-d122-4889-be6d-842accd0c072", "Styles": "margin-left:21.3pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "cb4d6b43-b63b-4d50-9233-ec5829411ef3", "Styles": "font-family:Wingdings;color:black", "Classes": "None", "Text": "\u00e8", "ParentId": "c4f13fd6-d122-4889-be6d-842accd0c072"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "a64b1d16-29cc-4a84-a841-c84ae71d4bdd", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "cb4d6b43-b63b-4d50-9233-ec5829411ef3"}, {"Element": "<span lang=\"EN-GB\">It\nis important to read the information under \u2018Other possible side effects\nof therapy for\u00a0hepatitis B\u2019.</span>", "ID": "a917ae90-f8ab-4671-984d-a4308e5bd803", "Styles": "None", "Classes": "None", "Text": "It is important to read the information under \u2018Other possible side effects of therapy for\u00a0hepatitis B\u2019.", "ParentId": "c4f13fd6-d122-4889-be6d-842accd0c072"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "961c8121-6f13-4ec7-89dc-991398c4d0c1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "4f83165e-5bd9-47ca-abc8-c3969713fa52", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "961c8121-6f13-4ec7-89dc-991398c4d0c1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Side effects that were\ncommonly reported in Lamivudine clinical trials were tiredness, respiratory\ntract infections, throat discomfort, headache, stomach discomfort and pain,\nnausea, vomiting and diarrhoea, <a name=\"OLE_LINK2\">increases in liver enzymes\nand enzymes produced in the muscles <i>(see below)</i></a>. </span></p>", "ID": "4b22c202-b0a6-424f-bc9a-c7ab7de3d95c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Side effects that were\ncommonly reported in Lamivudine clinical trials were tiredness, respiratory\ntract infections, throat discomfort, headache, stomach discomfort and pain,\nnausea, vomiting and diarrhoea, <a name=\"OLE_LINK2\">increases in liver enzymes\nand enzymes produced in the muscles <i>(see below)</i></a>. </span>", "ID": "139ad7d5-af5d-42fc-817b-cfc2dd05e6ff", "Styles": "color:black", "Classes": "None", "Text": "Side effects that were commonly reported in Lamivudine clinical trials were tiredness, respiratory tract infections, throat discomfort, headache, stomach discomfort and pain, nausea, vomiting and diarrhoea, . ", "ParentId": "4b22c202-b0a6-424f-bc9a-c7ab7de3d95c"}, {"Element": "<a name=\"OLE_LINK2\">increases in liver enzymes\nand enzymes produced in the muscles <i>(see below)</i></a>", "ID": "22c798db-3130-4eb6-a980-c45c97190ca5", "Styles": "None", "Classes": "None", "Text": "increases in liver enzymes and enzymes produced in the muscles ", "ParentId": "139ad7d5-af5d-42fc-817b-cfc2dd05e6ff"}, {"Element": "<i>(see below)</i>", "ID": "43ead845-87fe-47fd-b75d-7e4c71166fdf", "Styles": "None", "Classes": "None", "Text": "(see below)", "ParentId": "22c798db-3130-4eb6-a980-c45c97190ca5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f4ddb972-857a-454b-a0c5-64259850e2c5", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7dd7a7c-9b55-4d1f-994f-10e6d695bfa0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f4ddb972-857a-454b-a0c5-64259850e2c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Allergic reaction </span></b></p>", "ID": "cb19c659-df31-45d9-a6a1-cbb2bba4e852", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Allergic reaction </span></b>", "ID": "74ca2ef3-8b88-4b5f-a534-59c2fb359c15", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb19c659-df31-45d9-a6a1-cbb2bba4e852"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Allergic reaction </span>", "ID": "49faf6a8-c9a0-48bb-a017-7c7842964fa1", "Styles": "color:black", "Classes": "None", "Text": "Allergic reaction ", "ParentId": "74ca2ef3-8b88-4b5f-a534-59c2fb359c15"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\">These are rare (may\naffect up to 1 in 1,000 people). Signs include:</span></p>", "ID": "049afff8-82e2-4191-b551-274ecbc0d343", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">These are rare (may\naffect up to 1 in 1,000 people). Signs include:</span>", "ID": "540a0bac-e524-4c51-90ca-ccbc8146d259", "Styles": "None", "Classes": "None", "Text": "These are rare (may affect up to 1 in 1,000 people). Signs include:", "ParentId": "049afff8-82e2-4191-b551-274ecbc0d343"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">swelling of eyelids, face or\nlips</span></p>", "ID": "21330e57-5882-42b5-860e-def446ff85d8", "Styles": "margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a41314b0-7946-436a-9cd2-6cf5923be67f", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "21330e57-5882-42b5-860e-def446ff85d8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "22555cba-fe9d-4ecc-9990-6fc013a48721", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a41314b0-7946-436a-9cd2-6cf5923be67f"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">swelling of eyelids, face or\nlips</span>", "ID": "f639b4cd-162e-406d-b8ae-dbb3d97c403c", "Styles": "color:black", "Classes": "None", "Text": "swelling of eyelids, face or lips", "ParentId": "21330e57-5882-42b5-860e-def446ff85d8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">difficulty swallowing or\nbreathing</span></p>", "ID": "6c784e75-554a-438e-a66a-611104a30d00", "Styles": "margin-left:21.3pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b0b92b69-c94f-44e5-b386-b980e165415c", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6c784e75-554a-438e-a66a-611104a30d00"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a2ed61cd-c345-4863-a614-c1381af37df6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b0b92b69-c94f-44e5-b386-b980e165415c"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">difficulty swallowing or\nbreathing</span>", "ID": "4a1fb151-6fb1-4540-b985-89e53d0dc8da", "Styles": "color:black", "Classes": "None", "Text": "difficulty swallowing or breathing", "ParentId": "6c784e75-554a-438e-a66a-611104a30d00"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Contact\na doctor immediately</span></b><span lang=\"EN-GB\"> if you get these symptoms. <b>Stop\ntaking Lamivudine Teva</b>.</span></p>", "ID": "e8ff8466-26d6-46fa-a5e3-1c73439d26d5", "Styles": "margin-left:21.3pt;text-indent:-21.3pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings;color:black\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "5f1e16f6-dc05-4584-8e19-164ae14e8ad6", "Styles": "font-family:Wingdings;color:black", "Classes": "None", "Text": "\u00e8", "ParentId": "e8ff8466-26d6-46fa-a5e3-1c73439d26d5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "8a72c167-4249-4b61-8ad5-71c69e3ff7df", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "5f1e16f6-dc05-4584-8e19-164ae14e8ad6"}, {"Element": "<b><span lang=\"EN-GB\">Contact\na doctor immediately</span></b>", "ID": "cf332120-1a26-458e-9f76-9cf0179e1064", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e8ff8466-26d6-46fa-a5e3-1c73439d26d5"}, {"Element": "<span lang=\"EN-GB\">Contact\na doctor immediately</span>", "ID": "a9bd463e-a796-4a09-bf23-b41a05737f29", "Styles": "None", "Classes": "None", "Text": "Contact a doctor immediately", "ParentId": "cf332120-1a26-458e-9f76-9cf0179e1064"}, {"Element": "<span lang=\"EN-GB\"> if you get these symptoms. <b>Stop\ntaking Lamivudine Teva</b>.</span>", "ID": "e40bc1d6-8b4d-446e-a4f3-1f1c923be9ee", "Styles": "None", "Classes": "None", "Text": " if you get these symptoms. .", "ParentId": "e8ff8466-26d6-46fa-a5e3-1c73439d26d5"}, {"Element": "<b>Stop\ntaking Lamivudine Teva</b>", "ID": "b7204bfd-807e-4c58-a589-c0a365ced34b", "Styles": "None", "Classes": "None", "Text": "Stop taking Lamivudine Teva", "ParentId": "e40bc1d6-8b4d-446e-a4f3-1f1c923be9ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3f8bd56b-a35f-47cb-ad0a-2280c5da5c03", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c9621630-d495-44bf-aad3-2e60f358c970", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3f8bd56b-a35f-47cb-ad0a-2280c5da5c03"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Side effects thought to be caused by Lamivudine Teva</span></b></p>", "ID": "07e42018-ac8f-4110-b30f-f6be4b958571", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Side effects thought to be caused by Lamivudine Teva</span></b>", "ID": "027bd63a-8fc4-4a3a-8862-2a24d7b66d50", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07e42018-ac8f-4110-b30f-f6be4b958571"}, {"Element": "<span lang=\"EN-GB\">Side effects thought to be caused by Lamivudine Teva</span>", "ID": "6d45aa53-ed32-4e7f-bf17-776cf8800f51", "Styles": "None", "Classes": "None", "Text": "Side effects thought to be caused by Lamivudine Teva", "ParentId": "027bd63a-8fc4-4a3a-8862-2a24d7b66d50"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "982f3202-61bc-4544-a249-7654050d0180", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1a18370e-8e9d-4636-b715-624e06aa752c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "982f3202-61bc-4544-a249-7654050d0180"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">A very common side effect </span></b><span lang=\"EN-GB\">(these may affect <b>more than 1 in 10</b> people) which may show up\nin blood tests is:</span></p>", "ID": "03a4524b-cb95-4995-830a-af3c20ff6a48", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">A very common side effect </span></b>", "ID": "61be1f47-a3e8-4438-ba7e-762faed957f7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "03a4524b-cb95-4995-830a-af3c20ff6a48"}, {"Element": "<span lang=\"EN-GB\">A very common side effect </span>", "ID": "86f1f1f1-2b16-4963-ba82-0dbcad2548db", "Styles": "None", "Classes": "None", "Text": "A very common side effect ", "ParentId": "61be1f47-a3e8-4438-ba7e-762faed957f7"}, {"Element": "<span lang=\"EN-GB\">(these may affect <b>more than 1 in 10</b> people) which may show up\nin blood tests is:</span>", "ID": "43026801-712e-451f-a892-8c86885da079", "Styles": "None", "Classes": "None", "Text": "(these may affect  people) which may show up in blood tests is:", "ParentId": "03a4524b-cb95-4995-830a-af3c20ff6a48"}, {"Element": "<b>more than 1 in 10</b>", "ID": "1902d4f2-06ec-49d3-a995-c2ef103a57ce", "Styles": "None", "Classes": "None", "Text": "more than 1 in 10", "ParentId": "43026801-712e-451f-a892-8c86885da079"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">an increase in the level of some liver enzymes <i>(transaminases)</i>,\nwhich may be a sign of inflammation or damage in the liver.</span></p>", "ID": "503cccf0-7018-442f-ac87-1600ad224c9c", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "553196a6-0960-44aa-ac00-c3219382ae3e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "503cccf0-7018-442f-ac87-1600ad224c9c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e9e97c8d-9a57-43ba-b711-d4a2d6559f83", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "553196a6-0960-44aa-ac00-c3219382ae3e"}, {"Element": "<span lang=\"EN-GB\">an increase in the level of some liver enzymes <i>(transaminases)</i>,\nwhich may be a sign of inflammation or damage in the liver.</span>", "ID": "ffab64d1-10bb-45fa-ab84-f99fbbb92fd6", "Styles": "None", "Classes": "None", "Text": "an increase in the level of some liver enzymes , which may be a sign of inflammation or damage in the liver.", "ParentId": "503cccf0-7018-442f-ac87-1600ad224c9c"}, {"Element": "<i>(transaminases)</i>", "ID": "abd1815f-b7b2-476f-8cc3-f9418b560622", "Styles": "None", "Classes": "None", "Text": "(transaminases)", "ParentId": "ffab64d1-10bb-45fa-ab84-f99fbbb92fd6"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c5d243a1-9a80-4671-8c3a-43ddaea58a47", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a038a0ad-ebe5-436a-bc31-8779938342a9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c5d243a1-9a80-4671-8c3a-43ddaea58a47"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">A common side effect (</span></b><span lang=\"EN-GB\">these may affect<b> up to 1 in 10 </b>people) is:</span></p>", "ID": "c0440596-827e-4b77-8c80-31f43fc61763", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">A common side effect (</span></b>", "ID": "08e61e6c-7669-4c88-845f-b00f1ed45143", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c0440596-827e-4b77-8c80-31f43fc61763"}, {"Element": "<span lang=\"EN-GB\">A common side effect (</span>", "ID": "eea7bfbc-a3d0-4990-b65f-507473ddcdf7", "Styles": "None", "Classes": "None", "Text": "A common side effect (", "ParentId": "08e61e6c-7669-4c88-845f-b00f1ed45143"}, {"Element": "<span lang=\"EN-GB\">these may affect<b> up to 1 in 10 </b>people) is:</span>", "ID": "05b153a9-4d64-415e-9ca8-3f42787708d0", "Styles": "None", "Classes": "None", "Text": "these may affectpeople) is:", "ParentId": "c0440596-827e-4b77-8c80-31f43fc61763"}, {"Element": "<b> up to 1 in 10 </b>", "ID": "60583bfb-9012-4649-990a-fc1180bb925c", "Styles": "None", "Classes": "None", "Text": " up to 1 in 10 ", "ParentId": "05b153a9-4d64-415e-9ca8-3f42787708d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">cramps and muscle pains </span></p>", "ID": "2796a2ed-c3bd-404e-9b04-93fe7f778f0c", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ce603d30-3270-450e-a1eb-3b8ffa44a13d", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2796a2ed-c3bd-404e-9b04-93fe7f778f0c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "87c4d80f-d020-47f8-b170-2a61c4ed82ee", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ce603d30-3270-450e-a1eb-3b8ffa44a13d"}, {"Element": "<span lang=\"EN-GB\">cramps and muscle pains </span>", "ID": "d32a5a2a-0037-45a0-bf14-0523189ce29d", "Styles": "None", "Classes": "None", "Text": "cramps and muscle pains ", "ParentId": "2796a2ed-c3bd-404e-9b04-93fe7f778f0c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">skin rash or\n\u2018hives\u2019 anywhere on the body.</span></p>", "ID": "b5b78572-c326-4175-aedf-994015cfa6ae", "Styles": "margin-top:0in;margin-right:-1.7pt;margin-bottom:\n0in;margin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1d9d0b6b-1302-4413-ba2f-d7e121998ef9", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b5b78572-c326-4175-aedf-994015cfa6ae"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "28b6a0cd-812e-4955-87de-219c14e28595", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1d9d0b6b-1302-4413-ba2f-d7e121998ef9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">skin rash or\n\u2018hives\u2019 anywhere on the body.</span>", "ID": "c3f04c23-0fe5-49de-91d9-969e70c8db9c", "Styles": "color:black", "Classes": "None", "Text": "skin rash or \u2018hives\u2019 anywhere on the body.", "ParentId": "b5b78572-c326-4175-aedf-994015cfa6ae"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3c100e10-80e9-4b63-a2c7-58989ebee677", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7be9cd71-a706-454e-bf26-813df300da99", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3c100e10-80e9-4b63-a2c7-58989ebee677"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">A common side\neffect</span></b><span lang=\"EN-GB\"> which may show up in blood tests is:</span></p>", "ID": "e76dcd27-418f-466a-a831-c9680059614b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">A common side\neffect</span></b>", "ID": "997a5578-8b2b-4927-a185-e665261769bf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e76dcd27-418f-466a-a831-c9680059614b"}, {"Element": "<span lang=\"EN-GB\">A common side\neffect</span>", "ID": "2f709e26-eb7b-4f67-a505-38114dbc7f92", "Styles": "None", "Classes": "None", "Text": "A common side effect", "ParentId": "997a5578-8b2b-4927-a185-e665261769bf"}, {"Element": "<span lang=\"EN-GB\"> which may show up in blood tests is:</span>", "ID": "18a69bb0-63bc-4132-bbe3-8d0596d7085a", "Styles": "None", "Classes": "None", "Text": " which may show up in blood tests is:", "ParentId": "e76dcd27-418f-466a-a831-c9680059614b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">an increase in the level of an enzyme produced\nin the muscles <i>(creatine phosphokinase)</i> which may be a sign that body\ntissue is damaged.</span></p>", "ID": "1ce404bb-18e2-4154-acd3-8d7d7a0ab994", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1adec78a-e0a0-4873-a1b9-a6eb602cdab3", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "1ce404bb-18e2-4154-acd3-8d7d7a0ab994"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4c1f4f59-2c67-4996-a30b-16a5392c6e44", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1adec78a-e0a0-4873-a1b9-a6eb602cdab3"}, {"Element": "<span lang=\"EN-GB\">an increase in the level of an enzyme produced\nin the muscles <i>(creatine phosphokinase)</i> which may be a sign that body\ntissue is damaged.</span>", "ID": "4ddfe889-f3b0-4388-af9f-92b7c02f1ada", "Styles": "None", "Classes": "None", "Text": "an increase in the level of an enzyme produced in the muscles  which may be a sign that body tissue is damaged.", "ParentId": "1ce404bb-18e2-4154-acd3-8d7d7a0ab994"}, {"Element": "<i>(creatine phosphokinase)</i>", "ID": "ef7aa425-a4f1-4591-84b4-4c8849662f3d", "Styles": "None", "Classes": "None", "Text": "(creatine phosphokinase)", "ParentId": "4ddfe889-f3b0-4388-af9f-92b7c02f1ada"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4b9baf48-c060-42e1-aa89-4d931ce06aab", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b6d7abcc-5b18-4dc4-a13d-a5b6ee6c76b8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4b9baf48-c060-42e1-aa89-4d931ce06aab"}, {"Element": "<p class=\"MsoNormal\"><b><span lang=\"EN-GB\">Other side effects</span></b><span lang=\"EN-GB\" style=\"color:black\"> </span></p>", "ID": "a3509fa8-d5a8-40db-998a-0b3750732e8e", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Other side effects</span></b>", "ID": "67811763-5192-4e32-97e9-ceabf56f8c61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a3509fa8-d5a8-40db-998a-0b3750732e8e"}, {"Element": "<span lang=\"EN-GB\">Other side effects</span>", "ID": "5bafaf33-0391-47a6-843d-ac1b8517923b", "Styles": "None", "Classes": "None", "Text": "Other side effects", "ParentId": "67811763-5192-4e32-97e9-ceabf56f8c61"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> </span>", "ID": "8bfc4561-a2c5-4a8e-8cd6-f620ed95ffa4", "Styles": "color:black", "Classes": "None", "Text": " ", "ParentId": "a3509fa8-d5a8-40db-998a-0b3750732e8e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"color:black\">Other side effects<b> </b>have\noccurred in a very small number of people but their exact frequency is unknown</span></p>", "ID": "8680c975-1bfe-41fe-b13c-0cbda1415131", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Other side effects<b> </b>have\noccurred in a very small number of people but their exact frequency is unknown</span>", "ID": "39601503-cfa3-4f0a-8883-c99c76d03f74", "Styles": "color:black", "Classes": "None", "Text": "Other side effectshave occurred in a very small number of people but their exact frequency is unknown", "ParentId": "8680c975-1bfe-41fe-b13c-0cbda1415131"}, {"Element": "<b> </b>", "ID": "6adb970e-c1fd-4336-a200-819073c46ee5", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "39601503-cfa3-4f0a-8883-c99c76d03f74"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">breakdown of muscle tissue</span></p>", "ID": "f6039e10-de80-4d6c-8773-70f5e401e89d", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "9d5789a2-c9c3-4c5a-9dc1-7a17903134f4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f6039e10-de80-4d6c-8773-70f5e401e89d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "769e9499-bb27-4a00-9640-2a017b294ebc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "9d5789a2-c9c3-4c5a-9dc1-7a17903134f4"}, {"Element": "<span lang=\"EN-GB\">breakdown of muscle tissue</span>", "ID": "43dbc872-a52a-42d5-b6db-dd8dffded470", "Styles": "None", "Classes": "None", "Text": "breakdown of muscle tissue", "ParentId": "f6039e10-de80-4d6c-8773-70f5e401e89d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">a worsening of liver disease after Lamivudine\nTeva is stopped or during treatment if the hepatitis B virus becomes resistant\nto Lamivudine Teva. This can be fatal in some people.</span></p>", "ID": "af996ce9-2cba-4ece-85ee-a2412c42f1e1", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a5c496af-3d69-49c0-8cb8-3872de3818a8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "af996ce9-2cba-4ece-85ee-a2412c42f1e1"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "bca489e5-0c80-426f-aac1-5c6378413f58", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a5c496af-3d69-49c0-8cb8-3872de3818a8"}, {"Element": "<span lang=\"EN-GB\">a worsening of liver disease after Lamivudine\nTeva is stopped or during treatment if the hepatitis B virus becomes resistant\nto Lamivudine Teva. This can be fatal in some people.</span>", "ID": "88dee3ff-8747-475d-86ac-462d803db5cc", "Styles": "None", "Classes": "None", "Text": "a worsening of liver disease after Lamivudine Teva is stopped or during treatment if the hepatitis B virus becomes resistant to Lamivudine Teva. This can be fatal in some people.", "ParentId": "af996ce9-2cba-4ece-85ee-a2412c42f1e1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">lactic acidosis <i>(see the next section,\n\u2018Other possible side effects of therapy for Hepatitis B\u2019)</i>.</span></p>", "ID": "9de89142-986c-44ab-a7bf-c17a34f3e008", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1d63e11e-a396-4418-bd1b-a4aa7bf2e820", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9de89142-986c-44ab-a7bf-c17a34f3e008"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "85f3d3a1-528c-4b16-98f1-81a3c10a5ff4", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1d63e11e-a396-4418-bd1b-a4aa7bf2e820"}, {"Element": "<span lang=\"EN-GB\">lactic acidosis <i>(see the next section,\n\u2018Other possible side effects of therapy for Hepatitis B\u2019)</i>.</span>", "ID": "af918673-8559-4554-b88e-e0a2916bd4ca", "Styles": "None", "Classes": "None", "Text": "lactic acidosis .", "ParentId": "9de89142-986c-44ab-a7bf-c17a34f3e008"}, {"Element": "<i>(see the next section,\n\u2018Other possible side effects of therapy for Hepatitis B\u2019)</i>", "ID": "9e46c426-a3f0-4467-8b2d-6a7d260181d4", "Styles": "None", "Classes": "None", "Text": "(see the next section, \u2018Other possible side effects of therapy for Hepatitis B\u2019)", "ParentId": "af918673-8559-4554-b88e-e0a2916bd4ca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:.5in;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9b9c19a7-1d77-4c1d-b7d8-45d872ab210f", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:.5in;margin-bottom:.0001pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2686756b-db36-432e-a988-a33e2ff3a114", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9b9c19a7-1d77-4c1d-b7d8-45d872ab210f"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">A side effect which may show up in blood\ntests is:</span></p>", "ID": "9a4c898a-a066-493c-bc05-2fa9aa068368", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">A side effect which may show up in blood\ntests is:</span>", "ID": "e2805b74-f630-4c5f-8bcf-0840c3d16c78", "Styles": "None", "Classes": "None", "Text": "A side effect which may show up in blood tests is:", "ParentId": "9a4c898a-a066-493c-bc05-2fa9aa068368"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">a decrease in the number of cells involved in\nblood clotting <i>(thrombocytopenia)</i>.</span></p>", "ID": "cfe33432-cbd1-4bfd-bef5-2cc6bb006241", "Styles": "margin-left:21.3pt;text-indent:-21.3pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1405b062-c361-43c0-987f-0acd010b0fda", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cfe33432-cbd1-4bfd-bef5-2cc6bb006241"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "889c1916-e2fb-4d07-a199-e845591f502e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1405b062-c361-43c0-987f-0acd010b0fda"}, {"Element": "<span lang=\"EN-GB\">a decrease in the number of cells involved in\nblood clotting <i>(thrombocytopenia)</i>.</span>", "ID": "8b60d9d6-c66a-4bee-bfe0-cea2878485e0", "Styles": "None", "Classes": "None", "Text": "a decrease in the number of cells involved in blood clotting .", "ParentId": "cfe33432-cbd1-4bfd-bef5-2cc6bb006241"}, {"Element": "<i>(thrombocytopenia)</i>", "ID": "91941a16-7bc6-4efd-8f82-6818e98e75ab", "Styles": "None", "Classes": "None", "Text": "(thrombocytopenia)", "ParentId": "8b60d9d6-c66a-4bee-bfe0-cea2878485e0"}, {"Element": "<h2><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>If you get any side effects</span></h2>", "ID": "9f3ad88f-ed0b-4f51-81c3-161b912acd44", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal'>If you get any side effects</span>", "ID": "239fc306-08b5-49d6-81a6-96b8ede844e0", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-style:normal", "Classes": "None", "Text": "If you get any side effects", "ParentId": "9f3ad88f-ed0b-4f51-81c3-161b912acd44"}, {"Element": "<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span><b><span lang=\"EN-GB\">Talk\nto your doctor or pharmacist. </span></b><span lang=\"EN-GB\">This includes any\npossible side effects not listed in this leaflet. </span></p>", "ID": "8e9757b0-1a1a-48f2-a776-bbf162dfc285", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt;page-break-after:\navoid", "Classes": "['Action']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span></span>", "ID": "9b1f7494-5dfb-404d-a01a-65c5e6705ef7", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e8", "ParentId": "8e9757b0-1a1a-48f2-a776-bbf162dfc285"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0 </span>", "ID": "20b02b0c-e085-4968-a3c2-bed5cc87260d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "9b1f7494-5dfb-404d-a01a-65c5e6705ef7"}, {"Element": "<b><span lang=\"EN-GB\">Talk\nto your doctor or pharmacist. </span></b>", "ID": "20d18ef0-ddf0-4188-a3fd-c3d25e5ec17f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8e9757b0-1a1a-48f2-a776-bbf162dfc285"}, {"Element": "<span lang=\"EN-GB\">Talk\nto your doctor or pharmacist. </span>", "ID": "cac3adab-12e7-428c-9b07-eb172acee524", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor or pharmacist. ", "ParentId": "20d18ef0-ddf0-4188-a3fd-c3d25e5ec17f"}, {"Element": "<span lang=\"EN-GB\">This includes any\npossible side effects not listed in this leaflet. </span>", "ID": "61927982-57b6-4060-b3e5-f825297594d7", "Styles": "None", "Classes": "None", "Text": "This includes any possible side effects not listed in this leaflet. ", "ParentId": "8e9757b0-1a1a-48f2-a776-bbf162dfc285"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "d37813eb-36b5-418f-8c1a-9d09d2ef8371", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "507a0374-01f5-4835-8187-f9833978d867", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "d37813eb-36b5-418f-8c1a-9d09d2ef8371"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">Other possible side effects of therapy for Hepatitis B</span></b></p>", "ID": "441175a0-3046-4f11-8799-fb8045a0e48a", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Other possible side effects of therapy for Hepatitis B</span></b>", "ID": "c0f8a06f-07dc-4d52-842a-198f8ca44c6b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "441175a0-3046-4f11-8799-fb8045a0e48a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Other possible side effects of therapy for Hepatitis B</span>", "ID": "053a6266-f5a3-47e2-8e39-0131afae3717", "Styles": "color:black", "Classes": "None", "Text": "Other possible side effects of therapy for Hepatitis B", "ParentId": "c0f8a06f-07dc-4d52-842a-198f8ca44c6b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva and related medicines (NRTIs) may cause\nother conditions to develop during hepatitis B treatment.</span></p>", "ID": "00cd7eb6-b791-4dcb-8d48-65153fc0a8c3", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Lamivudine Teva and related medicines (NRTIs) may cause\nother conditions to develop during hepatitis B treatment.</span>", "ID": "dc808088-4926-4036-841d-31050a8cbb2f", "Styles": "color:black", "Classes": "None", "Text": "Lamivudine Teva and related medicines (NRTIs) may cause other conditions to develop during hepatitis B treatment.", "ParentId": "00cd7eb6-b791-4dcb-8d48-65153fc0a8c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b></p>", "ID": "18adc04f-d2ce-4983-b25b-4ca7457e1384", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></b>", "ID": "f5db5718-0f23-4dfd-8fc2-b2e9b24a63a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18adc04f-d2ce-4983-b25b-4ca7457e1384"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "19a42c8b-0e67-494e-bec2-ea230f2aa1c1", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "f5db5718-0f23-4dfd-8fc2-b2e9b24a63a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><b><span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is a rare but serious side effect</span></b></p>", "ID": "0b3de38e-f2c3-46b9-aa32-87454fed6f7f", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is a rare but serious side effect</span></b>", "ID": "4dbdd94d-6f5f-4b12-84c1-e0df3be49639", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b3de38e-f2c3-46b9-aa32-87454fed6f7f"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is a rare but serious side effect</span>", "ID": "892253cd-4367-4423-9ee8-56d8785ca660", "Styles": "color:black", "Classes": "None", "Text": "Lactic acidosis is a rare but serious side effect", "ParentId": "4dbdd94d-6f5f-4b12-84c1-e0df3be49639"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Some people taking Lamivudine Teva, or other medicines like\nit (NRTIs), develop a condition called lactic acidosis, together with an\nenlarged liver. </span></p>", "ID": "fa56b9c9-ab80-45fa-b5ba-cc152954aa96", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Some people taking Lamivudine Teva, or other medicines like\nit (NRTIs), develop a condition called lactic acidosis, together with an\nenlarged liver. </span>", "ID": "ab517d11-3242-4751-bd51-c5e6118234ca", "Styles": "color:black", "Classes": "None", "Text": "Some people taking Lamivudine Teva, or other medicines like it (NRTIs), develop a condition called lactic acidosis, together with an enlarged liver. ", "ParentId": "fa56b9c9-ab80-45fa-b5ba-cc152954aa96"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "788eff4a-83f4-4a5b-87bf-67ae9359545e", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "a11198fd-526a-4b76-a227-8f0e6ed1179f", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "788eff4a-83f4-4a5b-87bf-67ae9359545e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is caused by a build-up of lactic acid in\nthe body. It is rare; if it happens, it usually develops after a few months of\ntreatment. It can be life-threatening, causing failure of internal organs.</span></p>", "ID": "eb851a7b-244d-461d-8721-d110c048d702", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is caused by a build-up of lactic acid in\nthe body. It is rare; if it happens, it usually develops after a few months of\ntreatment. It can be life-threatening, causing failure of internal organs.</span>", "ID": "b3a1b720-d439-41cc-a8c8-0c89388a0a80", "Styles": "color:black", "Classes": "None", "Text": "Lactic acidosis is caused by a build-up of lactic acid in the body. It is rare; if it happens, it usually develops after a few months of treatment. It can be life-threatening, causing failure of internal organs.", "ParentId": "eb851a7b-244d-461d-8721-d110c048d702"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "24f2d6fe-2adf-4e8b-89bf-c2af4226e617", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "660a2913-5ae7-4010-857a-5e8158a990b6", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "24f2d6fe-2adf-4e8b-89bf-c2af4226e617"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is more likely to develop in people who\nhave liver disease, or in obese (very overweight) people, especially women.</span></p>", "ID": "bc7f6979-8c8c-42fe-a1ee-1c7b8cb4c10e", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Lactic acidosis is more likely to develop in people who\nhave liver disease, or in obese (very overweight) people, especially women.</span>", "ID": "07fa1a74-b3f8-4219-a22a-d7a2c89be27f", "Styles": "color:black", "Classes": "None", "Text": "Lactic acidosis is more likely to develop in people who have liver disease, or in obese (very overweight) people, especially women.", "ParentId": "bc7f6979-8c8c-42fe-a1ee-1c7b8cb4c10e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.7pt\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "906718cd-f08d-43e6-af40-3522b2884682", "Styles": "margin-right:-1.7pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "61674e60-012a-47b7-8fcd-bfdacf2783d4", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "906718cd-f08d-43e6-af40-3522b2884682"}, {"Element": "<h3><span style=\"font-size:11.0pt\">Signs of lactic acidosis include:</span></h3>", "ID": "d29d2538-f859-4bd1-a71d-24a61736fb1d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span style=\"font-size:11.0pt\">Signs of lactic acidosis include:</span>", "ID": "1d2135e9-8afa-478a-b1e1-5d1592926b84", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Signs of lactic acidosis include:", "ParentId": "d29d2538-f859-4bd1-a71d-24a61736fb1d"}, {"Element": "<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">deep, rapid, difficult breathing</span></b></p>", "ID": "f7b25e0c-f1df-4be3-9025-29f091d7b991", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "09405f39-a73b-465a-ae39-447df66da7b5", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f7b25e0c-f1df-4be3-9025-29f091d7b991"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "dfb35920-77fd-49fd-b85a-bb4d8c23dd1a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "09405f39-a73b-465a-ae39-447df66da7b5"}, {"Element": "<b><span lang=\"EN-GB\">deep, rapid, difficult breathing</span></b>", "ID": "0cf74c68-8f04-4e68-b740-72084e950e54", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7b25e0c-f1df-4be3-9025-29f091d7b991"}, {"Element": "<span lang=\"EN-GB\">deep, rapid, difficult breathing</span>", "ID": "1120a3e5-882c-4cb2-96ad-bad7ce339a52", "Styles": "None", "Classes": "None", "Text": "deep, rapid, difficult breathing", "ParentId": "0cf74c68-8f04-4e68-b740-72084e950e54"}, {"Element": "<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">drowsiness</span></b></p>", "ID": "e1105d89-977c-402e-bc69-ae1548e1ad56", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "54ef3672-e16f-4dbd-87dd-cdf9f87d794e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e1105d89-977c-402e-bc69-ae1548e1ad56"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5d17053e-ff40-4fc0-be3b-82127cbff5c2", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "54ef3672-e16f-4dbd-87dd-cdf9f87d794e"}, {"Element": "<b><span lang=\"EN-GB\">drowsiness</span></b>", "ID": "5b214f69-fa59-484d-9516-5aaa0ef1db45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e1105d89-977c-402e-bc69-ae1548e1ad56"}, {"Element": "<span lang=\"EN-GB\">drowsiness</span>", "ID": "f5fdfcdb-7fcf-4c0b-b439-19e7a208e8e3", "Styles": "None", "Classes": "None", "Text": "drowsiness", "ParentId": "5b214f69-fa59-484d-9516-5aaa0ef1db45"}, {"Element": "<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">numbness</span></b><span lang=\"EN-GB\"> or <b>weakness</b>\nin the limbs</span></p>", "ID": "7abe6cba-70f4-4022-bfcd-30784a68e7bc", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c3b2673b-65ff-4911-a399-f2926ecec20a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7abe6cba-70f4-4022-bfcd-30784a68e7bc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e65a7105-9e39-422e-9518-98159c42867f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c3b2673b-65ff-4911-a399-f2926ecec20a"}, {"Element": "<b><span lang=\"EN-GB\">numbness</span></b>", "ID": "059887d0-720a-4bd4-bad9-e4c2881f0923", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7abe6cba-70f4-4022-bfcd-30784a68e7bc"}, {"Element": "<span lang=\"EN-GB\">numbness</span>", "ID": "c9c0838f-3320-41c6-a4cb-2f46cb40ffac", "Styles": "None", "Classes": "None", "Text": "numbness", "ParentId": "059887d0-720a-4bd4-bad9-e4c2881f0923"}, {"Element": "<span lang=\"EN-GB\"> or <b>weakness</b>\nin the limbs</span>", "ID": "d7b8d150-5ea6-422c-876f-33b84016b508", "Styles": "None", "Classes": "None", "Text": " or  in the limbs", "ParentId": "7abe6cba-70f4-4022-bfcd-30784a68e7bc"}, {"Element": "<b>weakness</b>", "ID": "e6bb9efb-ec8d-494c-b2af-6fafc424f6cd", "Styles": "None", "Classes": "None", "Text": "weakness", "ParentId": "d7b8d150-5ea6-422c-876f-33b84016b508"}, {"Element": "<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">feeling sick</span></b><span lang=\"EN-GB\">\n(nausea), <b>being sick</b> (vomiting) </span></p>", "ID": "4f1b8a3e-46f6-4b7e-8b4f-ed1d45c94694", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3a7d5d19-cf60-4c1f-9161-03cccd1691cb", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "4f1b8a3e-46f6-4b7e-8b4f-ed1d45c94694"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ab42ee06-0ad8-4cb5-90ea-6305820d8992", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3a7d5d19-cf60-4c1f-9161-03cccd1691cb"}, {"Element": "<b><span lang=\"EN-GB\">feeling sick</span></b>", "ID": "eba27a7b-4300-4b05-a465-2af41ac5a36a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f1b8a3e-46f6-4b7e-8b4f-ed1d45c94694"}, {"Element": "<span lang=\"EN-GB\">feeling sick</span>", "ID": "7ef5ced8-cf95-494f-ac32-2f43f6440c93", "Styles": "None", "Classes": "None", "Text": "feeling sick", "ParentId": "eba27a7b-4300-4b05-a465-2af41ac5a36a"}, {"Element": "<span lang=\"EN-GB\">\n(nausea), <b>being sick</b> (vomiting) </span>", "ID": "bba11905-044e-443c-8d38-bd592a29d9ec", "Styles": "None", "Classes": "None", "Text": " (nausea),  (vomiting) ", "ParentId": "4f1b8a3e-46f6-4b7e-8b4f-ed1d45c94694"}, {"Element": "<b>being sick</b>", "ID": "daf3e4c1-42db-48bd-9f75-b28ca9d4dacf", "Styles": "None", "Classes": "None", "Text": "being sick", "ParentId": "bba11905-044e-443c-8d38-bd592a29d9ec"}, {"Element": "<p class=\"Bullet\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">stomach pain</span></b><span lang=\"EN-GB\">.</span></p>", "ID": "3d0b65ce-81ea-45d1-93f7-013c49217776", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in;\nline-height:normal", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e8dabe7c-5435-4b26-88b1-da6fea7c6e0e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3d0b65ce-81ea-45d1-93f7-013c49217776"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fbfca9d6-62af-494d-ab38-84719fb47faf", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e8dabe7c-5435-4b26-88b1-da6fea7c6e0e"}, {"Element": "<b><span lang=\"EN-GB\">stomach pain</span></b>", "ID": "e40984bf-c602-40de-b1cf-127dc2a59062", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d0b65ce-81ea-45d1-93f7-013c49217776"}, {"Element": "<span lang=\"EN-GB\">stomach pain</span>", "ID": "d269ad72-b6ab-46a7-925d-b33b45b350ad", "Styles": "None", "Classes": "None", "Text": "stomach pain", "ParentId": "e40984bf-c602-40de-b1cf-127dc2a59062"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "0e79af4a-29e9-4623-88e2-6f1712912e8f", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "3d0b65ce-81ea-45d1-93f7-013c49217776"}, {"Element": "<p class=\"Bullet\" style=\"margin-left:0in;text-indent:0in\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "25dea912-f502-4b46-828a-0bcbc7a75b17", "Styles": "margin-left:0in;text-indent:0in", "Classes": "['Bullet']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e802ae0a-739b-4ef1-bcb6-b1af1af1df40", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "25dea912-f502-4b46-828a-0bcbc7a75b17"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:6.0pt\"><span lang=\"EN-GB\">During your treatment,\nyour doctor will monitor you for signs of lactic acidosis. If you have any of\nthe symptoms listed above, or any other symptoms that worry you:</span></p>", "ID": "2133696e-a6ad-452c-ac5a-1a308c956460", "Styles": "margin-bottom:6.0pt", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">During your treatment,\nyour doctor will monitor you for signs of lactic acidosis. If you have any of\nthe symptoms listed above, or any other symptoms that worry you:</span>", "ID": "2748d1ac-8233-4d8f-8350-314b98cba9c0", "Styles": "None", "Classes": "None", "Text": "During your treatment, your doctor will monitor you for signs of lactic acidosis. If you have any of the symptoms listed above, or any other symptoms that worry you:", "ParentId": "2133696e-a6ad-452c-ac5a-1a308c956460"}, {"Element": "<p class=\"Action\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt\"><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span><b><span lang=\"EN-GB\">See your doctor as soon as possible</span></b><span lang=\"EN-GB\">.</span></p>", "ID": "5b612c72-60fc-4f73-b105-e97133e1406f", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:21.3pt;margin-bottom:.0001pt;text-indent:-21.3pt", "Classes": "['Action']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e8<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span></span>", "ID": "2c466bdd-791f-48ba-afff-ea1ccbf40e27", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e8", "ParentId": "5b612c72-60fc-4f73-b105-e97133e1406f"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\n</span>", "ID": "1416286d-011b-4ef8-990f-530517cc1c94", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0 ", "ParentId": "2c466bdd-791f-48ba-afff-ea1ccbf40e27"}, {"Element": "<b><span lang=\"EN-GB\">See your doctor as soon as possible</span></b>", "ID": "e20accec-5370-4f53-b9da-6a4278308e65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5b612c72-60fc-4f73-b105-e97133e1406f"}, {"Element": "<span lang=\"EN-GB\">See your doctor as soon as possible</span>", "ID": "12c9bca6-875e-42e7-b5ce-169395f2e2f2", "Styles": "None", "Classes": "None", "Text": "See your doctor as soon as possible", "ParentId": "e20accec-5370-4f53-b9da-6a4278308e65"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "e00116f2-4374-473b-9948-7aba3de8c26f", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "5b612c72-60fc-4f73-b105-e97133e1406f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44999fa7-5076-4bc8-90ba-0af0cbc14a02", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb25af51-b8c2-45a7-9b93-83481ca51546", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44999fa7-5076-4bc8-90ba-0af0cbc14a02"}, {"Element": "<p class=\"MsoFooter\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif'>Reporting of side effects</span></b></p>", "ID": "5c40903c-8749-4933-887d-e2b92ebb24c7", "Styles": "None", "Classes": "['MsoFooter']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif'>Reporting of side effects</span></b>", "ID": "d8443df2-f5e9-443a-9d4c-2cce45e47f52", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5c40903c-8749-4933-887d-e2b92ebb24c7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif'>Reporting of side effects</span>", "ID": "c452482a-f473-4e74-bc6d-f5905d76a73d", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Reporting of side effects", "ParentId": "d8443df2-f5e9-443a-9d4c-2cce45e47f52"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">If you get any side effects, talk to your doctor or pharmacist.</span><span lang=\"EN-GB\" style=\"color:red\"> </span><span lang=\"EN-GB\">This includes any\npossible side effects not listed in this leaflet. You can also report side\neffects directly via <span style=\"background:lightgrey\">the national reporting\nsystem listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a></span><span lang=\"EN-GB\">. By\nreporting side effects you can help provide more information on the safety of\nthis medicine.</span><span lang=\"EN-GB\"> </span></p>", "ID": "bf319011-347c-426d-b9a9-9b05578716d0", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">If you get any side effects, talk to your doctor or pharmacist.</span>", "ID": "5608bf83-4a90-4d1a-b848-60181f0f007c", "Styles": "None", "Classes": "None", "Text": "If you get any side effects, talk to your doctor or pharmacist.", "ParentId": "bf319011-347c-426d-b9a9-9b05578716d0"}, {"Element": "<span lang=\"EN-GB\" style=\"color:red\"> </span>", "ID": "7da5a56e-8440-47c3-82f6-d8f1f78dfa0f", "Styles": "color:red", "Classes": "None", "Text": " ", "ParentId": "bf319011-347c-426d-b9a9-9b05578716d0"}, {"Element": "<span lang=\"EN-GB\">This includes any\npossible side effects not listed in this leaflet. You can also report side\neffects directly via <span style=\"background:lightgrey\">the national reporting\nsystem listed in </span></span>", "ID": "90cec9c2-fd79-4e9c-92c3-b9b573648f9a", "Styles": "None", "Classes": "None", "Text": "This includes any possible side effects not listed in this leaflet. You can also report side effects directly via ", "ParentId": "bf319011-347c-426d-b9a9-9b05578716d0"}, {"Element": "<span style=\"background:lightgrey\">the national reporting\nsystem listed in </span>", "ID": "f887e38e-b506-4e83-917c-2f24874c63c1", "Styles": "background:lightgrey", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "90cec9c2-fd79-4e9c-92c3-b9b573648f9a"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a></span>", "ID": "a1e7b431-8e6c-4233-9f8c-4af77770fe4a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bf319011-347c-426d-b9a9-9b05578716d0"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:lightgrey\">Appendix V</span></a>", "ID": "2bc64a62-2320-4420-b2fe-5ec86a525c67", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a1e7b431-8e6c-4233-9f8c-4af77770fe4a"}, {"Element": "<span style=\"background:lightgrey\">Appendix V</span>", "ID": "97880a6e-550c-48e1-8ac9-3b18ad5ef21b", "Styles": "background:lightgrey", "Classes": "None", "Text": "Appendix V", "ParentId": "2bc64a62-2320-4420-b2fe-5ec86a525c67"}, {"Element": "<span lang=\"EN-GB\">. By\nreporting side effects you can help provide more information on the safety of\nthis medicine.</span>", "ID": "80b0654f-3432-451d-b6ad-69b22dabddf9", "Styles": "None", "Classes": "None", "Text": ". By reporting side effects you can help provide more information on the safety of this medicine.", "ParentId": "bf319011-347c-426d-b9a9-9b05578716d0"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "474cce6b-3c72-422a-b5ff-08e4710b0f86", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "bf319011-347c-426d-b9a9-9b05578716d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bf4fc5c7-07ad-4108-9a67-e1a319be62fb", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a14f1772-620d-4318-b522-c5be705343b5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bf4fc5c7-07ad-4108-9a67-e1a319be62fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nLamivudine Teva</span></b></p>", "ID": "18f9f403-9eca-4f1e-9516-df595b20a565", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nLamivudine Teva</span></b>", "ID": "70b17fc4-649e-4db8-a4eb-ef39287adaed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18f9f403-9eca-4f1e-9516-df595b20a565"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nLamivudine Teva</span>", "ID": "b803db62-b2aa-4ac3-93b3-7a671e123ac9", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Lamivudine Teva", "ParentId": "70b17fc4-649e-4db8-a4eb-ef39287adaed"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9ba9085d-7fc3-426d-8f85-6b5d7dd185ab", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "44dc6f30-8801-4c3f-9795-5d1a837624c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ba9085d-7fc3-426d-8f85-6b5d7dd185ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span></p>", "ID": "cb3a7703-79fe-45d2-a0f1-63b4dff8ff3d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span>", "ID": "bce11af8-7144-4345-a38d-78ef77b092e1", "Styles": "None", "Classes": "None", "Text": "Keep this medicine out of the sight and reach of children.", "ParentId": "cb3a7703-79fe-45d2-a0f1-63b4dff8ff3d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1e26afa-a6a6-4f3c-bf23-1910bfc30cf3", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "60d5048d-c0da-4230-b5b5-fdcdf899adb2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1e26afa-a6a6-4f3c-bf23-1910bfc30cf3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not take this medicine after the expiry date shown on the\ncontainer or carton and blister pack after EXP. The expiry date refers to the\nlast day of that month.</span></p>", "ID": "5a303bd3-4e26-417f-839f-3ac8443c917c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Do not take this medicine after the expiry date shown on the\ncontainer or carton and blister pack after EXP. The expiry date refers to the\nlast day of that month.</span>", "ID": "2ecefb5b-56ab-413e-8d69-6b5576998133", "Styles": "None", "Classes": "None", "Text": "Do not take this medicine after the expiry date shown on the container or carton and blister pack after EXP. The expiry date refers to the last day of that month.", "ParentId": "5a303bd3-4e26-417f-839f-3ac8443c917c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "87472acc-e7ee-4a06-905a-b6f2c4159000", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "71d02e66-d186-46bf-a56c-43bc8fe2ba95", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "87472acc-e7ee-4a06-905a-b6f2c4159000"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">This medicinal product does not require any special storage conditions</span></p>", "ID": "b38927ec-49c1-4a78-a203-a15f7af468c1", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">This medicinal product does not require any special storage conditions</span>", "ID": "b9e9bc48-6238-4e86-86df-28a5b9da0c81", "Styles": "None", "Classes": "None", "Text": "This medicinal product does not require any special storage conditions", "ParentId": "b38927ec-49c1-4a78-a203-a15f7af468c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "80fa1424-e467-4945-9e0f-58b682f04ea9", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "42aa0347-fb0f-4c16-9ba0-01dc5782c442", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "80fa1424-e467-4945-9e0f-58b682f04ea9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not use Lamivudine Teva if you notice any change in the\nappearance of the tablet.</span></p>", "ID": "42c7473f-f108-4952-a389-bbee10393450", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Do not use Lamivudine Teva if you notice any change in the\nappearance of the tablet.</span>", "ID": "9d279a20-afec-4c79-bdd6-829417462115", "Styles": "None", "Classes": "None", "Text": "Do not use Lamivudine Teva if you notice any change in the appearance of the tablet.", "ParentId": "42c7473f-f108-4952-a389-bbee10393450"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "13ac1b77-032b-49fd-9c35-0facdd68c01a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "db59bc8f-5ad1-4147-ac7d-8993b804064e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "13ac1b77-032b-49fd-9c35-0facdd68c01a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not throw away any medicines in your wastewater or household\nwaste. Ask your pharmacist how to throw away medicines you no longer use. These\nmeasures will help to protect the environment.</span></p>", "ID": "c58216d2-f557-4440-8a0a-b3d663d4f3a6", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Do not throw away any medicines in your wastewater or household\nwaste. Ask your pharmacist how to throw away medicines you no longer use. These\nmeasures will help to protect the environment.</span>", "ID": "fce7063f-23e9-4bfe-bccb-4dbd39dd1186", "Styles": "None", "Classes": "None", "Text": "Do not throw away any medicines in your wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.", "ParentId": "c58216d2-f557-4440-8a0a-b3d663d4f3a6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7185bc6b-84ed-4485-9f88-40c27bc16ed4", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6d4c7995-92f7-4b92-a86a-81586eb108f4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7185bc6b-84ed-4485-9f88-40c27bc16ed4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4a0a6229-7868-42dd-bc57-0d022217f5f6", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d0e02b9-0f7e-4770-995d-76bdb99b22cb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4a0a6229-7868-42dd-bc57-0d022217f5f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style=\"color:black\">Contents of the pack and other</span><span lang=\"EN-GB\">\ninformation</span></b></p>", "ID": "530336e1-d0f7-462a-8377-82e8c4e8d58f", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style=\"color:black\">Contents of the pack and other</span><span lang=\"EN-GB\">\ninformation</span></b>", "ID": "ef9c2005-1781-4ef9-92d2-374b08a91919", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "530336e1-d0f7-462a-8377-82e8c4e8d58f"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "566399ef-fa3e-4430-b844-24b8cb29b3fc", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ef9c2005-1781-4ef9-92d2-374b08a91919"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Contents of the pack and other</span>", "ID": "9332c36f-1be8-4bca-8096-93b4d3bd4a23", "Styles": "color:black", "Classes": "None", "Text": "Contents of the pack and other", "ParentId": "ef9c2005-1781-4ef9-92d2-374b08a91919"}, {"Element": "<span lang=\"EN-GB\">\ninformation</span>", "ID": "7225abd6-30d0-44d5-8eaf-a09b209f707d", "Styles": "None", "Classes": "None", "Text": " information", "ParentId": "ef9c2005-1781-4ef9-92d2-374b08a91919"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7950585e-0b40-4616-870a-e90e754c068c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "11fa4e19-7422-4c3e-a8b6-d00a27e4a8c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7950585e-0b40-4616-870a-e90e754c068c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What Lamivudine Teva contains</span></b></p>", "ID": "3c5c78d8-a495-47f9-ab99-4b4e9fdeffcc", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">What Lamivudine Teva contains</span></b>", "ID": "2d3d9a7d-2fd4-4c6d-b105-1126c4f1ba83", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3c5c78d8-a495-47f9-ab99-4b4e9fdeffcc"}, {"Element": "<span lang=\"EN-GB\">What Lamivudine Teva contains</span>", "ID": "4fd6cbd5-6b75-48d1-847e-88b58edc7d4e", "Styles": "None", "Classes": "None", "Text": "What Lamivudine Teva contains", "ParentId": "2d3d9a7d-2fd4-4c6d-b105-1126c4f1ba83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "3e1bb0d1-fccf-4340-957b-8a978b018a9d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "4fe3c716-d424-4be9-b02c-6a509e6a026a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3e1bb0d1-fccf-4340-957b-8a978b018a9d"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "03797328-679f-4f5a-bfac-3012c8c67832", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4fe3c716-d424-4be9-b02c-6a509e6a026a"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "284e6b15-8591-471b-a96e-c53dd5366aef", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "03797328-679f-4f5a-bfac-3012c8c67832"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The active substance is lamivudine. Each\nfilm-coated tablet contains 100\u00a0mg of lamivudine.</span></p>", "ID": "f769b831-f005-470a-a2bc-3e9be2054d82", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f81a1b72-d805-456c-be0b-bd2598c1d39e", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "f769b831-f005-470a-a2bc-3e9be2054d82"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d622b8d7-8a66-418e-886c-a56bb1418505", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f81a1b72-d805-456c-be0b-bd2598c1d39e"}, {"Element": "<span lang=\"EN-GB\">The active substance is lamivudine. Each\nfilm-coated tablet contains 100\u00a0mg of lamivudine.</span>", "ID": "3520f328-c759-4160-abfa-761b9c2fc99d", "Styles": "None", "Classes": "None", "Text": "The active substance is lamivudine. Each film-coated tablet contains 100\u00a0mg of lamivudine.", "ParentId": "f769b831-f005-470a-a2bc-3e9be2054d82"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The other ingredients are;<i><span style=\"color:green\"> </span></i></span></p>", "ID": "e7fadaca-6199-4f84-ae13-b89b8026c1c8", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "47512963-47e0-4144-a69e-e3d66441cfcb", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "e7fadaca-6199-4f84-ae13-b89b8026c1c8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6f6b1880-a26a-4364-b9aa-3f3ec3a932f3", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "47512963-47e0-4144-a69e-e3d66441cfcb"}, {"Element": "<span lang=\"EN-GB\">The other ingredients are;<i><span style=\"color:green\"> </span></i></span>", "ID": "1a328158-dd3f-42c3-90c0-c16cc8d45d66", "Styles": "None", "Classes": "None", "Text": "The other ingredients are;", "ParentId": "e7fadaca-6199-4f84-ae13-b89b8026c1c8"}, {"Element": "<i><span style=\"color:green\"> </span></i>", "ID": "556ecea4-ad51-48c4-848b-898203ef9585", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a328158-dd3f-42c3-90c0-c16cc8d45d66"}, {"Element": "<span style=\"color:green\"> </span>", "ID": "2738b5a7-3345-4cfe-aae6-93c404fa2ff5", "Styles": "color:green", "Classes": "None", "Text": " ", "ParentId": "556ecea4-ad51-48c4-848b-898203ef9585"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Tablet core: Microcrystalline cellulose, sodium starch\nglycolate, magnesium stearate. Tablet film coat: Hypromellose, titanium dioxide\n(E171), macrogol, polysorbate 80, iron oxide yellow (E172), iron oxide red\n(E172).</span></p>", "ID": "5de4419c-3de2-43b7-b810-bbf74855f166", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Tablet core: Microcrystalline cellulose, sodium starch\nglycolate, magnesium stearate. Tablet film coat: Hypromellose, titanium dioxide\n(E171), macrogol, polysorbate 80, iron oxide yellow (E172), iron oxide red\n(E172).</span>", "ID": "2cc7bf11-222b-41f0-9ada-278a8f981e11", "Styles": "color:black", "Classes": "None", "Text": "Tablet core: Microcrystalline cellulose, sodium starch glycolate, magnesium stearate. Tablet film coat: Hypromellose, titanium dioxide (E171), macrogol, polysorbate 80, iron oxide yellow (E172), iron oxide red (E172).", "ParentId": "5de4419c-3de2-43b7-b810-bbf74855f166"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bc0dec7b-ce4b-42f0-8843-9a8320bfb439", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4187df56-7f78-473a-887b-d900a4adf3ea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bc0dec7b-ce4b-42f0-8843-9a8320bfb439"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What Lamivudine Teva looks like and contents of the pack</span></b></p>", "ID": "39d8cc49-d518-4cc8-a9a5-fe13daa629c5", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">What Lamivudine Teva looks like and contents of the pack</span></b>", "ID": "f240ecf5-2391-45a5-b770-5631ed39639c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "39d8cc49-d518-4cc8-a9a5-fe13daa629c5"}, {"Element": "<span lang=\"EN-GB\">What Lamivudine Teva looks like and contents of the pack</span>", "ID": "07ebc552-9504-4639-8e66-f4bd9780f57a", "Styles": "None", "Classes": "None", "Text": "What Lamivudine Teva looks like and contents of the pack", "ParentId": "f240ecf5-2391-45a5-b770-5631ed39639c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b82bcd12-7515-42ca-a647-076ddd5fc03a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d7832ce7-e47e-4d31-be65-dfa99e23d3c9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b82bcd12-7515-42ca-a647-076ddd5fc03a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b114a1de-533b-4f15-b7fb-950e252c8e41", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d7832ce7-e47e-4d31-be65-dfa99e23d3c9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Orange</span><span lang=\"EN-GB\">, capsule shaped, biconvex film-coated\ntablet \u2013 engraved with \u201cL100\u201d on one side and plain on the\nother</span></p>", "ID": "33167913-224b-417d-89f7-04fb02ef2772", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Orange</span>", "ID": "dd1081b3-37d5-41fd-bda0-908a592f4a43", "Styles": "None", "Classes": "None", "Text": "Orange", "ParentId": "33167913-224b-417d-89f7-04fb02ef2772"}, {"Element": "<span lang=\"EN-GB\">, capsule shaped, biconvex film-coated\ntablet \u2013 engraved with \u201cL100\u201d on one side and plain on the\nother</span>", "ID": "4a1a052c-3315-4007-90b4-bf0d74135c76", "Styles": "None", "Classes": "None", "Text": ", capsule shaped, biconvex film-coated tablet \u2013 engraved with \u201cL100\u201d on one side and plain on the other", "ParentId": "33167913-224b-417d-89f7-04fb02ef2772"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9cdcf718-2b52-4192-bafb-9dafec2aa22d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e88de9be-2a9a-493f-a297-de4d9aa83880", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9cdcf718-2b52-4192-bafb-9dafec2aa22d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Lamivudine Teva is available in aluminium blisters containing 28,\n30, 84 or 100 tablets or HDPE containers containing 60 tablets.</span></p>", "ID": "5d974e24-c3d4-4321-97cb-aa4deeb6c35f", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Lamivudine Teva is available in aluminium blisters containing 28,\n30, 84 or 100 tablets or HDPE containers containing 60 tablets.</span>", "ID": "6ee20266-2676-4ae2-b9c7-bc87a0f5110e", "Styles": "None", "Classes": "None", "Text": "Lamivudine Teva is available in aluminium blisters containing 28, 30, 84 or 100 tablets or HDPE containers containing 60 tablets.", "ParentId": "5d974e24-c3d4-4321-97cb-aa4deeb6c35f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58789920-3337-4260-ad5c-39ff82343750", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "27682ce2-721f-44a6-90f8-e98f53f40eb4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58789920-3337-4260-ad5c-39ff82343750"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Not all pack sizes may beavailable in your country .</span></p>", "ID": "f5fcf94e-f3d5-4f27-86f1-24e407c49018", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Not all pack sizes may beavailable in your country .</span>", "ID": "6c50d0a1-1015-4e8f-8d21-860b71b6bf33", "Styles": "None", "Classes": "None", "Text": "Not all pack sizes may beavailable in your country .", "ParentId": "f5fcf94e-f3d5-4f27-86f1-24e407c49018"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "d586a113-acc7-461e-96ce-9f3fdcd95af6", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "30fa1a6c-b556-4b78-810c-0c2d5ab852de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d586a113-acc7-461e-96ce-9f3fdcd95af6"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "48717ace-0d42-4913-8ef1-af3177490bad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30fa1a6c-b556-4b78-810c-0c2d5ab852de"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "6b57a9e5-0a9a-4b8f-b848-9869024f2fea", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "48717ace-0d42-4913-8ef1-af3177490bad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "6923a2c5-6aac-436f-af8b-7a566eb8bac8", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "536a66f6-b66a-44c3-ae3f-eb697cf8655d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6923a2c5-6aac-436f-af8b-7a566eb8bac8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dd413841-da98-4b34-ae20-aec00dad0074", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "536a66f6-b66a-44c3-ae3f-eb697cf8655d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p>", "ID": "df66c157-0c3c-4668-92a1-06db0dfa6b2b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b>", "ID": "9464e059-acff-4c1a-a95a-bf1045337597", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "df66c157-0c3c-4668-92a1-06db0dfa6b2b"}, {"Element": "<span lang=\"EN-GB\">Marketing Authorisation Holder</span>", "ID": "f6fb936e-2274-4aa0-b2c5-349e1d2541e9", "Styles": "None", "Classes": "None", "Text": "Marketing Authorisation Holder", "ParentId": "9464e059-acff-4c1a-a95a-bf1045337597"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4948c6be-679f-4305-94e1-40f4a388b42c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "328fc4e6-5e94-45bd-b2ac-3ee509d0ec0f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4948c6be-679f-4305-94e1-40f4a388b42c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Teva B.V.</span></p>", "ID": "89ed551e-d84a-45ed-994c-380c0344e85d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Teva B.V.</span>", "ID": "e8739618-57e7-43f0-9a04-ff8ef9cabc6d", "Styles": "None", "Classes": "None", "Text": "Teva B.V.", "ParentId": "89ed551e-d84a-45ed-994c-380c0344e85d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Swensweg 5</span></p>", "ID": "d3a0df2e-50fe-442b-a261-898a87911737", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Swensweg 5</span>", "ID": "270428e0-75e8-4c9d-b17f-4b97e884e0e6", "Styles": "None", "Classes": "None", "Text": "Swensweg 5", "ParentId": "d3a0df2e-50fe-442b-a261-898a87911737"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">2031GA Haarlem</span></p>", "ID": "766a833d-9f8f-4c20-84bf-abbec95866e2", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">2031GA Haarlem</span>", "ID": "34f76a99-6eb8-40bd-a565-9bc9eeab3a09", "Styles": "None", "Classes": "None", "Text": "2031GA Haarlem", "ParentId": "766a833d-9f8f-4c20-84bf-abbec95866e2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Netherlands</span></p>", "ID": "7bea8d80-03c6-4b59-88e6-ffed543e80cb", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Netherlands</span>", "ID": "7dd96108-ea20-4122-9890-624f23dffbcf", "Styles": "None", "Classes": "None", "Text": "Netherlands", "ParentId": "7bea8d80-03c6-4b59-88e6-ffed543e80cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "93fbc903-0f95-498f-929e-c14324707768", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3d998341-af38-4d3d-9373-2cbcfffbf385", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "93fbc903-0f95-498f-929e-c14324707768"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>", "ID": "1eecee5b-185e-40f1-a42b-e1b6749c1162", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">Manufacturer</span></b>", "ID": "56ae4967-7fbe-4112-94f0-5fe143993ecb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1eecee5b-185e-40f1-a42b-e1b6749c1162"}, {"Element": "<span lang=\"EN-GB\">Manufacturer</span>", "ID": "8e34105c-d3e9-4f28-b3a6-64ecacd4840c", "Styles": "None", "Classes": "None", "Text": "Manufacturer", "ParentId": "56ae4967-7fbe-4112-94f0-5fe143993ecb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d945dca6-86ca-4da2-99f6-4cd635cc8dc0", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "84a7398b-4dcc-4104-8a8a-726c34e5b6f1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d945dca6-86ca-4da2-99f6-4cd635cc8dc0"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Teva Pharmaceutical Works Private Limited\nCompany</span></p>", "ID": "77cbaf62-6feb-44c6-9338-15cc7c8f3626", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Teva Pharmaceutical Works Private Limited\nCompany</span>", "ID": "32402afd-13d3-4781-a189-1b5b38fc687b", "Styles": "None", "Classes": "None", "Text": "Teva Pharmaceutical Works Private Limited Company", "ParentId": "77cbaf62-6feb-44c6-9338-15cc7c8f3626"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Pallagi \u00fat 13</span></p>", "ID": "b5bea683-d964-49e1-9185-8e9c19c98b60", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Pallagi \u00fat 13</span>", "ID": "894de404-0ae9-4875-9346-15f478aa3839", "Styles": "None", "Classes": "None", "Text": "Pallagi \u00fat 13", "ParentId": "b5bea683-d964-49e1-9185-8e9c19c98b60"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Debrecen</span><span lang=\"EN-GB\"> H-4042</span></p>", "ID": "78c93f98-efcf-4365-baa9-c6d12d1320d3", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Debrecen</span>", "ID": "500fa17f-459e-4081-a224-de224bd6b1b6", "Styles": "None", "Classes": "None", "Text": "Debrecen", "ParentId": "78c93f98-efcf-4365-baa9-c6d12d1320d3"}, {"Element": "<span lang=\"EN-GB\"> H-4042</span>", "ID": "f0a46102-1bae-45b7-9349-3025bb7ab932", "Styles": "None", "Classes": "None", "Text": " H-4042", "ParentId": "78c93f98-efcf-4365-baa9-c6d12d1320d3"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Hungary</span></p>", "ID": "fe58b2fa-9657-4997-9d16-8d2f9d341762", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Hungary</span>", "ID": "20655f92-8d1b-4e42-bb24-031cccd03808", "Styles": "None", "Classes": "None", "Text": "Hungary", "ParentId": "fe58b2fa-9657-4997-9d16-8d2f9d341762"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "700347c5-d5c6-4ceb-92b3-cbac7dd09327", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1aaa4a9f-4af9-4239-a6ec-500a204922b1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "700347c5-d5c6-4ceb-92b3-cbac7dd09327"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"NL\">Pharmachemie B.V.</span></p>", "ID": "55be274c-294b-4323-90c9-5d804f4f4bdc", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"NL\">Pharmachemie B.V.</span>", "ID": "41f853d4-bfa8-4e39-802b-929d62c07377", "Styles": "None", "Classes": "None", "Text": "Pharmachemie B.V.", "ParentId": "55be274c-294b-4323-90c9-5d804f4f4bdc"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"NL\">Swensweg 5</span></p>", "ID": "9025d7b1-506e-4866-9b1a-ff53e219ba16", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"NL\">Swensweg 5</span>", "ID": "889c56d2-e31c-4d65-9c8c-b1461a495e1b", "Styles": "None", "Classes": "None", "Text": "Swensweg 5", "ParentId": "9025d7b1-506e-4866-9b1a-ff53e219ba16"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"NL\">2031 GA Haarlem</span></p>", "ID": "d657fd50-7ba2-4e64-ad7f-adc978cb8d31", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"NL\">2031 GA Haarlem</span>", "ID": "77cf431c-b10d-4156-94c4-2cc39c7d2b0a", "Styles": "None", "Classes": "None", "Text": "2031 GA Haarlem", "ParentId": "d657fd50-7ba2-4e64-ad7f-adc978cb8d31"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">The Netherlands</span></p>", "ID": "59adcad8-09ce-49e7-8974-34eac90a9610", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">The Netherlands</span>", "ID": "133b3c07-39e7-4da6-a753-2f8b67193e1a", "Styles": "None", "Classes": "None", "Text": "The Netherlands", "ParentId": "59adcad8-09ce-49e7-8974-34eac90a9610"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f55dc66f-3493-44a0-ad7f-72313f8fe110", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "142f4ff5-d4c6-43af-aaba-14d55ac02ef0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f55dc66f-3493-44a0-ad7f-72313f8fe110"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Teva Operations\nPoland Sp.z o. o.</span></p>", "ID": "3bc37944-2cd7-428b-8b90-337b1e69f946", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Teva Operations\nPoland Sp.z o. o.</span>", "ID": "ce28d138-d8b1-421d-9e33-d919d153f660", "Styles": "None", "Classes": "None", "Text": "Teva Operations Poland Sp.z o. o.", "ParentId": "3bc37944-2cd7-428b-8b90-337b1e69f946"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Mogilska 80\nStr.</span></p>", "ID": "1c83225f-bf64-4b12-a3c7-f33eccd42054", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Mogilska 80\nStr.</span>", "ID": "b8fb72bb-fb5b-4447-8475-c68222457d92", "Styles": "None", "Classes": "None", "Text": "Mogilska 80 Str.", "ParentId": "1c83225f-bf64-4b12-a3c7-f33eccd42054"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">31-546\nKrak\u00f3w</span></p>", "ID": "56dcf589-921e-4e70-9b1b-d8b4f7e67350", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">31-546\nKrak\u00f3w</span>", "ID": "50310188-fa57-44be-b3fa-ad45ba171d1c", "Styles": "None", "Classes": "None", "Text": "31-546 Krak\u00f3w", "ParentId": "56dcf589-921e-4e70-9b1b-d8b4f7e67350"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Poland</span></p>", "ID": "1c1805ae-63d5-4619-8262-e61bb32c0504", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Poland</span>", "ID": "16dc4895-bd8f-4843-958c-e1b023938b78", "Styles": "None", "Classes": "None", "Text": "Poland", "ParentId": "1c1805ae-63d5-4619-8262-e61bb32c0504"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8322e3bb-27c4-4e0c-91cd-921fbf01eace", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fbb169dc-e47c-4591-af9a-fa975f9b4c2a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8322e3bb-27c4-4e0c-91cd-921fbf01eace"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">For any information about this medicine, please contact the local\nrepresentative of the Marketing Authorisation Holder</span></p>", "ID": "2a7a09ab-2f47-4a39-9dbd-a6595a5a5e27", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">For any information about this medicine, please contact the local\nrepresentative of the Marketing Authorisation Holder</span>", "ID": "bc31051f-b756-4ea6-9160-b26181510161", "Styles": "None", "Classes": "None", "Text": "For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder", "ParentId": "2a7a09ab-2f47-4a39-9dbd-a6595a5a5e27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><i><span lang=\"EN-GB\">\u00a0</span></i></b></p>", "ID": "a6acd18b-4110-40c3-bbba-0d0492bdfe76", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><i><span lang=\"EN-GB\">\u00a0</span></i></b>", "ID": "326cc577-a8fa-4f4d-bdfc-24df1cf80cea", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a6acd18b-4110-40c3-bbba-0d0492bdfe76"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "bd396bb3-d20c-4c0e-b862-c93d5b495a16", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "326cc577-a8fa-4f4d-bdfc-24df1cf80cea"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "793ae37a-149d-40f7-a32c-d3e697a2db67", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd396bb3-d20c-4c0e-b862-c93d5b495a16"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:401.4pt;margin-left:9.0pt;border-collapse:collapse\" width=\"535\">\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Teva Pharma Belgium N.V./S.A./AG </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel/T\u00e9l: +32 38207373</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB Teva Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +370 52660203</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;text-autospace:\n  none\"><span style=\"color:black\">\u0422\u0435\u0432\u0430</span><span style=\"color:black\"> </span><span style=\"color:black\">\u0424\u0430\u0440\u043c\u0430</span>\n<span lang=\"BG\">\u0415\u0410\u0414</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Te</span><span lang=\"RU\">\u043b.: +</span><span lang=\"BG\">359 2</span><span lang=\"EN-GB\">4899585</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\" style=\"background:yellow\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Luxembourg/Luxemburg </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Allemagne/<b> </b>Deutschland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l/Tel: +49 73140202</span><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">\u010cesk\u00e1 republika </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva Pharmaceuticals CR, s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+420 251007111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Magyarorsz\u00e1g </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva </span><span lang=\"EN-GB\">Gy\u00f3gyszergy\u00e1r Zrt.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +36 12886400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b>Danmark </b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Teva\n  Denmark A/S </p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tlf: +45 44985511</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Malta </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Teva Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">L-Irlanda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +353 </span><span lang=\"EN-GB\">19127700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: </span><span lang=\"DE\">+49 73140208</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\" style=\"background:yellow\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"NL\">Nederland </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:-1.15pt;line-height:normal;text-autospace:\n  none\"><span lang=\"NL\">Teva Nederland B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: +31 8000228400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NL\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\" style=\"color:black\"> Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: </span><span lang=\"EN-GB\">+372 6610801</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Norge</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Teva Norway AS</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Tlf: +47\n  66775590</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Specifar\n  A.B.E.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IS\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm Arzneimittel Vertriebs-GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +43 1970070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Teva Pharma,\n  S.L.U.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">T\u00e9l: +34 913873280</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals Polska Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +48223459300</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Sant\u00e9</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l: +33 155917800</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Pharma -\n  Produtos Farmac\u00eauticos Lda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel</span><span lang=\"EN-GB\">: </span><span lang=\"EN-GB\">+351\n  214767550</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Pliva Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +385 13720000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals S.R.L</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +40 212306524</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+353 19127700 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Pliva Ljubljana d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +386 15890390</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Finnland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Simi: +358 201805900</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +421 257267911</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Italia\n  S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+39 028917981</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Suomi/Finland</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Puh/Tel:\n  +358 201805900</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Specifar A.B.E.E.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +46 42121100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\"> fili\u0101le Latvij\u0101</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +371 67323666</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva UK\n  Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+44 1977628500</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>", "ID": "1c9a96d2-21ee-4a1c-822b-536d8793eff9", "Styles": "width:401.4pt;margin-left:9.0pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "                ", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Teva Pharma Belgium N.V./S.A./AG </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel/T\u00e9l: +32 38207373</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB Teva Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +370 52660203</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>", "ID": "efa8f3bc-148e-4bbd-b256-79e812c4e691", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Teva Pharma Belgium N.V./S.A./AG </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel/T\u00e9l: +32 38207373</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "b781c9c0-22b4-4005-92d5-c98d363a8caa", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "efa8f3bc-148e-4bbd-b256-79e812c4e691"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien </span></b></p>", "ID": "6b4b96b7-1c66-46a5-89fd-bed223c224b1", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b781c9c0-22b4-4005-92d5-c98d363a8caa"}, {"Element": "<b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien </span></b>", "ID": "67571429-83ce-45f0-8419-a1394fc733a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b4b96b7-1c66-46a5-89fd-bed223c224b1"}, {"Element": "<span lang=\"DE\">Belgi\u00eb/Belgique/Belgien </span>", "ID": "34c3d252-0dc0-4c5d-921c-c31d9e9de34d", "Styles": "None", "Classes": "None", "Text": "Belgi\u00eb/Belgique/Belgien ", "ParentId": "67571429-83ce-45f0-8419-a1394fc733a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Teva Pharma Belgium N.V./S.A./AG </span></p>", "ID": "4d857b71-b982-4197-9735-592c87d490e7", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b781c9c0-22b4-4005-92d5-c98d363a8caa"}, {"Element": "<span lang=\"DE\">Teva Pharma Belgium N.V./S.A./AG </span>", "ID": "0a0557fc-d246-408b-b7e1-e82e05964a5d", "Styles": "None", "Classes": "None", "Text": "Teva Pharma Belgium N.V./S.A./AG ", "ParentId": "4d857b71-b982-4197-9735-592c87d490e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel/T\u00e9l: +32 38207373</span><span lang=\"EN-GB\"> </span></p>", "ID": "009ca25d-55fa-41a9-bbc1-80a29cdad913", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b781c9c0-22b4-4005-92d5-c98d363a8caa"}, {"Element": "<span lang=\"EN-GB\">Tel/T\u00e9l: +32 38207373</span>", "ID": "d8081814-d9eb-484d-b48c-4f24f402b01b", "Styles": "None", "Classes": "None", "Text": "Tel/T\u00e9l: +32 38207373", "ParentId": "009ca25d-55fa-41a9-bbc1-80a29cdad913"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "d8aa7c5f-050d-4dcc-969d-6b4d90e3e54c", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "009ca25d-55fa-41a9-bbc1-80a29cdad913"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9dd1fc2b-57d2-45c2-952e-b3347d105894", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b781c9c0-22b4-4005-92d5-c98d363a8caa"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9bef0116-8615-4376-be90-959a3ed743f7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9dd1fc2b-57d2-45c2-952e-b3347d105894"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB Teva Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +370 52660203</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>", "ID": "3a755f08-5ea8-4d95-b171-d83b74bba9c7", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "efa8f3bc-148e-4bbd-b256-79e812c4e691"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>", "ID": "7006f18f-68c5-4152-97cf-0d5552c8b3fa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a755f08-5ea8-4d95-b171-d83b74bba9c7"}, {"Element": "<b><span lang=\"EN-GB\">Lietuva</span></b>", "ID": "0c6c1c09-0e8f-405d-b07e-9bc8caf69d9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7006f18f-68c5-4152-97cf-0d5552c8b3fa"}, {"Element": "<span lang=\"EN-GB\">Lietuva</span>", "ID": "d1abe0e8-9ba2-4c24-b240-c2783c98f621", "Styles": "None", "Classes": "None", "Text": "Lietuva", "ParentId": "0c6c1c09-0e8f-405d-b07e-9bc8caf69d9e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB Teva Baltics</span></p>", "ID": "2b80e133-1ef4-427f-b85b-c0beef479d85", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a755f08-5ea8-4d95-b171-d83b74bba9c7"}, {"Element": "<span lang=\"EN-GB\">UAB Teva Baltics</span>", "ID": "c4217b0b-8eec-4407-a69e-54e8f2a09700", "Styles": "None", "Classes": "None", "Text": "UAB Teva Baltics", "ParentId": "2b80e133-1ef4-427f-b85b-c0beef479d85"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +370 52660203</span></p>", "ID": "17242d33-a335-4579-aed6-055b1aa257d3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a755f08-5ea8-4d95-b171-d83b74bba9c7"}, {"Element": "<span lang=\"EN-GB\">Tel: +370 52660203</span>", "ID": "e065639e-dd37-453e-a35d-7b2fa6aeea24", "Styles": "None", "Classes": "None", "Text": "Tel: +370 52660203", "ParentId": "17242d33-a335-4579-aed6-055b1aa257d3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>", "ID": "abbba81d-868f-49db-8b99-c151e8b0d335", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a755f08-5ea8-4d95-b171-d83b74bba9c7"}, {"Element": "<span lang=\"PT-BR\">\u00a0</span>", "ID": "75f4f8d6-d010-477b-82b5-7c6360ac94fe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "abbba81d-868f-49db-8b99-c151e8b0d335"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;text-autospace:\n  none\"><span style=\"color:black\">\u0422\u0435\u0432\u0430</span><span style=\"color:black\"> </span><span style=\"color:black\">\u0424\u0430\u0440\u043c\u0430</span>\n<span lang=\"BG\">\u0415\u0410\u0414</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Te</span><span lang=\"RU\">\u043b.: +</span><span lang=\"BG\">359 2</span><span lang=\"EN-GB\">4899585</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\" style=\"background:yellow\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Luxembourg/Luxemburg </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Allemagne/<b> </b>Deutschland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l/Tel: +49 73140202</span><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>", "ID": "0bb7d633-7616-48a1-af3f-e1bdc00065fa", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;text-autospace:\n  none\"><span style=\"color:black\">\u0422\u0435\u0432\u0430</span><span style=\"color:black\"> </span><span style=\"color:black\">\u0424\u0430\u0440\u043c\u0430</span>\n<span lang=\"BG\">\u0415\u0410\u0414</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Te</span><span lang=\"RU\">\u043b.: +</span><span lang=\"BG\">359 2</span><span lang=\"EN-GB\">4899585</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\" style=\"background:yellow\">\u00a0</span></p>\n</td>", "ID": "6db3bc22-09b2-438e-995a-65bff34314cf", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "0bb7d633-7616-48a1-af3f-e1bdc00065fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b><b><span lang=\"EN-GB\"> </span></b></p>", "ID": "e0c5097a-4e12-49cb-8407-a36a81cc9f45", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6db3bc22-09b2-438e-995a-65bff34314cf"}, {"Element": "<b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b>", "ID": "c87ace4b-1aec-4cd5-8f33-cf9757266283", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e0c5097a-4e12-49cb-8407-a36a81cc9f45"}, {"Element": "<span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span>", "ID": "adddc915-1ba0-4601-b91e-ad5282359220", "Styles": "None", "Classes": "None", "Text": "\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f", "ParentId": "c87ace4b-1aec-4cd5-8f33-cf9757266283"}, {"Element": "<b><span lang=\"EN-GB\"> </span></b>", "ID": "c54a607b-f71f-49e3-abb8-bb522a3e6ca0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e0c5097a-4e12-49cb-8407-a36a81cc9f45"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "1ff2ce3f-517e-4e52-9cc7-6e21aa3dcd0f", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "c54a607b-f71f-49e3-abb8-bb522a3e6ca0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;text-autospace:\n  none\"><span style=\"color:black\">\u0422\u0435\u0432\u0430</span><span style=\"color:black\"> </span><span style=\"color:black\">\u0424\u0430\u0440\u043c\u0430</span>\n<span lang=\"BG\">\u0415\u0410\u0414</span></p>", "ID": "ced28a46-f020-4a5e-8220-334d6c5b22ec", "Styles": "margin-right:28.35pt;line-height:normal;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": " ", "ParentId": "6db3bc22-09b2-438e-995a-65bff34314cf"}, {"Element": "<span style=\"color:black\">\u0422\u0435\u0432\u0430</span>", "ID": "58bd9a7b-1915-42de-afac-b7f04cd8d259", "Styles": "color:black", "Classes": "None", "Text": "\u0422\u0435\u0432\u0430", "ParentId": "ced28a46-f020-4a5e-8220-334d6c5b22ec"}, {"Element": "<span style=\"color:black\"> </span>", "ID": "ad35515c-d6e0-4015-a310-85157401e8af", "Styles": "color:black", "Classes": "None", "Text": " ", "ParentId": "ced28a46-f020-4a5e-8220-334d6c5b22ec"}, {"Element": "<span style=\"color:black\">\u0424\u0430\u0440\u043c\u0430</span>", "ID": "81c85bd2-59c4-44c3-beec-147c7ce06f98", "Styles": "color:black", "Classes": "None", "Text": "\u0424\u0430\u0440\u043c\u0430", "ParentId": "ced28a46-f020-4a5e-8220-334d6c5b22ec"}, {"Element": "<span lang=\"BG\">\u0415\u0410\u0414</span>", "ID": "7fa1d1a4-c63e-4025-a9d2-2bf1d2a7a589", "Styles": "None", "Classes": "None", "Text": "\u0415\u0410\u0414", "ParentId": "ced28a46-f020-4a5e-8220-334d6c5b22ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Te</span><span lang=\"RU\">\u043b.: +</span><span lang=\"BG\">359 2</span><span lang=\"EN-GB\">4899585</span></p>", "ID": "33ce9b0a-7f1a-4d85-bbb0-ead49a952101", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6db3bc22-09b2-438e-995a-65bff34314cf"}, {"Element": "<span lang=\"EN-GB\">Te</span>", "ID": "9f0a2157-2ae3-4a58-a52a-4c81839610fe", "Styles": "None", "Classes": "None", "Text": "Te", "ParentId": "33ce9b0a-7f1a-4d85-bbb0-ead49a952101"}, {"Element": "<span lang=\"RU\">\u043b.: +</span>", "ID": "fbc14310-1547-46e1-b012-227fa6ad889a", "Styles": "None", "Classes": "None", "Text": "\u043b.: +", "ParentId": "33ce9b0a-7f1a-4d85-bbb0-ead49a952101"}, {"Element": "<span lang=\"BG\">359 2</span>", "ID": "abeef58d-907d-486d-8421-c35b92dafabf", "Styles": "None", "Classes": "None", "Text": "359 2", "ParentId": "33ce9b0a-7f1a-4d85-bbb0-ead49a952101"}, {"Element": "<span lang=\"EN-GB\">4899585</span>", "ID": "26cfcd7f-a5ae-453e-a188-d3ebdf94bce5", "Styles": "None", "Classes": "None", "Text": "4899585", "ParentId": "33ce9b0a-7f1a-4d85-bbb0-ead49a952101"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\" style=\"background:yellow\">\u00a0</span></p>", "ID": "05a69412-84c7-432d-9ffe-ca5aec460880", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6db3bc22-09b2-438e-995a-65bff34314cf"}, {"Element": "<span lang=\"PT-BR\" style=\"background:yellow\">\u00a0</span>", "ID": "c9c0737e-95f1-4fcc-9828-75ee8a84908e", "Styles": "background:yellow", "Classes": "None", "Text": "\u00a0", "ParentId": "05a69412-84c7-432d-9ffe-ca5aec460880"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Luxembourg/Luxemburg </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Allemagne/<b> </b>Deutschland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l/Tel: +49 73140202</span><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>", "ID": "e46cb608-1007-49a7-ad93-538d8bf71f3c", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "      ", "ParentId": "0bb7d633-7616-48a1-af3f-e1bdc00065fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Luxembourg/Luxemburg </span></b></p>", "ID": "078c4457-eb0f-4682-aa70-2b2e8c755339", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e46cb608-1007-49a7-ad93-538d8bf71f3c"}, {"Element": "<b><span lang=\"PT-BR\">Luxembourg/Luxemburg </span></b>", "ID": "b3b97ef9-da9b-4124-8c30-8f18b7a5cdd3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "078c4457-eb0f-4682-aa70-2b2e8c755339"}, {"Element": "<span lang=\"PT-BR\">Luxembourg/Luxemburg </span>", "ID": "1f1ef8ea-aca3-4f43-af55-72465243bd52", "Styles": "None", "Classes": "None", "Text": "Luxembourg/Luxemburg ", "ParentId": "b3b97ef9-da9b-4124-8c30-8f18b7a5cdd3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm GmbH</span></p>", "ID": "268e965c-9309-4d4f-9446-e037dd369827", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e46cb608-1007-49a7-ad93-538d8bf71f3c"}, {"Element": "<span lang=\"DE\">ratiopharm GmbH</span>", "ID": "11c4e290-ae0b-45e9-9202-9ff134ee4527", "Styles": "None", "Classes": "None", "Text": "ratiopharm GmbH", "ParentId": "268e965c-9309-4d4f-9446-e037dd369827"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Allemagne/<b> </b>Deutschland</span></p>", "ID": "023380e4-cbd5-484a-b07e-27c432854cc2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e46cb608-1007-49a7-ad93-538d8bf71f3c"}, {"Element": "<span lang=\"DE\">Allemagne/<b> </b>Deutschland</span>", "ID": "7c04659c-6177-4deb-b89d-a1488ddd03bb", "Styles": "None", "Classes": "None", "Text": "Allemagne/Deutschland", "ParentId": "023380e4-cbd5-484a-b07e-27c432854cc2"}, {"Element": "<b> </b>", "ID": "58cde28a-d270-41ca-aed1-ab64ba8e18c5", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "7c04659c-6177-4deb-b89d-a1488ddd03bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l/Tel: +49 73140202</span><b><span lang=\"EN-GB\"> </span></b></p>", "ID": "03ff9c0f-938e-4577-b481-8369fa758be9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e46cb608-1007-49a7-ad93-538d8bf71f3c"}, {"Element": "<span lang=\"EN-GB\">T\u00e9l/Tel: +49 73140202</span>", "ID": "29ec9bfb-ac42-4a41-9714-ec70ef0ba945", "Styles": "None", "Classes": "None", "Text": "T\u00e9l/Tel: +49 73140202", "ParentId": "03ff9c0f-938e-4577-b481-8369fa758be9"}, {"Element": "<b><span lang=\"EN-GB\"> </span></b>", "ID": "7cfac74a-9c84-4cc3-82f9-97f7bd6ad9a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "03ff9c0f-938e-4577-b481-8369fa758be9"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "a3586ebb-313d-48c2-8554-50cff0c5d661", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "7cfac74a-9c84-4cc3-82f9-97f7bd6ad9a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>", "ID": "035aa5a3-584d-4fd1-8bfa-ba2f7c87ecc5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e46cb608-1007-49a7-ad93-538d8bf71f3c"}, {"Element": "<span lang=\"PT-BR\">\u00a0</span>", "ID": "b9ed983e-4d2c-44a9-8e4e-d8e8cdce83b2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "035aa5a3-584d-4fd1-8bfa-ba2f7c87ecc5"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">\u010cesk\u00e1 republika </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva Pharmaceuticals CR, s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+420 251007111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Magyarorsz\u00e1g </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva </span><span lang=\"EN-GB\">Gy\u00f3gyszergy\u00e1r Zrt.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +36 12886400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "684eaa14-febf-408b-845a-e57d7c60974b", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">\u010cesk\u00e1 republika </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva Pharmaceuticals CR, s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+420 251007111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "4fe69ca3-d20f-4536-a158-a37d8b3e30d9", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "684eaa14-febf-408b-845a-e57d7c60974b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">\u010cesk\u00e1 republika </span></b></p>", "ID": "6b8acda9-1cfa-44bf-836f-6717cf97e7e9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe69ca3-d20f-4536-a158-a37d8b3e30d9"}, {"Element": "<b><span lang=\"PT-BR\">\u010cesk\u00e1 republika </span></b>", "ID": "6febcf48-e95e-424c-9a3b-3a54e8182147", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b8acda9-1cfa-44bf-836f-6717cf97e7e9"}, {"Element": "<span lang=\"PT-BR\">\u010cesk\u00e1 republika </span>", "ID": "f1af0563-dc55-4547-8919-49924ca6eda1", "Styles": "None", "Classes": "None", "Text": "\u010cesk\u00e1 republika ", "ParentId": "6febcf48-e95e-424c-9a3b-3a54e8182147"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva Pharmaceuticals CR, s.r.o. </span></p>", "ID": "96b849dd-c9fe-4915-90a8-14252a560167", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe69ca3-d20f-4536-a158-a37d8b3e30d9"}, {"Element": "<span lang=\"PT-BR\">Teva Pharmaceuticals CR, s.r.o. </span>", "ID": "46e2b104-dcd2-4e1d-97f6-21697534d518", "Styles": "None", "Classes": "None", "Text": "Teva Pharmaceuticals CR, s.r.o. ", "ParentId": "96b849dd-c9fe-4915-90a8-14252a560167"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+420 251007111</span></p>", "ID": "3a70e87e-d77b-4d53-a5f2-ed3c07c2241d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe69ca3-d20f-4536-a158-a37d8b3e30d9"}, {"Element": "<span lang=\"EN-GB\">Tel: </span>", "ID": "1c57d9ab-9d6d-4ac7-b26d-7dbb27e833be", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "3a70e87e-d77b-4d53-a5f2-ed3c07c2241d"}, {"Element": "<span lang=\"EN-GB\">+420 251007111</span>", "ID": "43daabb3-6ea0-4c2e-aa43-c75a48807a25", "Styles": "None", "Classes": "None", "Text": "+420 251007111", "ParentId": "3a70e87e-d77b-4d53-a5f2-ed3c07c2241d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "694fc90b-9273-41f9-bfeb-856d13d703ea", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe69ca3-d20f-4536-a158-a37d8b3e30d9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce355080-045c-4c9e-9e4f-1a547a103700", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "694fc90b-9273-41f9-bfeb-856d13d703ea"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Magyarorsz\u00e1g </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva </span><span lang=\"EN-GB\">Gy\u00f3gyszergy\u00e1r Zrt.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +36 12886400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "e77e529b-48e3-4c45-99de-27f627ee9861", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "684eaa14-febf-408b-845a-e57d7c60974b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Magyarorsz\u00e1g </span></b></p>", "ID": "fcbf60fc-216f-4b7d-881f-7b2f8dbcb976", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e77e529b-48e3-4c45-99de-27f627ee9861"}, {"Element": "<b><span lang=\"PT-BR\">Magyarorsz\u00e1g </span></b>", "ID": "df2741c1-b3e9-42da-a139-dd6dfd57f02c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fcbf60fc-216f-4b7d-881f-7b2f8dbcb976"}, {"Element": "<span lang=\"PT-BR\">Magyarorsz\u00e1g </span>", "ID": "6c9d6054-8ca5-41cf-b272-e84d6269100f", "Styles": "None", "Classes": "None", "Text": "Magyarorsz\u00e1g ", "ParentId": "df2741c1-b3e9-42da-a139-dd6dfd57f02c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Teva </span><span lang=\"EN-GB\">Gy\u00f3gyszergy\u00e1r Zrt.</span><span lang=\"EN-GB\"> </span></p>", "ID": "096b9e5f-0ee4-4654-a571-98c490791e42", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e77e529b-48e3-4c45-99de-27f627ee9861"}, {"Element": "<span lang=\"PT-BR\">Teva </span>", "ID": "dabe4aae-0b18-4382-a3d2-21e9badd4c33", "Styles": "None", "Classes": "None", "Text": "Teva ", "ParentId": "096b9e5f-0ee4-4654-a571-98c490791e42"}, {"Element": "<span lang=\"EN-GB\">Gy\u00f3gyszergy\u00e1r Zrt.</span>", "ID": "ad44974a-624a-42b7-88a9-06ed5a32c05d", "Styles": "None", "Classes": "None", "Text": "Gy\u00f3gyszergy\u00e1r Zrt.", "ParentId": "096b9e5f-0ee4-4654-a571-98c490791e42"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "ce6a2f99-cd0d-468c-b0ad-ca4ca3d805a6", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "096b9e5f-0ee4-4654-a571-98c490791e42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +36 12886400 </span></p>", "ID": "e0ecd3e2-4f38-4d1f-9772-2b510f8ad7a7", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e77e529b-48e3-4c45-99de-27f627ee9861"}, {"Element": "<span lang=\"PT-BR\">Tel.: +36 12886400 </span>", "ID": "b2cf6ce9-a371-4e38-b882-938d00e950c3", "Styles": "None", "Classes": "None", "Text": "Tel.: +36 12886400 ", "ParentId": "e0ecd3e2-4f38-4d1f-9772-2b510f8ad7a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "969ece5d-8927-4a1e-847a-496abeb3b00b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e77e529b-48e3-4c45-99de-27f627ee9861"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ddc22e83-d89a-49f7-a728-2ec17eb34505", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "969ece5d-8927-4a1e-847a-496abeb3b00b"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b>Danmark </b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Teva\n  Denmark A/S </p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tlf: +45 44985511</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Malta </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Teva Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">L-Irlanda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +353 </span><span lang=\"EN-GB\">19127700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "0e101f24-e264-4b5f-b806-7909377811dc", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b>Danmark </b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Teva\n  Denmark A/S </p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tlf: +45 44985511</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0e6f2382-d802-495f-8742-b4095f9f8c52", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "0e101f24-e264-4b5f-b806-7909377811dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b>Danmark </b></p>", "ID": "7968d0b9-aa68-43e5-a4be-39c928dd85e9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0e6f2382-d802-495f-8742-b4095f9f8c52"}, {"Element": "<b>Danmark </b>", "ID": "f10d86c8-adf1-4c83-971f-e97ac481d1d3", "Styles": "None", "Classes": "None", "Text": "Danmark ", "ParentId": "7968d0b9-aa68-43e5-a4be-39c928dd85e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Teva\n  Denmark A/S </p>", "ID": "cb017e2b-88da-47d9-9fc5-8a0cc1b99687", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "Teva   Denmark A/S ", "ParentId": "0e6f2382-d802-495f-8742-b4095f9f8c52"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tlf: +45 44985511</span></p>", "ID": "82eaa244-21e3-4178-8029-e97065c4edc6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0e6f2382-d802-495f-8742-b4095f9f8c52"}, {"Element": "<span lang=\"EN-GB\">Tlf: +45 44985511</span>", "ID": "0a1698e8-4dc2-48da-b5d0-73a2c9295f64", "Styles": "None", "Classes": "None", "Text": "Tlf: +45 44985511", "ParentId": "82eaa244-21e3-4178-8029-e97065c4edc6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dfffd8a6-1531-4d2e-8d0d-24ca368e1800", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0e6f2382-d802-495f-8742-b4095f9f8c52"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "35370527-7bec-4077-8ebf-017a570dfbf4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dfffd8a6-1531-4d2e-8d0d-24ca368e1800"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Malta </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Teva Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">L-Irlanda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +353 </span><span lang=\"EN-GB\">19127700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "862bfa88-5df8-4246-b736-10ea179a4885", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "      ", "ParentId": "0e101f24-e264-4b5f-b806-7909377811dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"PT-BR\">Malta </span></b></p>", "ID": "cd6c77d4-3f89-4a4d-896c-98e2d0893e98", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "862bfa88-5df8-4246-b736-10ea179a4885"}, {"Element": "<b><span lang=\"PT-BR\">Malta </span></b>", "ID": "3dc4d415-a4cf-49ce-8a32-cd5801b867c4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd6c77d4-3f89-4a4d-896c-98e2d0893e98"}, {"Element": "<span lang=\"PT-BR\">Malta </span>", "ID": "4dfe3346-ebf8-4ae1-b4fe-c0cb958ce586", "Styles": "None", "Classes": "None", "Text": "Malta ", "ParentId": "3dc4d415-a4cf-49ce-8a32-cd5801b867c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Teva Pharmaceuticals Ireland</span></p>", "ID": "c8cd96ba-014c-43e8-a1ff-6c2c6d5c5890", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "862bfa88-5df8-4246-b736-10ea179a4885"}, {"Element": "<span lang=\"EN-GB\">Teva Pharmaceuticals Ireland</span>", "ID": "22a86881-0355-449f-8cfb-0c29fa8749d4", "Styles": "None", "Classes": "None", "Text": "Teva Pharmaceuticals Ireland", "ParentId": "c8cd96ba-014c-43e8-a1ff-6c2c6d5c5890"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">L-Irlanda</span></p>", "ID": "1d06a217-081f-4e35-83a1-ee9ea30fcbbc", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "862bfa88-5df8-4246-b736-10ea179a4885"}, {"Element": "<span lang=\"EN-GB\">L-Irlanda</span>", "ID": "8e4cdf75-0ce6-47a5-8cd6-1333216fd58e", "Styles": "None", "Classes": "None", "Text": "L-Irlanda", "ParentId": "1d06a217-081f-4e35-83a1-ee9ea30fcbbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +353 </span><span lang=\"EN-GB\">19127700</span></p>", "ID": "ef9fb998-dbde-45f3-a120-6eb2e2db5699", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "862bfa88-5df8-4246-b736-10ea179a4885"}, {"Element": "<span lang=\"EN-GB\">Tel: +353 </span>", "ID": "3a049d37-bf71-486f-81cc-d3af8e71887c", "Styles": "None", "Classes": "None", "Text": "Tel: +353 ", "ParentId": "ef9fb998-dbde-45f3-a120-6eb2e2db5699"}, {"Element": "<span lang=\"EN-GB\">19127700</span>", "ID": "fc83bbcc-bd95-400f-8f53-20c32302966e", "Styles": "None", "Classes": "None", "Text": "19127700", "ParentId": "ef9fb998-dbde-45f3-a120-6eb2e2db5699"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c0c5ccf6-0d73-4d4d-8ad4-4d25feb2ccca", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "862bfa88-5df8-4246-b736-10ea179a4885"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2f1a28df-11b4-4d4c-93b6-e0d719e3ba0b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c0c5ccf6-0d73-4d4d-8ad4-4d25feb2ccca"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: </span><span lang=\"DE\">+49 73140208</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\" style=\"background:yellow\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"NL\">Nederland </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:-1.15pt;line-height:normal;text-autospace:\n  none\"><span lang=\"NL\">Teva Nederland B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: +31 8000228400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>", "ID": "45bac6af-eb35-4e1c-8fd9-10dcee11883d", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: </span><span lang=\"DE\">+49 73140208</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\" style=\"background:yellow\">\u00a0</span></p>\n</td>", "ID": "23613cbb-83fa-406d-b7a7-581c7f6841f8", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "45bac6af-eb35-4e1c-8fd9-10dcee11883d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>", "ID": "58e30f3e-322c-44c5-b466-7127f00bbcca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "23613cbb-83fa-406d-b7a7-581c7f6841f8"}, {"Element": "<b><span lang=\"DE\">Deutschland</span></b>", "ID": "3a35b6d0-5710-499d-b15a-b983b5291bb0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58e30f3e-322c-44c5-b466-7127f00bbcca"}, {"Element": "<span lang=\"DE\">Deutschland</span>", "ID": "d8d74353-d544-4071-bb1d-2ea870645e44", "Styles": "None", "Classes": "None", "Text": "Deutschland", "ParentId": "3a35b6d0-5710-499d-b15a-b983b5291bb0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva GmbH</span></p>", "ID": "ffd3308d-2f0b-44eb-97a7-77c0c139bcbf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "23613cbb-83fa-406d-b7a7-581c7f6841f8"}, {"Element": "<span lang=\"DE\">Teva GmbH</span>", "ID": "da2fa2fd-8e84-4166-a3cb-ad25d9939d77", "Styles": "None", "Classes": "None", "Text": "Teva GmbH", "ParentId": "ffd3308d-2f0b-44eb-97a7-77c0c139bcbf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: </span><span lang=\"DE\">+49 73140208</span></p>", "ID": "232cbc7f-da5f-4dcd-a540-9d2258540473", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "23613cbb-83fa-406d-b7a7-581c7f6841f8"}, {"Element": "<span lang=\"DE\">Tel: </span>", "ID": "cbba546b-7561-4301-9e94-3e03bff3327a", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "232cbc7f-da5f-4dcd-a540-9d2258540473"}, {"Element": "<span lang=\"DE\">+49 73140208</span>", "ID": "95b166f0-66da-4343-9b21-e5272be2fecc", "Styles": "None", "Classes": "None", "Text": "+49 73140208", "ParentId": "232cbc7f-da5f-4dcd-a540-9d2258540473"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\" style=\"background:yellow\">\u00a0</span></p>", "ID": "b66dca8d-ee21-475e-b399-3de75cc12694", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "23613cbb-83fa-406d-b7a7-581c7f6841f8"}, {"Element": "<span lang=\"DE\" style=\"background:yellow\">\u00a0</span>", "ID": "9e0682d4-4ba2-4b1d-8091-a5aee62f81fb", "Styles": "background:yellow", "Classes": "None", "Text": "\u00a0", "ParentId": "b66dca8d-ee21-475e-b399-3de75cc12694"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"NL\">Nederland </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:-1.15pt;line-height:normal;text-autospace:\n  none\"><span lang=\"NL\">Teva Nederland B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: +31 8000228400 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>", "ID": "45899d14-2051-410e-b3d8-f5652f568e73", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "45bac6af-eb35-4e1c-8fd9-10dcee11883d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"NL\">Nederland </span></b></p>", "ID": "28d9bfa6-9b00-48e7-8b37-579b5eb0483a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "45899d14-2051-410e-b3d8-f5652f568e73"}, {"Element": "<b><span lang=\"NL\">Nederland </span></b>", "ID": "d8925780-3825-4137-9ef6-181605d36673", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "28d9bfa6-9b00-48e7-8b37-579b5eb0483a"}, {"Element": "<span lang=\"NL\">Nederland </span>", "ID": "899f151c-306b-48e2-8574-895880f7f228", "Styles": "None", "Classes": "None", "Text": "Nederland ", "ParentId": "d8925780-3825-4137-9ef6-181605d36673"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:-1.15pt;line-height:normal;text-autospace:\n  none\"><span lang=\"NL\">Teva Nederland B.V.</span></p>", "ID": "8ed431a9-a8e0-4811-9341-f20794d7797b", "Styles": "margin-left:-1.15pt;line-height:normal;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "45899d14-2051-410e-b3d8-f5652f568e73"}, {"Element": "<span lang=\"NL\">Teva Nederland B.V.</span>", "ID": "d22d0ebe-0162-4d86-8f43-bf0af7fc5c0e", "Styles": "None", "Classes": "None", "Text": "Teva Nederland B.V.", "ParentId": "8ed431a9-a8e0-4811-9341-f20794d7797b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: +31 8000228400 </span></p>", "ID": "a75f2397-d891-436c-882b-c3ab31bf75de", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "45899d14-2051-410e-b3d8-f5652f568e73"}, {"Element": "<span lang=\"NL\">Tel: +31 8000228400 </span>", "ID": "5ff9be36-0bba-4452-a54e-643cfc4b26b9", "Styles": "None", "Classes": "None", "Text": "Tel: +31 8000228400 ", "ParentId": "a75f2397-d891-436c-882b-c3ab31bf75de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>", "ID": "612c35f6-934e-4e05-bfc2-119075ef79e3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "45899d14-2051-410e-b3d8-f5652f568e73"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "5e297d0c-4566-4b21-ad58-46977cfc9be0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "612c35f6-934e-4e05-bfc2-119075ef79e3"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NL\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\" style=\"color:black\"> Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: </span><span lang=\"EN-GB\">+372 6610801</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Norge</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Teva Norway AS</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Tlf: +47\n  66775590</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "bfa5603d-8ef2-404c-bde1-bd45532c6fd7", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NL\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\" style=\"color:black\"> Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: </span><span lang=\"EN-GB\">+372 6610801</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "b68da93a-c939-45a3-8f93-b30db99a207a", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "bfa5603d-8ef2-404c-bde1-bd45532c6fd7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NL\">Eesti</span></b></p>", "ID": "40fe2f37-8e94-4f28-9f9c-3eb5df9913aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b68da93a-c939-45a3-8f93-b30db99a207a"}, {"Element": "<b><span lang=\"NL\">Eesti</span></b>", "ID": "12c8b03a-be8e-45aa-a67b-3140b8f9330f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "40fe2f37-8e94-4f28-9f9c-3eb5df9913aa"}, {"Element": "<span lang=\"NL\">Eesti</span>", "ID": "fa9868b3-6617-4b1e-8f12-de4955be756e", "Styles": "None", "Classes": "None", "Text": "Eesti", "ParentId": "12c8b03a-be8e-45aa-a67b-3140b8f9330f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\" style=\"color:black\"> Eesti filiaal</span></p>", "ID": "b87ae207-c913-4af7-b33e-43913df13869", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b68da93a-c939-45a3-8f93-b30db99a207a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">UAB </span>", "ID": "32181d9b-88be-4f19-a98d-437e211d1470", "Styles": "color:black", "Classes": "None", "Text": "UAB ", "ParentId": "b87ae207-c913-4af7-b33e-43913df13869"}, {"Element": "<span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span>", "ID": "6ee56d4d-8318-488d-bcb2-5752af269066", "Styles": "font-family:\"TimesNewRomanPSMT\",serif", "Classes": "None", "Text": "Teva   Baltics", "ParentId": "b87ae207-c913-4af7-b33e-43913df13869"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> Eesti filiaal</span>", "ID": "41ded3c0-a659-4616-90ce-d3fdca92055a", "Styles": "color:black", "Classes": "None", "Text": " Eesti filiaal", "ParentId": "b87ae207-c913-4af7-b33e-43913df13869"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"NL\">Tel: </span><span lang=\"EN-GB\">+372 6610801</span></p>", "ID": "0446cef7-0213-4e5d-978b-4f0defe0148d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b68da93a-c939-45a3-8f93-b30db99a207a"}, {"Element": "<span lang=\"NL\">Tel: </span>", "ID": "13618a83-d78c-4746-8225-bcc356a2faeb", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "0446cef7-0213-4e5d-978b-4f0defe0148d"}, {"Element": "<span lang=\"EN-GB\">+372 6610801</span>", "ID": "2c790bd7-4abe-4c98-a12d-f70af79e9faf", "Styles": "None", "Classes": "None", "Text": "+372 6610801", "ParentId": "0446cef7-0213-4e5d-978b-4f0defe0148d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2a6e3e8f-bbd9-4bd3-ad84-05db5e59f56d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b68da93a-c939-45a3-8f93-b30db99a207a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f5d7c918-1193-4b0c-84df-346f17d859ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2a6e3e8f-bbd9-4bd3-ad84-05db5e59f56d"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Norge</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Teva Norway AS</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Tlf: +47\n  66775590</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "65b4d2b3-846e-43bb-b247-c4ca9dfbbc53", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "bfa5603d-8ef2-404c-bde1-bd45532c6fd7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Norge</b></p>", "ID": "a628ffbe-73a8-4e91-bc10-debf601cea96", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65b4d2b3-846e-43bb-b247-c4ca9dfbbc53"}, {"Element": "<b>Norge</b>", "ID": "23fe895f-4094-407a-acb0-2f6e18984adc", "Styles": "None", "Classes": "None", "Text": "Norge", "ParentId": "a628ffbe-73a8-4e91-bc10-debf601cea96"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Teva Norway AS</p>", "ID": "cdf1f807-46ec-4d39-b0dd-5eb9615cd4ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Teva Norway AS", "ParentId": "65b4d2b3-846e-43bb-b247-c4ca9dfbbc53"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Tlf: +47\n  66775590</p>", "ID": "61a83220-3382-45dc-966d-7b940a9c43cd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "Tlf: +47   66775590", "ParentId": "65b4d2b3-846e-43bb-b247-c4ca9dfbbc53"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60c2f733-ed6d-49ca-976a-a616e0954da7", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65b4d2b3-846e-43bb-b247-c4ca9dfbbc53"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ddb64424-a110-4366-84fd-50d6fdc71a6d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60c2f733-ed6d-49ca-976a-a616e0954da7"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Specifar\n  A.B.E.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IS\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm Arzneimittel Vertriebs-GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +43 1970070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n</tr>", "ID": "eaafae1d-8c68-4707-86cd-06d2f95e7563", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Specifar\n  A.B.E.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IS\">\u00a0</span></p>\n</td>", "ID": "1378a5bc-93be-4a9b-9d65-e2512bb60156", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "eaafae1d-8c68-4707-86cd-06d2f95e7563"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>", "ID": "dc7fc4a9-d82b-485b-b790-00db8d39fe7e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1378a5bc-93be-4a9b-9d65-e2512bb60156"}, {"Element": "<b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b>", "ID": "93377c14-bcc8-4fea-920f-7ee1b02ac505", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc7fc4a9-d82b-485b-b790-00db8d39fe7e"}, {"Element": "<span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span>", "ID": "0e034d39-d46f-4831-919e-17c4e895d7a5", "Styles": "None", "Classes": "None", "Text": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1", "ParentId": "93377c14-bcc8-4fea-920f-7ee1b02ac505"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Specifar\n  A.B.E.E.</span></p>", "ID": "3049bef4-54d7-4307-9cde-aac4f8693ec9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1378a5bc-93be-4a9b-9d65-e2512bb60156"}, {"Element": "<span lang=\"EN-GB\">Specifar\n  A.B.E.E.</span>", "ID": "df49bf35-c816-4ef0-978b-76512ff07ab1", "Styles": "None", "Classes": "None", "Text": "Specifar   A.B.E.E.", "ParentId": "3049bef4-54d7-4307-9cde-aac4f8693ec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>", "ID": "e0507d8d-46ff-4e12-8abe-bf3a3b030d4b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1378a5bc-93be-4a9b-9d65-e2512bb60156"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span>", "ID": "54e96f48-9742-4a2a-9d6a-a488f17b9146", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb: +", "ParentId": "e0507d8d-46ff-4e12-8abe-bf3a3b030d4b"}, {"Element": "<span lang=\"EL\">30 </span>", "ID": "733d3a7f-7aab-4bea-8319-f60f782ed267", "Styles": "None", "Classes": "None", "Text": "30 ", "ParentId": "e0507d8d-46ff-4e12-8abe-bf3a3b030d4b"}, {"Element": "<span lang=\"EN-GB\">2118805000</span>", "ID": "f5553bc9-30cb-48bb-9076-68d3ea4ac322", "Styles": "None", "Classes": "None", "Text": "2118805000", "ParentId": "e0507d8d-46ff-4e12-8abe-bf3a3b030d4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IS\">\u00a0</span></p>", "ID": "2d191cb0-f66a-4ecb-98f2-b6058da52289", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1378a5bc-93be-4a9b-9d65-e2512bb60156"}, {"Element": "<span lang=\"IS\">\u00a0</span>", "ID": "951086d9-4952-4f21-9a75-9cd31aa15d24", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2d191cb0-f66a-4ecb-98f2-b6058da52289"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm Arzneimittel Vertriebs-GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +43 1970070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>", "ID": "6ef60654-f8bc-472d-9145-4bb6f1deedd4", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "eaafae1d-8c68-4707-86cd-06d2f95e7563"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>", "ID": "6c25f425-fd82-4106-9513-4a4074150e09", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ef60654-f8bc-472d-9145-4bb6f1deedd4"}, {"Element": "<b><span lang=\"DE\">\u00d6sterreich</span></b>", "ID": "ad0c53b6-844f-4c26-acb2-70891d172fd1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6c25f425-fd82-4106-9513-4a4074150e09"}, {"Element": "<span lang=\"DE\">\u00d6sterreich</span>", "ID": "063d8b67-19cd-458f-9ca0-3ce6424aa7d7", "Styles": "None", "Classes": "None", "Text": "\u00d6sterreich", "ParentId": "ad0c53b6-844f-4c26-acb2-70891d172fd1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">ratiopharm Arzneimittel Vertriebs-GmbH</span></p>", "ID": "93ddc804-75e2-43ff-b625-2fdf2144470a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ef60654-f8bc-472d-9145-4bb6f1deedd4"}, {"Element": "<span lang=\"DE\">ratiopharm Arzneimittel Vertriebs-GmbH</span>", "ID": "d7ef14b0-22e9-404a-ad56-0af77c350228", "Styles": "None", "Classes": "None", "Text": "ratiopharm Arzneimittel Vertriebs-GmbH", "ParentId": "93ddc804-75e2-43ff-b625-2fdf2144470a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +43 1970070</span></p>", "ID": "5e78d205-81b1-4aad-8eff-5918ca134a4b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ef60654-f8bc-472d-9145-4bb6f1deedd4"}, {"Element": "<span lang=\"DE\">Tel: +43 1970070</span>", "ID": "18d84743-4ff4-40b3-8462-839fcc151080", "Styles": "None", "Classes": "None", "Text": "Tel: +43 1970070", "ParentId": "5e78d205-81b1-4aad-8eff-5918ca134a4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>", "ID": "b0157913-486c-4794-969e-84f8ac694d4d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ef60654-f8bc-472d-9145-4bb6f1deedd4"}, {"Element": "<span lang=\"PT-BR\">\u00a0</span>", "ID": "3586bab1-3f2e-4e16-8b4a-9f0c141f96eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b0157913-486c-4794-969e-84f8ac694d4d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Teva Pharma,\n  S.L.U.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">T\u00e9l: +34 913873280</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals Polska Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +48223459300</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "38f76549-2daa-42fd-9c7c-0de6aa8d6e49", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Teva Pharma,\n  S.L.U.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">T\u00e9l: +34 913873280</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>", "ID": "3a1aa46f-e0ee-4716-8efe-89c9108276b4", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "38f76549-2daa-42fd-9c7c-0de6aa8d6e49"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Espa\u00f1a</span></b></p>", "ID": "9558ceba-f21c-4ccb-881c-ecb81bd1eadc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a1aa46f-e0ee-4716-8efe-89c9108276b4"}, {"Element": "<b><span lang=\"PT-BR\">Espa\u00f1a</span></b>", "ID": "45cfd0ec-aa62-42f4-ab4f-a9240a8ca6c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9558ceba-f21c-4ccb-881c-ecb81bd1eadc"}, {"Element": "<span lang=\"PT-BR\">Espa\u00f1a</span>", "ID": "5b4bf9ad-78dc-4270-9da1-73d5491705ff", "Styles": "None", "Classes": "None", "Text": "Espa\u00f1a", "ParentId": "45cfd0ec-aa62-42f4-ab4f-a9240a8ca6c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Teva Pharma,\n  S.L.U.</span></p>", "ID": "5949414b-65fc-404b-83af-b5f79c56fbdd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a1aa46f-e0ee-4716-8efe-89c9108276b4"}, {"Element": "<span lang=\"PL\">Teva Pharma,\n  S.L.U.</span>", "ID": "ab688b8d-f735-4ed6-a29a-62235f7a36f5", "Styles": "None", "Classes": "None", "Text": "Teva Pharma,   S.L.U.", "ParentId": "5949414b-65fc-404b-83af-b5f79c56fbdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">T\u00e9l: +34 913873280</span></p>", "ID": "d9596796-b0e0-4475-a7eb-ec3ac9b5df1f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a1aa46f-e0ee-4716-8efe-89c9108276b4"}, {"Element": "<span lang=\"PT-BR\">T\u00e9l: +34 913873280</span>", "ID": "1b01006e-5c3e-4180-9c9f-512dfda27d89", "Styles": "None", "Classes": "None", "Text": "T\u00e9l: +34 913873280", "ParentId": "d9596796-b0e0-4475-a7eb-ec3ac9b5df1f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">\u00a0</span></p>", "ID": "c0fe91ea-22a5-405b-bb56-3199e5d822b2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a1aa46f-e0ee-4716-8efe-89c9108276b4"}, {"Element": "<span lang=\"PT-BR\">\u00a0</span>", "ID": "c59d46c8-9ff1-4508-b850-a6166e4b26dd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c0fe91ea-22a5-405b-bb56-3199e5d822b2"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals Polska Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +48223459300</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "5ddcc751-2097-4c79-b2b4-1712260ec203", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "38f76549-2daa-42fd-9c7c-0de6aa8d6e49"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Polska</span></b></p>", "ID": "873c42c9-a028-4b0b-9fa7-62e5468599e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ddcc751-2097-4c79-b2b4-1712260ec203"}, {"Element": "<b><span lang=\"PT-BR\">Polska</span></b>", "ID": "9f09712c-07c8-4b60-a5a2-9793192eb5a5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "873c42c9-a028-4b0b-9fa7-62e5468599e5"}, {"Element": "<span lang=\"PT-BR\">Polska</span>", "ID": "6ad8420e-301c-4fec-bddc-3d360a113340", "Styles": "None", "Classes": "None", "Text": "Polska", "ParentId": "9f09712c-07c8-4b60-a5a2-9793192eb5a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals Polska Sp. z o.o.</span></p>", "ID": "3d02ba3b-2ce4-4c8b-8617-bd4ceabdc7dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ddcc751-2097-4c79-b2b4-1712260ec203"}, {"Element": "<span lang=\"PT-BR\">Teva\n  Pharmaceuticals Polska Sp. z o.o.</span>", "ID": "aa99f2ca-c8e3-4928-b587-988e95e97e94", "Styles": "None", "Classes": "None", "Text": "Teva   Pharmaceuticals Polska Sp. z o.o.", "ParentId": "3d02ba3b-2ce4-4c8b-8617-bd4ceabdc7dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel.: +48223459300</span></p>", "ID": "1fbfd33e-76f7-4ffe-a4ab-81baafc936ef", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ddcc751-2097-4c79-b2b4-1712260ec203"}, {"Element": "<span lang=\"PT-BR\">Tel.: +48223459300</span>", "ID": "ed9a55fe-ee4d-4018-bd22-0ac452b1491b", "Styles": "None", "Classes": "None", "Text": "Tel.: +48223459300", "ParentId": "1fbfd33e-76f7-4ffe-a4ab-81baafc936ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "25a6fb91-5819-42be-ad80-1f9b6d0fd21a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ddcc751-2097-4c79-b2b4-1712260ec203"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2aafbdf5-6499-4f0f-bb32-bf510dad1cf0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "25a6fb91-5819-42be-ad80-1f9b6d0fd21a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Sant\u00e9</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l: +33 155917800</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Pharma -\n  Produtos Farmac\u00eauticos Lda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel</span><span lang=\"EN-GB\">: </span><span lang=\"EN-GB\">+351\n  214767550</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "83eada8a-e3e7-4298-9972-634e58f29a4a", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Sant\u00e9</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l: +33 155917800</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "6051658e-efb8-4efc-9065-774982b76203", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "83eada8a-e3e7-4298-9972-634e58f29a4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>", "ID": "6ad112a8-1f7a-401f-a115-bfcc4d4e8f35", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6051658e-efb8-4efc-9065-774982b76203"}, {"Element": "<b><span lang=\"EN-GB\">France</span></b>", "ID": "e7c0c671-3eb4-4b8b-94b1-8998d3db2d34", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ad112a8-1f7a-401f-a115-bfcc4d4e8f35"}, {"Element": "<span lang=\"EN-GB\">France</span>", "ID": "b4daab24-5107-4301-bd02-3c17ef53f794", "Styles": "None", "Classes": "None", "Text": "France", "ParentId": "e7c0c671-3eb4-4b8b-94b1-8998d3db2d34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Sant\u00e9</span></p>", "ID": "7de6c31e-9744-456b-8281-f4f1f7dcb293", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6051658e-efb8-4efc-9065-774982b76203"}, {"Element": "<span lang=\"EN-GB\">Teva\n  Sant\u00e9</span>", "ID": "d8842019-c6f0-41d2-ab4e-4a51560a7e08", "Styles": "None", "Classes": "None", "Text": "Teva   Sant\u00e9", "ParentId": "7de6c31e-9744-456b-8281-f4f1f7dcb293"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">T\u00e9l: +33 155917800</span></p>", "ID": "5df09a37-8988-49be-8c42-671cde16eb93", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6051658e-efb8-4efc-9065-774982b76203"}, {"Element": "<span lang=\"EN-GB\">T\u00e9l: +33 155917800</span>", "ID": "62c3223b-b039-40e5-bc3f-dd612a7d4322", "Styles": "None", "Classes": "None", "Text": "T\u00e9l: +33 155917800", "ParentId": "5df09a37-8988-49be-8c42-671cde16eb93"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9f0414fb-889f-4fca-a859-ab37d9e093f0", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6051658e-efb8-4efc-9065-774982b76203"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e62e70db-dff3-46ce-80c3-c6c072bd3568", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f0414fb-889f-4fca-a859-ab37d9e093f0"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Pharma -\n  Produtos Farmac\u00eauticos Lda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel</span><span lang=\"EN-GB\">: </span><span lang=\"EN-GB\">+351\n  214767550</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "08d51a0d-8b10-4b85-8e38-72541f7186bf", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "83eada8a-e3e7-4298-9972-634e58f29a4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>", "ID": "310ab45b-437a-41b5-b358-4d69bced3688", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08d51a0d-8b10-4b85-8e38-72541f7186bf"}, {"Element": "<b><span lang=\"PT-BR\">Portugal</span></b>", "ID": "456114ed-6fe3-4bc0-8c59-2e304ce8d5df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "310ab45b-437a-41b5-b358-4d69bced3688"}, {"Element": "<span lang=\"PT-BR\">Portugal</span>", "ID": "f4f08cca-df49-4ff5-988b-3e39ab0bd633", "Styles": "None", "Classes": "None", "Text": "Portugal", "ParentId": "456114ed-6fe3-4bc0-8c59-2e304ce8d5df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Pharma -\n  Produtos Farmac\u00eauticos Lda</span></p>", "ID": "dd8a0347-7377-40a8-86ea-964c89fae2a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08d51a0d-8b10-4b85-8e38-72541f7186bf"}, {"Element": "<span lang=\"PT-BR\">Teva Pharma -\n  Produtos Farmac\u00eauticos Lda</span>", "ID": "5eca0c93-feca-46a2-9e14-ca33a96d833e", "Styles": "None", "Classes": "None", "Text": "Teva Pharma -   Produtos Farmac\u00eauticos Lda", "ParentId": "dd8a0347-7377-40a8-86ea-964c89fae2a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Tel</span><span lang=\"EN-GB\">: </span><span lang=\"EN-GB\">+351\n  214767550</span></p>", "ID": "9c1899ae-f76e-4801-a643-7c4f8e59210c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08d51a0d-8b10-4b85-8e38-72541f7186bf"}, {"Element": "<span lang=\"PT-BR\">Tel</span>", "ID": "0e04acd5-94a7-49d9-9d95-73dea0b97af9", "Styles": "None", "Classes": "None", "Text": "Tel", "ParentId": "9c1899ae-f76e-4801-a643-7c4f8e59210c"}, {"Element": "<span lang=\"EN-GB\">: </span>", "ID": "668807c5-e66e-4cc6-b7a9-5422a17f12e4", "Styles": "None", "Classes": "None", "Text": ": ", "ParentId": "9c1899ae-f76e-4801-a643-7c4f8e59210c"}, {"Element": "<span lang=\"EN-GB\">+351\n  214767550</span>", "ID": "d253ae25-d79c-4c56-9694-52668a86646e", "Styles": "None", "Classes": "None", "Text": "+351   214767550", "ParentId": "9c1899ae-f76e-4801-a643-7c4f8e59210c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ac416392-4707-4e04-816c-f2e5df09c4b5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08d51a0d-8b10-4b85-8e38-72541f7186bf"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f466d395-163d-448b-8668-f4d58f23297e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ac416392-4707-4e04-816c-f2e5df09c4b5"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Pliva Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +385 13720000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals S.R.L</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +40 212306524</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "3840d7a8-ec94-4f86-b5c1-ec18858f1a8b", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Pliva Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +385 13720000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "f30f96a2-fed2-4c24-8a9f-90fff0ff1cf7", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "3840d7a8-ec94-4f86-b5c1-ec18858f1a8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>", "ID": "53a5212d-ad43-4364-ba7c-3500e52950f2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f30f96a2-fed2-4c24-8a9f-90fff0ff1cf7"}, {"Element": "<b><span lang=\"EN-GB\">Hrvatska</span></b>", "ID": "01082c24-5ece-4071-bd28-2ae9ec50981d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "53a5212d-ad43-4364-ba7c-3500e52950f2"}, {"Element": "<span lang=\"EN-GB\">Hrvatska</span>", "ID": "c6222346-2ec0-48cc-87a1-b2d46d205545", "Styles": "None", "Classes": "None", "Text": "Hrvatska", "ParentId": "01082c24-5ece-4071-bd28-2ae9ec50981d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Pliva Hrvatska d.o.o.</span></p>", "ID": "79d5db5e-489e-4912-83e3-2ef18551ae04", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f30f96a2-fed2-4c24-8a9f-90fff0ff1cf7"}, {"Element": "<span lang=\"EN-GB\">Pliva Hrvatska d.o.o.</span>", "ID": "0cbf238c-5797-447b-a5a7-d5d3fd6c0eb7", "Styles": "None", "Classes": "None", "Text": "Pliva Hrvatska d.o.o.", "ParentId": "79d5db5e-489e-4912-83e3-2ef18551ae04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +385 13720000</span></p>", "ID": "3aced56b-aed3-4e93-b7de-c63a45cdd272", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f30f96a2-fed2-4c24-8a9f-90fff0ff1cf7"}, {"Element": "<span lang=\"EN-GB\">Tel: +385 13720000</span>", "ID": "33127ea1-3490-457f-8352-96a4607f1c89", "Styles": "None", "Classes": "None", "Text": "Tel: +385 13720000", "ParentId": "3aced56b-aed3-4e93-b7de-c63a45cdd272"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "84e278df-099f-42a6-8ed3-c024d9d1f8ae", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f30f96a2-fed2-4c24-8a9f-90fff0ff1cf7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a550d409-e68d-445b-867f-dc6162a15e46", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84e278df-099f-42a6-8ed3-c024d9d1f8ae"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "003488b6-61b2-4fd8-abc5-0fc49250b500", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a550d409-e68d-445b-867f-dc6162a15e46"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals S.R.L</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +40 212306524</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "e0de1b54-0171-413e-905f-4394e5620a54", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "3840d7a8-ec94-4f86-b5c1-ec18858f1a8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Rom\u00e2nia</span></b></p>", "ID": "badeb7d9-6183-4406-ba94-c0f2241528ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0de1b54-0171-413e-905f-4394e5620a54"}, {"Element": "<b><span lang=\"PT-BR\">Rom\u00e2nia</span></b>", "ID": "109befc3-88cc-431e-9f4c-7a76486e80bc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "badeb7d9-6183-4406-ba94-c0f2241528ab"}, {"Element": "<span lang=\"PT-BR\">Rom\u00e2nia</span>", "ID": "8d4b4c9f-4712-4ca9-ad31-5cc052de25fb", "Styles": "None", "Classes": "None", "Text": "Rom\u00e2nia", "ParentId": "109befc3-88cc-431e-9f4c-7a76486e80bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva\n  Pharmaceuticals S.R.L</span></p>", "ID": "6548efb5-810f-4f92-aa96-9b947ee09076", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0de1b54-0171-413e-905f-4394e5620a54"}, {"Element": "<span lang=\"PT-BR\">Teva\n  Pharmaceuticals S.R.L</span>", "ID": "db9d49ca-ed08-41d9-9a55-237bd5409000", "Styles": "None", "Classes": "None", "Text": "Teva   Pharmaceuticals S.R.L", "ParentId": "6548efb5-810f-4f92-aa96-9b947ee09076"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +40 212306524</span></p>", "ID": "c4cb4d4e-49b7-4f66-becf-1c77bebcbe4a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0de1b54-0171-413e-905f-4394e5620a54"}, {"Element": "<span lang=\"EN-GB\">Tel: +40 212306524</span>", "ID": "97fabbc1-91aa-433a-bde8-a01d0f98f0f1", "Styles": "None", "Classes": "None", "Text": "Tel: +40 212306524", "ParentId": "c4cb4d4e-49b7-4f66-becf-1c77bebcbe4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "397590c5-1e77-4edf-8737-f92196cde49a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0de1b54-0171-413e-905f-4394e5620a54"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4d6dc45-fb9b-4722-bf01-456372e6aff4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "397590c5-1e77-4edf-8737-f92196cde49a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+353 19127700 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Pliva Ljubljana d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +386 15890390</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "ebd01a2a-e37a-4304-9f5d-66df3aa378b4", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+353 19127700 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "7bab0b07-f41b-46fc-b040-d59786015d88", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "ebd01a2a-e37a-4304-9f5d-66df3aa378b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>", "ID": "725c723a-1f26-43d1-b16c-a1f6c2c29f54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7bab0b07-f41b-46fc-b040-d59786015d88"}, {"Element": "<b><span lang=\"EN-GB\">Ireland</span></b>", "ID": "ba929a86-8a1a-4be5-ae4e-4bd02d1858ce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "725c723a-1f26-43d1-b16c-a1f6c2c29f54"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "6439e9cb-5e40-480c-9f5b-4b383a8136c9", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "ba929a86-8a1a-4be5-ae4e-4bd02d1858ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Ireland</span></p>", "ID": "6b445191-d45d-44ab-b35c-a6a34e05a9ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7bab0b07-f41b-46fc-b040-d59786015d88"}, {"Element": "<span lang=\"EN-GB\">Teva\n  Pharmaceuticals Ireland</span>", "ID": "a2ed9844-0821-465f-99da-a24a1d2242e8", "Styles": "None", "Classes": "None", "Text": "Teva   Pharmaceuticals Ireland", "ParentId": "6b445191-d45d-44ab-b35c-a6a34e05a9ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+353 19127700 </span></p>", "ID": "fc0e33ac-0f92-4966-a4b9-d9fd5c189d57", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7bab0b07-f41b-46fc-b040-d59786015d88"}, {"Element": "<span lang=\"EN-GB\">Tel: </span>", "ID": "5dc1e6b7-7ca5-41e5-9c9a-8dd1fa86fbc7", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "fc0e33ac-0f92-4966-a4b9-d9fd5c189d57"}, {"Element": "<span lang=\"EN-GB\">+353 19127700 </span>", "ID": "bd02aa2b-dd77-42bb-a0a1-d32290710c80", "Styles": "None", "Classes": "None", "Text": "+353 19127700 ", "ParentId": "fc0e33ac-0f92-4966-a4b9-d9fd5c189d57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "400c5fd7-6869-49b4-8743-6582ccf7cddc", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7bab0b07-f41b-46fc-b040-d59786015d88"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bf96d5bc-ef7d-4721-945d-101ab3b5e9f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "400c5fd7-6869-49b4-8743-6582ccf7cddc"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Pliva Ljubljana d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +386 15890390</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "e896b974-94e1-4657-9ea8-3e44de92c7fd", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "ebd01a2a-e37a-4304-9f5d-66df3aa378b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Slovenija</span></b></p>", "ID": "c701649f-dced-46ce-a32d-e63debc339dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e896b974-94e1-4657-9ea8-3e44de92c7fd"}, {"Element": "<b><span lang=\"PT-BR\">Slovenija</span></b>", "ID": "4b1158d0-ab5c-4a45-9320-30ef3f06c75d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c701649f-dced-46ce-a32d-e63debc339dc"}, {"Element": "<span lang=\"PT-BR\">Slovenija</span>", "ID": "4e23d891-916e-44a0-8948-d9e5074f9196", "Styles": "None", "Classes": "None", "Text": "Slovenija", "ParentId": "4b1158d0-ab5c-4a45-9320-30ef3f06c75d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"PT-BR\">Pliva Ljubljana d.o.o.</span></p>", "ID": "888fa7a4-22a7-41d9-99ed-7e68886ba3bd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e896b974-94e1-4657-9ea8-3e44de92c7fd"}, {"Element": "<span lang=\"PT-BR\">Pliva Ljubljana d.o.o.</span>", "ID": "aec443ae-0c3a-4471-979e-d7c55a3e861f", "Styles": "None", "Classes": "None", "Text": "Pliva Ljubljana d.o.o.", "ParentId": "888fa7a4-22a7-41d9-99ed-7e68886ba3bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +386 15890390</span></p>", "ID": "911593a0-370e-4e6f-b405-9eea03beac1e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e896b974-94e1-4657-9ea8-3e44de92c7fd"}, {"Element": "<span lang=\"EN-GB\">Tel: +386 15890390</span>", "ID": "9a3d84d4-206a-4710-be51-83cfd6b83deb", "Styles": "None", "Classes": "None", "Text": "Tel: +386 15890390", "ParentId": "911593a0-370e-4e6f-b405-9eea03beac1e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1852788-2d2a-430d-8ffd-6d1c1c5d4a61", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e896b974-94e1-4657-9ea8-3e44de92c7fd"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b27ca0c6-ecc7-436b-b069-28ee4e4ae893", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1852788-2d2a-430d-8ffd-6d1c1c5d4a61"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Finnland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Simi: +358 201805900</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +421 257267911</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>", "ID": "c3ebfc56-9418-4075-8b47-857b27a3bc00", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Finnland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Simi: +358 201805900</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0652b9af-5a80-47bf-b44c-753b862713e6", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "      ", "ParentId": "c3ebfc56-9418-4075-8b47-857b27a3bc00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>", "ID": "3c67fcd9-5661-4503-994a-416ba6e73fb0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0652b9af-5a80-47bf-b44c-753b862713e6"}, {"Element": "<b><span lang=\"EN-GB\">\u00cdsland</span></b>", "ID": "9563146d-4abb-446a-938d-fdb30f0eeab9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3c67fcd9-5661-4503-994a-416ba6e73fb0"}, {"Element": "<span lang=\"EN-GB\">\u00cdsland</span>", "ID": "d2834ac7-ad1c-4e5d-bcaf-93aa8259a8ba", "Styles": "None", "Classes": "None", "Text": "\u00cdsland", "ParentId": "9563146d-4abb-446a-938d-fdb30f0eeab9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>", "ID": "3f238c41-3d4b-4429-bea4-243ed8846f8a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0652b9af-5a80-47bf-b44c-753b862713e6"}, {"Element": "<span lang=\"EN-GB\">Teva Finland\n  Oy</span>", "ID": "765dda73-aa47-4706-92ee-c1f17564cb6f", "Styles": "None", "Classes": "None", "Text": "Teva Finland   Oy", "ParentId": "3f238c41-3d4b-4429-bea4-243ed8846f8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Finnland</span></p>", "ID": "4376a548-eb10-492d-8328-9f4d337fcc8f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0652b9af-5a80-47bf-b44c-753b862713e6"}, {"Element": "<span lang=\"EN-GB\">Finnland</span>", "ID": "6eead7c2-bb9a-4101-9b5f-f077d57ad881", "Styles": "None", "Classes": "None", "Text": "Finnland", "ParentId": "4376a548-eb10-492d-8328-9f4d337fcc8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Simi: +358 201805900</span><span lang=\"EN-GB\"> </span></p>", "ID": "4d2c9910-6e95-45ca-9c4c-69f005cf98d8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0652b9af-5a80-47bf-b44c-753b862713e6"}, {"Element": "<span lang=\"EN-GB\">Simi: +358 201805900</span>", "ID": "3558baf2-59b9-43a9-9dd5-f62bfbed5e43", "Styles": "None", "Classes": "None", "Text": "Simi: +358 201805900", "ParentId": "4d2c9910-6e95-45ca-9c4c-69f005cf98d8"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "7ecdd60d-c7e7-45f7-939d-74e37994f0af", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "4d2c9910-6e95-45ca-9c4c-69f005cf98d8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec32a7ee-d9f8-4c9c-a41e-f1e1ebdfd3a5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0652b9af-5a80-47bf-b44c-753b862713e6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e6f07f16-da51-46a1-a6d8-14cbe7e78100", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec32a7ee-d9f8-4c9c-a41e-f1e1ebdfd3a5"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +421 257267911</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>", "ID": "8d8f326a-d95a-4866-a355-b558a095ee1f", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "c3ebfc56-9418-4075-8b47-857b27a3bc00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>", "ID": "420b9bef-6b2e-4c20-8cee-9d7e0fa5d700", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d8f326a-d95a-4866-a355-b558a095ee1f"}, {"Element": "<b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b>", "ID": "2d00718e-e503-4456-8c12-08fdb0da8692", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "420b9bef-6b2e-4c20-8cee-9d7e0fa5d700"}, {"Element": "<span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span>", "ID": "40cee045-3b71-44ce-87e5-e0dc52e00c1e", "Styles": "None", "Classes": "None", "Text": "Slovensk\u00e1   republika", "ParentId": "2d00718e-e503-4456-8c12-08fdb0da8692"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva\n  Pharmaceuticals Slovakia s.r.o.</span></p>", "ID": "1ef7bdf9-708a-4a7c-a8a7-8dfbdd11ed2d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d8f326a-d95a-4866-a355-b558a095ee1f"}, {"Element": "<span lang=\"EN-GB\">Teva\n  Pharmaceuticals Slovakia s.r.o.</span>", "ID": "d9924c02-0d57-41ae-84e7-478c9415736e", "Styles": "None", "Classes": "None", "Text": "Teva   Pharmaceuticals Slovakia s.r.o.", "ParentId": "1ef7bdf9-708a-4a7c-a8a7-8dfbdd11ed2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +421 257267911</span></p>", "ID": "dc4a3fd6-6ad6-4fb9-8178-73644fa3e0ee", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d8f326a-d95a-4866-a355-b558a095ee1f"}, {"Element": "<span lang=\"EN-GB\">Tel: +421 257267911</span>", "ID": "1e883d61-07fe-4069-a49f-3173db479473", "Styles": "None", "Classes": "None", "Text": "Tel: +421 257267911", "ParentId": "dc4a3fd6-6ad6-4fb9-8178-73644fa3e0ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>", "ID": "341f776b-2957-4f9a-9f23-6d87b097d7b9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d8f326a-d95a-4866-a355-b558a095ee1f"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "1db9a073-ce68-4b2b-a38b-28bc2c15d8fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "341f776b-2957-4f9a-9f23-6d87b097d7b9"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Italia\n  S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+39 028917981</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Suomi/Finland</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Puh/Tel:\n  +358 201805900</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>\n</tr>", "ID": "af6c4b41-e33a-4998-b809-c6023f5615c9", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Italia\n  S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+39 028917981</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>", "ID": "43187db0-f010-4767-8005-48a7851b856b", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "af6c4b41-e33a-4998-b809-c6023f5615c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Italia</span></b></p>", "ID": "321bf94a-6513-4303-b3ca-dc9c25e5275d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "43187db0-f010-4767-8005-48a7851b856b"}, {"Element": "<b><span lang=\"PT-BR\">Italia</span></b>", "ID": "f01eb423-96f4-4353-a817-b28b341d0abc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "321bf94a-6513-4303-b3ca-dc9c25e5275d"}, {"Element": "<span lang=\"PT-BR\">Italia</span>", "ID": "8ecc5cd8-398d-4c0f-b6fe-dabe831cfc92", "Styles": "None", "Classes": "None", "Text": "Italia", "ParentId": "f01eb423-96f4-4353-a817-b28b341d0abc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">Teva Italia\n  S.r.l.</span></p>", "ID": "2354117a-2dfb-41c5-929e-0a8ec3e92819", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "43187db0-f010-4767-8005-48a7851b856b"}, {"Element": "<span lang=\"PT-BR\">Teva Italia\n  S.r.l.</span>", "ID": "9fd9b108-797c-40ac-8189-4b77346d0257", "Styles": "None", "Classes": "None", "Text": "Teva Italia   S.r.l.", "ParentId": "2354117a-2dfb-41c5-929e-0a8ec3e92819"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+39 028917981</span></p>", "ID": "e869eb4a-1d5b-4074-9b2d-25743b2c830c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "43187db0-f010-4767-8005-48a7851b856b"}, {"Element": "<span lang=\"EN-GB\">Tel: </span>", "ID": "7ebaaa71-d28a-49f5-8796-feb704690872", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "e869eb4a-1d5b-4074-9b2d-25743b2c830c"}, {"Element": "<span lang=\"EN-GB\">+39 028917981</span>", "ID": "b210551d-4cd9-4fcb-b03d-017b7a25a3b8", "Styles": "None", "Classes": "None", "Text": "+39 028917981", "ParentId": "e869eb4a-1d5b-4074-9b2d-25743b2c830c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>", "ID": "9ed14a3c-7bb7-49c1-9f06-9e876c9ba0ff", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "43187db0-f010-4767-8005-48a7851b856b"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "08086fff-c6c6-4331-b17a-4b2b7486e928", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ed14a3c-7bb7-49c1-9f06-9e876c9ba0ff"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Suomi/Finland</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Puh/Tel:\n  +358 201805900</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>", "ID": "3cc1e82b-668b-412a-ba85-17bf2759704b", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "af6c4b41-e33a-4998-b809-c6023f5615c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b>Suomi/Finland</b></p>", "ID": "58b5d8c5-f9de-425e-b3c9-95919bbe7e8d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3cc1e82b-668b-412a-ba85-17bf2759704b"}, {"Element": "<b>Suomi/Finland</b>", "ID": "7b9f9bfe-3d5e-4a86-b438-2a7de4f932a5", "Styles": "None", "Classes": "None", "Text": "Suomi/Finland", "ParentId": "58b5d8c5-f9de-425e-b3c9-95919bbe7e8d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva Finland\n  Oy</span></p>", "ID": "143a1f78-d086-420c-ab10-9a90fa7b5167", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3cc1e82b-668b-412a-ba85-17bf2759704b"}, {"Element": "<span lang=\"EN-GB\">Teva Finland\n  Oy</span>", "ID": "b19fb1a0-4398-433e-a08c-eb75d2479a53", "Styles": "None", "Classes": "None", "Text": "Teva Finland   Oy", "ParentId": "143a1f78-d086-420c-ab10-9a90fa7b5167"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Puh/Tel:\n  +358 201805900</p>", "ID": "7de2acf8-987a-45d3-9daa-d97457b1e41c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "Puh/Tel:   +358 201805900", "ParentId": "3cc1e82b-668b-412a-ba85-17bf2759704b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>", "ID": "410ceeeb-8384-41b9-8464-38a16f302355", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "3cc1e82b-668b-412a-ba85-17bf2759704b"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Specifar A.B.E.E.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +46 42121100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n</tr>", "ID": "10f7947e-41dc-493d-b298-3a64a7769016", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Specifar A.B.E.E.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n</td>", "ID": "97a3e195-f600-41e9-89e0-86bb6a3b358b", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "      ", "ParentId": "10f7947e-41dc-493d-b298-3a64a7769016"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>", "ID": "a67693c3-4635-4202-8ac8-19b51f29d0e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97a3e195-f600-41e9-89e0-86bb6a3b358b"}, {"Element": "<b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b>", "ID": "fa25e113-9b27-4eda-88a0-0f192357fb97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a67693c3-4635-4202-8ac8-19b51f29d0e3"}, {"Element": "<span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span>", "ID": "66515e0a-0b0c-4fc2-aa99-02f73754dad9", "Styles": "None", "Classes": "None", "Text": "\u039a\u03cd\u03c0\u03c1\u03bf\u03c2", "ParentId": "fa25e113-9b27-4eda-88a0-0f192357fb97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Specifar A.B.E.E.</p>", "ID": "66fb6aab-402a-4896-a90c-ac096b02ef46", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Specifar A.B.E.E.", "ParentId": "97a3e195-f600-41e9-89e0-86bb6a3b358b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></p>", "ID": "ef18aff9-3016-42ef-82e6-2076204b4dbc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97a3e195-f600-41e9-89e0-86bb6a3b358b"}, {"Element": "<span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span>", "ID": "a8720998-75d3-47ed-b16d-a97936781635", "Styles": "None", "Classes": "None", "Text": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1", "ParentId": "ef18aff9-3016-42ef-82e6-2076204b4dbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span><span lang=\"EL\">30 </span><span lang=\"EN-GB\">2118805000</span></p>", "ID": "0ebf3d65-74f6-4c98-be15-2cd1f54091b2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97a3e195-f600-41e9-89e0-86bb6a3b358b"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb: +</span>", "ID": "215fe1e4-3b60-4b7c-aa45-bd1b3a4be759", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb: +", "ParentId": "0ebf3d65-74f6-4c98-be15-2cd1f54091b2"}, {"Element": "<span lang=\"EL\">30 </span>", "ID": "bb893653-46d4-41a1-92ba-11163da6197c", "Styles": "None", "Classes": "None", "Text": "30 ", "ParentId": "0ebf3d65-74f6-4c98-be15-2cd1f54091b2"}, {"Element": "<span lang=\"EN-GB\">2118805000</span>", "ID": "9ea833a5-6caf-454c-9943-08c4078907b8", "Styles": "None", "Classes": "None", "Text": "2118805000", "ParentId": "0ebf3d65-74f6-4c98-be15-2cd1f54091b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>", "ID": "f6ed5a3f-6c59-4cd9-92a3-29cfb239d21d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "97a3e195-f600-41e9-89e0-86bb6a3b358b"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +46 42121100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>\n</td>", "ID": "6eae4b16-cf4d-4bca-937b-a005626154b0", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "10f7947e-41dc-493d-b298-3a64a7769016"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Sverige</span></b></p>", "ID": "939f5b49-e83f-40d6-adeb-989993be62dd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6eae4b16-cf4d-4bca-937b-a005626154b0"}, {"Element": "<b><span lang=\"DE\">Sverige</span></b>", "ID": "28bed1f9-732d-44c2-a866-68a728011cdd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "939f5b49-e83f-40d6-adeb-989993be62dd"}, {"Element": "<span lang=\"DE\">Sverige</span>", "ID": "0d29a07a-e1d2-49d6-9bdf-e35a47213898", "Styles": "None", "Classes": "None", "Text": "Sverige", "ParentId": "28bed1f9-732d-44c2-a866-68a728011cdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Teva Sweden AB</span></p>", "ID": "7e00d027-9eb5-470b-a86a-b275f263d5e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6eae4b16-cf4d-4bca-937b-a005626154b0"}, {"Element": "<span lang=\"DE\">Teva Sweden AB</span>", "ID": "58e798ea-5115-4e04-97a3-fa02865dbf88", "Styles": "None", "Classes": "None", "Text": "Teva Sweden AB", "ParentId": "7e00d027-9eb5-470b-a86a-b275f263d5e3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">Tel: +46 42121100</span></p>", "ID": "8326124f-1e3e-4150-a270-8d021f7a3b05", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6eae4b16-cf4d-4bca-937b-a005626154b0"}, {"Element": "<span lang=\"DE\">Tel: +46 42121100</span>", "ID": "1c5d8a71-1470-41e0-a8be-18484f28bd5a", "Styles": "None", "Classes": "None", "Text": "Tel: +46 42121100", "ParentId": "8326124f-1e3e-4150-a270-8d021f7a3b05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"DE\">\u00a0</span></p>", "ID": "0bf13516-cc6e-499e-a37a-2727ee80b8c8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6eae4b16-cf4d-4bca-937b-a005626154b0"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "54603962-61d4-4e2d-a1b8-5bb950b70010", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0bf13516-cc6e-499e-a37a-2727ee80b8c8"}, {"Element": "<tr style=\"page-break-inside:avoid;height:40.65pt\">\n<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\"> fili\u0101le Latvij\u0101</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +371 67323666</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva UK\n  Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+44 1977628500</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "e1534b8c-f0fa-4228-96d3-0bd198867e2e", "Styles": "page-break-inside:avoid;height:40.65pt", "Classes": "None", "Text": "   ", "ParentId": "1c9a96d2-21ee-4a1c-822b-536d8793eff9"}, {"Element": "<td style=\"width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"262\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\"> fili\u0101le Latvij\u0101</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +371 67323666</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "d942c967-d06b-4616-ba81-6e0c2f20df02", "Styles": "width:196.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "e1534b8c-f0fa-4228-96d3-0bd198867e2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>", "ID": "0a30a24e-5727-4aad-a779-e1efd3e00026", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d942c967-d06b-4616-ba81-6e0c2f20df02"}, {"Element": "<b><span lang=\"EN-GB\">Latvija</span></b>", "ID": "efc7ab2c-1299-4c9a-9de4-2b0c62276eae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a30a24e-5727-4aad-a779-e1efd3e00026"}, {"Element": "<span lang=\"EN-GB\">Latvija</span>", "ID": "5d75d078-6c2c-46a8-882d-20f1e1131822", "Styles": "None", "Classes": "None", "Text": "Latvija", "ParentId": "efc7ab2c-1299-4c9a-9de4-2b0c62276eae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">UAB </span><span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span><span lang=\"EN-GB\"> fili\u0101le Latvij\u0101</span></p>", "ID": "fc4a1a17-81de-49b8-976f-5b1c232e3ed7", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d942c967-d06b-4616-ba81-6e0c2f20df02"}, {"Element": "<span lang=\"EN-GB\">UAB </span>", "ID": "3a91fd7d-06c9-48a8-a742-b92c43e0741f", "Styles": "None", "Classes": "None", "Text": "UAB ", "ParentId": "fc4a1a17-81de-49b8-976f-5b1c232e3ed7"}, {"Element": "<span style='font-family:\"TimesNewRomanPSMT\",serif'>Teva\n  Baltics</span>", "ID": "6a4f0355-3d48-4777-a428-b7748dc4ed15", "Styles": "font-family:\"TimesNewRomanPSMT\",serif", "Classes": "None", "Text": "Teva   Baltics", "ParentId": "fc4a1a17-81de-49b8-976f-5b1c232e3ed7"}, {"Element": "<span lang=\"EN-GB\"> fili\u0101le Latvij\u0101</span>", "ID": "ab5e457c-72ce-4bf6-a6d8-b2777e46c255", "Styles": "None", "Classes": "None", "Text": " fili\u0101le Latvij\u0101", "ParentId": "fc4a1a17-81de-49b8-976f-5b1c232e3ed7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: +371 67323666</span></p>", "ID": "4db93ea3-03da-472a-9150-48b4a001f562", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d942c967-d06b-4616-ba81-6e0c2f20df02"}, {"Element": "<span lang=\"EN-GB\">Tel: +371 67323666</span>", "ID": "f1ef166d-a9c7-4738-9b51-e69f49dc99ab", "Styles": "None", "Classes": "None", "Text": "Tel: +371 67323666", "ParentId": "4db93ea3-03da-472a-9150-48b4a001f562"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "35f6d640-9f3a-4714-8b53-dc19b1e4356b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d942c967-d06b-4616-ba81-6e0c2f20df02"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b5294e2b-15e4-4958-bb54-43e881fa77cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "35f6d640-9f3a-4714-8b53-dc19b1e4356b"}, {"Element": "<td style=\"width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt\" valign=\"top\" width=\"274\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva UK\n  Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+44 1977628500</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "f3712b8f-a52c-4dc5-a373-a4e8c0db3416", "Styles": "width:2.85in;padding:0in 5.4pt 0in 5.4pt;\n  height:40.65pt", "Classes": "None", "Text": "     ", "ParentId": "e1534b8c-f0fa-4228-96d3-0bd198867e2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>", "ID": "71837368-303c-404c-97a5-1ef603902544", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f3712b8f-a52c-4dc5-a373-a4e8c0db3416"}, {"Element": "<b><span lang=\"EN-GB\">United\n  Kingdom</span></b>", "ID": "5b4feb0e-5f1a-471e-940a-f3428d7fa37d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "71837368-303c-404c-97a5-1ef603902544"}, {"Element": "<span lang=\"EN-GB\">United\n  Kingdom</span>", "ID": "73301cfb-9495-4bdb-ad74-8c17fcb4f1c4", "Styles": "None", "Classes": "None", "Text": "United   Kingdom", "ParentId": "5b4feb0e-5f1a-471e-940a-f3428d7fa37d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Teva UK\n  Limited</span></p>", "ID": "6dbf2c31-6920-40e4-96ed-c1c080ec2dcb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f3712b8f-a52c-4dc5-a373-a4e8c0db3416"}, {"Element": "<span lang=\"EN-GB\">Teva UK\n  Limited</span>", "ID": "b2d8d05f-e98b-4c3f-bc63-cd6614c67221", "Styles": "None", "Classes": "None", "Text": "Teva UK   Limited", "ParentId": "6dbf2c31-6920-40e4-96ed-c1c080ec2dcb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+44 1977628500</span></p>", "ID": "88d9908e-ac7b-4010-91bf-97ed841635cb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f3712b8f-a52c-4dc5-a373-a4e8c0db3416"}, {"Element": "<span lang=\"EN-GB\">Tel: </span>", "ID": "4e8e8d44-1448-403d-b314-8ca8519a1300", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "88d9908e-ac7b-4010-91bf-97ed841635cb"}, {"Element": "<span lang=\"EN-GB\">+44 1977628500</span>", "ID": "d1a9a843-facb-491a-b894-38286ff9ca73", "Styles": "None", "Classes": "None", "Text": "+44 1977628500", "ParentId": "88d9908e-ac7b-4010-91bf-97ed841635cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "90ab83a9-3346-49cd-8723-3cb597736ff4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f3712b8f-a52c-4dc5-a373-a4e8c0db3416"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6f76014d-750e-4391-98e8-5d51cf90e029", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "90ab83a9-3346-49cd-8723-3cb597736ff4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d4f83a2f-e089-4fbd-bc26-30630292da6a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ed48bd3c-55fc-4987-9425-26a1a26d27f9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d4f83a2f-e089-4fbd-bc26-30630292da6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">This leaflet was last revised in </span></b><span lang=\"EN-GB\">{MM/YYYY}.</span></p>", "ID": "44d381ec-9c3b-442e-bcfa-47d724e10cb5", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<b><span lang=\"EN-GB\">This leaflet was last revised in </span></b>", "ID": "0d3479b1-146f-4029-8505-d293712f0e3a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "44d381ec-9c3b-442e-bcfa-47d724e10cb5"}, {"Element": "<span lang=\"EN-GB\">This leaflet was last revised in </span>", "ID": "af719896-99e5-4923-99d9-3ff63564713a", "Styles": "None", "Classes": "None", "Text": "This leaflet was last revised in ", "ParentId": "0d3479b1-146f-4029-8505-d293712f0e3a"}, {"Element": "<span lang=\"EN-GB\">{MM/YYYY}.</span>", "ID": "15f7b22b-3bfd-4019-92ae-2ba4efef9984", "Styles": "None", "Classes": "None", "Text": "{MM/YYYY}.", "ParentId": "44d381ec-9c3b-442e-bcfa-47d724e10cb5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d3fc21db-3e60-4379-82c9-c00641fa2d91", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da0a0ff3-f473-46ce-9617-9359305cef5c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d3fc21db-3e60-4379-82c9-c00641fa2d91"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span><u><span lang=\"EN-GB\" style=\"color:blue\"> </span></u></p>", "ID": "a0e1991f-5920-459d-8846-de442899c088", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45ba5ec-8ab4-4b6e-beb4-59e5e871f040"}, {"Element": "<span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency </span>", "ID": "ad176173-a19c-4e41-8ab3-9744b66b1067", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency ", "ParentId": "a0e1991f-5920-459d-8846-de442899c088"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span>", "ID": "671341a0-9f5e-408a-8d57-48b23e726cce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a0e1991f-5920-459d-8846-de442899c088"}, {"Element": "<a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a>", "ID": "36cd7da5-f422-4c8d-b036-856a7544f9ed", "Styles": "None", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "671341a0-9f5e-408a-8d57-48b23e726cce"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:blue\"> </span></u>", "ID": "8ebfb9fc-3a15-4be3-8129-005853808611", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a0e1991f-5920-459d-8846-de442899c088"}, {"Element": "<span lang=\"EN-GB\" style=\"color:blue\"> </span>", "ID": "0224dd2e-f6e8-4c50-a6b9-ca6d75a6baad", "Styles": "color:blue", "Classes": "None", "Text": " ", "ParentId": "8ebfb9fc-3a15-4be3-8129-005853808611"}]}